Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

    0k5k10k15k20k25k30k35k40k↑ Number of records−4,000−3,000−2,000−1,00001,0002,0003,0004,0005,000Measured value →

          Number of people
          
104 763 (51.32% female)
          
          People with ≥2 records
          52.40%

          Median duration from first to last measurement
          2.25 years

Coding

Definition

OMOP Concept ID: 3029187— open in OHDSI Athena.
Part of collection: Natriuretic peptide.B prohormone N-Terminal with 1 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029187	p-probnp	ng/l (ng/l)	86654	251889	0.22%
3029187	p-probnp	— (—)	28113	49832	100.00%	Distribution not available
3029187	s-probnp	ng/l (ng/l)	1295	1508	0.00%
3029187	b-probnp	ng/l (ng/l)	591	1338	0.00%
3029187	p-pbnp-lb	ng/l (ng/l)	582	1239	0.00%
3029187	b-ntprobnp	ng/l (ng/l)	453	910	0.00%
3029187	p-ntprobnp	ng/l (ng/l)	400	1396	0.00%
3029187	p-probnp(ksks)	ng/l (ng/l)	283	541	0.00%
3029187	b-ntprobnp	— (—)	263	441	100.00%	Distribution not available
3029187	p-pro-bnp	ng/l (ng/l)	243	634	0.00%
3029187	s-probnp	— (—)	186	189	100.00%	Distribution not available
3029187	p-pbnp-o	ng/l (ng/l)	165	223	0.00%
3029187	p-probnp(k	ng/l (ng/l)	145	199	0.00%
3029187	b-probnp	— (—)	143	175	100.00%	Distribution not available
3029187	p-pbnp-lb	— (—)	141	174	100.00%	Distribution not available
3029187	p-ntprobnp	— (—)	98	196	100.00%	Distribution not available
3029187	b-probnp-o	ng/l (ng/l)	82	115	0.00%
3029187	p-probnpvt	ng/l (ng/l)	75	161	0.00%
3029187	p-prbnpvt	ng/l (ng/l)	72	82	0.00%
3029187	p-probnp(ksks)	— (—)	62	67	100.00%	Distribution not available
3029187	p-probnp(pika)	ng/l (ng/l)	61	103	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	ng/l (ng/l)	54	66	0.00%
3029187	p-vprobnp	ng/l (ng/l)	46	109	0.00%
3029187	b-probnp-o	— (—)	40	57	100.00%	Distribution not available
3029187	b-probnpo	ng/l (ng/l)	38	44	9.09%
3029187	p-pbnp-o	— (—)	33	36	100.00%	Distribution not available
3029187	p-prbnpvt	— (—)	31	45	100.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)	ng/l (ng/l)	25	29	0.00%
3029187	p-pro-bnp	— (—)	22	23	100.00%	Distribution not available
3029187	p-probnp-pika	ng/l (ng/l)	19	22	0.00%	Distribution not available
3029187	p-probnpvt	— (—)	19	24	100.00%	Distribution not available
3029187	p-probnp(	ng/l (ng/l)	19	22	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropepti(ko)	ng/l (ng/l)	15	15	0.00%
3029187	-bnp	ng/l (ng/l)	15	43	0.00%
3029187	p-prbnp-vt	ng/l (ng/l)	14	15	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)(pi)	ng/l (ng/l)	14	14	0.00%
3029187	-probnppoc	ng/l (ng/l)	14	17	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	ng/l (ng/l)	12	12	0.00%
3029187	nt-probnp	ng/l (ng/l)	11	14	0.00%
3029187	p-probnp(pi)	ng/l (ng/l)	11	11	0.00%
3029187	p-probnp(pika)	— (—)	11	14	100.00%	Distribution not available
3029187	s-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	ng/l (ng/l)	10	10	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	— (—)	10	11	100.00%	Distribution not available
3029187	p-probnp-pika	— (—)	9	12	100.00%	Distribution not available
3029187	p-probnpviitasaari	ng/l (ng/l)	9	10	0.00%	Distribution not available
3029187	p-probnpv	ng/l (ng/l)	9	13	0.00%	Distribution not available
3029187	b-pbnp-pt	ng/l (ng/l)	9	9	0.00%	Distribution not available
3029187	probnp	ng/l (ng/l)	9	25	0.00%
3029187	p-probnp(k	— (—)	8	8	100.00%	Distribution not available
3029187	natriureettinenpeptidi(p-probnp)	— (—)	8	8	100.00%	Distribution not available
3029187	p-probnp-o	ng/l (ng/l)	7	8	0.00%	Distribution not available
3029187	ps-probnp	ng/l (ng/l)	7	10	0.00%	Distribution not available
3029187	natriureettinenpeptidi(p-probnp)	ng/l (ng/l)	6	6	0.00%
3029187	p-probnp-p	ng/l (ng/l)	6	7	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)	— (—)	6	6	100.00%	Distribution not available
3029187	p-probnpv	— (—)	5	7	100.00%	Distribution not available	Distribution not available
3029187	p-probnp(	— (—)	5	5	100.00%	Distribution not available	Distribution not available
3029187	p-pbnp-hy	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropepti(ko)	— (—)	5	5	100.00%	Distribution not available

Cohort

Number of people: 104 763 (51.32% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

People with ≥2 records: 52.40%
Median number of measurements per person: 2.0
Median duration from first to last measurement: 2.25 years

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Reference range

N people

N records

—

85774

216600

0-900/50-75v

3875

10055

<486/miehetyli75

2698

6615

<376/miehet65-74

2400

5895

<738/naisetyli75

2346

5397

<229/Miehetyli65V

2279

4465

0-1800/yli75v

2098

5064

<301/naiset65-74

1944

4215

<352/Naisetyli65V

1687

3166

0-486

1615

3699

0-738

1405

2968

Alle125ng/l,katsoohjekirja/kaikki

1360

3558

0-241

1308

2784

<194/Miehet50-65V

1275

4532

<210/miehet55-64

1079

2462

0-285

1026

2222

<222/Naiset50-65V

959

2464

<287/naiset55-64

892

1804

0-161

755

1620

<155/Naisetalle50V

746

2191

<84/Miehetalle50V

710

3085

0-247

649

1427

<194/miehet50-65v

620

1186

0-450/alle50v

585

1460

<486/miehetyli74v

579

1076

<222/naiset50-65v

521

839

<738/naisetyli74v

493

852

<249/naiset45-54

491

960

<130/naiset18-44

485

941

0-116

481

1187

<241/miehet65-74v

443

824

<121/miehet45-54

403

906

<285/naiset65-74v

401

634

0-169

381

765

0-84

347

772

0-63

282

841

<86/miehet18-44

253

594

<247/naiset55-64v

216

345

<161/miehet55-64v

203

396

<155/naisetalle50v

190

318

<84/miehetalle50v

154

224

<116/naisetalle45v

143

251

<169/naiset45-54v

102

158

<84/miehet45-54v

155

<63/miehetalle45v

121

<194

<222

<155

katsoohjekirjastakohtaTulkinta/kaikki

<84

Value range per person

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10293

72106

1.63

323.01

3.5

2.9

1951.18

1375.77

ng/l

19.35

8857

61639

COPD, hospital admissions

8665

50506

1.76

321.79

4.1

3.0

2090.27

1649.31

ng/l

10.66

7669

43774

COPD related to multimorbidity

7656

43550

1.84

318.30

4.3

3.1

2298.44

1726.60

ng/l

13.63

6800

37827

Benign neoplasms

15708

64661

1.47

316.13

3.2

2.9

1507.56

1369.28

ng/l

2.34

13348

54544

Transplanted organ and tissue status

1729

7186

3.55

315.93

7.8

2.5

4380.70

1075.46

ng/l

25.89

1641

5994

Depression or dysthymia

12039

47697

1.56

313.77

3.1

3.0

1135.89

1400.43

ng/l

8.79

9958

41212

COPD, early/later onset

8688

50825

1.75

312.37

4.0

3.0

2118.34

1645.71

ng/l

11.32

7684

44048

Gonarthrosis, primary, with knee surgery

10439

60975

1.65

310.61

3.1

3.0

1380.65

1587.38

ng/l

4.61

8978

52764

Benzodiazepine use

17141

85982

1.58

307.65

3.1

2.9

1305.13

1410.17

ng/l

2.19

14231

73176

ILD medications: immunosuppressive drugs

10144

60118

1.87

307.65

4.1

2.6

1683.35

1133.82

ng/l

15.70

8938

50424

Autoimmune diseases excluding thyroid diseases, strict definition

16857

67458

1.52

307.65

3.2

2.9

1742.96

1325.67

ng/l

16.27

14567

56883

Sleep disorders (combined)

19812

74603

2.12

307.65

3.3

2.8

1083.11

1378.86

ng/l

16.48

16283

63965

Spondylopathies

15788

58604

1.95

307.65

3.1

2.9

1211.27

1541.92

ng/l

18.09

13600

49877

Implicit bacterial Sepsis

8695

44286

2.49

307.65

4.9

2.9

3188.02

1454.99

ng/l

76.19

7802

38012

Congenital malformations of heart and great arteries

2644

8895

4.61

307.65

4.9

3.0

1034.07

1220.99

ng/l

1.64

2415

7422

Coronary atherosclerosis

17042

51293

3.23

307.65

3.9

2.6

1872.80

1099.30

ng/l

57.12

15386

43100

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

4159

22723

2.36

307.65

3.5

2.8

969.15

1007.78

ng/l

0.33

3418

19550

Hyperlipidaemia, other/unspecified

8716

44830

2.61

307.65

3.7

2.8

1910.05

1417.75

ng/l

11.52

7608

38500

Asthma, unspecified (mode)

11361

41273

2.85

307.65

3.6

2.4

1328.11

1077.56

ng/l

8.74

9799

34701

Diseases of arteries, arterioles and capillaries (FINNGEN)

5987

9180

7.70

307.65

3.8

1.5

2438.25

374.37

ng/l

76.39

5431

7119

Cardiomyopathy (excluding other)

3910

9889

11.27

307.65

8.3

1.9

2672.72

637.25

ng/l

88.11

3742

8057

Oxycodone

7094

39466

2.25

307.65

3.8

2.8

1820.75

1550.71

ng/l

3.54

6311

33852

Concussion

7946

38655

2.05

307.65

3.2

2.8

1424.01

1290.95

ng/l

1.75

6625

32885

Non-rheumatic valve diseases

14914

30078

7.82

307.65

4.4

1.8

1875.85

605.84

ng/l

148.05

13718

24375

Viral Sepsis

3964

19735

2.89

307.65

5.2

2.9

2742.07

1432.69

ng/l

20.68

3546

16848

Other diseases of urinary system

17214

70503

1.51

307.65

3.2

2.9

1610.70

1339.63

ng/l

8.42

14626

60015

Explicit Sepsis

8373

47322

2.15

307.65

4.3

2.8

3235.99

1392.60

ng/l

70.55

7541

40404

Parasetamol

14748

38050

2.30

307.65

3.2

2.6

1472.39

1201.35

ng/l

6.96

12416

31678

Pacemaker

8998

41641

3.95

307.65

5.9

3.0

2488.23

1833.24

ng/l

23.34

8284

35934

Renal tubulo-interstitial diseases

17508

76728

2.16

307.65

4.2

2.7

3086.21

994.63

ng/l

208.67

15492

64811

Other soft tissue disorders, not elsewhere classified

17557

62516

2.05

307.65

3.2

2.9

1373.64

1450.35

ng/l

1.08

14773

52903

Venous thromboembolism

10742

65822

1.97

307.65

3.5

3.0

1520.30

1585.85

ng/l

0.63

9499

56376

Iron deficiency anaemia

7714

47421

1.99

307.65

4.5

3.0

2454.47

1562.87

ng/l

29.41

6758

40560

Implicit Sepsis

16321

67985

2.46

307.65

4.3

2.7

2363.43

1192.37

ng/l

94.82

14368

57674

Oral corticosteroids

22487

74912

2.23

307.65

3.8

2.7

1425.47

1361.29

ng/l

1.09

19580

62873

Other septicaemia

7310

42382

2.18

307.65

4.3

2.9

3353.54

1448.39

ng/l

62.08

6600

36270

Other systemic involvement of connective tissue (FG)

4698

26413

2.23

307.65

3.4

2.8

1239.73

1442.25

ng/l

3.44

4097

22471

Sleep apnoea, including avohilmo

19238

73035

2.08

307.65

3.3

2.8

1045.85

1375.18

ng/l

20.44

15830

62727

Aortic aneurysm

4857

27506

2.40

307.65

3.7

3.1

1923.22

1686.33

ng/l

2.15

4372

23763

Thoracic aortic aneurysm

3135

14786

3.76

307.65

3.6

3.0

1423.52

1355.40

ng/l

0.37

2841

12823

Bacterial Sepsis

9794

48576

2.43

307.65

4.8

2.8

3094.17

1405.55

ng/l

86.07

8774

41607

20205

75176

1.57

307.65

3.6

2.7

1553.93

1346.45

ng/l

6.71

17178

63712

Rotator cuff syndrome

10710

55450

1.63

307.65

3.0

2.9

1093.92

1442.65

ng/l

16.24

9264

47491

Other diseases of pleura

9251

51181

2.06

307.65

4.5

3.0

2344.75

1656.37

ng/l

22.25

8343

44187

Other pulmonary diagnosis

14639

44002

1.90

307.65

3.3

2.4

1399.18

1052.04

ng/l

14.27

12471

36856

Asthma

15479

43590

2.28

307.65

3.4

2.4

1111.11

1053.83

ng/l

0.93

13254

36503

COPD/asthma/ILD related infections

18966

62460

1.71

307.65

3.5

2.6

1601.32

1103.11

ng/l

30.30

16285

52549

Condition for Implicit Sepsis (Organ dysfunction codes)

18155

71519

2.34

307.65

4.1

2.7

2119.32

1113.80

ng/l

84.63

15863

60353

Amiodarone users

2496

11052

4.82

307.65

7.9

3.1

2398.86

1682.73

ng/l

10.04

2373

9611

Septicaemia

8214

46388

2.19

307.65

4.3

2.9

3268.24

1418.66

ng/l

69.91

7406

39667

Certain infectious and parasitic diseases

17627

59385

1.65

307.65

3.4

2.6

1632.80

1066.21

ng/l

37.71

15136

49779

Other arthrosis

8990

43216

1.71

307.65

3.0

2.9

1186.68

1373.33

ng/l

3.47

7679

36978

Implicit viral Sepsis

3960

19710

2.89

307.65

5.2

2.9

2744.97

1433.94

ng/l

20.69

3542

16830

Congenital malformations of aortic and mitral valves

1029

2796

9.14

307.65

5.2

3.1

795.68

1196.26

ng/l

2.84

961

2352

Obesity related asthma

6772

32753

2.89

307.65

3.7

2.8

1100.22

1266.73

ng/l

2.51

5758

27860

Asthma, hospital admission 2, infections

10860

61854

2.10

307.65

3.9

2.9

1432.70

1533.61

ng/l

1.45

9424

52337

Diseases of arteries, arterioles and capillaries

14251

65060

2.09

307.65

3.9

2.9

2581.48

1377.12

ng/l

73.88

12811

55674

Other headache syndromes

6459

38953

1.92

307.65

2.8

2.7

879.33

1271.20

ng/l

13.75

5398

33077

Asthma, hospital admissions , main diagnosis only

14350

83620

1.76

307.65

3.5

2.9

1170.49

1425.04

ng/l

11.32

12279

70608

Any operation in hilmo

603

367

9.56

307.65

3.1

1.3

1443.90

471.44

ng/l

5.20

491

281

Arthropathies

14104

50869

1.53

307.65

3.0

2.9

1423.18

1342.99

ng/l

0.92

11836

42768

Other antidepressants

18231

67333

1.56

307.65

3.1

3.0

1242.20

1493.31

ng/l

11.66

15142

57760

Excluding asthma or asthma-COPD overlap

14599

44002

1.89

307.65

3.3

2.4

1376.71

1052.04

ng/l

12.76

12451

36856

Asthma, hospital admissions 3, pneumonia

6999

40340

2.22

307.65

4.3

3.0

1741.53

1758.17

ng/l

0.10

6210

34472

Asthma (mode)

14872

43906

2.21

307.65

3.3

2.4

1093.21

1054.63

ng/l

0.52

12695

36776

Shoulder lesions

14045

58294

1.68

307.65

3.0

2.9

1110.00

1453.26

ng/l

19.47

12039

49727

Malaise and fatigue

10654

44983

2.60

307.65

3.8

2.7

1971.60

1428.12

ng/l

19.04

9158

38238

Biguanides

17674

72350

1.73

307.65

3.2

2.8

1548.42

1282.26

ng/l

11.10

14846

61662

Any reimbursement code in KELA

8367

19039

2.49

307.65

3.2

1.9

1085.46

505.65

ng/l

29.09

6953

14792

Depression medications

3544

4076

4.98

307.65

2.8

1.3

761.90

251.57

ng/l

13.04

2779

2950

Asthma-related pneumonia or sepsis

6999

40340

2.22

307.65

4.3

3.0

1741.53

1758.17

ng/l

0.10

6210

34472

Pneumonia, organism unspecified

18393

73723

2.23

307.65

4.0

2.7

2054.97

1090.11

ng/l

85.95

16235

61846

Calcific aortic valvular stenosis, operated

8059

38029

3.90

307.65

4.4

3.1

2514.86

1885.98

ng/l

14.89

7487

32778

Coxarthrosis

9601

41750

1.85

307.65

3.2

2.9

1539.86

1502.43

ng/l

0.31

8375

35855

Valvular heart disease excluding rheumatic fever

15028

30174

7.89

307.65

4.5

1.8

1872.87

605.00

ng/l

149.54

13828

24454

Asthma (only as main-diagnosis)

13734

43590

2.28

307.65

3.4

2.4

1135.75

1053.83

ng/l

1.49

11715

36503

Hypothyroidism and >3 levothyroxin purchases

3346

3924

5.77

307.65

3.2

1.3

824.37

259.51

ng/l

11.95

2669

2883

Disorders of gallbladder, biliary tract and pancreas

17417

79661

1.58

307.65

3.2

2.9

1549.70

1382.50

ng/l

3.92

14896

67858

Abdominal and pelvic pain

17765

63050

1.56

307.65

3.2

2.9

1343.90

1405.96

ng/l

0.85

14976

53547

Type 2 diabetes

18797

68981

1.90

307.65

3.4

2.7

1724.02

1162.22

ng/l

33.90

15914

58364

Neurological diseases, wide definition

4434

9422

2.67

307.65

3.3

2.5

1220.88

972.46

ng/l

2.51

3588

7873

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

20879

69889

2.61

307.65

4.3

2.5

1773.95

1129.81

ng/l

48.06

18475

58335

Cholelithiasis

14579

74318

1.54

307.65

3.1

2.9

1498.68

1424.06

ng/l

0.99

12333

63478

Nonischemic cardiomyopathy

1666

4373

13.30

307.65

7.8

2.4

1921.11

1135.50

ng/l

7.93

1601

3615

Other/unspecified dorsalgia

6163

38402

1.86

307.65

3.3

2.9

1178.71

1533.30

ng/l

10.98

5217

32530

Conductive and sensorineural hearing loss

14622

71081

1.64

307.65

3.2

3.0

1465.13

1476.14

ng/l

0.10

12425

61037

Congenital malformations of the circulatory system

2710

10126

3.85

307.65

4.8

3.0

964.74

1218.46

ng/l

2.94

2463

8480

Cardiomyopathy, other and unspecified

2290

5507

12.06

307.65

7.7

1.8

2401.38

606.84

ng/l

39.20

2158

4485

Coronary artery bypass grafting

6061

25418

2.56

307.65

4.2

2.7

2711.87

1418.50

ng/l

44.70

5598

21626

Bacterial infection, other or unspecified

11032

56640

2.30

307.65

4.2

2.8

2835.93

1302.32

ng/l

76.27

9836

48309

AV-block

4621

13556

5.91

307.65

5.3

1.9

2426.37

782.51

ng/l

69.32

4227

11122

Asthma, excluding more controls

14829

37262

2.58

307.65

3.3

1.9

1071.13

647.98

ng/l

34.17

12682

30581

Used for control exclusion in common control thyroid runs

17583

64906

1.49

307.65

3.3

2.9

1538.38

1332.11

ng/l

5.83

14914

54715

Headache

10653

52751

1.94

307.65

3.1

2.6

978.28

1154.21

ng/l

5.03

8882

44166

Hypertensive diseases

15752

41818

2.66

307.65

3.3

2.4

1497.39

835.37

ng/l

36.16

13456

34582

Obesity due to excess calories

8607

41373

2.72

307.65

3.6

2.8

1234.29

1115.75

ng/l

1.67

7078

35085

Other nutritional deficiencies

11859

60595

2.39

307.65

3.5

2.8

1239.04

1157.34

ng/l

1.16

9824

51318

Dizziness and giddiness

14449

72421

1.95

307.65

3.3

2.9

1391.82

1443.89

ng/l

0.67

12349

61847

Cough

7145

35458

2.38

307.65

3.3

2.5

1234.00

1355.79

ng/l

1.46

6068

30027

Abnormal findings on diagnostic imaging of lung

9147

59026

1.86

307.65

3.8

3.0

1608.67

1604.79

ng/l

0.03

8133

50909

Cerebrovascular diseases

13752

70188

1.63

307.65

3.5

3.0

2021.14

1395.68

ng/l

30.67

12047

60218

Other and unspecified iron deficiency

5949

35731

2.09

307.65

4.3

3.0

2398.73

1564.25

ng/l

21.31

5189

30637

Other and unspecified anaemias

8364

50387

2.06

307.65

4.2

3.0

2782.07

1649.78

ng/l

44.08

7479

43378

Acute bronchitis

7297

44925

1.90

307.65

4.2

3.0

1869.75

1645.54

ng/l

3.11

6234

38269

Dyspnoea

23651

75068

3.63

307.65

4.0

2.7

1619.86

1351.47

ng/l

12.29

20595

63455

Gout, idiopatic and unspecified

4825

29471

2.23

307.65

5.0

3.1

3272.85

1653.18

ng/l

38.06

4316

25576

Complications of medical and surgical care

12902

81971

1.74

307.65

3.5

2.9

1892.31

1355.31

ng/l

21.63

11091

69870

Diseases of the musculoskeletal system and connective tissue

8147

26007

1.71

307.65

3.0

2.8

1347.19

1391.39

ng/l

0.32

6736

21821

Oedema, not elsewhere classified

6754

32388

2.94

307.65

3.8

2.7

1780.54

1433.98

ng/l

4.74

5867

27603

Other heart diseases

14205

15228

10.87

307.65

4.4

1.5

1402.99

308.57

ng/l

97.37

12805

11451

Other acute lower respiratory infections

9132

56405

1.79

307.65

4.2

3.0

1871.24

1564.99

ng/l

6.09

7831

47856

Abnormalities of breathing

21682

48709

3.58

307.65

3.7

2.5

1422.38

1336.44

ng/l

1.48

18496

40826

Other disorders of fluid, electrolyte and acid-base balance

6239

32656

2.53

307.65

4.2

2.9

2679.83

1467.40

ng/l

39.58

5512

27860

Fever of other and unknown origin

10494

52032

2.31

307.65

4.0

2.7

1957.72

1332.29

ng/l

18.33

9246

43994

Haemorrhage from respiratory passages

7126

32555

2.73

307.65

4.2

2.6

2096.05

1617.49

ng/l

9.91

6249

27857

Sensorineural hearing loss

14101

69129

1.65

307.65

3.2

3.0

1475.16

1501.78

ng/l

0.28

11985

59492

Symptoms and signs involving cognition, perception, emotional state and behaviour

18507

79721

1.92

307.65

3.2

2.9

1405.68

1372.81

ng/l

0.39

15675

67720

Other neurological diseases

13358

74042

1.69

307.65

3.4

3.0

1664.80

1502.86

ng/l

3.12

11684

63345

Abnormalities of heart beat

7531

31036

3.36

307.65

3.6

2.5

1378.91

1457.45

ng/l

0.78

6390

26241

Hypertensive heart and/or renal disease

6420

21130

3.78

307.65

4.6

2.6

3162.56

1200.83

ng/l

81.47

5780

17988

Pain, not elsewhere classified

4463

23857

2.29

307.65

3.4

2.6

1238.54

1230.48

ng/l

0.04

3862

20151

COPD (mode)

6705

28300

2.56

307.65

4.0

2.5

2145.50

1283.48

ng/l

25.20

5934

24219

Coxarthrosis [arthrosis of hip](FG)

10409

49604

1.80

307.65

3.2

2.8

1523.19

1464.17

ng/l

0.63

9099

42443

Benign neoplasm: Colon

9251

45439

1.91

307.65

3.5

3.0

1716.60

1417.04

ng/l

5.15

8072

38781

Bicuspidal aortic valve syndrome

893

2556

8.68

307.65

4.0

3.1

804.69

1207.86

ng/l

2.43

829

2161

Ischemic heart diseases

19345

56130

3.15

307.65

3.7

2.5

1665.06

1045.61

ng/l

44.47

17353

46975

Ischaemic heart disease, wide definition

19229

55591

3.19

307.65

3.7

2.5

1657.99

1049.08

ng/l

43.66

17248

46563

Follow-up examination after treatment for conditions other than malignant neoplasms

7161

28880

1.83

307.65

3.0

2.6

1317.02

1393.72

ng/l

0.65

6015

24438

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

17994

68927

1.86

307.65

3.3

2.7

1797.23

1169.27

ng/l

36.73

15232

58333

Pain in throat and chest

19487

48045

3.29

307.65

3.3

2.5

1234.24

1341.95

ng/l

2.19

16549

40329

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6046

13402

2.58

307.65

3.1

2.3

1266.80

1018.17

ng/l

3.56

4992

11114

Symptoms and signs involving the urinary system

14364

73808

1.76

307.65

3.3

3.0

1799.53

1408.58

ng/l

13.67

12269

63096

Symptoms and signs involving the digestive system and abdomen

17838

63060

1.56

307.65

3.3

2.9

1419.14

1406.83

ng/l

0.11

15078

53557

Finngen Rheumatological endpoints

17154

61627

1.80

307.65

3.1

2.8

1402.87

1301.90

ng/l

1.63

14595

51658

First line medication for Crohn's disease

21682

69510

1.99

307.65

3.7

2.6

1484.82

1318.04

ng/l

4.41

18726

58063

Acute tubulo-interstitial nephritis

10874

63634

1.76

307.65

3.6

2.8

2305.30

1086.26

ng/l

73.53

9462

54027

Symptoms and signs involving the circulatory and respiratory systems

20604

48801

2.57

307.65

3.3

2.5

1274.30

1334.87

ng/l

0.93

17285

40888

18270

62438

2.24

307.65

3.8

2.6

1954.26

1103.47

ng/l

66.63

16110

52530

COPD differential diagnosis

14469

43917

1.87

307.65

3.3

2.4

1384.30

1054.58

ng/l

12.89

12347

36785

Anaemias

3982

3772

9.33

307.65

4.1

1.4

1909.50

282.84

ng/l

41.80

3441

2796

Benign neoplasm of colon, rectum, anus and anal canal

11375

72380

1.67

307.65

3.4

3.0

1701.31

1504.02

ng/l

3.30

9927

62321

Renal failure

9811

50678

2.47

307.65

5.3

3.0

5046.54

1334.73

ng/l

217.87

8940

43618

Angina pectoris

13988

48159

2.79

307.65

3.8

2.6

1754.82

1129.17

ng/l

33.91

12539

40571

Dorsalgia

18122

61896

1.80

307.65

3.1

2.9

1167.45

1501.40

ng/l

17.94

15348

52256

Covid-19 confirmed case

5225

27966

2.44

307.65

4.3

3.0

1930.51

1496.45

ng/l

7.01

4705

23844

7556

41663

2.18

307.65

3.9

2.9

1219.17

1429.18

ng/l

4.99

6478

35034

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

19448

77835

2.13

307.65

3.9

2.7

1998.31

1096.07

ng/l

79.86

17163

65244

Artificial joint operation, meniscal resection

15951

79355

1.49

307.65

3.0

1249.65

1471.07

ng/l

7.84

13656

67783

Autoimmune diseases excluding thyroid diseases

17414

69294

1.53

307.65

3.2

2.9

1723.37

1321.87

ng/l

16.27

15049

58452

Gastro-oesophageal reflux disease

12609

70329

1.89

307.65

3.1

2.9

1272.71

1351.77

ng/l

0.97

10373

60135

Disorders of eyelid, lacrimal system and orbit

14457

81352

1.57

307.65

3.1

3.0

1299.61

1452.96

ng/l

4.03

12311

69406

Asthma (only as main-diagnosis), excluding more controls

13271

37262

2.58

307.65

3.4

1.9

1084.89

647.98

ng/l

33.91

11328

30581

Codes for special purposes

7295

42461

2.05

307.65

4.0

2.9

1719.42

1345.86

ng/l

7.78

6515

35799

Type 2 diabetes, definitions combined

18036

67842

1.85

307.65

3.4

2.7

1526.21

1172.98

ng/l

18.64

15243

57526

Lower back pain or/and sciatica

18387

84566

1.72

307.65

3.1

2.9

1158.91

1422.46

ng/l

12.94

15603

71641

Injuries to the head

18289

85512

1.53

307.65

3.2

2.9

1614.37

1328.52

ng/l

12.25

15480

72409

Senile cataract

11668

49188

1.72

307.65

3.4

2.8

1875.87

1220.47

ng/l

26.72

10119

42234

Bronchitis

17833

84804

1.52

307.65

3.7

2.8

1619.26

1350.26

ng/l

10.03

15178

71778

Left ventricular outflow tract obstruction (LVOTO), broad definition

2533

7804

7.04

307.65

4.7

3.0

1158.30

1102.35

ng/l

0.25

2338

6552

Cardiodefibrillation

9067

46260

3.27

307.65

4.8

3.0

2071.29

1592.14

ng/l

21.31

8335

39978

Other diseases of intestines

18879

69949

1.78

307.65

3.2

2.8

1398.21

1318.99

ng/l

1.24

16015

58951

Complications of procedures, not elsewhere classified

14277

81027

1.76

307.65

3.4

2.9

1863.01

1299.41

ng/l

24.89

12361

68659

Cardiovascular diseases (excluding rheumatic etc)

12086

17336

5.19

307.65

3.5

1.5

1000.00

291.66

ng/l

50.31

10205

12877

Conduction disorders

7833

20868

5.68

307.65

5.0

1.8

2068.47

694.26

ng/l

101.08

7049

17016

Complications of surgical and medical care, not elsewhere classified

18774

83280

1.91

307.65

3.4

2.9

1840.18

1304.34

ng/l

30.30

16242

70450

Disorders of choroid and retina

14709

75260

1.64

307.65

3.3

3.0

2117.84

1378.67

ng/l

37.33

12682

64418

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

20234

80669

2.23

307.65

4.0

2.7

2089.45

1189.57

ng/l

85.06

17761

67963

Pain in joint

9506

39944

1.77

307.65

2.9

2.8

1112.96

1349.85

ng/l

5.73

7895

34024

Left bundle-branch block

1840

5286

8.06

307.65

5.0

1.8

1648.94

660.76

ng/l

23.58

1664

4317

Other diseases of pericardium

1031

2844

7.89

307.65

5.2

1.8

2096.03

586.04

ng/l

8.11

972

2326

Other anaemias

8443

50752

2.05

307.65

4.2

3.0

2771.23

1648.49

ng/l

44.07

7551

43692

Coronary angioplasty

7770

34642

2.28

307.65

4.1

2.7

2307.45

1294.13

ng/l

34.57

6946

29400

All pneumoniae

19922

77650

2.14

307.65

3.9

2.7

1973.74

1082.27

ng/l

79.68

17563

64980

Spinal stenosis

10516

50702

2.04

307.65

3.3

3.0

1343.69

1653.23

ng/l

12.09

9183

43580

Hernia

16233

77790

1.58

307.65

3.2

2.9

1487.21

1364.22

ng/l

2.36

13917

65770

Atrial fibrillation and flutter

9282

11291

9.97

307.65

4.4

1.5

1695.38

341.13

ng/l

131.11

8477

8685

Acute renal failure

4150

23264

2.51

307.65

5.7

3.0

4531.26

1333.68

ng/l

78.45

3791

20006

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

7282

14721

3.88

307.65

2.9

1.5

1139.11

301.41

ng/l

39.97

6205

11171

Arthrosis

12847

47229

1.69

307.65

3.0

2.8

1296.60

1399.51

ng/l

1.77

10936

40151

Other joint disorders

13762

50801

1.57

307.65

2.9

1221.15

1340.26

ng/l

2.24

11465

42713

Gonarthrosis,primary

16691

74748

1.61

307.65

3.1

3.0

1269.51

1505.23

ng/l

9.28

14271

64161

Diseases of the skin and subcutaneous tissue

17520

64110

1.49

307.65

3.2

2.8

1604.71

1271.17

ng/l

12.68

14873

54139

Other disorders of urethra and urinary system

12096

59830

1.73

307.65

3.2

2.8

1680.07

1410.40

ng/l

5.72

10294

50945

Type 2 diabetes, wide definition

16897

63225

2.19

307.65

3.6

2.7

1984.00

1224.06

ng/l

50.57

14598

53867

Cardiac arrhythmias

15417

26169

5.85

307.65

3.9

1.9

1337.90

466.13

ng/l

105.34

13602

20675

Myocarditis

1045

1806

10.45

307.65

9.1

1.5

1139.40

338.00

ng/l

13.93

956

1356

Polyarthropathies

13116

48263

2.18

307.65

3.7

2.9

2115.51

1378.54

ng/l

30.37

11421

40901

Syncope and collapse

9250

44365

2.37

307.65

3.7

2.8

1725.39

1457.87

ng/l

5.83

7995

37793

Influenza and pneumonia

20690

76624

2.14

307.65

3.9

2.6

1904.98

1066.42

ng/l

74.56

18184

64020

Non-allergic asthma (mode), excluding more controls

3217

15968

2.47

307.65

3.4

2.0

1194.43

753.11

ng/l

6.08

2823

13266

Asthma, unspecified (mode), excluding more controls

10996

35352

3.26

307.65

3.6

1.9

1271.79

659.38

ng/l

54.81

9481

29144

Dorsopathies

17345

62136

1.56

307.65

3.0

2.9

1167.16

1498.97

ng/l

19.83

14622

52443

Pure hypercholesterolaemia

16126

59896

2.35

307.65

3.3

2.8

1686.00

1276.03

ng/l

19.92

14075

50937

Antihypertensive medication - note that there are other indications

9355

16926

3.59

307.65

3.4

1.7

1154.35

423.63

ng/l

36.55

7737

13024

ILD differential diagnosis

14457

43906

1.87

307.65

3.3

2.4

1382.85

1054.63

ng/l

12.77

12336

36776

Non-ischemic cardiomyopathy

8879

24867

6.68

307.65

5.5

2.1

2739.13

837.65

ng/l

170.95

8304

20620

Asthma/COPD (KELA code 203)

17129

77111

1.79

307.65

3.3

2.8

1246.04

1360.05

ng/l

2.74

14689

64897

General symptoms and signs

21344

61402

2.03

307.65

3.4

2.7

1428.05

1228.85

ng/l

6.04

18221

51531

Intracranial trauma

9548

39400

2.10

307.65

3.2

2.7

1444.36

1279.48

ng/l

2.97

8026

33489

Bleeding

15935

75404

1.82

307.65

3.8

2.9

2009.82

1339.07

ng/l

40.71

13941

64220

Obesity, other/unspecified

5490

27934

2.45

307.65

3.4

2.7

1114.96

1116.01

ng/l

0.01

4553

23616

Cardiomyopathies, Primary/intrinsic

3851

9149

12.67

307.65

8.4

1.8

2657.22

658.88

ng/l

84.08

3686

7444

Other functional intestinal disorders

7829

47921

1.83

307.65

3.5

2.9

1614.70

1532.02

ng/l

0.63

6722

40979

Persons encountering health services in other circumstances, wide

22485

77237

1.71

307.65

3.3

2.9

1529.64

1361.89

ng/l

4.82

19221

65268

Cholelithiasis, broad definition with cholecystitis

15174

75253

1.55

307.65

3.2

2.9

1538.87

1417.96

ng/l

2.11

12870

64263

Type 2 diabetes, definitions combined, including avohilmo

18018

67212

1.85

307.65

3.4

2.7

1509.85

1170.91

ng/l

17.13

15190

56997

Heart failure, strict

18215

51326

5.49

307.65

6.1

2.3

3371.63

888.28

ng/l

307.65

17085

43505

Aplastic and other anaemias

9047

53603

2.04

307.65

4.3

3.0

2923.31

1620.48

ng/l

58.35

8101

46127

Unstable angina pectoris

8135

41250

2.16

307.65

4.1

2.9

2147.65

1394.25

ng/l

24.09

7338

35311

COPD/asthma related infections

18966

62460

1.71

307.65

3.5

2.6

1601.32

1103.11

ng/l

30.30

16285

52549

Paroxysmal tachycardia

5189

9476

7.41

307.65

5.3

1.5

1462.48

343.97

ng/l

93.47

4681

7295

Systemic connective tissue disorders

6388

39485

2.01

307.65

3.5

3.0

1311.56

1483.19

ng/l

2.62

5616

33684

Diabetes, varying definitions

19051

70383

1.88

307.65

3.4

2.7

1730.20

1154.15

ng/l

33.38

16147

59389

Major coronary heart disease event

16488

60835

2.49

307.65

4.0

2.8

2144.68

1196.96

ng/l

68.68

14965

51656

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3008

11889

3.48

307.65

4.6

3.0

1582.82

1258.32

ng/l

2.21

2756

9947

Disorders of thyroid, IBD co-morbidities

2884

7750

3.32

307.65

4.0

2.4

1120.16

1029.22

ng/l

0.74

2471

6588

Diabetes medication

18715

73637

1.77

307.65

3.2

2.8

1714.24

1207.59

ng/l

27.67

15767

62368

Non-invasive ventilation

2872

11380

2.84

307.65

4.3

1.9

2211.07

512.34

ng/l

47.57

2612

9324

Dentinal caries

3786

20383

2.29

307.65

4.8

2.9

2482.57

1290.53

ng/l

17.26

3353

17427

Endocrine, nutritional and metabolic diseases

13739

38847

2.04

307.65

3.2

2.5

1470.49

1003.23

ng/l

18.19

11451

32454

Artrosis, including avohilmo

14523

55459

1.60

307.65

2.9

1285.37

1492.99

ng/l

6.27

12283

47145

Tramadol

16317

55854

2.32

307.65

3.3

2.7

1471.53

1310.29

ng/l

3.03

13860

47133

Nutritional anaemias

8962

56934

1.84

307.65

4.3

3.0

2401.14

1570.03

ng/l

31.37

7870

48738

Diabetes mellitus

19103

70432

1.88

307.65

3.4

2.7

1731.97

1151.30

ng/l

33.99

16185

59434

Nerve, nerve root and plexus disorders

18683

82801

1.59

307.65

3.1

2.9

1364.44

1414.23

ng/l

0.67

15913

70262

Low back pain

13103

60478

1.95

307.65

3.2

2.9

1204.81

1476.39

ng/l

8.60

11001

51143

Other (not insulin) diabetes medications

17934

71314

1.74

307.65

3.2

2.8

1591.88

1227.64

ng/l

17.46

15052

60669

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

16988

78171

1.59

307.65

3.2

2.9

1468.46

1386.02

ng/l

1.19

14583

66421

Asthma-related infections

10860

61854

2.10

307.65

3.9

2.9

1432.70

1533.61

ng/l

1.45

9424

52337

Codeine or tramadol medication

22299

76042

1.90

307.65

3.3

2.8

1389.77

1389.10

ng/l

0.01

18973

64280

Gonarthrosis [arthrosis of knee](FG)

14496

55941

1.77

307.65

3.0

2.8

1271.40

1374.77

ng/l

1.93

12378

47492

Other specific joint derangements/joint disorders

11253

48297

1.75

307.65

2.9

2.8

1091.12

1242.97

ng/l

3.30

9347

40631

DVT of lower extremities and pulmonary embolism

8502

50973

2.16

307.65

3.6

3.0

1478.73

1665.38

ng/l

2.78

7535

43726

Provisional assignment of new diseases of uncertain etiology

7282

42398

2.05

307.65

4.0

2.9

1720.61

1345.67

ng/l

7.81

6504

35748

Cardiomyopathy

5467

13471

11.07

307.65

7.5

1.8

2540.22

675.12

ng/l

102.67

5189

10940

Other cataract

8199

40231

1.92

307.65

3.5

2.8

1887.15

1319.23

ng/l

14.56

7149

34602

Osteopathies and chondropathies

9309

60580

1.69

307.65

3.5

2.9

1766.92

1375.57

ng/l

10.02

8000

51523

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

12253

74083

1.86

307.65

3.7

2.9

1572.58

1495.37

ng/l

1.01

10794

63454

Hard cardiovascular diseases

17605

60393

2.50

307.65

3.7

2.7

1862.59

1046.61

ng/l

60.35

15736

50869

Diseases of pulp and periapical tissues

5775

34818

1.97

307.65

3.9

2.8

1822.09

1230.73

ng/l

9.00

5026

29712

Type 2 diabetes, strict (exclude DM1)

18081

68223

1.85

307.65

3.4

2.7

1529.95

1173.58

ng/l

18.96

15285

57858

Disorders of lipoprotein metabolism and other lipidaemias

18639

62701

2.44

307.65

3.3

2.7

1722.93

1246.45

ng/l

23.85

16189

53105

Hypertensive diseases (excluding secondary)

10083

15356

5.04

307.65

3.3

1.5

1308.50

300.46

ng/l

58.38

8528

11571

Other dorsopathies, not elsewhere classified

17722

61988

1.68

307.65

3.0

2.9

1158.65

1498.98

ng/l

20.08

14963

52327

Opioids

18221

57720

1.89

307.65

3.1

2.7

1410.13

1290.87

ng/l

2.29

15436

48438

Other intervertebral disc disorders

14718

60020

1.70

307.65

3.0

2.9

1044.04

1507.48

ng/l

34.93

12503

50909

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

18270

62438

2.24

307.65

3.8

2.6

1954.26

1103.47

ng/l

66.63

16110

52530

Glucagon-like peptide-1 (GLP-1) analogues

11447

57990

2.09

307.65

3.8

2.9

2284.18

1415.69

ng/l

43.99

9902

50080

Vocal cord dysfunction

2184

6788

3.86

307.65

3.3

1.8

1168.31

436.78

ng/l

13.92

1856

5561

Pneumonias (Asthma/COPD co-morbidities)

19843

77620

2.15

307.65

3.9

2.7

1969.60

1083.36

ng/l

79.35

17501

64966

Obesity and other hyperalimentation

11460

58680

2.43

307.65

3.5

2.8

1230.92

1142.47

ng/l

1.31

9476

49693

Heart failure and antihypertensive medication

8962

9759

17.44

307.65

6.7

1.8

2982.00

567.41

ng/l

166.87

8474

7878

Heart failure and bmi 25plus

10250

29394

5.03

307.65

6.1

2.3

3029.39

817.69

ng/l

231.52

9577

24423

Gout, FINNGEN

5764

36064

2.09

307.65

4.9

3.1

3187.56

1675.18

ng/l

40.43

5165

31248

Obesity

11413

58389

2.44

307.65

3.5

2.8

1231.65

1142.81

ng/l

1.31

9437

49439

Neurological diseases

14679

47204

1.74

307.65

3.1

2.8

1208.79

1420.71

ng/l

6.01

12191

40192

Statin medication

11954

36833

2.11

307.65

3.3

2.5

1486.95

973.97

ng/l

19.25

10104

30522

Other chronic obstructive pulmonary disease

8584

46074

1.94

307.65

4.0

2.9

2099.97

1658.47

ng/l

9.82

7593

39754

Myocardial infarction, strict

10646

40752

2.69

307.65

4.2

2.6

2502.39

1209.53

ng/l

69.47

9717

34460

Cardiac arrest

1224

2982

5.28

307.65

5.2

1.6

3053.95

454.37

ng/l

26.49

1116

2344

COPD

8962

47292

1.96

307.65

4.0

2.9

2088.38

1642.98

ng/l

10.44

7921

40790

Psychiatric diseases

18462

69411

1.44

307.65

3.1

2.9

1369.53

1339.79

ng/l

0.31

15463

59333

Coronary revascularization (ANGIO or CABG)

10170

38873

2.51

307.65

4.0

2.6

2339.19

1237.69

ng/l

54.03

9227

32919

Chronic kidney disease

6516

35748

2.61

307.65

5.6

3.0

6044.72

1453.63

ng/l

170.17

5979

30785

Other CVD (FINNGEN)

2496

4760

7.17

307.65

4.2

1.5

2142.27

421.64

ng/l

34.92

2196

3731

STROKE

11260

40339

2.46

307.65

3.5

2.4

1648.62

826.43

ng/l

47.92

9863

33372

Diverticular disease of intestine

14397

60290

1.92

307.65

3.3

2.9

1564.34

1425.83

ng/l

2.63

12452

51655

Cerebrovascular diseases (FINNGEN)

5891

11779

4.87

307.65

3.5

1.5

1649.51

331.49

ng/l

63.34

5117

9061

Pain in limb

15024

61242

2.14

307.65

3.3

2.9

1462.66

1446.24

ng/l

0.13

12761

51952

Constipation

16197

77592

1.73

307.65

3.2

3.0

1420.67

1448.11

ng/l

0.30

13713

66447

Continuous positive airway pressure

4347

10084

5.93

307.65

4.0

1.9

1918.37

600.70

ng/l

49.32

3456

8315

Fall on same level

19285

76870

1.54

307.65

3.2

2.9

1594.85

1236.52

ng/l

17.71

16262

65057

Pulmonary heart disease

6277

34427

2.58

307.65

3.8

3.1

1401.70

1688.31

ng/l

6.18

5624

29613

Disorders of lens

12532

52677

1.76

307.65

3.4

2.8

1855.32

1171.93

ng/l

30.65

10888

45071

Chronic lower respiratory diseases

22229

77281

1.77

307.65

3.4

2.8

1339.48

1360.21

ng/l

0.24

19045

65029

Hypertension, essential

16394

41289

2.93

307.65

3.1

2.4

1472.45

838.59

ng/l

38.65

14011

34164

Spondylosis

9597

54023

1.79

307.65

3.0

2.9

1069.70

1516.16

ng/l

25.31

8253

46254

Pulmonary embolism

6277

34271

2.59

307.65

3.8

3.0

1401.70

1674.66

ng/l

5.66

5624

29456

All influenza

4312

24504

2.18

307.65

4.3

2.8

2095.62

1328.84

ng/l

13.94

3772

20710

Other arrhythmias

15363

39506

4.41

307.65

3.7

1.8

1262.22

539.40

ng/l

88.69

13438

31569

Hypertension

15730

41804

2.65

307.65

3.3

2.4

1499.46

835.58

ng/l

36.24

13433

34571

GASTRO-related operations

13852

42627

1.82

307.65

3.3

2.6

1517.67

1126.43

ng/l

13.69

11559

35721

Gastrointestinal diseases

9157

29594

1.69

307.65

3.2

2.6

1337.13

1157.84

ng/l

2.28

7591

24756

Early onset COPD, excluding more controls

3880

19471

2.64

307.65

3.8

2.5

1481.03

1146.85

ng/l

3.70

3412

16625

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2572

5936

5.12

307.65

4.2

2.5

1645.93

1293.39

ng/l

2.94

2330

5123

Sciatica+with lumbago

8318

50433

1.81

307.65

3.0

2.9

963.45

1372.94

ng/l

24.30

7170

42833

Heart failure and coronary heart disease

8263

32356

3.08

307.65

6.3

2.9

4514.95

1563.02

ng/l

165.46

7664

27764

Dental caries

4239

23010

2.23

307.65

4.9

2.9

2355.98

1288.94

ng/l

17.02

3758

19648

Infections, IBD-co-morbidities

2972

7524

3.77

307.65

4.1

2.5

2398.61

1097.06

ng/l

18.10

2627

6451

Sleep apnoea

18566

72382

2.15

307.65

3.3

2.8

1066.87

1366.69

ng/l

16.46

15278

62168

All-cause Heart Failure

17843

50564

5.41

307.65

5.9

2.2

3360.24

889.24

ng/l

307.65

16719

42846

Heart failure,strict

16933

41513

6.90

307.65

6.2

2.0

3281.43

699.36

ng/l

307.65

15951

34891

Use of hypnotics and sedatives

18150

76730

1.51

307.65

3.1

2.9

1417.36

1350.78

ng/l

0.98

15281

65249

Gonarthrosis

12313

45598

1.80

307.65

3.1

2.9

1282.83

1427.67

ng/l

2.91

10503

38929

Aortic valve malfunction, age under 60 years

2344

7306

7.07

307.65

4.4

3.0

1145.32

1110.78

ng/l

0.13

2166

6139

Any gastric operation

13852

42627

1.82

307.65

3.3

2.6

1517.67

1126.43

ng/l

13.69

11559

35721

ILD medications

22499

71782

2.03

307.65

3.8

2.6

1501.08

1309.27

ng/l

5.85

19416

60107

ILD medications: prednisolone, methylprednisolone, prednisone

22454

71419

2.13

307.65

3.8

2.6

1523.01

1313.29

ng/l

6.78

19424

59838

Inflammatory bowel disease treatment related agents

22913

75704

2.04

307.65

3.8

2.7

1426.51

1353.99

ng/l

1.28

19837

63444

Other disorders of ear

16456

76295

1.63

307.65

3.1

2.9

1388.97

1418.31

ng/l

0.34

13905

65137

Other bacterial diseases

20258

76134

2.33

307.65

3.9

2.7

2290.43

1111.88

ng/l

112.71

17899

64004

Benign neoplasm of colon, rectum, anus and anal canal

10524

47447

1.93

307.65

3.4

2.9

1642.93

1372.20

ng/l

5.47

9160

40350

Factors influencing health status and contact with health services

5873

15113

2.24

307.65

3.2

2.3

1629.26

1233.70

ng/l

6.05

4953

12678

Soft tissue disorders

17700

63234

1.60

307.65

3.1

2.9

1315.74

1460.58

ng/l

3.40

14866

53435

Calcific aortic valvular stenosis

8059

38029

3.90

307.65

4.4

3.1

2514.86

1885.98

ng/l

14.89

7487

32778

Calcific aortic valvular stenosis, including rheumatic fever

8066

38123

3.87

307.65

4.4

3.1

2514.59

1885.86

ng/l

14.91

7493

32857

Insulin medication

10942

59462

1.86

307.65

3.9

2.9

2563.23

1355.18

ng/l

57.83

9546

50814

Other disorders of skin and subcutaneous tissue

12132

76546

1.68

307.65

3.5

2.9

2180.90

1379.42

ng/l

32.84

10525

65359

Asthma (diagnoses ohter than nonallergic)

16238

84310

1.95

307.65

3.5

2.9

1261.31

1432.57

ng/l

6.12

13985

71247

Operations 2 for CAVS

8039

38010

3.88

307.65

4.4

3.1

2518.25

1886.54

ng/l

14.96

7468

32763

Autoimmune diseases

18471

69574

1.47

307.65

3.2

2.9

1553.80

1319.89

ng/l

7.75

15695

58673

Diseases of oesophagus, stomach and duodenum

20565

76678

1.91

307.65

3.2

2.9

1472.38

1349.06

ng/l

2.52

17377

65089

Pain (limb, back, neck, head abdominally)

12940

43671

1.64

307.65

3.2

2.9

1439.41

1494.94

ng/l

0.56

10972

37196

Persons encountering health services for examination and investigation

11845

36880

1.80

307.65

3.3

2.7

1518.88

1438.44

ng/l

0.88

10053

31189

Codeine

18497

57256

2.09

307.65

3.2

2.7

1361.64

1286.74

ng/l

1.26

15727

48112

Secondary hypertension

1322

3468

5.45

307.65

3.5

1.6

5680.23

408.15

ng/l

35.93

1180

2688

Examination and observation for other reasons

11094

36247

2.21

307.65

3.4

2.7

1420.25

1402.35

ng/l

0.12

9632

30707

Presence of other functional implants

11358

50595

1.96

307.65

3.4

2.6

1947.03

1369.18

ng/l

20.67

9694

43106

Other chronic obstructive pulmonary disease, including avohilmo

10393

58041

1.82

307.65

3.9

3.0

1958.82

1555.36

ng/l

10.95

9116

50211

Gout

5764

29012

2.48

307.65

4.9

3.0

3187.56

1745.67

ng/l

36.32

5165

25131

Metabolic disorders

20932

67113

2.48

307.65

3.5

2.7

1734.12

1197.74

ng/l

33.34

18165

56489

Persons encountering health services for specific procedures and health care

21339

75494

2.09

307.65

3.7

2.7

1977.42

1110.86

ng/l

67.13

18651

63034

Fitting and adjustment of other devices

7008

41379

1.99

307.65

3.5

2.9

1718.69

1524.02

ng/l

2.93

6089

35468

Asthma-related pneumonia

6988

40265

2.22

307.65

4.3

3.0

1742.30

1759.91

ng/l

0.10

6202

34406

Left ventricular outflow tract obstruction, narrow definition

1201

3360

8.34

307.65

5.4

3.2

890.80

1216.46

ng/l

2.20

1117

2832

Other retinal disorders

11675

65220

1.68

307.65

3.4

3.0

2294.74

1489.14

ng/l

31.87

10078

56099

General examination and investigation of persons without complaint and reported diagnosis

11919

36714

1.99

307.65

3.5

2.7

1429.02

1427.78

ng/l

0.01

10161

31073

Insulin, intermediate and long-acting

10106

64576

1.84

307.65

3.9

3.0

2583.89

1424.31

ng/l

49.37

8815

55298

Calcific aortic valvular stenosis, diagnosis (helper)

8039

38010

3.88

307.65

4.4

3.1

2518.25

1886.54

ng/l

14.96

7468

32763

Hypertensive Heart Disease

5830

20024

3.90

307.65

4.7

2.6

2764.51

1229.82

ng/l

67.71

5237

17052

Hypothyroidism (congenital or acquired)

3386

3937

5.82

307.65

3.2

1.3

843.15

259.42

ng/l

12.66

2696

2890

Persons encountering health services in other circumstances

6131

36153

2.00

307.65

3.4

2.9

1498.85

1291.86

ng/l

3.13

5139

30572

Atrial fibrillation and flutter with reimbursement

8160

9598

11.58

307.65

4.5

1.5

1635.10

367.97

ng/l

166.27

7542

7440

Other heart diseases, wide

25131

44667

5.40

307.65

3.9

1.8

1453.40

521.84

ng/l

142.34

22344

35306

Myocardial infarction

11785

42741

2.87

307.65

4.2

2.6

2537.58

1190.01

ng/l

80.84

10766

36098

Myocardial infarction, without ST-elevation

9294

48900

2.52

307.65

4.3

3.1

3073.43

1649.09

ng/l

61.37

8450

42172

Heart failure, not strict

23519

54676

5.88

307.65

5.1

2.0

2416.65

616.35

ng/l

307.65

21610

45499

Insulin, combination of fast acting with intermediate-acting or long-acting

10971

69372

1.69

307.65

3.9

3.0

2564.57

1446.12

ng/l

50.34

9571

59234

Asthma, including avohilmo

21415

81872

1.72

307.65

3.3

2.9

1183.70

1444.80

ng/l

14.46

18219

69166

Medical observation and evaluation for suspected diseases and conditions

14126

36863

2.36

307.65

3.4

2.7

1426.57

1437.64

ng/l

0.08

11833

31182

Other special examinations and investigations of persons without complaint or reported diagnosis

12611

36876

1.99

307.65

3.3

2.7

1408.14

1438.31

ng/l

0.30

10753

31188

Cardiovascular diseases

10464

13517

5.25

307.65

3.4

1.5

945.27

312.85

ng/l

35.98

8658

9947

Diseases of the respiratory system

11315

36952

1.71

307.65

3.2

2.5

1437.61

1117.20

ng/l

9.19

9647

31088

Diabetes, insulin treatment (Kela reimbursement)

18953

75126

1.78

307.65

3.3

2.8

1815.86

1235.92

ng/l

33.41

16068

63732

Hypothyroidism, drug reimbursement

1929

2962

5.68

307.65

3.1

1.4

977.18

274.35

ng/l

9.10

1623

2261

Presence of cardiac and vascular implants and grafts

13491

42820

4.53

307.65

5.6

2.7

2323.27

1497.99

ng/l

50.88

12513

36638

Adjustment and management of implanted device

4882

22070

4.17

307.65

5.9

3.0

2537.00

1619.87

ng/l

24.19

4503

18976

Hypothyroidism, levothyroxine purchases

3346

3924

5.77

307.65

3.2

1.3

824.37

259.51

ng/l

11.95

2669

2883

Persons encountering health services for other counselling and medical advice, not elsewhere classified

19865

76354

1.67

307.65

3.2

2.9

1512.85

1336.45

ng/l

4.35

17047

64581

Valvular operations

4344

11464

10.03

307.65

5.1

1.9

1861.43

703.60

ng/l

52.70

4137

9346

Episodal and paroxysmal disorders

20633

65846

1.83

307.65

3.2

2.8

1203.47

1480.54

ng/l

14.18

17218

56014

Pulmonary heart disease, diseases of pulmonary circulation

7042

37854

2.68

307.65

4.3

3.0

1576.19

1704.99

ng/l

1.59

6337

32550

Erysipelas

11038

60823

2.06

307.65

3.9

2.8

2319.28

1254.11

ng/l

56.80

9698

51755

Emergency coronary revascularization (for ACS)

11775

54100

2.01

307.65

4.0

3.0

2442.51

1585.99

ng/l

36.93

10653

46617

Major coronary heart disease event excluding revascularizations

15041

58029

2.46

307.65

4.1

2.8

2294.64

1221.35

ng/l

75.02

13650

49342

Congenital malformations of cardiac septa

1205

4014

4.41

307.25

5.5

3.1

1115.77

1135.02

ng/l

0.06

1085

3335

Dental operations

12157

44455

1.56

306.60

3.3

2.9

1686.18

1676.03

ng/l

0.07

10437

38014

Care involving use of rehabilitation procedures

10226

68395

1.59

304.85

3.3

2.7

1633.64

1151.49

ng/l

15.11

8909

57581

Undetermined asthma, excluding more controls

2085

9370

2.89

303.70

3.4

2.0

1111.57

711.62

ng/l

6.42

1765

7800

Hernia of abdominal wall, postoperative

3110

16479

2.41

302.16

3.4

2.6

1804.16

1192.50

ng/l

5.81

2693

14180

Diarrhoea and gastroenteritis of presumed infectious origin

10903

70382

1.55

301.73

3.6

2.9

1964.00

1353.79

ng/l

18.68

9239

59373

Any mental disorder

18837

71924

1.42

301.33

3.1

2.9

1381.03

1369.80

ng/l

0.10

15758

61530

Dental pulpitis 2

12915

47742

1.53

300.56

3.2

3.0

1722.68

1599.78

ng/l

1.56

11052

40846

Diseases of the ear and mastoid process

18756

72274

1.41

299.30

3.0

2.9

1267.03

1374.68

ng/l

2.18

15553

61297

Transient ischemic attack

9802

57865

1.66

297.50

3.6

3.0

1867.33

1538.77

ng/l

7.21

8665

49836

Dental caries 1

14154

53150

1.50

296.95

3.2

3.0

1637.41

1571.68

ng/l

0.72

12104

45510

Dental caries, including avohilmo

14138

53107

1.50

296.32

3.2

3.0

1636.94

1572.09

ng/l

0.70

12089

45469

Nausea and vomiting

4518

26430

2.03

294.86

3.8

3.0

2074.35

1624.38

ng/l

4.31

3878

22623

Hypo-osmolality and hyponatraemia

3328

18584

2.45

293.23

4.0

2.9

2269.15

1505.69

ng/l

13.30

2902

15911

Primary gonarthrosis, bilateral

9253

57314

1.67

291.57

3.1

3.0

1375.28

1557.43

ng/l

3.34

7955

49508

Dental pulpitis 2, only avohilmo

13124

48884

1.51

291.49

3.2

3.0

1695.20

1602.90

ng/l

1.05

11226

41861

Endocarditis

790

2239

7.21

290.66

5.4

1.9

3533.27

659.32

ng/l

12.96

741

1828

Diseases of oral cavity, salivary glands and jaws

15851

60884

1.45

290.13

3.3

2.9

1549.65

1475.61

ng/l

0.90

13484

51875

Benign neoplasms

11132

44299

1.54

288.99

3.1

2.9

1365.35

1230.55

ng/l

1.73

9392

36793

Dental caries 1 and operation codes

15314

58694

1.46

288.04

3.2

3.0

1496.16

1552.82

ng/l

0.68

13035

50243

Dental caries 3

14676

55659

1.48

288.00

3.2

3.0

1606.11

1542.93

ng/l

0.70

12517

47652

Chronic periapical parodontitis

3548

19968

2.24

287.87

4.4

2.8

2100.58

1246.43

ng/l

9.93

3158

17158

Insulin, fast-acting

5904

37909

1.83

285.64

4.0

3.0

2854.78

1364.70

ng/l

37.64

5143

32290

Dental caries 3 and operation codes

15768

60794

1.45

284.32

3.2

3.0

1472.41

1526.03

ng/l

0.65

13414

52017

Gout, strict definition

3531

20738

2.43

280.25

5.2

3.1

3423.59

1674.48

ng/l

31.04

3176

18070

Lumbar disc prolapse

9959

55992

1.57

279.75

3.0

2.9

937.12

1387.61

ng/l

28.96

8464

47592

Peripheral artery disease

8482

48042

1.71

279.72

4.1

3.0

3504.51

1574.00

ng/l

80.10

7639

41400

Symptoms and signs involving the skin and subcutaneous tissue

10797

77857

1.54

277.61

3.2

2.9

1319.91

1352.07

ng/l

0.28

9295

66177

Meniscus derangement

9339

44655

1.60

277.58

2.9

1061.83

1360.79

ng/l

11.15

7889

38100

Gout, unspecified

3935

23810

2.27

276.30

5.1

3.1

3343.45

1643.35

ng/l

33.82

3531

20688

Familial hypercholesterolemia, with ischemic heart disease

2045

10087

3.30

275.49

4.5

2.7

2100.42

1485.90

ng/l

6.48

1819

8574

Stroke, including SAH

11444

62392

1.56

274.12

3.6

3.0

2148.55

1471.35

ng/l

27.66

10038

53623

Infections of the skin and subcutaneous tissue

8450

58255

1.61

273.95

3.6

3.0

1926.76

1244.49

ng/l

17.49

7181

49232

Hypertrophic cardiomyopathy

1026

3780

7.00

273.88

8.0

3.1

2375.56

1467.49

ng/l

6.27

977

3258

Ulcer of lower limb, not elsewhere classified

2790

15298

2.67

273.45

4.1

3.2

4038.30

1660.85

ng/l

34.80

2515

13261

Benign neoplasm: Colon

9453

66815

1.63

273.14

3.5

3.0

1730.44

1531.80

ng/l

2.69

8257

57741

Later onset COPD, excluding more controls

4290

20519

2.19

272.66

4.3

2.6

2523.42

1517.41

ng/l

21.03

3834

17737

Dental caries 3, only avohilmo

14856

56965

1.46

272.55

3.1

1521.42

1576.52

ng/l

0.65

12661

48854

Unspecified haematuria

7490

44032

1.72

272.11

3.4

3.1

2165.47

1591.66

ng/l

13.06

6495

38126

Dental caries 1, only avohilmo

14296

54549

1.47

272.11

3.1

1565.10

1604.44

ng/l

0.39

12217

46796

Conotruncal defects

360

541

20.89

270.07

8.0

5.0

851.88

886.87

ng/l

0.09

348

445

Diseases of pulp and periapical tissues, including avohilmo

17868

71426

1.40

269.38

3.1

3.0

1390.35

1445.60

ng/l

0.74

15113

60677

Dental pulpitis 4

17885

71502

1.40

269.31

3.1

3.0

1393.61

1444.42

ng/l

0.65

15123

60756

Dental pulpitis 1

17877

71529

1.40

267.95

3.1

3.0

1394.00

1444.21

ng/l

0.64

15116

60779

Familial hypercholesterolemia

3168

18064

2.43

267.45

4.0

2.9

1802.77

1521.65

ng/l

2.95

2807

15569

Other CVD

3796

22893

2.26

267.14

4.3

3.2

2259.78

1929.16

ng/l

2.22

3332

19810

Stroke, excluding SAH

10953

59970

1.56

264.35

3.6

3.0

2203.52

1511.00

ng/l

26.56

9602

51628

Congenital malformations, deformations and chromosomal abnormalities

7790

50893

1.61

262.29

3.4

2.8

1301.93

1135.97

ng/l

2.12

6708

42413

Non-allergic asthma (mode)

3217

17692

2.18

261.95

3.4

2.5

1194.43

1197.38

ng/l

0.01

2823

14997

Falls/tendency to fall

17554

67508

1.39

261.64

3.1

2.9

1514.09

1229.67

ng/l

10.95

14739

57229

Parodontitis or operation codes

14626

82126

1.44

260.33

3.1

2.9

1444.05

1315.92

ng/l

2.15

12424

70036

Visual disturbances and blindness

8114

56790

1.63

260.25

3.4

3.0

1418.26

1453.19

ng/l

0.29

6909

48496

Other systemic involvement of connective tissue

4770

30105

1.94

258.93

3.4

3.0

1236.53

1499.75

ng/l

5.60

4159

25795

Hypothyroidism, strict autoimmune

11889

57794

1.49

258.56

3.1

2.8

1346.76

1368.16

ng/l

0.18

9956

48990

Parodontitis

14601

82123

1.44

258.30

3.1

2.9

1444.43

1315.86

ng/l

2.15

12403

70033

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9402

67686

1.57

257.97

3.5

2.9

1936.48

1388.90

ng/l

16.46

8087

57887

Dental operations, only avohilmo

12661

47950

1.49

256.85

3.2

3.0

1605.04

1694.76

ng/l

1.13

10861

41090

Chronic periodontitis, including avohilmo

14526

82093

1.44

255.24

3.1

2.9

1439.52

1313.07

ng/l

2.10

12336

70012

Diseases of the eye and adnexa

11939

43268

1.48

254.95

3.0

2.7

1364.00

1044.80

ng/l

9.43

9992

36169

Polycystic ovarian syndrome, consortium definition

9831

42029

1.54

254.51

2.8

2.7

1021.79

1117.83

ng/l

1.29

8116

35172

Disorders of the thyroid gland

15215

76036

1.42

253.19

3.3

2.9

1346.06

1444.03

ng/l

1.76

12854

64748

Migraine

5846

31862

1.71

253.04

2.8

2.6

637.02

1045.41

ng/l

20.00

4810

26671

Ischaemic Stroke, excluding all haemorrhages

10356

57773

1.57

249.95

3.7

3.0

2291.70

1547.47

ng/l

27.47

9074

49792

Cystitis

13500

62007

1.45

249.53

3.1

2.9

1425.09

1390.38

ng/l

0.34

11484

52829

Polyarthrosis

3613

20588

2.14

249.48

3.3

2.8

1306.05

1485.50

ng/l

1.75

3113

17669

Myalgia

3380

19310

2.08

248.24

3.0

2.8

965.83

1292.18

ng/l

6.35

2757

16421

Other disorders of teeth and supporting structures

3572

21054

2.09

246.63

4.0

2.9

1928.82

1322.35

ng/l

6.45

3112

18099

Other diseases of the respiratory system

3870

23785

2.12

245.67

4.9

3.2

2281.92

1869.41

ng/l

3.91

3492

20524

Other respiratory disorders and diseases

3870

23785

2.12

245.67

4.9

3.2

2281.92

1869.41

ng/l

3.91

3492

20524

Dermatitis

9533

69195

1.54

243.54

3.3

2.9

1568.99

1346.22

ng/l

3.90

8176

58985

Autoimmune diseases related-to ILD

13063

86946

1.43

243.28

3.2

2.9

1323.03

1364.12

ng/l

0.46

11162

73411

Diaphragmatic hernia

6313

43121

1.75

242.71

3.3

3.0

1371.45

1471.55

ng/l

1.00

5447

36998

Other or ill-defined heart diseases

924

3110

4.33

242.51

6.2

1.8

1786.88

679.55

ng/l

6.72

816

2483

Dialysis, with operation codes

2297

12071

2.64

242.41

6.5

2.9

8631.71

1057.70

ng/l

84.18

2160

10315

Symptoms and signs involving the nervous and musculoskeletal systems

9137

66045

1.55

241.50

3.1

3.0

1294.77

1444.53

ng/l

2.15

7853

56394

Undetermined asthma

2085

10330

2.57

239.80

3.4

2.4

1111.57

1149.90

ng/l

0.18

1765

8769

Pleural effusion

3017

17590

2.37

238.37

4.5

3.1

2886.92

1796.71

ng/l

13.97

2753

15161

Genitourinary diseases

9231

32437

1.54

237.85

3.3

2.8

1713.01

960.08

ng/l

29.39

7743

27323

Insulin, fast-acting or short human

5930

39695

1.73

237.03

4.0

3.0

2861.79

1442.21

ng/l

34.45

5166

33842

Hypothyroidism, strict autoimmune, 3 medication purchases required

13285

68709

1.43

236.75

3.0

2.9

1310.11

1419.13

ng/l

1.86

11126

58467

Allergic asthma (mode), excluding more controls

2812

14755

2.09

236.65

2.8

1.9

869.78

586.09

ng/l

5.19

2355

12021

Certain disorders involving the immune mechanism

3127

18012

2.18

236.28

5.0

2.9

1589.38

1315.04

ng/l

2.12

2741

15367

Respiratory insufficiency

1671

7926

3.17

235.03

5.8

2.7

2298.71

1602.46

ng/l

5.07

1532

6835

Gingivitis and periodontal diseases

15172

60122

1.41

234.05

3.1

2.9

1426.32

1444.10

ng/l

0.15

12867

51257

Cardiomyopathy, Hypertrophic obstructive

480

1130

11.85

231.94

9.5

1.8

2508.50

608.85

ng/l

13.59

460

921

Intestinal infectious diseases

14388

86187

1.40

231.86

3.6

2.9

1923.77

1319.80

ng/l

25.85

12195

72879

Mood disorders, excluding more controls

14739

68871

1.40

231.43

3.0

2.9

1085.26

1309.07

ng/l

6.96

12079

58806

Disorder of lipoprotein metabolism, unspecified

2635

14831

2.46

230.93

3.8

2.9

2074.79

1479.04

ng/l

5.24

2317

12734

Other reaction to severe stress, and adjustment disorders

4519

28096

1.79

230.53

3.4

2.7

1013.28

989.15

ng/l

0.13

3754

23362

Other external causes of accidental injury

13693

51758

1.42

230.50

3.1

2.9

1522.11

1246.36

ng/l

8.43

11481

44192

Early onset COPD

3880

24055

2.02

229.68

3.8

2.9

1481.03

1394.21

ng/l

0.47

3412

20669

Intracranial injury

9012

63085

1.53

229.27

3.3

3.0

1668.73

1488.54

ng/l

3.13

7585

53767

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

13955

63065

1.42

228.11

2.9

1299.76

1256.11

ng/l

0.53

12070

53038

Malignant neoplasm, wide definition for exclusion

13958

63079

1.42

228.09

2.9

1300.34

1255.85

ng/l

0.54

12073

53050

Hypotension

3250

19671

2.27

228.08

4.2

3.2

2247.45

1978.79

ng/l

1.65

2839

17026

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

13956

63071

1.42

227.97

2.9

1300.31

1255.80

ng/l

0.54

12071

53044

Parodontitis and operation codes

13574

81197

1.42

227.77

3.1

2.9

1396.74

1297.09

ng/l

1.38

11514

69309

Hypothyroidism, other/unspecified

14027

71109

1.41

226.34

3.2

2.9

1323.33

1441.76

ng/l

2.21

11777

60527

Atherosclerosis, excluding cerebral and coronary sclerosis

7896

45565

1.65

226.11

4.1

3.0

3615.05

1612.51

ng/l

78.21

7123

39316

Accidents

13653

51758

1.42

225.18

3.1

2.9

1522.77

1246.36

ng/l

8.05

11456

44192

Visual disturbances

7310

51526

1.61

224.77

3.4

3.0

1294.39

1401.53

ng/l

1.39

6241

44011

Pericarditis

702

2147

5.54

223.00

4.8

1.9

2073.65

634.35

ng/l

3.39

647

1723

Systemic sclerosis (FG)

607

1793

8.67

221.03

4.7

2.8

674.14

1021.22

ng/l

3.13

567

1501

Dysphagia

4174

26510

1.91

219.59

3.5

2.9

1426.54

1549.86

ng/l

1.10

3561

22875

Hypothyreosis and Thyroxine purchase for inclusion criteria

14506

74181

1.39

219.55

3.1

2.9

1320.68

1433.92

ng/l

2.14

12173

63179

Septal defects

1041

3889

3.76

219.14

4.9

3.4

1120.63

1214.54

ng/l

0.32

929

3253

Other and unspecified dermatitis

7806

55871

1.57

216.90

3.3

2.9

1566.38

1318.09

ng/l

3.92

6703

47599

Dental pulpitis 4, only avohilmo

17853

73761

1.35

216.83

2.9

3.0

1257.24

1463.19

ng/l

7.63

15027

62799

Coxarthrosis, primary

10569

69642

1.50

215.86

3.2

3.0

1512.28

1591.09

ng/l

1.08

9270

60004

Oter anti-inflammatory and antirheumatic agents, non-steroids

4403

15265

1.88

215.36

3.1

3.4

1532.10

2276.15

ng/l

15.20

3768

13464

Other medical care

6789

46695

1.64

214.55

3.7

2.9

2117.76

1381.77

ng/l

22.21

6138

39808

Degeneration of macula and posterior pole

8683

53019

1.59

214.41

3.4

3.1

1987.25

1658.23

ng/l

6.36

7482

45993

L04AD Calcineurin inhibitors

1680

8097

2.78

213.90

7.8

2.9

4106.97

1016.49

ng/l

22.59

1608

6814

Nephropathy related operations

2166

11659

2.55

213.43

6.3

3.1

8760.91

1297.42

ng/l

75.67

2047

10003

ILD, hospital admission 2, with pulmonary infections

1876

9742

2.85

212.73

4.6

2.8

2106.50

1545.95

ng/l

3.99

1703

8414

Diseases of the digestive system

7649

54950

1.58

212.70

3.7

3.1

2211.10

1619.27

ng/l

11.39

6631

47136

Dental pulpitis 1, only avohilmo

17860

74000

1.35

212.12

2.9

3.0

1250.52

1465.17

ng/l

8.30

15024

63006

Exposure to unspecified factor

14662

88875

1.37

211.36

3.1

3.0

1539.45

1339.82

ng/l

4.86

12158

75532

Congenital malformations of great arteries

423

900

8.73

210.03

7.6

3.5

1170.19

1061.81

ng/l

0.23

397

738

Carpal tunnel syndrome

9543

64018

1.49

208.90

3.0

2.9

1223.41

1301.08

ng/l

0.86

8104

54458

ILD, hospital admissions

2832

16910

2.32

208.62

4.2

3.2

1790.05

1777.02

ng/l

0.05

2562

14684

L04AA Selective immunosuppressants

3217

19211

2.02

207.93

5.5

2.8

2672.64

1101.42

ng/l

18.90

2948

16269

Neoplasms

10615

41852

1.45

207.33

3.0

2.9

1361.16

1192.33

ng/l

2.19

8922

34726

COPD, hospital admission 2, with asthma infections

5876

34870

1.73

206.62

4.5

3.1

2321.62

1817.50

ng/l

8.33

5222

30166

Migraine with aura

2735

15248

2.02

205.59

2.7

2.6

605.26

1019.26

ng/l

9.70

2267

12741

Oxicams

4386

15677

1.83

205.52

3.1

3.4

1365.93

2238.27

ng/l

27.61

3744

13796

Viral pneumonia

2086

11045

2.44

205.40

4.5

2.8

2434.61

1324.71

ng/l

10.87

1872

9380

Other abnormal uterine and vaginal bleeding

3743

16465

1.92

202.54

3.1

2.8

1230.48

1491.81

ng/l

2.69

3080

14002

Interstitial lung disease endpoints

2859

17250

2.27

202.21

4.2

3.2

1819.95

1801.82

ng/l

0.06

2588

14992

Interstitial lung disease

2859

17250

2.27

202.21

4.2

3.2

1819.95

1801.82

ng/l

0.06

2588

14992

Other interstitial pulmonary diseases

2859

17257

2.27

201.93

4.2

3.2

1819.95

1786.67

ng/l

0.12

2588

15004

Hypokalaemia

2047

10966

2.52

201.65

3.9

2.8

1784.12

1351.46

ng/l

4.92

1809

9323

Injuries to the knee and lower leg

18381

84479

1.32

200.23

3.0

1360.92

1374.22

ng/l

0.13

15467

71651

Other respiratory diseases principally affecting the interstitium

3312

20719

2.10

200.11

4.3

3.2

2144.40

1814.46

ng/l

2.46

2994

17955

Personality disorders, excluding more controls

3005

17379

1.94

199.48

2.7

885.17

889.28

ng/l

0.02

2399

14446

External causes of morbidity and mortality

10785

40151

1.44

199.07

3.1

2.8

1478.14

1200.63

ng/l

6.44

9102

34170

L04AX Other immunosuppressants

8042

58611

1.52

197.97

3.6

2.8

1303.57

1202.91

ng/l

1.03

7019

49604

Diagnoses used for exclusion with ILD

4367

28750

1.83

197.60

4.6

3.1

1558.99

1681.39

ng/l

1.10

3832

24716

Malignant neoplasm

14130

65501

1.38

197.59

2.9

3.0

1328.48

1287.15

ng/l

0.48

12220

55345

Acute upper respiratory infections of multiple and unspecified sites

10679

60227

1.43

197.18

3.7

2.8

1325.99

1343.10

ng/l

0.15

9021

50854

Second line medication for Crohn's disease

8186

59858

1.51

196.84

3.6

2.8

1293.17

1199.78

ng/l

0.94

7137

50645

Dronedarone medication

662

2233

6.59

195.58

4.4

1.9

1658.83

605.50

ng/l

10.04

587

1836

Acute sinusitis

6959

45805

1.54

195.46

3.1

2.8

1130.38

1171.39

ng/l

0.28

5760

38484

Enlarged lymph nodes

2406

13395

2.18

194.95

3.8

2.7

1397.57

1260.26

ng/l

0.50

2106

11333

Injuries to the thorax

7151

51581

1.57

194.70

3.4

3.1

1656.87

1557.28

ng/l

0.97

6140

44166

Other arthritis (FG)

4589

30236

1.74

193.65

3.3

2.8

1682.98

1270.40

ng/l

4.60

3969

25666

Coxibs

4761

16287

1.74

193.64

2.9

3.4

1409.10

2202.20

ng/l

23.94

3922

14254

Other pulmonary heart/vessel disease

1055

4638

4.38

193.18

8.8

3.2

2539.42

1901.74

ng/l

3.38

997

3980

Rheumatoid arthritis

5138

31567

1.69

191.85

3.2

2.8

1525.56

1432.34

ng/l

0.78

4496

26967

Selective serotonin reuptake inhibitors

16174

67503

1.34

191.61

2.9

3.0

1129.43

1493.11

ng/l

22.77

13297

57884

Other specified/unspecified arthritis

3974

25421

1.80

190.96

3.3

2.9

1664.54

1295.85

ng/l

3.41

3428

21681

Systemic sclerosis

607

1995

7.57

190.50

4.7

2.9

674.14

1013.93

ng/l

3.19

567

1668

Systemic sclerosis, icd10

603

1998

7.63

187.68

4.7

2.9

676.34

958.45

ng/l

2.44

563

1672

Secondary right heart disease

970

4179

4.70

187.55

9.1

3.1

2502.17

1871.07

ng/l

3.26

922

3594

Osteoporosis

4613

29975

1.82

187.38

3.9

3.0

1776.27

1636.31

ng/l

1.13

4029

25770

Other disorders of lacrimal gland

5203

35738

1.68

186.15

3.2

2.9

1102.71

1352.49

ng/l

4.70

4413

30515

Paracetamol of NSAID medication

2698

7395

2.02

185.74

3.1

3.2

1732.80

1778.95

ng/l

0.14

2266

6361

Cholecystectomy

11268

77126

1.42

185.60

3.0

2.9

1371.00

1463.80

ng/l

1.22

9573

65888

Other disorders of veins

6015

42444

1.61

184.63

3.3

2.8

1376.29

1295.12

ng/l

0.63

5069

36162

Substance abuse, excluding more controls

8111

52046

1.49

184.62

3.1

3.0

1605.90

1386.28

ng/l

3.00

6831

44598

Sarcoidosis

2233

12612

2.29

183.84

5.3

2.9

1131.60

1304.94

ng/l

1.57

1949

10758

ILD, hospital admissions 1, main diag only

2514

15082

2.32

183.30

4.2

3.2

1769.64

1778.84

ng/l

0.03

2285

13130

Varicose veins

10630

61768

1.44

183.05

3.2

2.9

1459.37

1495.87

ng/l

0.36

9166

52821

Other diseases of the digestive system

5530

38859

1.67

182.56

4.0

3.2

2386.30

1756.95

ng/l

10.94

4814

33532

Excessive, frequent and irregular menstruation

5274

19514

1.65

182.47

2.8

2.7

961.45

1331.88

ng/l

9.84

4357

16345

Injuries to the shoulder and upper arm

12945

85405

1.37

182.03

3.1

3.0

1406.40

1413.26

ng/l

0.06

10965

72664

Other symptoms and signs involving the circulatory and respiratory systems

1077

4599

3.22

180.90

3.9

2.6

1706.19

1417.01

ng/l

0.65

956

3912

Allergic asthma (mode)

2812

16056

1.90

180.11

2.8

2.3

869.78

924.33

ng/l

0.38

2355

13305

Functional dyspepsia

4029

26322

1.78

180.00

3.2

2.8

1233.83

1331.49

ng/l

0.59

3377

22494

Retention of urine

5899

35429

1.64

178.83

3.5

3.1

2320.64

1730.53

ng/l

10.03

5143

30767

Unspecified kidney failure

1925

10725

2.57

178.36

5.2

3.0

5412.41

1497.46

ng/l

48.72

1754

9266

Other symptoms and signs involving cognitive functions and awareness

7376

51010

1.54

177.77

3.2

3.0

1727.46

1661.89

ng/l

0.48

6241

43922

Care involving dialysis

1404

6911

2.90

177.44

5.0

2.9

11552.60

1179.67

ng/l

68.28

1327

5869

Injury, poisoning and certain other consequences of external causes

8686

31806

1.47

177.18

3.1

2.8

1498.60

1220.00

ng/l

5.18

7340

26954

Irritable bowel syndrome

3890

25238

1.76

173.83

2.9

2.8

952.64

1201.43

ng/l

5.09

3205

21316

Disorders of other endocrine glands

6337

44646

1.55

173.43

3.5

3.0

1972.60

1389.74

ng/l

7.41

5378

37854

COPD, hospital admissions 1, only main diagnosis

6298

38983

1.62

172.96

4.2

3.1

2100.21

1796.57

ng/l

4.18

5579

33805

Non-selective monoamine reuptake inhibitors

6294

43889

1.57

172.74

3.1

2.9

1153.13

1474.54

ng/l

8.86

5297

37855

Other gastritis (incl. Duodenitis)

3844

25374

1.81

171.54

3.6

3.0

1754.33

1529.89

ng/l

1.85

3379

21903

GI-bleeding

5499

39053

1.64

170.56

4.0

3.2

2408.86

1773.42

ng/l

11.11

4819

33682

Depression

13788

75286

1.34

170.30

2.9

1040.36

1251.30

ng/l

5.96

11229

63795

Hernia of abdominal wall

7100

52427

1.52

168.70

3.3

3.0

1617.16

1404.17

ng/l

2.56

6124

44976

Disorders of lacrimal system

6372

46199

1.56

168.14

3.2

2.9

1187.92

1370.70

ng/l

2.97

5400

39409

Anxiety disorders, excluding more controls

11829

61079

1.37

167.38

3.1

2.9

1014.48

1211.32

ng/l

4.02

9705

51933

Chronic gastritis

4878

34086

1.69

167.10

3.4

3.0

1801.04

1626.95

ng/l

1.39

4204

29498

Extreme obesity with alveolar hypoventilation

823

3380

4.30

165.89

4.8

2.9

1649.44

1246.17

ng/l

1.09

703

2898

Rheumatism, unspecified

2214

12793

2.14

163.40

2.8

2.7

845.56

1188.64

ng/l

3.73

1852

10906

Recurrent or chronic depression

5164

25486

1.58

162.42

2.8

830.57

1013.24

ng/l

2.11

4133

21672

Mood disorders

15215

80583

1.31

162.23

2.9

1065.78

1323.90

ng/l

9.52

12425

68424

Mood [affective] disorders

15165

80412

1.31

162.06

2.9

1066.59

1319.45

ng/l

9.12

12385

68268

Acetic acid derivatives and related substances

4687

16252

1.66

161.75

3.0

3.4

1562.27

2204.90

ng/l

11.53

3910

14233

5543

35643

1.67

161.73

3.5

3.2

2177.50

1931.43

ng/l

2.74

4784

31052

Presence of other devices

3919

26338

1.78

161.52

3.3

2.8

1606.14

1707.42

ng/l

0.77

3518

22536

Cervical disc disorders

5647

40279

1.58

161.50

3.0

2.9

955.83

1443.99

ng/l

25.18

4795

34503

Other diseases of anus and rectum

4818

33510

1.66

161.36

3.5

2.9

1795.79

1564.71

ng/l

2.18

4070

28743

Right bundle-branch block

680

2496

4.40

161.29

4.3

1.9

1515.10

638.37

ng/l

8.60

586

2041

Other and unspecified polyneuropathies, also in other diseases

3264

21300

1.92

161.04

3.8

3.2

2053.36

1652.17

ng/l

3.14

2900

18458

Any event in cancer register

13992

66294

1.33

160.88

2.9

1310.61

1258.66

ng/l

0.67

12049

55901

Volume depletion

1666

9005

2.50

160.83

4.7

3.0

2921.82

1765.76

ng/l

10.66

1472

7692

Primary_lymphoid and hematopoietic malignant neoplasms

4013

27226

1.77

160.59

3.8

3.2

1819.23

1605.82

ng/l

1.89

3622

23442

Chronic periodontitis

2433

14628

2.08

160.02

4.4

2.9

2734.63

1313.89

ng/l

14.55

2192

12636

Polyneuropathies and other disorders of the peripheral nervous system

3648

24357

1.83

159.97

3.8

3.1

1993.15

1624.02

ng/l

3.10

3237

21068

ILD medications: azathioprine

2015

11216

2.12

159.51

4.9

2.6

1779.83

1175.37

ng/l

2.93

1798

9375

COPD-related respiratory insufficiency

2226

13369

2.27

159.45

5.3

3.1

2560.50

1905.89

ng/l

5.18

2016

11595

Internal derangement of knee

5388

37811

1.57

159.28

2.9

1170.02

1284.86

ng/l

1.23

4451

32164

Atrial septal defect

656

2326

4.26

159.17

6.0

3.2

1134.29

1069.88

ng/l

0.18

596

1929

Glomerular diseases

2871

18038

1.94

158.28

4.2

3.1

5815.34

1422.00

ng/l

54.61

2595

15511

Reimbursement for rheumatic diseases

8675

66141

1.43

157.55

3.1

2.9

1284.64

1327.87

ng/l

0.41

7587

56011

Deforming dorsopathies

4021

26895

1.70

157.44

3.2

2.9

1093.60

1369.04

ng/l

4.72

3412

22839

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2402

14534

2.08

156.26

4.0

3.0

2671.48

1449.98

ng/l

11.24

2019

12467

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

6878

45036

1.53

155.66

3.1

1462.93

1493.86

ng/l

0.22

6210

38585

Other symptoms and signs involving the nervous and musculoskeletal systems

6039

43780

1.53

154.88

3.1

3.0

1100.78

1362.46

ng/l

4.50

5191

37296

Menorrhagia

4960

18730

1.62

154.85

2.9

2.7

979.66

1369.97

ng/l

10.71

4083

15783

Cellulitis

3171

20400

1.82

152.26

3.8

3.0

2219.23

1345.56

ng/l

10.03

2728

17379

Hyperkalaemia

1071

5126

3.26

151.39

5.9

2.9

4809.02

1737.42

ng/l

21.20

985

4405

CR(E)ST syndrome

410

1236

11.04

151.39

4.7

2.8

630.28

954.90

ng/l

2.06

384

1028

Temporomandibular joint disorders

2048

11576

2.02

150.08

2.9

2.7

705.99

1095.60

ng/l

9.51

1708

9830

Right ventricular outflow tract obstruction

201

300

17.82

149.63

9.4

5.1

736.58

904.58

ng/l

0.51

195

245

Azathioprine

2015

11471

2.06

148.37

4.9

2.7

1779.83

1237.68

ng/l

2.43

1798

9575

Soft tissue disorders related to use, overuse and pressure

4032

27482

1.69

148.20

3.3

2.9

1275.72

1376.39

ng/l

0.75

3507

23524

Substance use, excluding alcohol

2464

14796

1.91

148.11

3.1

2.9

1410.42

1136.51

ng/l

1.52

2002

12336

Primary_lymphoid and hematopoietic malignant neoplasms

4013

27776

1.73

146.10

3.8

3.1

1819.23

1623.36

ng/l

1.65

3622

23962

Disorders of synovium and tendon

7438

50291

1.44

145.72

2.9

1165.68

1307.04

ng/l

1.68

6301

42738

Glomerular disorders in diseases classified elsewhere

1902

11050

2.22

144.16

4.6

3.1

6744.39

1467.73

ng/l

49.30

1725

9490

ILD, hospital admissions 3, with pneumonia sepsis

1564

8755

2.57

143.59

4.7

2.9

2181.13

1574.34

ng/l

5.00

1433

7550

Open wound of head

7863

59118

1.43

143.49

3.3

3.1

1929.61

1525.62

ng/l

8.34

6678

50574

Subjective visual disturbances

3547

23746

1.73

143.20

3.3

2.9

1093.13

1316.26

ng/l

3.19

2992

20282

Cutaneous abscess, furuncle and carbuncle

3408

22434

1.72

142.97

3.6

3.0

2124.85

1218.35

ng/l

9.72

2896

19004

Deposits [accretions] on teeth

1084

4938

2.78

142.75

7.0

3.0

2203.64

1220.60

ng/l

3.75

967

4184

Disturbances of skin sensation

3485

23000

1.70

142.71

2.8

812.28

1131.51

ng/l

6.84

2906

19381

Other diseases of upper respiratory tract

17776

76752

1.27

142.28

3.0

1228.80

1509.14

ng/l

12.74

14981

65487

Fibromyalgia

1140

5421

2.58

141.86

2.5

2.6

506.70

972.24

ng/l

12.53

913

4547

Peripheral arterial reconstruction

3137

21079

1.90

140.95

4.3

3.2

4011.59

1895.91

ng/l

33.70

2844

18367

Hyperplasia of prostate

6273

26346

1.53

140.89

3.2

3.1

1767.70

1662.14

ng/l

0.73

5388

22999

Iron deficiency anaemia secondary to blood loss (chronic)

2719

17444

1.92

140.74

5.2

3.0

2668.33

1616.28

ng/l

13.70

2414

14973

Fracture of rib(s), sternum and thoracic spine

4693

33515

1.62

139.42

3.5

3.1

1765.80

1627.80

ng/l

1.12

4056

28836

Dermatitis and eczema

16214

87735

1.28

138.96

3.1

2.9

1447.89

1368.50

ng/l

1.07

13644

74405

Congenital malformations of pulmonary and tricuspid valves

187

281

18.15

138.78

9.1

4.4

673.84

740.97

ng/l

0.21

182

229

Acute upper respiratory infections

15997

82594

1.28

138.46

3.4

2.9

1300.24

1419.56

ng/l

2.51

13450

70218

COPD, hospital admissions 3, with asthma pneumonia sepsis

4815

29555

1.64

138.27

4.6

3.1

2459.41

1913.58

ng/l

8.11

4303

25635

Disorders of vestibular function (Vertigo)

7350

56023

1.46

136.60

3.1

3.0

1235.76

1454.64

ng/l

3.76

6200

48140

Pain in thoracic spine

2108

12506

1.98

136.21

2.9

2.8

841.31

1425.30

ng/l

12.57

1809

10590

Personality disorders

3005

19232

1.72

135.64

2.7

885.17

920.07

ng/l

0.17

2399

15875

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3016

19270

1.71

135.06

2.8

2.7

951.64

999.83

ng/l

0.27

2417

16126

Type 1 diabetes, wide definition, subgroup 1

2633

16411

1.80

134.98

3.6

2.8

3586.65

1112.51

ng/l

30.35

2283

13750

Other anxiety disorders

5003

31335

1.52

134.80

3.0

2.7

898.44

1036.13

ng/l

1.33

3957

26004

Polyuria

3611

24820

1.72

134.07

3.2

3.1

1446.94

1539.03

ng/l

0.69

3060

21484

Cervicalgia

3047

19963

1.77

134.02

3.1

2.9

1201.84

1515.53

ng/l

3.54

2592

17035

Cervicobrachial syndrome

3079

20140

1.74

133.42

2.7

2.8

909.40

1296.62

ng/l

4.50

2677

17079

Other symptoms and signs involving the digestive system and abdomen

2470

15460

1.88

132.72

3.3

2.8

1183.46

1331.41

ng/l

1.05

2065

13270

Mixed connective tissue disease

1077

5322

2.80

132.62

3.7

2.9

923.06

1204.34

ng/l

2.24

966

4499

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4187

29280

1.60

131.21

3.4

3.0

1678.30

1396.50

ng/l

2.83

3602

24878

Exclusions for E4_PCOS_CONSORTIUM

9484

46395

1.36

130.35

2.9

2.8

1104.68

1198.36

ng/l

1.00

7875

38927

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

9103

49022

1.40

130.01

3.1

3.0

1789.14

1447.31

ng/l

7.52

7861

41922

Disorders of adult personality and behaviour

3094

20113

1.68

129.78

2.6

2.8

914.61

929.42

ng/l

0.06

2485

16590

Anxiety (asthma-related co-morbidities)

7041

41651

1.41

129.73

3.0

2.8

932.84

1011.60

ng/l

0.60

5592

34840

Cardiac murmurs and other cardiac sounds

1127

5410

2.43

129.12

2.8

2.9

1189.21

1294.84

ng/l

0.31

938

4542

All influenza (not pneumonia)

2123

12813

1.94

128.75

4.1

2.8

1848.68

1213.93

ng/l

5.53

1818

10738

Sequelae of external causes of morbidity and mortality

3839

26821

1.66

128.27

3.5

3.0

2087.32

1454.30

ng/l

7.52

3423

23047

Poisoning by drugs, medicaments and biological substances

2753

17534

1.74

128.19

2.9

1048.63

1085.77

ng/l

0.18

2228

14566

Mental and behavioural disorders due to psychoactive substance use

8367

61436

1.38

128.14

3.1

3.0

1618.99

1384.70

ng/l

3.45

7047

52262

Superficial injury of lower leg

3309

22169

1.68

127.80

3.3

3.0

1420.97

1338.33

ng/l

0.47

2735

18768

Streptococcal septicaemia

1442

8021

2.40

127.52

4.5

2.9

3101.58

1379.12

ng/l

14.25

1288

6855

Bacterial pneumoniae

6334

42219

1.47

127.50

3.9

2.8

2381.61

1360.44

ng/l

29.47

5626

35913

Diseases of inner ear

8461

65230

1.40

127.12

3.1

3.0

1260.49

1460.72

ng/l

3.29

7126

55983

Abnormal findings on examination of blood, without diagnosis

7349

53267

1.44

126.19

3.4

3.1

1924.89

1577.53

ng/l

5.81

6453

46006

Systemic sclerosis,strict definition

268

680

18.27

125.76

5.3

3.1

561.91

863.14

ng/l

1.75

252

570

Neurotic, stress-related and somatoform disorders

11969

68708

1.31

125.75

3.1

2.8

998.55

1174.11

ng/l

3.37

9770

57912

Viral infections characterized by skin and mucous membrane lesions

5704

42286

1.48

125.49

3.6

3.0

1623.72

1331.98

ng/l

3.50

4905

35924

Phlebitis and thrombophlebitis (not including DVT)

3404

23295

1.70

125.13

3.2

3.0

1468.47

1465.60

ng/l

0.01

2945

19972

Migraine without aura

1839

10491

1.92

124.87

2.7

2.5

486.81

847.70

ng/l

9.39

1505

8604

Substance abuse

8111

60317

1.38

124.54

3.1

3.0

1605.90

1390.83

ng/l

2.92

6831

51315

Anxiety disorders

12144

69697

1.30

124.40

3.1

2.8

1000.72

1185.95

ng/l

3.76

9923

58759

Mycoses

3770

26267

1.64

124.29

3.8

3.0

1496.97

1403.82

ng/l

0.62

3241

22463

Injuries to the abdomen, lower back, lumbar spine and pelvis

5812

43198

1.48

123.76

3.5

3.1

1910.83

1590.25

ng/l

5.08

4968

36857

Heartburn

1553

8757

2.18

123.25

3.4

2.8

1236.58

1371.98

ng/l

0.55

1304

7508

Explicit bacterial Sepsis

1657

9620

2.17

123.06

4.4

2.9

3051.89

1398.42

ng/l

14.16

1481

8204

Other pleural conditions

1855

11338

2.17

122.54

4.7

3.0

2855.43

1830.02

ng/l

7.39

1693

9780

Gastroduodenal ulcer

4448

32172

1.59

122.00

3.9

3.1

2242.34

1797.05

ng/l

5.27

3941

27857

Hallux valgus (acquired)

5047

26551

1.52

121.76

2.8

1122.44

1326.76

ng/l

3.77

4283

22641

Anosmia

307

747

5.43

121.61

3.0

1.4

635.26

391.10

ng/l

3.00

255

567

Other diseases of hard tissues of teeth

8953

52481

1.36

120.86

3.3

2.8

1113.83

1201.03

ng/l

0.88

7524

44727

Postmenopausal bleeding

4308

16724

1.61

120.86

3.1

2.8

1144.68

1482.51

ng/l

7.57

3649

14287

Complex cardiac defects

165

259

22.78

120.78

11.1

3.7

760.07

799.05

ng/l

0.11

160

216

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7241

54642

1.40

120.37

3.1

2.9

1124.20

1301.91

ng/l

2.60

5976

46628

Glucosamine medication

8682

55324

1.40

120.37

3.1

3.0

1403.60

1595.11

ng/l

3.47

7397

47794

Chronic rhinitis, nasopharyngitis and pharyngitis

4193

29720

1.56

119.94

2.8

2.9

840.58

1209.79

ng/l

12.11

3437

25292

Somatoform disorder

2182

13507

1.87

119.72

3.0

2.8

853.59

1199.49

ng/l

3.35

1791

11438

Malignant neoplasm of skin

10620

65102

1.35

119.30

3.2

3.1

1974.49

1598.61

ng/l

10.00

9137

56274

Injuries to the hip and thigh

7411

52839

1.41

119.26

3.4

3.1

2172.82

1675.68

ng/l

9.73

6404

45338

Chronic sinusitis

5873

43983

1.45

119.21

2.9

992.07

1277.19

ng/l

7.25

4886

37426

All anxiety disorders

7087

43420

1.39

118.51

2.9

2.7

929.04

1046.82

ng/l

1.07

5621

36236

Behavioural syndromes associated with physiological disturbances and physical factors

3520

23998

1.60

118.14

3.2

2.9

1217.02

1151.24

ng/l

0.27

2852

20047

Other hearing loss

4664

33742

1.56

117.69

3.3

3.1

1972.18

1940.14

ng/l

0.14

3913

29306

Type of accident

3864

27183

1.59

117.65

3.5

3.0

1628.52

1402.44

ng/l

2.21

3320

23110

Myocardial infarction, with ST-elevation

3136

21685

1.76

117.39

4.0

3.3

2592.55

1893.33

ng/l

7.12

2863

18789

Ventral hernia

3719

26272

1.64

117.12

3.3

3.0

1730.45

1469.96

ng/l

1.96

3224

22589

Dentofacial anomalies [including malocclusion]

3215

21353

1.63

117.02

3.2

2.7

750.97

957.13

ng/l

3.76

2692

17977

Specific personality disorders

2541

16226

1.72

115.71

2.6

2.8

933.45

955.14

ng/l

0.08

2033

13369

Symptoms and signs concerning food and fluid intake

1528

8743

2.14

115.42

3.6

2.8

1702.28

1428.29

ng/l

1.17

1316

7442

Unspecified fall

7091

54588

1.40

115.11

3.3

3.1

1800.21

1511.37

ng/l

4.91

5895

46611

Other sleep disorders

1574

9091

2.09

114.11

3.4

2.9

1273.84

1561.09

ng/l

1.54

1331

7826

Problems related to lifestyle

1313

7087

2.18

114.02

2.9

2.8

1271.00

1072.50

ng/l

1.04

1096

5940

7077

52520

1.44

113.85

3.3

3.1

1913.73

1764.65

ng/l

1.40

6148

45583

Other specified/unspecified systemic involvement of connective tissue

951

4743

2.73

113.44

3.7

2.9

944.78

1190.48

ng/l

1.69

854

3999

Chronic laryngitis and laryngotracheitis

2142

13555

1.90

113.40

3.2

3.0

1017.58

1427.71

ng/l

6.15

1722

11699

Poisoning by medicine

2427

15445

1.74

113.23

2.9

991.04

1082.52

ng/l

0.55

1972

12825

Diseases of liver

4920

36483

1.51

113.06

3.6

3.0

1799.10

1363.34

ng/l

5.76

4170

31345

Asthma and allergy, excluding more controls

1191

6013

2.15

112.52

2.7

1.9

649.92

449.67

ng/l

1.59

966

4818

Use of pramipexole

3490

24713

1.67

112.36

3.3

3.0

1516.36

1527.27

ng/l

0.04

2978

21374

Complications of internal orthopaedic prosthetic devices, implants and grafts

3759

27044

1.64

112.20

3.4

3.0

1796.56

1527.58

ng/l

2.61

3263

23380

1665

9720

1.99

111.97

4.8

2.8

1353.11

1089.15

ng/l

1.66

1441

8184

Heart failure and hypertrophic cardiomyopathy

442

1716

7.52

111.89

12.7

3.1

4025.82

1606.65

ng/l

10.69

428

1480

Missing teeth due to accident, extraction or parodontitis

1808

11047

2.02

111.88

4.2

2.9

1619.44

1322.70

ng/l

1.51

1626

9551

Ovarian cyst

4591

18951

1.51

111.48

2.8

2.7

913.03

1295.22

ng/l

9.58

3802

15910

Other bacterial intestinal infections

2798

18885

1.74

111.16

4.2

3.0

2683.48

1619.21

ng/l

11.66

2463

16177

3886

26881

1.66

110.80

3.5

3.2

2124.79

1979.49

ng/l

0.93

3323

23400

Bacterial pneumonia, not elsewhere classified

5968

40248

1.44

110.70

3.9

2.8

2399.49

1381.93

ng/l

27.19

5308

34260

Coxarthrosis, primary, with hip surgery

7852

59478

1.40

110.60

3.2

3.1

1594.24

1639.04

ng/l

0.40

6890

51372

Sequelae with surgical and medical care as external cause

3081

21336

1.71

110.39

3.5

3.1

2186.60

1499.21

ng/l

6.61

2746

18369

Gastric ulcer

3033

20959

1.72

110.32

4.0

3.0

2197.90

1793.39

ng/l

3.31

2693

18128

Convulsions, not elsewhere classified

2892

19020

1.65

110.27

3.0

2.7

1535.45

1309.55

ng/l

1.55

2447

15973

Idiopathic gout

1611

9833

2.23

109.87

4.7

3.1

3040.63

1640.38

ng/l

12.74

1445

8563

Type 1 diabetes

3179

21656

1.61

108.92

3.6

2.8

3494.74

1213.07

ng/l

31.46

2765

18213

Combinations of oral blood glucose lowering drugs

4348

32018

1.55

108.49

3.3

2.9

1476.72

1315.21

ng/l

1.67

3742

27806

DVT of lower extremities

3025

20912

1.70

108.23

3.2

3.0

1592.90

1653.61

ng/l

0.20

2623

17990

Diseases of male genital organs

7780

30622

1.38

107.67

3.2

1657.35

1550.75

ng/l

0.77

6571

26233

Zoster [herpes zoster]

2807

19201

1.74

107.66

3.8

3.1

1857.48

1639.94

ng/l

1.12

2450

16550

Impingement syndrome of shoulder

3564

25201

1.60

107.53

3.0

2.8

831.78

1231.66

ng/l

12.94

3002

21641

Skin changes due to chronic exposure to nonionizing radiation

6715

50264

1.44

106.81

3.3

3.2

1934.31

1794.93

ng/l

1.19

5831

43680

Exclusions for E4_PCOS_BROAD

2180

13879

1.80

106.35

3.4

3.1

1356.97

1280.35

ng/l

0.20

1855

11722

Coagulation defects, purpura and other haemorrhagic conditions

2669

17903

1.72

106.24

3.8

3.1

1835.35

1494.32

ng/l

3.10

2339

15273

Actinic keratosis

6566

49272

1.45

105.90

3.3

3.2

1945.75

1809.57

ng/l

1.13

5712

42825

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4500

33113

1.50

105.85

3.6

2.9

1259.88

1234.41

ng/l

0.13

3865

28165

Other diseases of blood and blood-forming organs, wide

3194

22317

1.65

105.82

3.7

3.0

1709.43

1387.22

ng/l

2.52

2789

19190

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1479

8914

2.28

105.76

4.4

3.2

2200.94

1644.21

ng/l

2.87

1346

7700

Benign neoplasm: Colon, unspecified

3924

28580

1.60

105.05

3.5

3.1

1917.35

1556.52

ng/l

3.42

3387

24654

Umbilical hernia

3783

27169

1.57

104.70

3.2

3.0

1519.42

1337.11

ng/l

1.31

3227

23259

Diabetic retinopathy, excluding more controls

4076

16682

1.61

104.40

3.8

3.1

3187.25

1200.90

ng/l

36.51

3568

13789

Exposure to other specified factors

9782

74364

1.30

104.24

3.0

2.9

1363.47

1240.51

ng/l

1.67

8069

62965

Basal cell carcinoma, including avohilmo

9753

62973

1.34

104.13

3.2

3.1

1961.23

1640.85

ng/l

7.34

8429

54537

269

8127

0.26

104.05

2.8

3.2

3354.20

1934.13

ng/l

2.13

222

7062

Superficial injury of head

3174

22070

1.62

103.68

3.3

3.1

1837.85

1571.28

ng/l

2.53

2679

18811

Nonorganic sleeping disorders, excluding more controls

2073

12994

1.78

103.62

3.2

2.9

1121.31

1184.61

ng/l

0.28

1671

10987

Extracorporeal dialysis

1014

5437

2.61

102.84

5.3

3.1

12847.51

1313.98

ng/l

53.27

957

4672

Sequelae of cerebrovascular disease

5957

40645

1.45

102.79

3.9

3.1

2290.26

1751.21

ng/l

10.11

5177

35166

Other noninflammatory disorders of uterus, except cervix

3385

16206

1.63

102.66

2.9

2.8

1206.23

1504.60

ng/l

4.76

2865

13832

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

8264

45518

1.37

102.60

3.2

3.0

1861.79

1506.89

ng/l

7.53

7136

39026

Diseases of the myoneural junction and muscle

1886

11962

1.95

102.20

3.5

3.1

2016.73

1620.33

ng/l

1.72

1598

10285

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1779

10744

1.85

102.15

2.9

2.8

1042.38

951.77

ng/l

0.36

1417

8826

Bipolar affective disorders

2057

12908

1.76

101.09

2.6

2.8

765.70

1026.66

ng/l

2.85

1651

10760

Abnormal results of function studies

1262

7141

2.21

101.02

4.0

3.0

1823.41

1326.23

ng/l

1.99

1092

6067

Type 1 diabetes, wide definition

2712

18169

1.65

100.81

3.6

2.8

3609.55

1203.11

ng/l

29.46

2353

15261

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

8117

44898

1.37

100.23

3.1

1810.41

1513.59

ng/l

5.69

6997

38501

Diabetic nephropathy, excluding more controls

2335

13087

1.83

98.51

4.4

3.2

5820.18

1329.62

ng/l

56.55

2118

10907

Other diseases of liver

2466

16564

1.73

98.37

3.4

3.0

1537.65

1313.57

ng/l

1.07

2037

14156

Other enthesopathies

3995

29078

1.51

98.18

2.8

899.06

1239.41

ng/l

10.41

3399

24739

Misadventures to patients during surgical and medical care

2063

13402

1.83

97.81

3.9

3.0

2141.02

1366.28

ng/l

6.86

1807

11493

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

8008

44514

1.36

97.18

3.1

1832.91

1521.87

ng/l

6.04

6902

38188

Basal cell carcinoma

9493

62320

1.33

96.90

3.2

3.1

1977.58

1647.69

ng/l

7.51

8196

53992

Unspecified acute lower respiratory infection

2048

13202

1.80

96.47

4.5

3.0

1888.01

1469.39

ng/l

2.67

1799

11196

Other complications of surgical and medical care, not elsewhere classified

1381

8107

2.07

96.02

3.5

2.9

1557.84

1255.23

ng/l

1.29

1194

6904

Primary coxarthrosis, bilateral

4770

36553

1.50

95.80

3.4

3.1

1564.96

1680.45

ng/l

1.14

4175

31599

Mental and behavioural disorders due to tobacco

1213

6897

2.20

95.60

3.3

2.9

1587.73

1141.21

ng/l

2.40

1010

5845

Other congenital malformations of heart

156

287

13.12

95.58

9.9

3.3

861.13

854.04

ng/l

0.01

149

232

Seropositive rheumatoid arthritis

3768

27428

1.54

95.14

3.2

2.8

1542.60

1389.26

ng/l

1.40

3333

23341

Smoking dependency

1213

6913

2.19

94.89

3.3

2.9

1587.73

1136.83

ng/l

2.44

1010

5853

Bacterial intestinal infections, IBD co-morbidities

2781

19360

1.67

94.84

4.2

3.1

2689.25

1651.85

ng/l

11.02

2450

16589

Other malignant neoplasms of skin (=non-melanoma skin cancer)

9310

60576

1.33

94.61

3.2

3.1

2063.85

1651.54

ng/l

9.91

8017

52497

Other skin changes

2584

17830

1.72

94.47

3.6

3.1

1761.23

1561.09

ng/l

1.03

2281

15392

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

2325

15755

1.77

94.03

3.4

3.1

1561.65

1461.13

ng/l

0.54

2104

13548

Other disorders of eyelid

7117

55161

1.37

94.03

3.1

3.0

1480.51

1588.34

ng/l

1.24

6110

47533

Chronic ulcer of skin, not elsewhere classified

1170

6766

2.34

93.70

4.5

3.1

3510.09

1679.47

ng/l

8.48

1051

5834

Sleep disorders

2505

16840

1.65

93.08

3.3

3.0

1170.12

1253.92

ng/l

0.39

2031

14194

Hypertensive Renal Disease

644

3005

3.10

92.88

4.4

2.7

7393.73

1458.47

ng/l

20.23

583

2582

Unspecified urinary incontinence

1426

8667

2.09

92.66

3.3

3.0

1353.49

1457.01

ng/l

0.40

1087

7440

Operations for atrial fibrillation

376

1487

7.20

92.13

4.7

3.1

1603.60

1437.06

ng/l

0.31

367

1292

Asthma and allergy

1191

6433

2.00

92.11

2.7

2.3

649.92

726.26

ng/l

0.35

966

5228

Thyrotoxicosis, other and/or unspecified

2619

17941

1.65

92.03

4.2

2.8

1382.35

1258.45

ng/l

0.93

2255

15304

Panic disorder

1448

8468

1.89

91.64

2.9

2.7

959.12

932.80

ng/l

0.05

1152

6937

Benign paroxysmal vertigo

4302

32449

1.50

91.57

3.1

3.0

1192.31

1478.34

ng/l

4.85

3612

28002

Viral hepatitis, IBD co-morbidity

513

2026

2.90

91.30

2.9

2.4

1717.33

716.88

ng/l

1.36

423

1679

Any event in hilmo or specialist outpatient

108

21.46

90.68

3.0

1.2

713.41

482.79

ng/l

0.66

Paralytic ileus and intestinal obstruction

3928

29152

1.51

90.65

3.3

3.0

1825.63

1632.64

ng/l

1.29

3424

25082

Urticaria and erythema

4437

33174

1.45

90.44

3.3

2.9

1243.02

1193.79

ng/l

0.23

3685

28051

Symptoms and signs involving speech and voice

4701

35827

1.45

90.02

3.3

3.0

1251.39

1428.79

ng/l

2.14

4033

30739

Trochanteric bursitis

1969

12906

1.79

88.76

3.0

2.8

1129.10

1388.34

ng/l

1.63

1704

11074

Elevated blood glucose level

1240

7280

2.13

88.73

3.8

3.1

2269.84

1489.58

ng/l

3.60

1059

6224

Disorders of mineral metabolism

1199

6971

2.15

88.37

3.6

2.8

2633.72

1238.39

ng/l

5.37

1039

5927

Emotionally unstable personality disorder

1130

6225

2.02

87.31

2.3

2.7

666.85

697.39

ng/l

0.10

860

4992

Endometriosis

4286

18777

1.46

87.19

2.6

2.7

951.97

1308.42

ng/l

6.15

3557

15800

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1271

7517

2.07

86.92

3.6

3.0

1569.39

1266.04

ng/l

1.21

1081

6372

Alcohol use disorder, Swedish definition

7674

57552

1.32

86.60

3.1

3.0

1654.68

1430.18

ng/l

3.20

6529

49130

Migraine with aura and triptan purchases

1416

8366

1.87

86.50

2.6

2.7

468.71

736.02

ng/l

3.79

1136

6816

8390

61228

1.30

86.39

3.1

3.0

1642.63

1421.92

ng/l

3.42

7130

52202

Other diseases of lip and oral mucosa

2303

15683

1.69

86.02

3.2

2.9

1481.88

1326.78

ng/l

0.60

1978

13537

Benign neoplasm: Colon, unspecified

3924

29660

1.53

86.02

3.5

3.1

1917.35

1585.41

ng/l

2.97

3387

25776

Other and unspecified effects of external causes

3103

22021

1.53

85.95

3.0

2.9

1175.97

1195.97

ng/l

0.09

2575

18474

Kidney transplant status

761

3855

2.61

85.92

3.8

3.1

7685.57

910.52

ng/l

24.86

739

3273

Other postsurgical states

918

4948

2.37

85.90

4.6

2.5

1020.95

1223.77

ng/l

1.42

845

4190

Mouth breathing

5409

42079

1.39

85.46

3.0

955.59

1207.22

ng/l

4.81

4535

36035

Benign neoplasm: Sigmoid colon

2813

20178

1.64

85.09

3.5

3.1

1481.85

1478.59

ng/l

0.01

2496

17376

Open wound of lower leg

2037

13550

1.74

84.79

3.9

3.1

2005.24

1530.57

ng/l

3.65

1777

11534

Emphysema

1201

7175

2.18

84.59

3.9

3.0

1851.34

1891.47

ng/l

0.11

1072

6183

Diseases of external ear

4626

35405

1.43

84.54

3.2

3.1

1407.19

1449.76

ng/l

0.29

3738

30417

Idiopathic pulmonary fibrosis

1362

8553

2.16

84.30

4.4

3.2

1699.67

1963.51

ng/l

1.39

1245

7445

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3016

21294

1.52

83.77

2.8

951.64

1032.34

ng/l

0.52

2417

17677

Other hammer toe(s) (acquired)

2716

18069

1.63

83.72

3.0

2.9

1248.53

1483.76

ng/l

2.68

2309

15513

Localized swelling, mass and lump of skin and subcutaneous tissue

4317

32755

1.45

83.69

3.3

3.0

1356.64

1374.37

ng/l

0.09

3746

28021

Schizophrenia or delusion, excluding more controls

3569

25832

1.48

83.17

2.7

2.8

1100.97

1201.46

ng/l

0.63

2888

21810

Viral pneumonia (unknown virus, not influenza)

919

4982

2.29

82.69

4.3

3.0

1791.39

1310.91

ng/l

1.81

821

4183

Spondylolisthesis/Spondylolysis

2531

17650

1.63

82.57

3.1

2.8

1011.50

1380.37

ng/l

6.63

2159

15092

Need for other prophylactic measures

846

4532

2.46

82.47

3.8

3.1

1612.93

1301.43

ng/l

0.76

769

3854

Persons with potential health hazards related to communicable diseases

3627

26204

1.45

82.18

3.1

2.8

1630.50

983.96

ng/l

5.12

3019

21585

Epilepsy

4020

29984

1.45

82.14

3.0

1419.98

1627.68

ng/l

2.13

3438

25733

Haemorrhoids and perianal venous thrombosis

4504

34572

1.44

82.00

3.4

2.9

1377.23

1578.37

ng/l

2.72

3890

29753

Inguinal hernia

8863

49097

1.29

81.76

3.3

3.1

1676.94

1522.02

ng/l

1.91

7659

41851

Hypertension, Pulmonary Arterial

213

609

8.82

81.08

12.5

2.8

1485.17

1224.39

ng/l

0.73

208

507

Radiculopathy

2506

17585

1.64

80.87

3.3

3.0

1234.37

1744.66

ng/l

9.02

2149

15144

Haemorrhage, not elsewhere classified

665

3358

2.88

80.58

4.6

2.8

3089.66

1683.27

ng/l

5.32

599

2884

Adhesive capsulitis of shoulder

2416

16807

1.64

80.55

3.1

2.9

1242.95

1407.82

ng/l

1.30

2096

14459

7974

59824

1.30

80.42

3.1

3.0

1676.07

1428.60

ng/l

3.90

6791

51021

Noninfective enteritis and colitis

6057

47999

1.35

79.85

3.2

3.0

1519.86

1343.74

ng/l

1.70

5167

40663

Other metabolic disorders

1583

9989

1.81

79.72

3.6

2.6

1189.55

1016.13

ng/l

0.75

1370

8378

Injuries to the elbow and forearm

9372

70311

1.27

79.70

3.1

2.9

1551.26

1291.57

ng/l

5.11

7901

59451

Benign neoplasm of other and ill-defined parts of digestive system

2622

18726

1.63

79.45

3.4

3.0

1517.48

1414.05

ng/l

0.50

2277

16097

Bacterial pneumonia (organism specified)

6750

49650

1.34

79.18

3.9

3.0

2390.82

1652.94

ng/l

16.82

5988

42461

Nonalcoholic fatty liver disease

1211

7223

2.01

79.05

3.0

2.9

1069.97

1033.77

ng/l

0.09

960

6060

Unspecified mental disorder

4963

38366

1.38

78.84

2.7

2.9

998.11

1222.75

ng/l

4.11

4064

32277

Parodontitis or/and operation codes

9020

44261

1.29

78.74

3.0

1398.64

1124.45

ng/l

4.92

7627

37345

Other blood glucose lowering drugs, excl. Insulins

2692

19396

1.62

78.68

3.6

3.0

1959.97

1505.65

ng/l

3.19

2309

16796

Candidiasis

1762

11526

1.77

78.68

3.8

2.9

1441.46

1324.72

ng/l

0.53

1490

9784

Pain and other conditions associated with female genital organs and menstrual cycle

1867

11564

1.67

78.40

2.4

2.5

664.83

892.65

ng/l

1.49

1491

9542

Covid-19 suspected case

2224

15054

1.61

78.18

3.3

2.8

1283.79

1108.57

ng/l

0.87

1955

12496

Persistent mood disorders

2553

17917

1.59

78.13

3.1

2.9

1052.91

1359.21

ng/l

4.19

2079

15239

SLE (Finngen)

537

2458

2.96

78.02

3.5

2.8

1332.09

1085.92

ng/l

0.63

479

2051

Suicide or other Intentional self-harm

2727

19228

1.54

77.98

2.9

2.8

1022.28

1102.38

ng/l

0.45

2186

16094

Polymyalgia rheumatica

2255

15950

1.74

77.81

3.7

3.1

1694.94

1790.99

ng/l

0.51

1988

13784

Thyrotoxicosis

3351

24753

1.50

77.68

4.0

2.9

1389.95

1288.89

ng/l

0.81

2894

21093

Sicca syndrome [Sjögren]

1284

7906

2.00

77.52

3.1

2.9

912.89

1207.36

ng/l

3.21

1103

6715

Childhood asthma (age<16), excluding more controls

734

2772

2.21

77.44

3.5

1.8

398.08

272.55

ng/l

0.94

552

2041

Lesion of ulnar nerve

1890

12600

1.73

77.44

3.2

3.0

1392.54

1363.51

ng/l

0.09

1589

10821

Inflammatory diseases of female pelvic organs

7241

44041

1.31

77.44

2.7

882.96

1048.53

ng/l

3.85

5855

36981

Injuries to the ankle and foot

8209

61247

1.28

77.29

3.0

2.9

1289.89

1143.65

ng/l

1.93

6786

51435

Vasomotor and allergic rhinitis

4221

31416

1.41

77.21

2.8

2.9

915.04

1117.08

ng/l

1.85

3412

26408

Urticaria

3429

25231

1.47

76.98

3.3

2.9

1069.72

1157.46

ng/l

0.62

2825

21263

Benign neoplasm: Transverse colon

1595

10514

1.91

76.85

3.5

3.1

1747.89

1478.68

ng/l

0.89

1416

9063

Other noninfective gastroenteritis and colitis

3250

23859

1.50

76.85

3.4

3.1

1665.30

1477.02

ng/l

1.01

2792

20317

Disorders of skin appendages

5664

44677

1.35

76.55

3.1

2.9

1302.91

1182.40

ng/l

1.16

4791

37608

Irregular menses

4748

29469

1.38

76.36

2.6

2.5

756.39

838.86

ng/l

0.65

3878

24395

Disorders of muscles

1349

8317

1.90

76.36

3.5

3.0

1229.35

1522.96

ng/l

1.96

1166

7105

Peripheral artery operations in Hilmo

2113

14653

1.72

76.21

4.0

3.1

4510.27

1771.79

ng/l

28.14

1901

12642

In situ neoplasms

5084

38155

1.39

75.94

3.3

3.0

1949.75

1503.85

ng/l

5.29

4412

32480

Other shoulder lesions

1181

7022

1.96

75.64

3.2

2.9

949.57

1315.74

ng/l

2.83

983

5955

Other bursopathies

1907

12857

1.73

75.54

3.2

2.9

1642.62

1527.97

ng/l

0.34

1641

11051

Preparatory care for dialysis

719

3838

2.69

75.28

4.0

3.2

11272.39

1277.22

ng/l

34.43

683

3305

Osteoporosis with pathological fracture (FG)

1146

7034

2.16

75.28

4.0

2.9

1562.56

1633.27

ng/l

0.28

989

6019

Disorders of sclera, cornea, iris and ciliary body

7273

59375

1.30

75.26

3.1

2.9

1460.81

1321.97

ng/l

1.59

6205

50392

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

874

5033

2.53

75.25

4.0

3.1

2287.45

1663.87

ng/l

1.79

796

4332

Benign neoplasm: Ascending colon

2019

14001

1.75

75.21

3.5

3.1

1639.53

1469.42

ng/l

0.94

1798

12057

Other and unspecified drugs and medicaments

1189

7223

2.02

74.66

3.6

3.1

1630.16

1351.30

ng/l

0.99

1015

6141

Wet age-related macular degeneration

3058

22561

1.59

74.44

3.4

3.3

2219.24

2055.87

ng/l

0.94

2651

19624

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

2093

14585

1.71

74.13

3.6

3.1

1825.89

1543.64

ng/l

1.56

1888

12534

Disorders of vitreous body and globe

7483

60296

1.31

74.08

3.1

2.9

1515.00

1355.40

ng/l

1.74

6463

51935

Implicit fungal Sepsis

590

2947

2.94

73.85

5.6

2.9

2689.76

1248.45

ng/l

5.48

528

2523

Other disorders of kidney and ureter

1909

13053

1.75

73.79

3.7

3.1

4455.35

1488.95

ng/l

24.00

1714

11253

Propionic acid derivatives

4390

16634

1.41

73.51

3.2

3.4

1551.69

2170.40

ng/l

10.67

3655

14539

Fungal Sepsis

634

3259

2.79

73.05

5.5

2.9

2607.61

1264.02

ng/l

5.44

567

2780

Enthesopathies of lower limb, excluding foot

2746

19715

1.53

73.05

2.8

928.91

1277.86

ng/l

5.35

2288

16722

Other extrapyramidal and movement disorders in other diseases

3258

24397

1.51

72.84

3.2

3.1

1271.67

1539.07

ng/l

2.19

2776

21089

Mental and behavioural disorders due to alcohol

6869

54372

1.31

72.77

3.1

3.0

1660.08

1403.25

ng/l

3.57

5821

46347

Generalized anxiety disorder

1398

8603

1.77

72.75

2.8

2.7

679.60

888.86

ng/l

1.09

1078

7032

Diseases of salivary glands

2545

18119

1.56

72.50

3.0

2.8

1394.22

1254.80

ng/l

0.64

2183

15531

Other embolism and thrombosis

1906

13000

1.71

72.29

3.3

3.0

1769.50

1606.76

ng/l

0.57

1666

11141

Other diseases of intestine

1818

12308

1.75

72.28

3.7

2.9

2050.40

1564.58

ng/l

2.81

1592

10640

Benign neoplasm: Sigmoid colon

2813

20757

1.58

72.24

3.5

3.1

1481.85

1555.32

ng/l

0.31

2496

18003

Enterocolitis due to Clostridium difficile

1677

11211

1.80

72.22

4.8

3.2

3455.57

1788.41

ng/l

11.89

1501

9626

Temporomandibular joint disorders, including avohilmo

4329

33087

1.38

72.20

2.7

657.26

981.25

ng/l

11.96

3529

27576

Fracture of lower leg, including ankle

7559

62013

1.29

71.80

3.0

2.9

1514.84

1309.11

ng/l

2.93

6416

52737

Mental and behavioural disorders due to alcohol, excluding acute intoxication

6004

48215

1.33

71.77

3.1

3.0

1666.89

1380.33

ng/l

3.72

5091

41110

Leisure time condition

2305

16199

1.60

71.46

3.5

3.1

1640.93

1470.31

ng/l

1.03

1940

13817

Kela-code for severe mental illness

4489

34730

1.38

71.43

2.7

2.9

1005.67

1257.33

ng/l

4.49

3682

29233

Other symptoms and signs involving the urinary system

1546

10150

1.83

71.38

3.3

3.1

1841.53

1545.63

ng/l

0.87

1400

8783

Disorders of vitreous body

7251

58694

1.31

71.27

3.0

2.9

1491.29

1338.13

ng/l

1.60

6254

50560

Cervicocranial syndrome

1441

9199

1.81

70.82

3.0

2.8

933.51

1472.35

ng/l

5.57

1251

7851

Extrapyramidal and movement disorders

5515

44362

1.36

70.80

3.1

1287.92

1608.73

ng/l

5.75

4709

38325

Nonorganic sleeping disorders

2073

14164

1.61

70.65

3.2

3.0

1121.31

1226.31

ng/l

0.53

1671

11876

Family history of certain disabilities and chronic diseases leading to disablement

486

2148

2.70

70.46

2.7

2.3

692.53

669.56

ng/l

0.07

373

1717

Polyp of the female genital tract

4113

18167

1.42

70.29

2.8

2.7

1079.29

1375.88

ng/l

3.31

3428

15375

Special screening examination for other diseases and disorders

1044

6078

1.96

70.03

3.6

2.7

2227.42

1426.19

ng/l

2.52

882

5138

Fracture of lumbar spine and pelvis

3315

25059

1.50

69.84

3.7

3.1

2168.09

1797.57

ng/l

3.69

2876

21522

Other or unspecified ileus, impaction or obstruction

2767

20284

1.55

69.82

3.3

3.0

1853.05

1696.02

ng/l

0.70

2411

17489

Benign neoplasm: Rectum, anus and anal canal

3004

22458

1.54

69.78

3.3

3.1

1539.97

1494.36

ng/l

0.24

2607

19386

Arthropathies in other diseases classified elsewhere

564

2773

2.75

69.70

3.8

3.1

3385.53

1333.61

ng/l

7.94

474

2359

Presbycusis

2438

17651

1.63

69.59

3.4

3.2

2287.84

2291.77

ng/l

0.01

1999

15400

Purpura and other haemorrhagic conditions

1833

12462

1.70

69.56

3.9

3.1

1945.43

1520.77

ng/l

3.02

1636

10680

Sulfasalazine

3694

28031

1.42

68.84

3.0

2.6

1300.35

1260.41

ng/l

0.26

3176

23595

Female genital prolapse

4037

17733

1.42

68.79

2.8

2.7

984.52

1425.00

ng/l

12.17

3433

15055

Alcohol use disorder, ICD-based

5504

44033

1.34

68.74

3.1

3.0

1662.19

1372.02

ng/l

3.41

4662

37507

Other peripheral vascular diseases

1128

6891

1.98

68.52

3.4

2.9

1352.98

1264.11

ng/l

0.30

986

5825

Abnormal involuntary movements

1822

12414

1.70

68.50

3.3

3.0

1203.57

1442.01

ng/l

1.76

1552

10644

Amputation of toe

1178

7458

2.06

68.45

3.8

3.2

5114.42

1811.09

ng/l

18.05

1063

6447

Benign neoplasm: Rectum

2652

19531

1.58

68.36

3.3

3.1

1492.46

1475.49

ng/l

0.08

2298

16858

Cholecystitis

2167

15354

1.64

68.27

3.6

3.1

1892.03

1826.65

ng/l

0.24

1884

13232

Benign neoplasm of other and ill-defined parts of digestive system

2622

19233

1.57

68.22

3.4

3.0

1517.48

1468.87

ng/l

0.20

2277

16591

Other and unspecified disorders of skin and subcutaneous tissue

995

5945

2.11

68.12

3.6

3.0

1903.81

1402.17

ng/l

2.09

764

5073

Insomnia

1761

11745

1.66

68.10

3.3

3.0

1183.06

1182.58

ng/l

0.00

1418

9842

Voice disturbances

3576

27260

1.45

68.04

3.1

2.9

1082.37

1340.69

ng/l

3.64

3050

23401

Childhood asthma (age<16)

734

2914

2.10

68.01

3.5

2.2

398.08

429.89

ng/l

0.14

552

2182

Other necrotizing vasculopathies (FG)

949

5621

2.17

67.88

3.6

3.0

1663.89

1519.40

ng/l

0.44

852

4820

ILD-related respiratory insufficiency

614

3299

2.99

67.78

6.0

3.2

2520.32

1852.27

ng/l

2.06

580

2875

Flat foot [pes planus] (acquired)

1252

7826

1.88

67.70

2.8

922.93

1204.59

ng/l

1.80

1046

6681

Other viral diseases

3039

22242

1.46

67.61

3.7

2.9

1368.59

1174.41

ng/l

1.42

2607

18467

Amputation

1632

11073

1.80

67.47

4.1

3.1

5099.45

1775.80

ng/l

27.05

1468

9581

Benign neoplasm: Transverse colon

1595

10837

1.83

67.12

3.5

3.1

1747.89

1534.19

ng/l

0.64

1416

9406

Non-follicular lymphoma, hilmo, excluding all cancers

1479

9848

1.85

66.74

3.7

3.1

1854.81

1550.59

ng/l

1.83

1357

8481

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1383

9000

1.85

66.40

3.9

3.1

2187.27

1465.90

ng/l

3.96

1219

7715

Vascular disorders of the intestines

1123

7043

2.04

66.21

4.5

3.0

3143.85

1851.44

ng/l

5.03

1021

6105

Rheumatoid arthritis, including avohilmo

5551

44879

1.34

66.18

3.2

3.0

1490.78

1413.55

ng/l

0.67

4849

38370

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

3695

27922

1.40

66.04

2.9

2.8

856.56

986.49

ng/l

1.57

2972

23117

Chronic periodontitis, complicated

1377

9005

1.86

65.64

4.4

3.0

2999.23

1350.55

ng/l

9.09

1237

7739

Dialysis

615

3204

2.57

65.51

3.9

3.1

11259.17

979.30

ng/l

31.15

588

2737

Direct fill therapy

1619

10766

1.70

65.40

4.8

3.0

2380.14

1190.15

ng/l

6.86

1441

9103

Disorders of calcium metabolism

907

5326

2.14

65.38

3.7

2.8

3035.99

1271.90

ng/l

5.31

798

4527

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2536

17902

1.49

64.92

3.7

2.8

999.85

1072.94

ng/l

0.49

2099

14724

Adverse effects, not elsewhere classified

2202

15506

1.56

64.69

3.0

2.9

1195.00

1170.46

ng/l

0.09

1839

13026

Pain associated with micturition

1585

10613

1.73

64.51

3.3

3.0

1109.84

1407.82

ng/l

2.35

1319

9111

Benign neoplasm: Ascending colon

2019

14424

1.68

64.48

3.5

3.1

1639.53

1558.91

ng/l

0.34

1798

12519

Mixed hyperlipidaemia

673

3669

2.48

64.04

3.9

2.9

2588.25

1348.16

ng/l

3.18

589

3146

Transport accidents

5688

40512

1.31

64.04

2.9

1209.86

1163.38

ng/l

0.33

4689

34509

Traumatic subdural haemorrhage

1977

13674

1.64

63.97

3.6

3.0

2227.22

1947.44

ng/l

1.71

1726

11947

Other viral diseases, not elsewhere classified

2059

14293

1.57

63.90

3.8

3.1

1231.68

1296.71

ng/l

0.29

1777

11982

Benign neoplasm: Caecum

1579

10806

1.80

63.77

3.6

3.1

1836.07

1470.20

ng/l

1.43

1392

9291

Other and unspecified myopathies

1307

8537

1.88

63.52

3.5

3.2

2309.59

1743.11

ng/l

1.93

1113

7349

Injuries to the neck

2572

18671

1.50

63.22

2.9

3.0

1070.89

1325.21

ng/l

3.30

2124

15747

Osteomyelitis

972

5904

2.08

63.11

3.9

3.1

3970.67

1648.58

ng/l

14.41

868

5103

Diplopia

1800

12468

1.67

62.75

3.3

3.0

1200.11

1469.11

ng/l

2.06

1555

10725

Other disorders of patella

1894

12989

1.59

62.49

2.6

2.8

865.10

947.93

ng/l

0.32

1502

10949

Scoliosis

996

5925

1.92

62.40

3.3

2.9

1002.47

1402.29

ng/l

2.98

832

4968

Other degenerative diseases of the nervous system

3894

22850

1.40

62.37

2.9

1974.89

1666.28

ng/l

2.85

3249

19832

Systemic lupus erythematosus

537

2707

2.63

61.75

3.5

2.8

1332.09

1020.02

ng/l

1.00

479

2246

Anti-inflammatory and antirheumatic products, non-steroids

4297

16635

1.37

61.74

3.2

3.4

1662.43

2170.27

ng/l

6.87

3606

14540

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1813

12780

1.69

61.13

3.3

3.0

1914.31

1457.25

ng/l

2.58

1555

11138

Persons encountering health services for specific procedures, not carried out

926

5462

1.98

61.13

2.9

2.8

1906.62

989.27

ng/l

3.66

767

4541

Other specified congenital malformation syndromes affecting multiple systems

221

714

4.26

61.07

4.8

4.2

1131.35

810.95

ng/l

0.66

195

581

Other overlap syndromes

335

1426

3.71

61.04

3.7

3.0

820.65

1225.08

ng/l

1.80

305

1200

Speech therapy

3818

29876

1.41

60.84

3.2

3.0

1570.18

1456.23

ng/l

0.77

3467

25685

Other disorders of adrenal gland

636

3410

2.39

60.81

4.4

3.1

1471.04

1200.30

ng/l

0.52

560

2887

Other benign neoplasms of skin

5194

41233

1.33

60.77

3.2

3.0

1667.13

1458.94

ng/l

1.75

4425

35072

Post-traumatic stress disorder

658

3416

2.12

60.34

2.5

2.6

748.63

753.05

ng/l

0.01

533

2759

Unknown and unspecified causes of morbidity

960

5742

1.95

60.26

3.1

2.7

1593.55

1461.13

ng/l

0.30

869

4838

Conjunctivitis (acute, non atopic)

3197

24110

1.42

60.17

3.2

3.0

1236.89

1231.46

ng/l

0.02

2690

20415

Fissure and fistula of anal and rectal regions

3199

24328

1.43

59.89

2.9

1121.71

1319.14

ng/l

2.52

2709

20773

Other local infections of skin and subcutaneous tissue

1339

8794

1.78

59.51

3.8

3.0

2340.17

1377.94

ng/l

3.96

1158

7479

Retinal vascular occlusion

1937

13934

1.66

59.51

3.6

3.2

2382.55

1800.15

ng/l

4.28

1701

12124

SLE, strict definition

518

2620

2.64

59.37

3.5

2.8

1335.05

969.80

ng/l

1.20

459

2165

SLE, ICD10

518

2620

2.64

59.37

3.5

2.8

1335.05

969.80

ng/l

1.20

459

2165

Other dialysis

487

2445

2.84

59.32

3.9

3.2

12377.37

1115.94

ng/l

23.74

468

2092

Intestinal stricture

4501

36107

1.37

59.18

3.3

3.1

1816.64

1630.84

ng/l

1.39

3930

31152

Abnormalities of gait and mobility

1784

12599

1.68

59.18

3.1

3.2

2014.29

1689.24

ng/l

1.27

1558

10927

Adrenocortical insufficiency

540

2788

2.60

59.07

4.6

3.0

1273.75

1145.87

ng/l

0.25

482

2360

Other disorders of bone

2348

17041

1.51

58.50

2.9

1059.85

1152.33

ng/l

0.49

1930

14384

Retinal vascular disorders

1967

14220

1.65

58.41

3.6

3.2

2421.13

1815.70

ng/l

4.39

1727

12376

Glaucoma

8818

66250

1.25

58.11

3.1

1665.46

1614.52

ng/l

0.41

7543

57137

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1388

9137

1.71

57.98

3.5

2.6

1233.53

998.15

ng/l

1.00

1201

7662

Alcohol abuse, main dg, excluding more controls

1717

11792

1.61

57.75

3.1

3.0

1561.01

1222.96

ng/l

1.96

1444

10082

Other general symptoms and signs

590

3029

2.28

57.74

3.0

2.8

1587.80

1216.98

ng/l

0.45

480

2528

Other and unspecified local infections of skin and subcutaneous tissue

1257

8202

1.79

57.66

3.9

3.0

2430.70

1353.70

ng/l

4.37

1089

6971

Superficial injury of thorax

1954

13886

1.58

57.47

3.4

3.1

1457.56

1572.04

ng/l

0.48

1679

11846

Acute gastritis

1148

7396

1.86

57.27

3.6

3.0

1926.02

1652.87

ng/l

0.56

1003

6353

Neuralgia and neuritis, unspecified

694

3877

2.20

57.12

3.0

963.79

1304.39

ng/l

2.12

599

3285

Superficial injury of hip and thigh

2083

15055

1.57

56.94

3.5

3.2

2164.86

1766.47

ng/l

1.83

1782

12887

Bronchiectasis

1257

8379

1.86

56.93

4.0

3.0

1646.82

1685.88

ng/l

0.11

1105

7250

Non-follicular lymphoma

1479

10197

1.76

56.78

3.7

3.2

1854.81

1631.10

ng/l

1.13

1357

8829

Fibroblastic disorders

3396

26368

1.41

56.64

3.1

3.0

1478.66

1654.33

ng/l

1.56

2900

22793

Mixed and other personality disorders

836

4848

1.96

56.55

2.6

2.8

847.75

849.38

ng/l

0.00

663

3942

Benign neoplasm: Rectum, anus and anal canal

3004

23171

1.47

56.53

3.3

3.1

1539.97

1567.46

ng/l

0.13

2607

20111

Benign neoplasm: Rectum

2652

20127

1.51

56.50

3.3

3.1

1492.46

1562.17

ng/l

0.39

2298

17494

Systemic lupus erythematosus, unspecified

456

2245

2.75

56.42

3.4

2.8

1267.48

963.46

ng/l

0.82

412

1860

Dislocation, sprain and strain of joints and ligaments at neck level

1533

10302

1.63

56.17

2.6

2.9

763.51

1058.12

ng/l

3.50

1247

8524

Other problems related to primary support group, including family circumstances

1015

6005

1.80

55.91

4.8

2.9

933.66

837.10

ng/l

0.42

840

4889

Later onset COPD

4880

31422

1.37

55.83

4.3

3.1

2635.73

2008.88

ng/l

9.80

4335

27431

Any prescribed medicine buy

12.68

55.78

4.5

5.2

1447.07

1144.67

ng/l

0.26

KRA_PSY_EATING, excluding more controls

544

2682

2.18

55.72

3.0

2.6

982.35

544.88

ng/l

0.50

417

2134

Papulosquamous disorders

5260

42976

1.31

55.60

3.0

2.9

1270.18

1291.25

ng/l

0.14

4472

36763

Noninfectious colitis NAS

1724

12036

1.61

55.41

3.1

1663.97

1449.53

ng/l

0.71

1475

10221

Other enthesopathy of foot (+metatarsalgia)

1239

8063

1.75

55.35

2.9

2.8

875.06

1225.66

ng/l

4.45

1053

6873

Benign neoplasm: Caecum

1579

11121

1.73

55.33

3.6

3.1

1836.07

1526.28

ng/l

1.11

1392

9670

Otitis externa

2666

19975

1.46

55.32

3.0

1220.20

1337.76

ng/l

0.83

2164

17051

Charcot foot

283

1151

3.71

55.16

3.9

2.4

4544.19

909.41

ng/l

11.11

247

943

Metatarsalgia

1173

7566

1.78

54.83

2.9

2.8

881.87

1220.21

ng/l

4.08

1000

6449

Visual impairment including blindness (binocular or monocular)

1031

6587

1.92

54.47

3.7

3.2

2432.75

1846.82

ng/l

2.27

858

5626

Exclusion endpoint for clefts

248

911

3.55

54.39

4.8

4.0

1203.48

850.17

ng/l

0.78

218

734

Acute pancreatitis

2708

20532

1.46

54.12

3.3

3.1

1767.08

1554.79

ng/l

1.27

2371

17633

Restless leg syndrome

1635

11458

1.65

54.08

3.2

3.0

1276.95

1404.85

ng/l

0.36

1383

9840

Benign neoplasm: Stomach

1427

9821

1.74

53.97

3.8

3.0

1395.80

1420.81

ng/l

0.09

1230

8413

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

2596

19735

1.50

53.96

2.8

3.1

1154.36

1454.12

ng/l

4.90

2354

17029

Keratitis

4418

35452

1.33

53.79

3.1

3.0

1415.52

1304.41

ng/l

0.91

3758

30140

Abnormal findings on diagnostic imaging of other body structures

1735

12303

1.62

53.73

3.1

2.9

1428.98

1336.69

ng/l

0.31

1491

10550

Disorders of parathyroid gland

3159

24333

1.44

53.65

3.5

3.0

2782.58

1637.47

ng/l

9.70

2726

20905

Disorders resulting from impaired renal tubular function

561

3072

2.50

53.47

3.7

3.1

8900.45

1330.13

ng/l

23.59

531

2628

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1259

8495

1.81

53.40

3.9

3.1

2448.04

1715.62

ng/l

3.46

1097

7336

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

2011

14861

1.61

53.10

3.6

3.3

2567.47

2020.99

ng/l

4.12

1765

12860

Diabetic retinopathy

5185

27028

1.35

53.06

4.0

3.5

3177.17

1669.50

ng/l

29.71

4540

23124

Cardiomyopathy in other diseases

124

328

10.68

52.97

13.2

2.0

5158.98

558.82

ng/l

11.14

113

271

Other necrotizing vasculopathies

1093

7167

1.89

52.96

3.5

3.1

1876.51

1577.22

ng/l

0.85

981

6178

Thyroiditis, ILD-related definition

1346

8989

1.68

52.90

3.1

2.9

1198.07

1140.52

ng/l

0.16

1128

7588

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

3378

26658

1.42

52.79

3.0

3.1

1387.66

1489.27

ng/l

0.56

3062

23032

Superficial injury of abdomen, lower back and pelvis

1800

12728

1.56

52.73

3.5

3.0

1572.62

1448.93

ng/l

0.55

1523

10782

Disorders of conjunctiva

10427

75557

1.20

52.69

3.0

2.9

1150.97

1274.45

ng/l

2.09

8716

63774

Pruritus

1392

9433

1.68

52.61

3.3

3.0

1907.49

1409.75

ng/l

2.39

1188

8021

Other and unspecified visual disturbances

1251

8352

1.75

52.22

3.3

3.0

1276.08

1358.85

ng/l

0.28

1087

7154

Other condition

1631

11370

1.60

52.12

3.4

3.0

1546.79

1347.28

ng/l

0.95

1445

9603

Secondary and unspecified malignant neoplasm of lymph nodes

1234

8306

1.79

51.98

3.7

3.1

1868.16

1593.33

ng/l

1.25

1106

7129

Immunodeficiencies

646

3649

2.19

51.91

4.3

3.0

1567.05

1226.24

ng/l

0.86

576

3069

Other disorders of nervous system

954

6051

1.93

51.83

3.1

3.0

1157.86

1376.06

ng/l

1.18

804

5151

Viral and other specified intestinal infections

1931

13354

1.50

51.47

4.2

2.9

1841.97

1325.47

ng/l

2.10

1653

10856

Ascites

1057

6886

1.86

51.22

4.7

2.9

3334.53

1526.56

ng/l

8.94

974

5966

Schizophrenia or delusion

3569

27978

1.35

50.96

2.7

2.9

1100.97

1213.75

ng/l

0.74

2888

23449

Trigger finger

1775

12652

1.56

50.56

3.0

2.8

1229.29

1316.62

ng/l

0.24

1511

10856

Schizophrenia, schizotypal and delusional disorders

3593

28221

1.35

50.54

2.7

2.9

1082.61

1218.36

ng/l

1.00

2908

23668

Fracture of shoulder and upper arm

4820

39389

1.31

50.52

3.1

1777.92

1496.97

ng/l

3.25

4076

33636

Inflammatory diseases of prostate (prostatitis)

1806

13040

1.58

50.22

3.2

1454.83

1626.03

ng/l

0.58

1483

11377

Other diseases of oesophagus

1436

9983

1.68

50.22

3.6

3.1

1873.16

1757.18

ng/l

0.32

1260

8619

Synovial cyst of popliteal space [Baker]

1054

6861

1.83

50.15

3.4

2.9

1582.94

1585.41

ng/l

0.00

916

5877

Faecal incontinence

1302

8888

1.73

50.13

2.8

1433.95

1439.89

ng/l

0.01

1067

7693

Multiple myeloma, excluding all cancers (controls excluding all cancers)

775

4797

2.15

49.99

4.9

3.1

1942.94

1675.72

ng/l

0.90

711

4146

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

430

2099

2.45

49.80

3.0

2.8

3427.39

577.36

ng/l

5.11

375

1707

Seronegative rheumatoid arthritis

1607

11356

1.60

49.49

3.2

2.8

1567.96

1348.35

ng/l

1.16

1390

9698

Multiple myeloma and malignant plasma cell neoplasms

767

4747

2.15

49.47

4.9

3.2

1928.08

1682.04

ng/l

0.81

703

4102

Failure and rejection of transplanted organs and tissues

224

860

4.11

49.35

6.5

3.0

5281.04

717.01

ng/l

5.26

213

709

Phobic anxiety disorders

1064

6718

1.70

49.24

2.8

2.7

823.93

815.51

ng/l

0.02

847

5440

Other and unspecified urticaria

2161

15901

1.47

49.13

3.3

2.9

1115.75

1174.12

ng/l

0.24

1754

13398

Fenamates

2084

10186

1.50

49.08

2.9

3.3

1263.22

2031.05

ng/l

9.02

1753

8964

Superficial injury of wrist and hand

2020

14662

1.48

48.84

3.0

1280.58

1188.63

ng/l

0.33

1637

12320

In situ neoplasms

5084

42087

1.30

48.78

3.3

3.0

1949.75

1553.68

ng/l

4.32

4412

36160

Pleural plaque

1633

11877

1.66

48.54

3.8

3.2

1706.37

1972.64

ng/l

2.07

1428

10394

Spondylopathies (FG)

1504

10389

1.58

48.47

2.8

1031.33

1177.98

ng/l

0.68

1252

8724

Benign neoplasm of other and unspecified endocrine glands

1650

11785

1.59

48.40

3.2

3.0

1781.40

1302.96

ng/l

1.82

1443

10061

Fall on same level involving ice and snow

7520

64190

1.23

48.36

2.9

3.0

1306.31

1330.36

ng/l

0.19

6316

54642

Drug-induced adrenocortical insufficiency

296

1328

3.43

48.21

5.3

3.2

1197.41

1040.45

ng/l

0.18

265

1128

Parkinson's disease, excluding more controls

2009

14500

1.53

47.97

2.9

1358.41

1741.44

ng/l

4.67

1729

12719

Tobacco use

655

3795

2.09

47.68

3.0

2.9

1328.94

1152.62

ng/l

0.61

568

3212

Anaemia in chronic diseases classified elsewhere

421

2202

2.83

47.67

5.4

3.1

8356.58

1482.50

ng/l

21.23

401

1897

Other specified and unspecified personality disorders

956

6016

1.78

47.66

2.7

2.8

934.36

970.54

ng/l

0.11

780

4944

Asthma and opportunity respiratory infection

742

4598

2.12

46.99

3.9

3.0

1451.62

1580.11

ng/l

0.35

648

3967

Hallux rigidus

1935

14268

1.52

46.85

2.8

2.9

966.45

1347.87

ng/l

6.58

1639

12289

Migraine without aura and triptan purchases

1277

8508

1.60

46.77

2.5

2.6

403.82

670.69

ng/l

4.81

1019

6907

Acute suppurative otitis media

2071

14058

1.44

46.30

3.3

2.8

1106.32

981.16

ng/l

0.43

1668

11259

Benign neoplasm: Stomach

1427

10127

1.67

46.19

3.8

3.0

1395.80

1515.69

ng/l

0.56

1230

8718

Dermatophytosis

1749

12750

1.56

46.17

3.7

3.1

1609.42

1515.23

ng/l

0.33

1517

10972

Follow-up examination after treatment for malignant neoplasms

1454

10231

1.62

46.17

3.0

2.8

1789.62

1717.55

ng/l

0.18

1271

8791

Allergic rhinitis

2883

21944

1.37

46.02

2.7

2.9

719.00

945.76

ng/l

2.58

2292

18178

Fibrosis and cirrhosis of liver

1065

7138

1.81

45.99

3.9

3.0

2134.95

1427.37

ng/l

2.83

956

6132

Other aneurysm

846

5402

1.96

45.95

4.2

3.0

2074.10

1635.39

ng/l

2.13

773

4641

Fracture of femur

4149

31004

1.33

45.59

3.5

3.2

2633.05

1949.23

ng/l

10.16

3598

26690

Benign neoplasm: Adrenal gland

1015

6738

1.82

45.46

3.4

3.0

1778.25

1290.09

ng/l

1.62

897

5763

Glomerulonephritis

1310

9074

1.66

45.31

3.5

3.2

5122.59

1433.07

ng/l

17.01

1186

7735

Methotrexate

1859

13608

1.51

45.21

3.1

2.7

1307.96

1316.01

ng/l

0.03

1647

11517

Hypermobility syndrome

475

2460

2.19

45.16

2.3

2.6

552.95

629.82

ng/l

0.18

391

1977

Psoriatic and enteropathic arthropathies

1364

9430

1.61

45.11

3.0

2.8

1294.59

1169.42

ng/l

0.51

1165

8003

Blepharochalasis

4303

35474

1.33

45.09

3.0

1239.48

1471.63

ng/l

3.88

3671

30640

Spontaneous rupture of synovium and tendon

1115

7503

1.74

45.08

3.0

1249.83

1532.16

ng/l

1.62

946

6458

Artificial joint re-operation

1090

7479

1.83

44.76

3.2

3.1

1658.09

1507.71

ng/l

0.38

926

6471

Squamous cell neoplasms and carcinomas of the skin

2011

15282

1.54

44.61

3.6

3.3

2567.47

2054.74

ng/l

3.69

1765

13275

Amyloidosis

365

1856

2.94

44.55

8.0

3.0

3710.72

1528.36

ng/l

7.38

342

1586

Amyloidosis, other/unspecified

314

1520

3.31

44.47

8.5

3.0

3827.92

1430.38

ng/l

7.24

296

1297

Leiomyoma of uterus

5507

25703

1.26

44.15

2.7

985.54

1042.75

ng/l

0.44

4552

21476

Other and unspecified tonsillitis

2883

18791

1.35

44.12

2.9

2.8

908.41

843.55

ng/l

0.33

2260

15298

Psoriatic arthropathies

1201

8149

1.65

43.95

2.9

1296.04

1195.05

ng/l

0.34

1022

6966

Multiple myeloma and malignant plasma cell neoplasms

767

4899

2.06

43.91

4.9

3.1

1928.08

1712.87

ng/l

0.67

703

4242

Hyperkinetic disorders, excluding more controls

536

2774

1.99

43.88

3.2

2.9

569.51

452.43

ng/l

0.30

377

2115

Asthma mixed form (mode), excluding more controls

630

3636

1.98

43.88

3.2

2.0

1200.40

755.66

ng/l

2.58

540

3047

Psoriasis

3561

28604

1.34

43.72

3.0

1349.04

1275.19

ng/l

0.44

3017

24420

Stomatitis and related lesions

975

6334

1.74

43.65

3.2

2.9

1273.87

1265.95

ng/l

0.02

806

5354

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

700

4366

2.11

43.52

4.0

3.1

2019.50

1482.88

ng/l

2.32

648

3728

Diffuse large B-cell lymphoma, helper endpoint

700

4366

2.11

43.52

4.0

3.1

2019.50

1482.88

ng/l

2.32

648

3728

Pyogenic arthritis

903

5830

1.81

43.39

3.7

3.0

2000.16

1561.65

ng/l

2.04

791

5018

Moderate visual impairment, binocular

534

3100

2.36

43.33

3.9

3.2

3087.04

1985.42

ng/l

2.68

438

2668

Parkinson's disease, strict definition, excluding more controls

1861

13588

1.52

43.19

2.9

1394.53

1767.80

ng/l

4.05

1601

11909

Other coagulation defects

866

5519

1.81

43.14

3.7

3.0

1613.05

1361.53

ng/l

0.98

729

4655

Injuries to unspecified part of trunk, limb or body region

1246

8622

1.65

42.97

4.0

3.1

2152.75

1513.81

ng/l

3.34

1090

7352

Organic, including symptomatic, mental disorders

7923

49718

1.23

42.96

3.2

2037.19

1759.21

ng/l

4.37

6727

43295

Other/unspecified synovitis and tenosynovitis

1418

9986

1.58

42.96

3.1

2.9

1430.51

1443.50

ng/l

0.03

1169

8518

Plantar fascial fibromatosis

1162

7881

1.66

42.93

2.7

2.8

753.29

1234.79

ng/l

8.23

955

6727

Lung diseases due to external agents

2050

15532

1.49

42.87

3.8

3.2

2033.15

1967.72

ng/l

0.23

1806

13430

Bronchitis, not specified as acute or chronic

1140

7736

1.67

42.66

3.6

2.9

1521.95

1529.39

ng/l

0.02

992

6537

Hydronephrosis

1535

11083

1.57

42.65

3.1

2.9

2758.27

1204.78

ng/l

12.20

1346

9509

Other specified/unspecified soft tissue disorders

727

4506

1.96

42.49

3.4

3.0

1432.24

1676.75

ng/l

0.93

616

3841

Open wound of ankle and foot

1208

8283

1.64

42.48

3.6

3.1

2410.79

1374.72

ng/l

5.04

1030

7003

Retinal detachments and breaks

5122

43075

1.28

42.37

3.3

3.0

1878.18

1475.71

ng/l

6.34

4427

37228

Fracture of foot, except ankle

2593

20002

1.38

42.37

3.0

2.9

1387.05

1164.55

ng/l

1.35

2183

16846

Budesonide

1494

10603

1.54

42.35

3.0

2.7

1201.92

1252.61

ng/l

0.16

1259

8850

Neuromuscular dysfunction of bladder

1219

8454

1.66

42.31

3.0

1426.74

1500.16

ng/l

0.23

1024

7307

Other diseases of jaws

847

5393

1.81

42.05

3.2

2.8

1246.96

1254.54

ng/l

0.02

706

4580

Immunodeficiency with predominantly antibody defects

361

1806

2.60

42.03

4.9

2.9

1566.18

1016.79

ng/l

0.92

332

1512

Vitreous haemorrhage

1377

9828

1.62

41.79

3.5

3.1

3538.76

1567.74

ng/l

11.88

1227

8438

Other disorders of glucose regulation and pancreatic internal secretion

1061

7138

1.70

41.70

3.5

3.1

3588.96

1583.35

ng/l

7.02

933

6044

Acute pancreatitis (for exclusion)

2708

21289

1.39

41.65

3.3

3.1

1767.08

1556.28

ng/l

1.26

2371

18291

Other (seronegative) rheumatoid arthritis, wide

2650

20818

1.40

41.44

3.3

3.0

1568.60

1449.54

ng/l

0.75

2307

17890

Convalescence

700

4296

1.94

41.43

3.4

2.6

1233.97

1016.89

ng/l

0.97

578

3610

Inflammatory disease of uterus

1310

9057

1.56

41.33

2.4

2.6

660.26

869.71

ng/l

2.71

1052

7537

Leiomyoma of uterus

7921

38830

1.21

41.29

2.7

1026.99

1171.11

ng/l

2.44

6582

32816

Other benign neoplasms of skin

5194

43730

1.27

41.22

3.2

3.0

1667.13

1501.39

ng/l

1.23

4425

37500

Weight loss

1292

9130

1.63

41.20

3.3

3.1

1691.03

1584.40

ng/l

0.31

1100

7852

Injury of muscle and tendon at shoulder and upper arm level

4922

41293

1.28

41.17

3.1

3.0

1132.84

1357.46

ng/l

3.70

4209

35686

Recurring oral aphthae, including avohilmo

1656

12122

1.52

41.00

3.2

3.1

1137.75

1367.07

ng/l

1.84

1394

10342

Spondyloarthritis

2224

16932

1.42

40.91

3.3

3.0

1526.40

1553.38

ng/l

0.09

1903

14401

Viral pneumonia (known virus, not influenza)

379

1997

2.66

40.82

4.8

3.1

3580.77

1466.71

ng/l

4.11

349

1715

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1106

6620

1.58

40.77

3.8

3.0

792.69

740.22

ng/l

0.14

814

5062

Striking against or struck by other objects

3469

27818

1.31

40.73

3.2

3.0

1418.63

1231.88

ng/l

1.09

2792

23457

Brachial plexus disorders

938

6096

1.70

40.68

2.5

2.7

652.25

887.34

ng/l

1.66

791

5106

Other disorders of bladder

1694

12589

1.53

40.40

3.2

3.1

1705.68

1666.13

ng/l

0.10

1402

10980

Respiratory disorders in diseases classified elsewhere

255

1177

3.52

40.32

5.4

3.0

1154.19

1201.28

ng/l

0.11

238

1004

Other other unspecified disorders of the circulatory system

573

3435

2.17

40.28

4.5

3.1

2336.34

1551.15

ng/l

1.16

516

2946

Hyperparathyroidism

2734

21465

1.40

40.22

3.4

3.0

3006.75

1673.84

ng/l

10.00

2360

18430

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

314

1465

2.51

40.02

4.8

3.9

1115.58

937.87

ng/l

0.35

271

1195

Open wound of wrist and hand

4997

41304

1.25

40.00

3.0

1232.48

1256.56

ng/l

0.13

4073

34998

Benign neoplasm of other and unspecified endocrine glands

1650

12182

1.52

39.98

3.2

3.0

1781.40

1338.25

ng/l

1.61

1443

10446

Nail disorders

986

6583

1.70

39.84

3.4

3.1

1538.89

1188.89

ng/l

1.08

850

5539

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3659

29933

1.32

39.81

3.2

3.0

1527.24

1408.85

ng/l

0.99

3234

25699

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

726

4483

1.84

39.78

3.3

2.9

1247.34

1286.66

ng/l

0.09

601

3731

Noninflammatory disorders of female genital tract

4757

19630

1.27

39.76

2.9

2.7

959.66

1327.53

ng/l

7.40

3947

16433

Seropositive rheumatoid arthritis, wide

3768

30929

1.32

39.61

3.2

3.0

1542.60

1418.96

ng/l

1.02

3333

26555

Delirium, not induced by alcohol and other psychoactive substances

1700

12727

1.54

39.50

3.4

3.3

2890.40

2038.40

ng/l

4.73

1460

11091

Thrombocytopenia, unspecified

955

6431

1.76

39.33

4.0

3.1

2085.93

1544.67

ng/l

2.66

860

5516

Hydrocele

1658

12269

1.51

39.21

3.7

3.3

2301.72

1909.40

ng/l

1.74

1428

10703

Redundant prepuce, phimosis and paraphimosis

2265

17257

1.40

39.20

3.3

3.2

1570.73

1459.77

ng/l

0.48

1891

14604

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1509

10801

1.50

39.17

2.7

2.6

825.20

919.01

ng/l

0.47

1195

8993

TMD related operations

1707

12544

1.47

39.05

3.0

2.8

841.04

1004.96

ng/l

0.93

1426

10491

Amenorrhoea

519

2873

1.96

39.01

2.5

2.7

594.02

870.34

ng/l

1.85

414

2317

Seborrhoeic dermatitis

1239

8740

1.61

38.86

3.4

3.0

1678.70

1456.13

ng/l

0.54

1042

7465

Mental and behavioural disorders due to sedatives or hypnotics

738

4613

1.82

38.69

2.8

2.9

1447.10

1091.88

ng/l

0.61

592

3823

Nontoxic multinodular goitre

2777

22139

1.38

38.68

3.0

2.9

1242.91

1443.71

ng/l

1.76

2398

19023

Diabetic nephropathy

2347

18306

1.45

38.63

4.4

3.6

5811.15

1785.23

ng/l

46.41

2128

15738

Monoamine oxidase A inhibitors

1532

11184

1.52

38.52

3.1

2.9

926.37

1377.50

ng/l

6.41

1267

9658

Cerebral palsy and other paralytic syndromes

1398

10045

1.55

38.49

3.4

3.1

1240.89

1569.56

ng/l

2.14

1203

8555

Lateral epicondylitis

1478

10646

1.51

38.47

2.6

2.8

715.84

1077.79

ng/l

5.41

1238

9033

Degenerative macular diseases

1891

14500

1.50

38.43

3.4

3.2

1834.56

1756.85

ng/l

0.27

1636

12577

Diffuse large B-cell lymphoma

700

4509

2.01

38.43

4.0

3.1

2019.50

1584.94

ng/l

1.66

648

3874

Other and unspecified disorders of vitreous body

5727

48792

1.25

38.35

2.9

1015.45

1280.62

ng/l

5.59

4905

42035

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

6580

44303

1.23

38.16

2.9

3.1

1543.79

1537.10

ng/l

0.04

5782

38022

Other/unspecified seropositive rheumatoid arthritis

3717

30595

1.31

38.04

3.2

3.0

1554.35

1419.36

ng/l

1.14

3286

26274

Collagenous colitis

1143

7996

1.64

37.99

3.6

3.0

1588.86

1326.49

ng/l

1.26

991

6818

Deviated nasal septum

4267

35399

1.28

37.98

3.0

1023.35

1354.81

ng/l

8.09

3548

30432

Suggestive for eosinophilic asthma

1187

8352

1.62

37.97

3.2

2.9

1201.57

1453.03

ng/l

1.28

1032

7138

Hypopituitarism

762

4835

1.79

37.88

3.2

1230.53

1164.90

ng/l

0.08

634

4058

Spinal instabilities

390

2073

2.35

37.80

3.2

2.9

673.71

1093.20

ng/l

3.24

332

1740

Complications of cardiac and vascular prosthetic devices, implants and grafts

361

1948

2.73

37.76

5.9

3.1

3796.73

1677.09

ng/l

5.59

338

1688

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1024

7038

1.69

37.69

3.9

3.1

2288.15

1474.29

ng/l

3.58

889

6016

Disorders of ocular muscles, binocular movement, accommodation and refraction

5196

43379

1.24

37.66

3.1

2.9

1119.13

1215.22

ng/l

0.91

4313

36596

Cirrhosis of liver, NAS

739

4811

1.93

37.62

4.0

3.1

2173.55

1490.02

ng/l

2.24

668

4145

Other female pelvic inflammatory diseases

1887

14236

1.44

37.60

2.8

2.7

1002.25

1027.56

ng/l

0.10

1496

12123

Other epidermal thickening

608

3727

2.01

37.60

4.2

3.0

2013.52

1304.00

ng/l

1.93

546

3144

TMD related pain

388

2039

2.28

37.39

2.8

552.51

770.86

ng/l

1.22

305

1679

Other crystal arthropathies

328

1720

2.86

37.32

4.3

3.1

2042.30

1810.40

ng/l

0.44

284

1482

Barrett oesophagus

708

4558

1.94

37.32

3.3

3.0

1582.28

1410.70

ng/l

0.44

604

3928

Reactive arthropathies

1026

6976

1.64

37.11

3.2

3.0

1539.44

1306.80

ng/l

0.66

900

5951

Mental and behavioural disorders due to opioids

344

1711

2.30

36.93

3.3

3.1

1219.57

895.46

ng/l

0.50

277

1347

Intestinal adhesions without obstruction

1156

8173

1.63

36.93

3.3

2.9

1837.95

1548.35

ng/l

0.91

1011

7047

Other diseases of stomach and duodenum

896

6037

1.76

36.90

3.4

3.0

1765.37

1603.01

ng/l

0.24

779

5209

Other and unspecified injuries of lower leg

801

5167

1.74

36.78

3.2

2.9

1409.53

1174.36

ng/l

0.80

661

4340

Decubitus ulcer and pressure area

870

5883

1.80

36.62

4.7

3.2

4030.35

1880.44

ng/l

8.34

763

5083

Carbimazole or st.post thyroidectomy, condition for graves disease

2378

18577

1.38

36.58

3.9

2.8

1181.27

1147.29

ng/l

0.18

2031

15806

Other disorders of conjunctiva

1934

14871

1.46

36.42

3.7

3.1

1432.92

1545.15

ng/l

0.62

1687

12860

Other diseases of arteries and capillaries

1232

8818

1.60

36.40

3.9

3.0

2736.53

1443.59

ng/l

9.01

1081

7541

Alcohol abuse, main dg

1717

12807

1.45

36.31

3.1

3.0

1561.01

1298.99

ng/l

1.29

1444

10817

Abnormal weight loss

1184

8445

1.62

36.30

3.3

3.2

1646.69

1597.59

ng/l

0.12

1013

7280

Unspecified misadventure during surgical and medical care

737

4788

1.87

36.30

4.1

3.1

1995.11

1381.58

ng/l

1.88

657

4096

Other and unspecified coagulation defects

558

3322

1.97

36.26

3.3

2.8

1251.14

1083.84

ng/l

0.46

478

2773

Pneumonia due to other infectious organisms, not elsewhere classified

450

2561

2.22

36.23

4.7

2.7

2041.76

1129.09

ng/l

2.96

397

2163

Benign neoplasm: Adrenal gland

1015

7074

1.70

36.17

3.4

3.0

1778.25

1331.49

ng/l

1.40

897

6070

Ulcer of oesophagus

1056

7422

1.69

36.12

3.6

3.0

1965.85

1697.82

ng/l

0.78

913

6436

Other noninfective disorders of lymphatic vessels and lymph nodes

494

2892

2.13

36.11

3.8

2.9

1293.10

1258.11

ng/l

0.09

438

2424

Benign neoplasm: Descending colon

961

6666

1.74

35.96

3.6

3.1

1690.84

1488.21

ng/l

0.58

865

5733

Sulfonylureas

5864

40335

1.24

35.89

3.9

3.1

2941.49

1717.45

ng/l

30.20

5068

35040

Car occupant injured in other and unspecified transport accidents

1935

14659

1.41

35.80

3.0

1132.35

1270.05

ng/l

0.76

1592

12283

Open wound of forearm

1100

7667

1.61

35.77

3.8

3.0

2014.64

1482.68

ng/l

1.47

920

6497

Abnormal blood-pressure reading, without diagnosis

502

2897

2.01

35.75

2.7

2.6

821.17

1238.82

ng/l

2.59

420

2435

Dissection of aorta

515

3105

2.16

35.75

4.1

3.0

2067.01

1650.64

ng/l

1.00

473

2659

Crystal arthropathies, rheuma endpoint

328

1749

2.79

35.69

4.3

3.0

2042.30

1812.94

ng/l

0.43

284

1508

Dislocation, sprain and strain of joints and ligaments of knee

6848

54940

1.20

35.56

2.7

2.8

794.16

1043.40

ng/l

9.33

5644

46148

Embolic stroke with flimmer

405

2259

2.34

35.56

4.6

2.5

3232.21

1340.39

ng/l

8.28

365

1911

Disorders of breast

5632

44524

1.22

35.46

2.5

2.7

976.31

1070.29

ng/l

1.01

4762

37348

Superficial injury of shoulder and upper arm

1329

9592

1.53

35.39

3.2

3.1

1252.30

1486.33

ng/l

1.50

1110

8152

Fracture of skull and facial bones

2432

19108

1.36

35.12

3.2

3.0

1543.83

1361.56

ng/l

1.07

2056

16235

Fall on and from stairs and steps

3176

25848

1.32

35.11

3.1

3.0

1474.32

1447.61

ng/l

0.13

2684

22098

Congenital malformations and deformations of the musculoskeletal system

749

4731

1.71

34.96

3.1

3.4

906.14

945.08

ng/l

0.11

613

3886

Agranulocytosis

1379

10100

1.53

34.92

3.6

3.0

1536.48

1319.49

ng/l

0.83

1230

8615

Chronic pancreatitis

1596

11977

1.49

34.92

3.0

3.1

1845.95

1443.23

ng/l

2.01

1400

10282

Eosinophilic disease (BM)

224

999

3.05

34.90

3.9

2.5

2214.18

1015.15

ng/l

1.02

201

855

Other inflammation of eyelid

1602

11985

1.48

34.89

3.1

3.0

1231.73

1439.15

ng/l

1.27

1363

10266

Injury of unspecified body region

950

6513

1.68

34.81

4.2

3.2

2257.81

1529.64

ng/l

3.25

830

5532

Arterial embolism and thrombosis

883

6028

1.75

34.75

4.5

3.1

3609.06

1765.62

ng/l

6.93

803

5183

Acidosis

317

1663

2.68

34.68

3.8

2.9

3647.12

1338.03

ng/l

5.42

287

1425

Appendectomy

7701

64806

1.18

34.57

2.8

2.9

967.30

1191.18

ng/l

7.14

6469

54477

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

5522

30728

1.23

34.48

2.6

2.7

1090.95

1079.98

ng/l

0.07

4683

25688

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

5522

30730

1.23

34.45

2.6

2.7

1090.95

1079.90

ng/l

0.07

4683

25690

Other disorders of gingiva or/and edentulous alveolar ridge

632

3962

1.88

34.44

4.5

3.1

1678.22

1352.98

ng/l

0.84

563

3382

Carcinoma in situ of skin of other and unspecified parts of face

1260

9333

1.64

34.42

3.5

3.3

2756.02

1889.27

ng/l

3.02

1108

8079

Other and unspecified vascular occlusions

1430

10708

1.56

34.42

3.6

3.2

2329.48

1795.47

ng/l

2.80

1242

9298

Chondropathies

1687

12651

1.44

34.34

2.9

3.0

1070.47

1257.94

ng/l

0.98

1371

10686

Ingrowing nail

636

3981

1.85

34.08

3.3

3.0

1633.96

1163.81

ng/l

0.96

549

3320

Lung cancer and mesothelioma

2711

18632

1.35

34.05

3.1

2.6

1465.62

1425.43

ng/l

0.22

2466

16079

Ankylosing spondylitis

1003

6896

1.61

34.03

2.9

991.83

1540.34

ng/l

5.04

832

5865

Correction of physiology of bite - demanding therapy visit

709

4521

1.76

33.99

3.1

2.8

947.24

869.43

ng/l

0.18

577

3752

Excessive attrition of teeth

4794

21819

1.25

33.99

3.0

2.8

973.96

1107.15

ng/l

1.19

3949

18453

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3459

28412

1.29

33.94

2.9

3.0

1261.84

1324.04

ng/l

0.35

2924

24141

Hodgkin lymphoma

377

2061

2.28

33.80

3.8

2.9

1524.39

1370.08

ng/l

0.25

339

1718

Alcohol dependence

3435

28289

1.29

33.48

3.1

1628.81

1444.21

ng/l

1.08

2917

24220

Other disorders of the musculoskeletal system and connective tissue

1885

14574

1.43

33.35

3.2

3.0

1406.24

1453.37

ng/l

0.18

1635

12486

Other mental disorders due to brain damage and dysfunction and to physical disease

1672

12835

1.49

33.33

3.5

3.3

1774.10

1863.95

ng/l

0.28

1422

11168

Other and unspecified nerve root and plexus disorders, also in other diseases

2146

16744

1.38

33.33

2.9

834.01

1199.83

ng/l

4.41

1792

14291

Osteonecrosis

793

5342

1.77

33.19

3.6

3.0

1658.92

1284.21

ng/l

0.84

698

4565

Use of disulfiram, acamprosate or naltrexone

948

6504

1.62

32.87

2.6

2.9

939.13

1081.51

ng/l

0.51

753

5427

Colonic or urogenital fistula

3399

28038

1.29

32.86

2.9

3.0

1146.77

1375.70

ng/l

3.40

2880

23982

Other disorders of white blood cells

732

4841

1.79

32.78

3.6

3.0

2004.76

1462.03

ng/l

1.14

633

4122

Other and unspecified nonorganic psychotic disorders

1745

13138

1.40

32.76

2.5

2.9

935.43

1057.66

ng/l

0.67

1346

10804

Marfan's syndrome

101

311

5.80

32.75

4.5

3.0

858.62

906.59

ng/l

0.08

258

Disorders of oesophagus in diseases classified elsewhere

337

1855

2.55

32.53

4.2

2.9

2040.90

1441.26

ng/l

1.24

295

1598

Conjunctivitis

8834

68088

1.16

32.49

2.9

1082.92

1199.64

ng/l

1.64

7321

57258

Eating disorder

544

3205

1.80

32.44

3.0

2.7

982.35

553.36

ng/l

0.49

417

2508

Assault

1124

7892

1.52

32.29

2.6

2.9

1256.68

964.97

ng/l

1.21

882

6423

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1897

14783

1.42

32.21

3.6

3.1

2039.83

1560.64

ng/l

2.98

1676

12759

Opening and dilatation of root channel of tooth

673

4304

1.76

32.20

3.3

2.9

1606.58

1027.65

ng/l

1.49

544

3597

Other and unspecified injuries of head

782

5239

1.73

32.15

3.4

3.1

1659.69

1544.37

ng/l

0.35

659

4462

Other eating disorders

339

1739

2.12

32.06

3.4

2.9

1244.14

629.38

ng/l

0.42

258

1352

Contact with and exposure to communicable diseases

2405

18808

1.32

31.90

2.8

893.17

863.24

ng/l

0.09

1930

15242

Tubulo-interstitial nephritis, not specified as acute or chronic

941

6549

1.64

31.89

3.3

2.9

2407.55

1331.84

ng/l

6.15

798

5581

Psychotic depression

677

4333

1.75

31.88

3.0

1186.62

1272.52

ng/l

0.19

573

3731

Early lumbar disc prolapse, operated

709

4510

1.67

31.85

2.4

2.8

591.53

785.49

ng/l

0.40

552

3641

Nontoxic goitre/thyroid nodule

4090

34561

1.27

31.85

3.0

2.9

1237.04

1363.66

ng/l

1.19

3523

29552

Follow-up care involving plastic surgery

492

2958

1.99

31.70

3.2

2.5

1671.23

858.55

ng/l

2.30

370

2468

Other and unspecified mood [affective] disorders

595

3653

1.77

31.67

2.8

793.96

851.57

ng/l

0.22

466

2988

Disorders of continuity of bone

1046

7376

1.57

31.59

3.4

2.9

1431.72

1149.23

ng/l

1.24

906

6199

Dermatitis due to substances taken internally

675

4376

1.78

31.58

3.5

3.0

1554.71

1345.03

ng/l

0.52

574

3683

Other/unspecified cytomegaloviral diseases

270

1370

2.66

31.33

5.7

3.2

3541.82

927.01

ng/l

5.14

256

1155

Lack of expected normal physiological development

124

343

3.45

31.20

10.5

5.0

1562.06

804.12

ng/l

0.64

113

256

conjunctival haemorrhage

1035

7450

1.62

30.97

4.1

3.1

1462.19

1577.87

ng/l

0.43

903

6424

Pure hyperglyceridaemia

331

1808

2.39

30.97

4.0

2.9

2038.46

1273.44

ng/l

1.03

298

1531

Cytomegalovirus infection, IBD co-morbidity

310

1655

2.45

30.92

5.5

3.2

3387.22

998.58

ng/l

5.45

294

1402

Other specified/unspecified spondylopathies

408

2400

2.23

30.89

3.8

3.1

1529.26

1898.75

ng/l

0.78

358

2061

Postprocedural disorders of nervous system

631

3972

1.74

30.84

2.4

2.7

406.64

782.83

ng/l

6.04

519

3219

Insulin, fast-acting (human)

1514

11313

1.43

30.82

3.4

2.9

3623.35

1311.43

ng/l

17.57

1322

9399

Chondrocostal junction syndrome [Tietze]

488

2967

2.00

30.81

3.1

3.0

948.40

1162.67

ng/l

0.67

402

2491

Other peripheral vertigo

1228

9063

1.54

30.76

3.1

3.0

1110.75

1470.07

ng/l

3.52

1027

7831

Myositis

368

2075

2.25

30.67

3.6

3.1

1333.82

1470.32

ng/l

0.30

327

1760

Asthma mixed form (mode)

630

4011

1.77

30.57

3.2

2.6

1200.40

1339.79

ng/l

0.41

540

3407

Discitis, unspecified

275

1445

2.75

30.55

5.1

3.2

2726.58

1653.03

ng/l

1.81

253

1265

Hypotension due to drugs

260

1366

3.01

30.51

4.9

3.3

2946.54

1864.57

ng/l

1.45

232

1185

Haemolytic anaemias

473

2874

2.03

30.45

4.7

3.1

1945.33

1479.55

ng/l

1.29

414

2456

Hodgkin lymphoma, hilmo

377

2133

2.19

30.44

3.8

3.0

1524.39

1256.69

ng/l

0.52

339

1807

Other diseases of blood and blood-forming organs

899

6295

1.66

30.40

3.5

3.1

1745.89

1405.05

ng/l

1.33

745

5369

Psoriasis vulgaris

2222

17649

1.35

30.36

3.0

1321.79

1355.39

ng/l

0.14

1887

15073

Fentanyl

1415

10642

1.48

30.30

3.8

2.9

1882.08

1869.82

ng/l

0.03

1254

9118

Carcinoma in situ of skin of other and unspecified parts of face

1260

9529

1.59

30.27

3.5

3.3

2756.02

1963.03

ng/l

2.60

1108

8307

Sequelae of other external causes

675

4440

1.77

30.21

3.8

3.0

2210.33

1374.08

ng/l

2.65

618

3768

Otitis externa, unspecified

1167

8445

1.51

30.17

3.0

1079.84

1289.86

ng/l

1.21

953

7150

Lichen simplex chronicus and prurigo

831

5730

1.68

30.13

3.5

3.0

2402.15

1377.35

ng/l

2.27

725

4865

Acute pharyngitis

1203

8575

1.47

30.04

3.1

2.8

1086.03

952.71

ng/l

0.23

948

6991

Acute laryngitis and tracheitis

906

6057

1.55

29.98

3.7

2.8

895.93

1021.20

ng/l

0.35

734

4845

Injuries to the wrist and hand

12909

84853

1.13

29.97

3.0

2.9

1249.51

1307.63

ng/l

0.68

10680

72088

Olecranon bursitis

796

5439

1.69

29.94

3.7

3.1

1557.66

1637.05

ng/l

0.20

716

4680

Speech and linguistic disorders, excluding more controls

579

3347

1.74

29.89

4.5

3.3

1368.17

1114.32

ng/l

0.61

491

2709

Speech disturbances, not elsewhere classified

1192

8806

1.55

29.86

4.2

3.2

1704.94

1757.47

ng/l

0.14

1039

7590

Iridocyclitis

2725

22179

1.31

29.82

3.1

3.0

1515.60

1353.80

ng/l

0.91

2343

18924

Other infectious diseases

1054

7613

1.58

29.72

4.2

3.1

2507.03

1738.82

ng/l

3.68

943

6529

Corns and callosities

902

6340

1.64

29.64

3.5

3.0

2178.11

1338.27

ng/l

4.11

794

5395

Secondary uncertain malignant neoplasm

1764

13792

1.43

29.61

3.5

3.2

1867.58

1726.57

ng/l

0.63

1567

11929

Inflammatory bowel disease

3520

29290

1.26

29.57

3.1

2.9

1329.73

1229.76

ng/l

0.64

2994

24718

Sudden idiopathic hearing loss

1327

9956

1.50

29.51

3.3

3.0

1753.95

1512.10

ng/l

0.55

1101

8607

Benign neoplasm: Descending colon

961

6926

1.65

29.48

3.6

3.1

1690.84

1540.20

ng/l

0.40

865

5982

Preparation and fitting of bite rail to mouth

1341

9921

1.46

29.48

2.9

2.8

776.46

945.47

ng/l

0.93

1132

8283

Strabismus

2882

23489

1.29

29.47

3.2

3.1

1206.80

1298.66

ng/l

0.49

2423

19902

Panniculitis affecting regions of neck and back

476

2881

1.94

29.43

3.2

2.9

885.98

1412.63

ng/l

4.03

403

2437

Nephrotic syndrome

424

2519

2.08

29.40

3.3

7163.65

1272.29

ng/l

9.50

389

2162

Cytomegaloviral disease

313

1700

2.37

29.39

5.4

3.1

3364.64

1000.43

ng/l

5.41

296

1431

Diseases of tongue

822

5674

1.67

29.33

3.0

1126.14

1400.04

ng/l

0.97

689

4882

Other/unspecified enthesopathies of lower limb, excluding foot

766

5143

1.65

29.31

2.9

845.30

1338.90

ng/l

4.67

637

4347

Fracture of forearm

7014

57822

1.18

29.29

3.0

2.9

1522.99

1297.08

ng/l

3.45

5930

48996

Other/unspecified rheumatoid arthritis

1759

13763

1.42

29.27

3.4

3.0

1791.38

1565.61

ng/l

1.23

1555

11808

Herpesviral [herpes simplex] infections

1298

9628

1.47

29.12

3.3

3.0

1601.27

1328.60

ng/l

1.05

1123

8167

Other noninflammatory disorders of vagina

857

5898

1.61

29.12

2.9

2.8

1114.85

1322.12

ng/l

0.56

709

4999

Seborrhoeic keratosis

3123

26045

1.30

29.08

3.2

3.0

1567.81

1433.27

ng/l

0.69

2759

22518

Superficial injury of forearm

987

6966

1.55

28.92

3.2

3.0

1602.22

1264.21

ng/l

1.56

825

5861

Benign lipomatous neoplasm

3713

31292

1.26

28.82

3.0

1187.16

1327.25

ng/l

1.64

3171

26613

Hypoglycaemia, other or unspecified

806

5530

1.65

28.80

3.5

3.2

3641.55

1602.83

ng/l

5.43

712

4679

Other diseases of biliary tract

1168

8648

1.54

28.80

3.0

3.1

1628.30

1620.46

ng/l

0.02

1021

7440

Other disorders of eye and adnexa

1508

11442

1.43

28.75

3.1

3.0

1400.25

1311.92

ng/l

0.21

1281

9690

Cluster headache, strict

365

2036

2.06

28.72

2.6

2.8

652.89

1051.60

ng/l

1.62

287

1720

Thyrotoxicosis with diffuse goitre

1490

11266

1.42

28.70

3.3

2.8

1209.63

1125.43

ng/l

0.36

1269

9579

Ganglion

2243

17838

1.33

28.69

2.5

2.8

852.64

1187.16

ng/l

6.77

1879

15150

Personal history of malignant neoplasm

459

2787

1.97

28.67

3.4

2.5

1378.45

995.14

ng/l

0.61

384

2315

Other congenital malformations

788

5312

1.61

28.60

3.5

3.2

1150.92

1011.47

ng/l

0.42

686

4401

Infective dermatitis

1419

10740

1.45

28.57

3.5

3.0

1907.27

1425.87

ng/l

1.96

1214

9176

Pneumocystosis

268

1442

2.75

28.56

4.6

3.0

2307.26

1254.82

ng/l

2.02

250

1231

Schizophrenia

1665

12768

1.39

28.55

2.5

3.0

1036.04

1145.37

ng/l

0.36

1358

10673

Urolithiasis

4384

37564

1.24

28.48

3.0

3.1

1468.67

1630.15

ng/l

1.53

3726

32462

Cluster headache, wide

402

2317

1.99

28.46

2.7

2.8

820.95

1129.70

ng/l

0.76

320

1951

Sequelae of injuries, of poisoning and of other consequences of external causes

2645

21526

1.30

28.35

2.8

3.0

1118.41

1228.08

ng/l

0.78

2204

18296

Personal history of other diseases and conditions

844

5712

1.57

28.34

4.1

2.4

1245.17

787.93

ng/l

2.16

704

4599

Suppurative and unspecified otitis media

3195

23273

1.26

28.29

3.3

2.9

1271.45

1178.53

ng/l

0.43

2594

19156

Oesophagitis

737

5036

1.71

28.25

3.4

3.1

1616.32

1552.55

ng/l

0.14

645

4311

ILD medications: pirfenidone

196

972

3.69

28.22

4.0

2.8

1141.03

1442.83

ng/l

0.58

180

844

Acquired haemolytic anaemia

356

2068

2.25

28.00

4.6

3.2

2168.46

1525.67

ng/l

1.59

317

1772

Atypical facial pain

625

4111

1.76

27.90

2.5

2.9

612.17

1134.72

ng/l

6.74

522

3483

Other specified/unspecified hearing loss

1088

7986

1.54

27.87

3.4

3.1

1669.07

1787.79

ng/l

0.39

975

6922

Achilles tendinitis

1205

8902

1.48

27.87

3.0

2.9

1043.72

1392.32

ng/l

1.88

1001

7636

Visual field defects

1116

8235

1.53

27.73

3.5

3.1

1851.56

1639.13

ng/l

0.73

952

7085

Other follicular disorders

708

4727

1.66

27.67

3.2

2.9

1856.81

1096.76

ng/l

1.82

592

3955

Gout due to impairment of renal function

200

999

3.43

27.56

5.7

3.1

7123.54

1663.01

ng/l

8.05

190

868

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

567

3569

1.72

27.45

2.8

3.0

1221.51

986.81

ng/l

0.50

449

2861

Orchitis and epididymitis

1136

8362

1.51

27.44

3.9

3.2

1927.99

1672.51

ng/l

0.54

987

7272

Otalgia

841

5853

1.60

27.38

3.1

842.10

1237.39

ng/l

3.24

696

4983

Impacted cerumen

1331

10144

1.48

27.35

3.5

3.2

1687.07

1694.47

ng/l

0.02

1021

8798

ILD medications: nintedanib

134

578

5.26

27.34

4.0

2.9

961.03

1401.04

ng/l

1.07

120

499

Erythema intertrigo

352

2058

2.24

27.18

3.6

3.1

1665.26

1383.46

ng/l

0.36

315

1768

Schizoaffective disorder

760

5165

1.62

27.11

2.5

2.9

843.96

969.56

ng/l

0.54

615

4273

Ocular pain

862

6040

1.58

27.03

3.4

2.9

1120.68

1144.32

ng/l

0.05

744

5052

Tinnitus

2878

23860

1.29

26.78

2.7

2.9

1055.47

1300.59

ng/l

1.47

2402

20527

Hyperhidrosis

313

1701

2.12

26.77

3.4

2.5

991.02

1021.26

ng/l

0.07

258

1385

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

727

4879

1.61

26.74

2.6

2.9

863.83

1011.34

ng/l

0.42

578

4054

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

237

1258

2.87

26.61

4.3

3.0

1351.11

1339.13

ng/l

0.01

212

1071

Special screening examination for infectious and parasitic diseases

1823

10490

1.34

26.59

2.4

693.01

798.38

ng/l

0.41

1321

8598

Endometriosis of pelvic peritoneum

1414

10512

1.40

26.45

2.4

2.5

593.99

903.12

ng/l

4.43

1136

8751

Invasive ventilation

923

6649

1.58

26.41

3.7

3.1

3644.37

1580.23

ng/l

6.92

773

5694

Pre-eclampsia

1747

13571

1.35

26.40

2.7

2.5

899.36

685.44

ng/l

1.40

1455

11203

Pneumonia due to Streptococcus pneumoniae

529

3388

1.82

26.39

4.0

2.7

2059.79

1259.40

ng/l

3.03

458

2870

5-aminosalicylic acid

2137

17055

1.32

26.25

3.0

2.7

1389.16

1182.49

ng/l

1.12

1790

14213

Gingival hyperplasia

404

2429

1.99

26.15

5.1

3.0

1928.66

1332.66

ng/l

1.32

359

2079

Disorders of psychological development

769

4804

1.56

26.08

4.7

3.3

1172.01

1058.96

ng/l

0.33

625

3774

Adenomyosis (Endometriosis of uterus)

1566

12133

1.40

26.07

2.6

2.8

988.90

1366.29

ng/l

4.15

1320

10370

Other otitis externa (chronic)

777

5419

1.63

26.00

3.1

3.0

1150.18

1332.45

ng/l

0.81

603

4601

Ptosis of eyelid

1475

11493

1.44

25.91

3.0

1452.52

1557.37

ng/l

0.38

1261

9941

!Aliquae complicationes praecoces traumatis

516

3308

1.83

25.87

4.1

3.1

1949.59

1473.25

ng/l

1.14

445

2819

Early complications of trauma

516

3308

1.83

25.87

4.1

3.1

1949.59

1473.25

ng/l

1.14

445

2819

Postmenopausal osteoporosis with pathological fracture

919

6781

1.64

25.82

3.7

3.1

1541.83

1631.73

ng/l

0.33

788

5810

Cholangitis (primary sclerosing, PSC)

790

5557

1.63

25.80

3.2

1628.07

1722.13

ng/l

0.24

706

4754

Sub-endpoint used in defining T1D endpoints

3543

29388

1.24

25.80

3.6

3.2

3581.77

1628.55

ng/l

25.48

3079

24832

Obsessive-compulsive disorder

462

2794

1.78

25.70

2.4

2.8

923.64

824.40

ng/l

0.09

354

2261

Restrictive cardiomyopathy

348

8.43

25.70

14.2

3.1

3782.98

1795.88

ng/l

1.68

298

Congenital iodine-deficiency syndrome/hypothyroidism

435

2715

1.97

25.58

4.1

3.0

1654.37

1491.85

ng/l

0.34

381

2304

Drug-induced cataract

334

1947

2.20

25.58

4.5

3.1

2023.23

1027.16

ng/l

1.76

303

1642

Corneal ulcer

1997

15942

1.33

25.56

3.0

1281.60

1293.26

ng/l

0.04

1694

13517

Drug-induced osteoporosis with pathological fracture

261

1451

2.65

25.50

5.4

3.1

1777.55

1250.36

ng/l

1.61

232

1236

Lymphoid leukaemia

759

5350

1.67

25.49

3.2

1984.98

1687.28

ng/l

0.93

674

4594

Acute and subacute iridocyclitis

2244

18200

1.31

25.40

3.2

3.0

1521.99

1347.73

ng/l

0.82

1934

15518

Benign neoplasm: Skin of other and unspecified parts of face

1415

10942

1.43

25.27

3.3

3.1

1694.55

1541.92

ng/l

0.45

1201

9377

Other noninflammatory disorders of vulva and perineum

904

6431

1.52

25.16

2.9

2.7

967.94

1219.18

ng/l

1.73

761

5439

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

542

3440

1.69

25.06

2.4

942.93

434.06

ng/l

0.99

455

2786

Disorders of tooth development and eruption

404

2317

1.85

25.02

5.9

3.1

1211.40

934.11

ng/l

0.53

346

1884

Artificial opening status

654

4466

1.70

24.99

3.4

2.6

1728.04

1404.88

ng/l

0.60

581

3806

Postmenopausal atrophic vaginitis

3199

16115

1.27

24.90

2.6

2.7

754.24

1358.27

ng/l

28.64

2752

13804

Anterior Iridocyclitis

2383

19499

1.30

24.88

3.2

3.0

1516.92

1373.86

ng/l

0.67

2052

16643

Emotional disorders starting during childhood or adolecense, excluding more controls

217

1006

2.23

24.81

3.0

3.5

554.22

428.83

ng/l

0.27

146

758

Giant cell arteritis

632

4389

1.79

24.74

3.4

3.0

1532.01

1640.43

ng/l

0.25

566

3789

Eating disorders

762

5204

1.55

24.73

3.2

2.8

1467.07

935.50

ng/l

0.86

608

4183

Cramp and spasm

543

3557

1.77

24.64

3.0

3.1

990.22

1317.03

ng/l

1.24

453

3016

Intestinal malabsorption

543

3561

1.76

24.54

3.1

2.9

2184.08

1138.69

ng/l

2.01

482

2982

Other symptoms and signs involving general sensations and perceptions

508

3302

1.82

24.51

3.4

3.2

1318.09

1631.21

ng/l

1.55

422

2823

Carcinoma in situ of skin

1161

8899

1.52

24.51

3.6

3.2

2560.69

1660.24

ng/l

2.91

1019

7677

Pre-eclampsia or eclampsia

1917

15223

1.32

24.42

2.8

2.5

888.08

698.85

ng/l

1.32

1602

12623

L01XE Protein kinase inhibitors

783

5618

1.65

24.40

3.2

3.1

1567.24

1331.64

ng/l

0.76

717

4842

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2789

23082

1.26

24.36

2.8

2.9

1102.18

1083.90

ng/l

0.06

2254

19430

Autoimmune hyperthyroidism

650

4390

1.64

24.34

3.2

2.7

1273.10

1050.87

ng/l

0.68

558

3700

Myeloproliferative diseases

1148

8726

1.49

24.27

3.4

3.1

2203.83

1557.15

ng/l

2.12

1009

7518

Neuroendocrine tumor and carcinoma of small intestine

237

1302

2.73

24.23

4.3

3.1

1351.11

1350.10

ng/l

0.00

212

1113

Dissociative [conversion] disorders

353

2042

1.93

24.16

2.8

2.7

652.20

1007.65

ng/l

1.69

284

1685

392

2469

2.11

24.15

4.2

3.1

1925.56

1836.52

ng/l

0.13

354

2137

Trigeminal neuralgia

721

5034

1.63

24.06

2.9

3.0

979.99

1391.13

ng/l

3.22

612

4286

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

443

2851

1.95

23.89

3.8

3.0

1575.75

1525.16

ng/l

0.07

399

2433

Unspecified/other endometriosis

699

4741

1.57

23.80

2.6

833.82

971.00

ng/l

0.34

570

3891

Alzheimer’s disease (Atypical or mixed), excluding more controls

1194

7893

1.48

23.79

3.4

3.1

2346.11

2262.05

ng/l

0.19

979

6906

Hypertrophy of breast in women and men

1956

15676

1.32

23.77

2.5

2.7

938.74

964.73

ng/l

0.10

1599

13199

Other endocrine disorders

503

3091

1.74

23.72

4.2

3.8

923.71

1184.55

ng/l

1.32

423

2603

Rash and other nonspecific skin eruption

1161

8772

1.45

23.71

3.3

3.0

1584.84

1413.38

ng/l

0.37

1027

7500

Calculus of kidney and ureter

3970

34254

1.22

23.63

3.0

3.1

1427.95

1599.68

ng/l

1.58

3369

29566

Diseases of peritoneum

1291

9951

1.43

23.48

3.7

3.1

4380.11

1522.39

ng/l

14.24

1124

8524

Examination and encounter for administrative purposes

517

3382

1.76

23.46

3.2

2.8

1231.15

1514.66

ng/l

1.11

449

2907

Abnormal findings on examination of urine, without diagnosis

554

3706

1.74

23.37

4.1

3.1

4283.74

1495.34

ng/l

4.64

499

3178

Unspecified privation

1266

9705

1.43

23.30

3.3

3.1

2116.71

1495.02

ng/l

3.46

1107

8261

Viral warts

1012

7459

1.47

23.26

3.7

3.0

1722.64

1175.97

ng/l

1.78

879

6240

Other diseases of pancreas

967

7189

1.53

23.24

3.3

3.0

1536.52

1473.46

ng/l

0.18

844

6178

Colorectal cancer, excluding all cancers (controls excluding all cancers)

3967

33249

1.23

23.13

2.8

3.1

1548.13

1653.47

ng/l

0.74

3459

28658

Assault by bodily force

622

4163

1.61

23.11

2.6

2.9

1136.43

886.47

ng/l

0.65

493

3368

Acute generalized exanthematous pustulosis

549

3668

1.74

23.08

3.6

3.0

1624.96

1242.70

ng/l

0.99

474

3097

Cyst of kidney

940

7012

1.55

23.04

3.4

3.1

2191.41

1513.17

ng/l

2.07

821

6060

Acute bronchiolitis

413

2237

1.77

22.90

5.8

3.9

2033.51

1310.48

ng/l

1.08

352

1789

Mental disorders, not otherwise specified

723

5007

1.56

22.89

2.6

2.8

843.19

898.12

ng/l

0.16

571

4122

Thyroiditis

787

5609

1.56

22.85

3.2

2.8

1045.37

1142.47

ng/l

0.31

671

4718

Dental caries 2 and operation codes, only avohilmo

7283

50524

0.87

22.80

2.9

3.0

826.55

1160.85

ng/l

12.37

5856

42773

Small fibre neuropathy

390

2463

2.01

22.77

3.6

3.0

1845.52

1298.13

ng/l

1.44

339

2121

Monoarthritis, not elsewhere classified

487

3150

1.76

22.74

3.5

3.0

1761.11

1363.53

ng/l

0.60

419

2670

Postprocedural musculoskeletal disorders, not elsewhere classified

916

6800

1.54

22.71

3.2

3.1

1369.17

1461.29

ng/l

0.30

803

5864

Pregnancy hypertension

3633

27838

1.21

22.71

2.6

2.4

844.08

715.53

ng/l

1.13

3045

22919

Non-allergic asthma

1084

8169

1.46

22.59

3.2

1158.98

1495.81

ng/l

2.00

949

7017

Macular pucker

2090

17294

1.34

22.54

3.3

3.1

1812.18

1476.01

ng/l

1.62

1811

15121

Superficial injury of ankle and foot

1044

7727

1.44

22.47

2.9

3.0

1291.72

1032.67

ng/l

1.21

870

6374

Lesion of lateral popliteal nerve

611

4200

1.67

22.42

3.3

3.0

1447.74

1388.92

ng/l

0.11

550

3595

Xerosis cutis

246

1390

2.49

22.36

5.0

3.1

2196.08

1401.48

ng/l

1.20

224

1193

Duodenal ulcer

1551

12350

1.38

22.27

3.8

3.1

2568.96

1934.02

ng/l

3.27

1369

10748

Pre-eclampsia or poor fetal growth

2381

19455

1.26

22.25

2.6

2.4

788.07

646.54

ng/l

1.12

1972

15915

Mental retardation, excluding more controls

354

2067

1.89

22.20

3.3

3.4

1572.98

1058.12

ng/l

0.54

294

1755

Palmar fascial fibromatosis [Dupuytren]

2197

18158

1.31

22.15

3.3

3.1

1744.87

1868.54

ng/l

0.62

1907

15789

Ulcerative colitis, NAS

1440

11232

1.37

22.08

3.3

3.0

1404.03

1235.56

ng/l

0.63

1216

9437

malignant neoplasm of male genital organs

6181

34998

1.18

22.07

3.1

3.3

2005.32

1832.68

ng/l

1.37

5330

30684

Allergic urticaria

812

5819

1.52

21.99

3.7

3.0

1105.55

1223.62

ng/l

0.41

676

4866

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

4220

31854

1.19

21.97

2.6

2.5

853.97

751.02

ng/l

0.94

3541

26265

Lymphoid leukaemia

759

5503

1.60

21.91

3.2

1984.98

1742.60

ng/l

0.70

674

4759

Reactive arthropathies, FINNGEN

746

5281

1.55

21.89

3.3

2.9

1607.79

1235.48

ng/l

0.88

655

4430

Medial epicondylitis

413

2589

1.82

21.87

2.6

2.9

751.75

1079.62

ng/l

1.70

343

2179

Arthropathic psoriasis

1263

9751

1.41

21.84

2.9

3.0

1274.80

1239.00

ng/l

0.11

1076

8284

Algoneurodystrophy

344

2058

1.92

21.81

2.3

2.6

889.07

816.11

ng/l

0.12

282

1693

Excessive vomiting in pregnancy

629

4269

1.58

21.69

2.3

2.6

373.60

627.79

ng/l

5.19

491

3482

Attention to artificial openings

519

3500

1.76

21.69

3.7

2.9

1959.86

1416.29

ng/l

1.62

466

3020

Ulcerative colitis

2654

22168

1.25

21.63

3.2

3.0

1394.30

1255.35

ng/l

0.77

2252

18736

Secondary polycythaemia

321

1938

2.07

21.56

3.9

3.0

1466.90

1354.25

ng/l

0.22

267

1635

Hyperkinetic disorders

541

3474

1.60

21.55

3.2

3.4

569.05

603.10

ng/l

0.07

380

2628

Melanocytic naevi

3074

26032

1.23

21.52

3.2

2.9

1427.46

1211.36

ng/l

1.28

2624

21941

Sacroiliitis, not elsewhere classified

389

2376

1.78

21.43

2.5

2.9

544.94

970.20

ng/l

2.24

309

1938

Benign neoplasm: Small intestine

558

3861

1.75

21.43

3.5

3.1

2014.20

1505.23

ng/l

0.91

491

3309

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

407

2608

1.89

21.40

3.5

3.2

1351.32

1638.36

ng/l

0.95

358

2242

Carcinoid syndrome

175

911

3.07

21.32

4.9

3.1

886.41

1295.36

ng/l

1.42

161

791

therapeutic use

436

2877

1.89

21.28

3.8

3.0

1481.24

1253.73

ng/l

0.54

359

2451

Abdominal aortic aneurysm (AAA)

1538

12216

1.37

21.27

3.7

3.2

3377.93

2089.98

ng/l

7.80

1371

10621

Coeliac disease

1326

10315

1.38

21.27

3.2

3.0

1530.99

1224.70

ng/l

0.75

1131

8766

Malignant neoplasm of bronchus and lung

1954

22168

0.77

21.26

2.9

3.3

1511.67

2105.07

ng/l

8.54

1761

19220

Toxic effects of substances chiefly nonmedicinal as to source

1145

8714

1.41

21.21

3.0

1255.06

1255.41

ng/l

0.00

965

7303

Dermatopolymyositis (FG)

209

1115

2.47

21.18

4.6

2.8

1091.41

1251.72

ng/l

0.34

192

938

Acute appendicitis, no complications

6190

54926

1.15

21.17

2.8

2.9

987.26

1149.45

ng/l

2.53

5169

46252

Other strabismus

2141

17479

1.28

21.11

3.1

3.0

1075.52

1206.46

ng/l

0.65

1780

14713

Crohn disease

1275

9837

1.38

21.07

2.9

3.0

1333.21

1114.91

ng/l

0.95

1089

8211

Generalized skin eruption due to drugs and medicaments

479

3173

1.76

21.02

3.8

3.0

1658.21

1228.65

ng/l

1.01

412

2689

Bicipital tendinitis

563

3842

1.66

21.00

3.3

3.0

787.86

1239.46

ng/l

3.72

489

3274

Carcinoma in situ of skin

1161

9096

1.47

20.99

3.6

3.2

2560.69

1736.45

ng/l

2.50

1019

7915

Disturbance of activity and attention

498

3158

1.62

20.96

3.2

3.3

582.48

495.21

ng/l

0.18

346

2391

Social phobias

555

3677

1.59

20.95

2.6

895.53

709.31

ng/l

0.31

435

2939

Amputation of foot

383

2478

1.99

20.93

4.2

3.2

6734.19

1744.70

ng/l

8.92

358

2169

Focal epilepsy

2454

20486

1.27

20.82

3.1

3.2

1499.38

1526.05

ng/l

0.10

2129

17529

284

1635

2.03

20.82

2.4

2.8

528.28

687.49

ng/l

0.78

228

1359

Diseases of spleen

252

1443

2.28

20.82

4.4

3.0

1957.10

1365.10

ng/l

0.91

238

1233

Isolated proteinuria

359

2236

1.92

20.69

4.3

3.0

5463.03

1342.03

ng/l

4.48

320

1906

Vitamin deficiency, wide

571

3924

1.66

20.67

3.8

3.0

1855.91

1536.36

ng/l

0.67

493

3364

Vitamin deficiency

571

3924

1.66

20.67

3.8

3.0

1855.91

1536.36

ng/l

0.67

493

3364

Other disorders starting during childhood or adolecense, excluding more controls

234

1177

2.02

20.65

6.1

3.6

1539.34

654.52

ng/l

1.24

180

892

L02BX Other hormone antagonists and related agents

784

5860

1.61

20.58

3.5

3.3

1825.89

1902.06

ng/l

0.18

706

5189

Benign neoplasm: Skin of other and unspecified parts of face

1415

11244

1.38

20.58

3.3

3.1

1694.55

1623.95

ng/l

0.18

1201

9690

Other/unspecified disorders of vestibular function

531

3654

1.73

20.52

3.4

3.0

1349.31

1541.65

ng/l

0.57

463

3133

Vasculitis limited to skin, not elsewhere classified

362

2293

1.96

20.49

4.1

3.1

1814.29

1409.28

ng/l

1.10

323

1943

Acute alcohol intoxication, ICD10

2093

17203

1.28

20.42

3.0

1610.58

1304.16

ng/l

1.87

1739

14573

Nonhereditary hypogammaglobulinemia

152

729

2.82

20.42

4.2

2.9

1415.53

829.96

ng/l

0.71

144

601

Biological medication for rheuma

1375

10737

1.35

20.34

2.6

2.9

1019.13

927.35

ng/l

0.31

1185

8895

Nummular dermatitis

1009

7676

1.46

20.33

3.4

3.1

1608.15

1443.92

ng/l

0.36

870

6583

Cerebral aneurysm, nonruptured

1047

8001

1.45

20.31

2.7

2.9

1092.36

1261.71

ng/l

0.78

909

6816

Maternal care for other conditions predominantly related to pregnancy

1328

10106

1.34

20.29

2.2

2.3

572.01

452.42

ng/l

0.45

1012

8121

Speech and linguistic disorders

590

3825

1.56

20.26

4.7

3.7

1371.88

1144.35

ng/l

0.52

500

3042

Drug-induced neutropenia

851

6323

1.51

20.25

3.3

3.0

1474.22

1197.57

ng/l

0.85

765

5402

Temporal arteritis

556

3923

1.75

20.19

3.4

3.0

1542.68

1623.71

ng/l

0.16

497

3375

Ectropion of eyelid

605

4308

1.68

20.15

3.3

2019.87

2300.17

ng/l

0.92

528

3763

Benign neoplasm: Skin of eyelid, including canthus

1946

16042

1.31

20.14

3.2

3.0

1607.28

1415.54

ng/l

0.84

1670

13807

Myeloproliferative diseases (CML excluded)

1032

7943

1.47

20.11

3.3

3.1

2254.47

1576.97

ng/l

2.09

897

6848

Pollen allergy

1301

9927

1.35

20.09

2.7

3.0

709.01

739.16

ng/l

0.08

973

7991

Malignant neoplasm of respiratory system and intrathoracic organs

2313

25285

0.79

20.09

2.9

3.3

1533.33

2036.72

ng/l

6.58

2084

21959

Other abnormalities of plasma proteins

238

1374

2.38

20.06

4.5

3.2

3378.81

1369.31

ng/l

3.03

223

1181

Colectomy operation

2248

18830

1.29

20.05

3.1

1765.86

1652.08

ng/l

0.38

1949

16285

Erosion of teeth

177

884

2.42

19.95

4.3

3.0

2106.90

698.92

ng/l

1.90

159

734

Calcific tendinitis of shoulder

632

4430

1.58

19.95

3.1

2.9

721.98

1151.52

ng/l

3.58

542

3756

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

4565

24507

1.20

19.92

3.0

3.2

1868.01

1680.15

ng/l

1.28

3940

21253

Other specified/unspecified dorsopathies

432

2820

1.76

19.90

2.9

1184.46

1531.89

ng/l

1.13

360

2382

Hypoparathyroidism

496

3394

1.75

19.85

4.1

3.1

1300.60

1257.34

ng/l

0.12

426

2873

Lichen ruber planus, wide definition including periferal and oral lichen planus

2605

22060

1.26

19.85

2.8

2.9

1103.36

1318.71

ng/l

1.57

2192

18953

Complications of other internal prosthetic devices, implants and grafts

520

3577

1.71

19.82

3.3

3.0

1768.62

1502.94

ng/l

0.61

458

3038

Pneumonitis due to solids and liquids

1077

8318

1.44

19.80

3.6

3.2

2329.10

2042.84

ng/l

0.86

930

7179

Infections with a predominantly sexual mode of transmission

2461

20448

1.24

19.79

2.7

1171.87

870.08

ng/l

2.36

1932

16763

Nasal polyp

2377

19926

1.26

19.75

2.8

3.0

1246.69

1481.22

ng/l

1.92

2041

17223

Carcinoma in situ of skin of ear and external auricular canal

232

1352

2.47

19.73

3.5

3.4

4468.11

2169.35

ng/l

2.40

211

1193

Radial styloid tenosynovitis [de Quervain]

530

3574

1.62

19.71

2.8

915.66

1043.62

ng/l

0.49

441

2982

Malignant neoplasm of small intestine

331

2101

2.06

19.70

4.0

3.1

1772.23

1515.00

ng/l

0.35

297

1822

Disorders of refraction and accommodation

2495

20777

1.24

19.69

3.0

967.21

1123.73

ng/l

1.42

2033

17462

Other and unspecified primary disorders of muscles

117

514

3.29

19.67

3.7

3.4

1281.64

1198.55

ng/l

0.05

110

438

Suppurative and necrotic conditions of lower respiratory tract

700

5084

1.58

19.61

4.0

3.1

2080.58

1689.99

ng/l

1.32

637

4390

Other disorders of the genitourinary system

1655

13486

1.34

19.60

2.9

3.0

1376.15

1363.55

ng/l

0.03

1383

11597

Focal brain injury

760

5524

1.51

19.46

3.2

2.9

1675.45

1712.46

ng/l

0.08

640

4797

Other/unspecified enthesopathies, not elsewhere classified

1050

8044

1.42

19.43

3.2

3.0

1201.93

1631.68

ng/l

3.07

899

6905

Allergic contact dermatitis

1350

10613

1.35

19.40

2.9

2.8

902.74

1051.75

ng/l

1.07

1104

8912

Meralgia paraesthetica

417

2736

1.79

19.37

2.8

2.9

665.13

1066.65

ng/l

4.35

353

2336

Other and unspecified vasculitis limited to skin

331

2083

1.98

19.31

4.1

3.1

1859.00

1409.11

ng/l

1.16

297

1769

Benign lipomatous neoplasm

3713

32344

1.20

19.28

3.0

1187.16

1369.95

ng/l

2.52

3171

27785

Gluteal tendinitis

416

2710

1.76

19.28

2.5

2.8

833.65

1155.24

ng/l

1.25

338

2283

Psoriatic arthropathies, ICD10

1155

8965

1.39

19.25

2.9

3.0

1292.81

1177.00

ng/l

0.38

981

7587

Cerebral cysts

577

3999

1.60

19.23

3.5

3.0

1488.70

1441.43

ng/l

0.09

488

3355

Polyarthritis, unspecified

437

2884

1.74

19.21

3.5

3.1

1488.56

1331.46

ng/l

0.36

383

2462

Morphin

259

1531

2.17

19.21

4.6

3.0

1737.42

1871.27

ng/l

0.18

233

1326

Hepatic failure, not elsewhere classified

476

3241

1.74

19.15

4.5

3.1

2460.65

1468.20

ng/l

2.96

420

2782

Other orthopaedic follow-up care

659

4714

1.56

19.09

2.9

2.8

1208.61

1098.70

ng/l

0.36

556

3974

Post-traumatic wound infection, not elsewhere classified

318

1961

1.94

19.07

3.6

3.1

1891.89

1312.90

ng/l

1.52

272

1665

Salpingitis and oophoritis

1922

15807

1.29

18.99

2.7

2.6

953.61

924.02

ng/l

0.14

1582

13440

FESS (DNB20)

1315

10372

1.36

18.97

2.8

2.9

825.64

1198.85

ng/l

3.78

1055

8752

Arterial embolism and thrombosis of lower extremity artery

510

3539

1.72

18.97

4.6

3.0

3930.32

1670.77

ng/l

4.90

456

3049

Infective bursitis

369

2370

1.85

18.92

3.4

3.1

1593.76

1505.40

ng/l

0.12

311

2049

Other disorders of penis

1080

8337

1.41

18.83

3.4

1396.40

1540.73

ng/l

0.43

920

7240

Other keratitis

1140

8831

1.38

18.76

3.0

2.9

1572.05

1274.18

ng/l

1.19

978

7415

Other and unspecified immunodeficiencies with predominantly antibody defects

164

832

2.55

18.73

5.0

2.9

1415.96

926.38

ng/l

0.75

152

685

Other retinal artery occlusion

357

2327

1.95

18.72

3.7

3.2

2556.42

1777.29

ng/l

1.65

311

2008

Dislocation, sprain and strain of joints and ligaments of thorax

381

2455

1.80

18.70

3.6

3.0

1269.87

1289.23

ng/l

0.04

327

2070

Acute lymphadenitis

574

3978

1.57

18.69

2.9

3.0

1071.53

1136.77

ng/l

0.17

479

3314

Endometriosis of rectovaginal septum and vagina

860

6421

1.46

18.64

2.8

845.20

1386.86

ng/l

5.99

713

5491

Cluster headache, strict, including avohilmo

455

3013

1.67

18.63

2.5

2.9

622.91

940.09

ng/l

1.62

361

2488

severe traumatic brain injury, does not include concussion

2957

25456

1.23

18.62

3.4

3.2

2054.44

1885.25

ng/l

1.01

2541

21996

Dislocation of lens

234

1360

2.25

18.62

3.6

3.1

2785.45

1803.12

ng/l

1.13

207

1189

Ehlers-Danlos syndrome

369

3.14

18.61

2.0

2.8

791.24

774.18

ng/l

0.01

291

Disorders of plasma-protein metabolism, not elsewhere classified

106

455

3.34

18.61

4.0

3.0

857.94

991.66

ng/l

0.20

389

Other fall from one level to another

2342

19622

1.25

18.60

3.1

1337.17

1375.21

ng/l

0.12

1974

16694

Rheumatic fever incl heart disease

467

3187

1.73

18.58

4.9

3.2

2532.85

1968.54

ng/l

1.35

427

2737

Other arterial embolism and thrombosis

407

2705

1.81

18.56

4.3

3.1

3629.89

1709.29

ng/l

2.93

375

2322

Ethmoidectomy

1370

10892

1.34

18.53

2.8

2.9

884.97

1214.48

ng/l

2.74

1099

9205

Dermatographic urticaria

626

4421

1.54

18.47

2.7

2.8

681.50

959.11

ng/l

2.50

517

3654

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1608

13165

1.34

18.46

3.2

2467.08

1673.21

ng/l

5.15

1447

11356

Other psoriatic arthropathies

1120

8708

1.39

18.45

2.9

1315.91

1136.03

ng/l

0.67

948

7359

Carcinoma in situ of skin of upper limb, including shoulder

356

2359

2.01

18.45

3.3

3.2

2553.23

1694.98

ng/l

2.28

312

2036

Alzheimer disease, excluding more controls

2620

14880

1.26

18.44

2.9

2256.43

1819.59

ng/l

3.39

2166

13033

Giant cell arteritis with polymyalgia rheumatica

556

3998

1.70

18.31

3.4

3.1

1542.68

1615.59

ng/l

0.14

497

3439

Pneumothorax

871

6586

1.47

18.29

3.7

3.0

1764.48

1682.09

ng/l

0.17

779

5633

Appendicitis, broad definition

9008

75328

1.12

18.20

2.9

1089.81

1249.00

ng/l

3.18

7571

63637

Focal epilepsy, strict definition

2281

19174

1.26

18.18

3.2

1557.70

1548.80

ng/l

0.03

1983

16415

Other specified/unspecified bacterial intestinal infections

802

6006

1.49

18.15

3.2

3.1

1451.75

1445.77

ng/l

0.02

693

5127

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

1741

14368

1.32

18.14

3.2

3.3

2373.72

1968.78

ng/l

1.72

1518

12499

Personal history of medical treatment

134

643

2.84

18.13

3.4

2.8

2353.94

1426.34

ng/l

0.86

120

528

Renal tubulo-interstitial disorders in diseases classified elsewhere

161

844

2.72

18.12

4.6

2.9

3538.64

1001.73

ng/l

6.16

148

716

Nonsuppurative otitis media

1873

13192

1.27

18.09

3.4

3.0

1229.06

1258.94

ng/l

0.08

1532

10870

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

2657

22798

1.25

18.06

3.0

3.2

1653.85

1716.67

ng/l

0.26

2307

19694

Lichen planus

1607

13147

1.32

18.05

3.0

1110.38

1355.17

ng/l

2.17

1375

11292

Lesion of plantar nerve

769

5733

1.51

18.03

2.8

2.9

714.92

1191.81

ng/l

8.27

653

4890

Agoraphobia

220

1195

2.01

18.02

2.6

649.69

740.01

ng/l

0.18

169

960

Recurrent dislocation and subluxation of joint

581

4036

1.54

18.01

2.5

2.8

857.56

988.47

ng/l

0.28

459

3336

Pyothorax

551

3907

1.64

18.00

3.9

3.2

2128.32

1762.92

ng/l

0.98

496

3377

Bell's palsy

1345

10735

1.35

17.96

3.2

3.0

1447.73

1425.96

ng/l

0.06

1125

9157

Diseases of appendix

9097

75898

1.12

17.95

2.9

1091.96

1253.91

ng/l

3.30

7648

64135

Other abnormal findings of blood chemistry

517

3599

1.65

17.93

3.2

3.0

1689.66

1342.77

ng/l

1.10

436

3075

Rare circulating lymphoid malignancy

407

2722

1.78

17.89

3.5

3.3

1351.32

1690.09

ng/l

1.35

358

2345

Seropositive rheumatoid arthritis, strict definition

1839

15224

1.29

17.88

3.0

2.9

1400.68

1272.92

ng/l

0.71

1637

13043

Prepatellar bursitis

532

3710

1.62

17.88

3.6

3.1

1432.72

1506.41

ng/l

0.14

459

3178

Rheumatic valve diseases

358

2336

1.87

17.88

5.2

3.1

2672.36

2128.27

ng/l

1.00

327

1992

Cluster headache, wide,, including avohilmo

492

3346

1.62

17.83

2.6

2.9

761.92

980.33

ng/l

0.63

394

2773

Malignant neoplasm of prostate

6064

34540

1.16

17.81

3.1

3.3

2017.41

1838.77

ng/l

1.42

5234

30360

Acute and transient psychotic disorders

1156

9013

1.36

17.81

2.7

2.9

904.91

1173.08

ng/l

2.38

945

7525

Benign neoplasm: Small intestine

558

4006

1.66

17.77

3.5

3.1

2014.20

1425.81

ng/l

1.16

491

3446

Acute appendicitis

8322

71635

1.12

17.77

2.9

1073.66

1232.33

ng/l

3.30

6999

60476

Oesophageal varices

527

3717

1.65

17.72

3.4

3.0

1707.17

1512.19

ng/l

0.32

467

3184

Mixed conductive and sensorineural hearing loss

1589

13016

1.32

17.69

3.2

3.1

1520.64

1628.54

ng/l

0.47

1350

11286

Benign neoplasm of mouth and pharynx

1297

10360

1.36

17.66

3.0

1494.49

1390.03

ng/l

0.36

1112

8855

Rosacea

1203

9484

1.36

17.64

3.0

2.9

1092.73

1203.44

ng/l

0.50

1011

8060

Benign neoplasm: Skin of ear and external auricular canal

517

3631

1.66

17.63

3.4

3.1

2231.57

1727.54

ng/l

1.20

432

3115

Bulimia nervosa (incl. atypical)

201

1062

2.04

17.62

2.0

2.5

390.32

464.28

ng/l

0.24

150

809

Haemorrhage in early pregnancy

2345

19179

1.23

17.61

2.4

2.5

499.69

715.04

ng/l

6.01

1946

15863

Orthopaedic devices associated with adverse incidents

282

1790

2.15

17.57

3.9

3.1

1725.38

1297.43

ng/l

0.75

225

1538

Carcinoma in situ of skin of trunk

450

3142

1.79

17.55

3.6

3.2

2718.14

1975.17

ng/l

1.77

397

2718

Lichen planus, including avohilmo

2250

19040

1.26

17.48

2.9

1169.69

1348.80

ng/l

0.98

1902

16356

Other chondrocalcinosis

209

1233

2.49

17.47

4.5

3.2

2279.45

1673.12

ng/l

1.21

185

1073

Acute peritonitis

799

6021

1.48

17.45

4.0

3.1

6226.22

1620.00

ng/l

15.68

714

5153

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

5777

50892

1.14

17.43

2.7

2.8

984.81

1116.67

ng/l

1.48

4745

42618

Personal history of certain other diseases

139

651

2.40

17.43

3.9

2.7

1346.44

912.52

ng/l

0.64

112

491

Dermatopolymyositis

212

1212

2.24

17.41

4.6

3.0

1086.06

1252.58

ng/l

0.36

193

1026

Fluid overload

239

6.11

17.40

5.8

3.2

9881.09

1231.34

ng/l

3.25

207

Other specified disorders of muscle

341

2176

1.81

17.39

3.7

3.1

1373.35

1500.25

ng/l

0.20

297

1831

Oligomenorrhoea

302

1831

1.81

17.38

2.7

2.8

743.00

989.06

ng/l

0.59

241

1499

Recurrent dislocation of patella

333

2049

1.73

17.38

2.2

2.8

1060.63

780.68

ng/l

0.40

242

1629

Paralytic ileus

502

3511

1.66

17.36

4.0

3.1

2313.97

1626.64

ng/l

1.78

444

3036

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1611

8341

1.28

17.32

2.1

2.2

321.38

338.48

ng/l

0.11

1233

6455

Other obstetric conditions, not elsewhere classified

1677

8733

1.27

17.28

2.1

2.2

328.62

344.77

ng/l

0.10

1285

6773

Selective deficiency of immunoglobulin G [IgG] subclasses

103

450

3.20

17.28

3.9

3.0

709.69

661.36

ng/l

0.11

371

Ovarian dysfunction

447

2949

1.60

17.26

2.3

2.5

450.38

561.07

ng/l

0.60

356

2331

Other infective otitis externa

672

4910

1.52

17.23

2.9

3.0

1438.13

1319.09

ng/l

0.27

551

4173

Infection of intervertebral disc (pyogenic)

195

1105

2.39

17.22

3.9

3.2

3015.03

1633.08

ng/l

1.57

167

970

Primary open-angle glaucoma

4825

42166

1.18

17.21

3.2

1807.18

1805.49

ng/l

0.01

4107

36548

Diabetic neuropathy

1550

12747

1.34

17.11

4.1

3.6

3059.73

1965.01

ng/l

5.38

1411

10951

Ankylosing spondylitis, ICD10

927

7082

1.41

17.09

2.9

931.82

1192.86

ng/l

1.72

764

5939

Hidradenitis suppurativa

308

1893

1.80

17.07

2.4

2.8

1190.74

795.73

ng/l

0.69

248

1546

Benign neoplasm: Rectosigmoid junction

552

3978

1.64

17.03

3.4

3.0

2130.02

1543.58

ng/l

1.04

484

3404

Congenital malformations of trachea and bronchus

146

753

2.73

17.02

6.1

3.4

744.40

1405.46

ng/l

3.75

131

636

Other and unspecified disorders of white blood cells

508

3573

1.64

17.01

3.4

3.0

1923.39

1447.18

ng/l

1.01

432

3043

Entropion and trichiasis of eyelid

1211

9737

1.39

16.98

3.1

3.2

1999.17

1973.56

ng/l

0.05

1066

8472

Benign neoplasm: Duodenum

366

2452

1.86

16.97

3.6

3.0

2021.13

1415.93

ng/l

0.84

318

2093

Vascular diseases of the intestine

528

3768

1.65

16.93

4.1

3.0

3372.20

1637.09

ng/l

4.65

480

3233

Female infertility, associated with anovulation

397

2549

1.62

16.91

2.3

2.4

340.00

468.85

ng/l

0.82

313

1988

Use of biperiden

607

4380

1.55

16.88

2.5

2.9

819.12

1222.57

ng/l

2.53

504

3700

Myocardial infarction, unclassifiable

3517

27577

1.20

16.88

4.6

3.3

3203.62

2117.31

ng/l

15.93

3114

23903

Ménière disease

1227

9834

1.37

16.85

3.1

3.0

1293.52

1519.49

ng/l

0.62

1046

8454

Residual foreign body in soft tissue

503

3482

1.59

16.79

2.9

3.0

1175.89

1311.15

ng/l

0.32

439

2948

Atopic dermatitis, strict definition with reimbursement

2384

19443

1.22

16.78

2.9

2.8

1149.98

923.69

ng/l

0.92

1898

15975

Eosinophilia

225

1325

2.15

16.78

4.1

3.1

2205.27

1209.26

ng/l

0.79

202

1151

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

1392

11347

1.34

16.74

3.2

2473.21

1628.93

ng/l

4.70

1250

9784

Other and unspecified mononeuropathies, also in other diseases

396

2664

1.75

16.71

3.5

3.0

1851.07

1425.91

ng/l

0.92

334

2283

Gestational [pregnancy-induced] hypertension

1919

15813

1.25

16.68

2.5

2.4

778.48

653.35

ng/l

0.85

1607

12937

Other and unspecified epidermal thickening

328

2108

1.83

16.65

4.0

3.1

2052.90

1286.55

ng/l

1.21

294

1788

Abscess of anal and rectal regions

853

6451

1.42

16.62

2.9

2.8

1332.76

1207.19

ng/l

0.31

727

5418

Carcinoma in situ of skin of ear and external auricular canal

232

1425

2.29

16.60

3.5

3.4

4468.11

2382.40

ng/l

2.05

211

1271

Urethral stricture

764

5787

1.49

16.49

3.5

3.2

2101.85

1777.36

ng/l

0.54

640

5070

Fall involving bed

444

3114

1.74

16.42

3.9

3.3

2717.70

2019.34

ng/l

1.56

388

2717

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

455

3095

1.61

16.41

2.7

2.9

928.21

1166.13

ng/l

0.65

392

2591

Disorders of magnesium metabolism

113

540

3.14

16.32

4.1

3.0

2687.88

1088.29

ng/l

3.45

104

461

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

546

3942

1.61

16.25

4.1

3.1

2179.73

1593.71

ng/l

1.00

500

3376

Vertigo of central origin

239

1461

2.13

16.23

3.2

3.1

1143.93

1520.43

ng/l

1.37

193

1248

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

416

2881

1.75

16.16

3.6

3.2

2184.95

1888.68

ng/l

0.69

380

2502

Special screening examination for neoplasms

532

3778

1.57

16.14

3.1

2.8

1774.14

1672.23

ng/l

0.15

437

3230

Vasomotor rhinitis (mode)

822

6261

1.44

16.12

3.0

1372.21

1228.47

ng/l

0.21

677

5339

Allergic conjunctivitis

6019

53447

1.13

16.10

2.7

2.8

990.50

1116.20

ng/l

1.39

4942

44754

Parodontitis, operation under 40 years and operation codes

385

2478

1.61

16.10

2.9

2.6

1293.02

476.03

ng/l

1.56

284

1778

Endometriosis of ovary

1631

13326

1.28

16.08

2.6

854.47

1171.75

ng/l

3.74

1334

11244

Other and unspecified rosacea

923

7141

1.41

16.03

3.1

3.0

1156.62

1207.15

ng/l

0.15

776

6064

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

847

6438

1.41

16.02

2.6

948.49

798.08

ng/l

0.42

713

5393

Melanocytic naevi, other sites/unspecified

778

5853

1.44

16.01

3.7

2.9

1457.00

1219.93

ng/l

0.70

679

4908

Other operation for atrial fibrillation

111

558

3.76

15.97

4.4

3.4

2173.34

1543.56

ng/l

0.52

105

468

Vitamin D deficiency

199

1123

2.10

15.91

3.6

3.0

2487.86

1026.52

ng/l

1.56

166

928

Glaucoma suspect

4929

44363

1.16

15.87

3.2

3.1

1488.26

1536.06

ng/l

0.28

4241

38277

Other forms of systemic lupus erythematosus

117

558

2.79

15.86

3.1

1382.43

953.36

ng/l

0.60

105

470

Atrophic disorders of skin

1610

13290

1.29

15.85

3.0

2.8

1103.49

1124.27

ng/l

0.08

1378

11273

Acute posthaemorrhagic anaemia

480

3400

1.64

15.78

4.9

3.0

2879.19

1755.09

ng/l

4.47

421

2936

Parodontitis, under 40 years and operation codes

383

2475

1.60

15.75

2.9

2.6

1299.64

466.22

ng/l

1.59

282

1777

Hypertrophy of breast

1567

12824

1.28

15.75

2.3

2.6

646.04

794.84

ng/l

1.06

1275

10719

Effects of foreign body entering through natural orifice

2555

21894

1.22

15.74

3.1

1301.48

1297.40

ng/l

0.01

2141

18573

Correction of physiology of bite - very demanding therapy visit

280

1732

1.83

15.71

2.6

2.8

943.56

819.67

ng/l

0.19

236

1435

Early lumbar disc prolapse operation

731

5392

1.42

15.69

2.3

2.7

583.03

673.67

ng/l

0.17

572

4309

Central retinal artery occlusion

333

2227

1.87

15.68

4.0

3.3

2754.47

1995.71

ng/l

1.47

310

1938

Hyperaldosteronism

365

2461

1.77

15.65

3.5

3.0

1778.70

1195.05

ng/l

1.28

311

2120

Primary open-angle glaucoma, strict

3891

34611

1.19

15.64

3.2

1816.87

1779.94

ng/l

0.17

3329

30027

Focal epilepsy, mode (most common among epilepsy diagnosis)

2122

17972

1.24

15.55

3.2

3.1

1507.21

1546.00

ng/l

0.13

1856

15366

Acute alcohol intoxication

2973

25828

1.20

15.53

3.2

3.1

1688.90

1513.81

ng/l

0.93

2524

22078

Mental retardation

354

2308

1.69

15.51

3.3

3.8

1572.98

1178.74

ng/l

0.37

294

1929

Secondary parkinsonism, excluding more controls

321

2089

1.80

15.50

3.2

2.8

1160.13

1634.92

ng/l

2.28

274

1794

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

504

3631

1.63

15.50

3.6

3.2

2040.94

1909.33

ng/l

0.28

464

3136

Background retinopathy and retinal vascular changes

285

1823

1.91

15.46

3.5

3.1

2154.84

1648.56

ng/l

1.03

243

1555

Arthropod-borne viral fevers and viral haemorrhagic fevers

1098

8733

1.36

15.46

3.0

3.1

972.48

1370.62

ng/l

3.46

975

7435

Protozoal diseases

348

2324

1.78

15.45

4.5

3.1

2040.75

1304.99

ng/l

1.65

319

1970

Acute lymphocytic leukaemia, helper endpoint

264

3.41

15.45

3.0

3.8

623.20

1070.67

ng/l

1.04

218

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

264

3.41

15.45

3.0

3.8

623.20

1070.67

ng/l

1.04

218

Hypertrophic disorders of skin

530

3754

1.53

15.42

2.9

1304.87

997.68

ng/l

0.46

431

3105

Additional codes for the location of defect, injury or illness

636

4702

1.50

15.39

3.1

1281.54

1327.87

ng/l

0.12

572

3984

Cystic kidney disease

377

2540

1.71

15.39

3.0

3.1

5427.76

1236.57

ng/l

8.28

341

2161

Complications predominantly related to the puerperium

2070

17378

1.23

15.36

2.3

2.5

564.04

657.51

ng/l

0.92

1682

14350

Malignant melanoma, excluding all cancers (controls excluding all cancers)

2245

19239

1.24

15.35

3.0

3.1

1698.12

1548.14

ng/l

0.52

1941

16567

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1864

15727

1.27

15.34

3.0

3.1

1547.06

1540.11

ng/l

0.02

1621

13536

Drug-induced thyroiditis

186

6.48

15.31

6.6

2.7

1554.12

835.94

ng/l

1.25

152

Tongue abnormality

758

5797

1.47

15.30

3.0

1085.51

1384.63

ng/l

1.06

639

4941

Congenital malformations of the urinary system

578

4183

1.51

15.28

3.1

3.2

4180.50

1220.66

ng/l

8.54

525

3511

Parodontitis, under 40 years, or operation codes

405

2669

1.57

15.25

2.8

2.6

1296.24

505.31

ng/l

1.57

297

1925

Varicose veins of other sites

742

5612

1.45

15.21

3.3

3.0

1066.78

1375.48

ng/l

1.68

626

4732

Fracture at wrist and hand level

3610

31739

1.17

15.19

3.0

1420.52

1258.06

ng/l

0.77

3027

26853

Viral infections of the central nervous system

748

5643

1.44

15.19

3.1

2.9

996.51

1265.87

ng/l

1.96

607

4737

Carcinoma in situ of skin of upper limb, including shoulder

356

2466

1.88

15.18

3.3

2553.23

1832.13

ng/l

1.70

312

2139

Muscle strain

320

2061

1.74

15.15

3.3

3.1

961.36

1216.59

ng/l

0.66

272

1729

Other disorders involving the immune mechanism, not elsewhere classified

337

2215

1.74

15.14

4.3

3.2

4615.30

1278.47

ng/l

6.58

299

1861

Acne

569

4031

1.47

15.08

3.2

2.9

1394.43

633.16

ng/l

2.35

447

3143

Other specified/unspecified inflammatory spondylopathies

413

2791

1.60

15.06

2.7

2.9

1200.71

1121.34

ng/l

0.10

352

2315

Other specified/unspecified necrotizing vasculopathies

206

1229

2.16

15.05

3.9

3.1

2231.40

1446.24

ng/l

1.35

184

1045

Disorders of iron metabolism

179

1008

2.20

15.05

2.5

3.0

631.94

892.02

ng/l

0.86

143

863

Bruxism

181

1000

2.09

15.04

2.8

3.0

615.84

700.85

ng/l

0.24

144

822

Injury of other and unspecified intrathoracic organs

745

5667

1.45

15.02

3.2

3.1

1901.60

1604.15

ng/l

0.79

655

4866

Benign neoplasm: Skin of eyelid, including canthus

1946

16510

1.26

14.97

3.2

3.0

1607.28

1490.66

ng/l

0.42

1670

14271

Retinal haemorrhage

340

2293

1.81

14.97

3.6

3.1

2076.56

1629.95

ng/l

0.75

297

1983

Parodontitis, under 40 years

403

2665

1.56

14.94

2.8

2.6

1302.59

506.08

ng/l

1.58

295

1921

Glaucoma secondary to other eye disorders

529

3839

1.57

14.92

3.5

3.2

3054.97

1855.93

ng/l

2.76

457

3289

Injury of muscle and tendon at lower leg level

1654

13756

1.27

14.92

3.2

3.0

1547.90

1317.44

ng/l

0.86

1391

11776

Muscular dystrophy

119

592

2.75

14.92

3.3

3.4

1566.83

1167.10

ng/l

0.23

103

485

Other immunodeficiencies

135

690

2.45

14.90

4.1

3.3

1254.80

1056.55

ng/l

0.29

117

579

Benign neoplasm: Duodenum

366

2524

1.79

14.89

3.6

3.1

2021.13

1383.74

ng/l

0.92

318

2169

Carcinoma in situ of skin of scalp and neck

351

2424

1.85

14.88

3.6

3.3

2518.68

1921.86

ng/l

1.28

318

2125

Follicular lymphoma

551

4051

1.57

14.87

3.1

3.0

1511.32

1395.97

ng/l

0.28

485

3454

Melanocytic naevi of trunk

1173

9398

1.33

14.85

3.1

3.0

1458.37

1296.51

ng/l

0.54

1024

7934

Dependent personality disorder

247

1522

1.92

14.83

2.9

1178.50

876.17

ng/l

0.44

205

1270

Myotonic disorders

111

532

2.75

14.82

2.8

3.0

946.26

958.89

ng/l

0.01

440

Lactose intolerance

318

2058

1.73

14.81

2.9

1439.97

1026.81

ng/l

0.72

269

1698

Malignant neoplasm of breast

6307

41428

1.13

14.74

2.7

2.8

1126.56

1203.44

ng/l

0.81

5342

35038

Prurigo nodularis

329

2200

1.80

14.74

4.0

3.1

2393.80

1349.02

ng/l

1.43

287

1876

Neovascular glaucoma

526

3823

1.57

14.73

3.5

3.2

3064.53

1743.07

ng/l

3.23

454

3278

Event of undetermined intent

577

4187

1.49

14.71

3.0

1586.12

1163.23

ng/l

1.05

474

3515

Congenital malformations of the respiratory system

208

1232

2.05

14.65

5.3

3.7

1213.84

1292.47

ng/l

0.08

187

1039

Sacrococcygeal disorders, not elsewhere classified

314

2032

1.73

14.63

2.4

2.8

584.91

1034.06

ng/l

4.25

251

1701

Emotional disorders and disorders of social functioning with onset specific to childhood

230

1317

1.80

14.57

3.0

3.7

424.62

642.93

ng/l

0.52

151

990

Puerperal sepsis

1261

10202

1.31

14.56

2.3

2.6

645.75

737.96

ng/l

0.59

1045

8594

Carcinoma in situ of skin of trunk

450

3260

1.70

14.54

3.6

3.3

2718.14

1949.27

ng/l

1.93

397

2858

Sequelae of injuries of neck and trunk

338

2251

1.72

14.43

2.6

3.1

907.80

1130.94

ng/l

0.90

282

1915

Abnormal findings in nipple discharge synovial fluid wound secretions

194

1134

2.10

14.43

3.1

3.2

2533.00

1220.91

ng/l

0.59

174

959

Pneumonia derived septicemia

402

2783

1.65

14.35

3.8

3.1

2619.80

1617.19

ng/l

2.64

341

2381

Complications of genitourinary prosthetic devices, implants and grafts

309

2033

1.78

14.34

3.3

2.9

1966.25

1202.72

ng/l

1.40

257

1718

Hepatomegaly and splenomegaly, not elsewhere classified

131

679

2.48

14.27

4.4

3.0

1477.51

1171.06

ng/l

0.38

114

590

Kyphosis

183

1064

2.18

14.27

4.0

3.2

1162.11

1374.70

ng/l

0.44

162

915

Benign neoplasm of eye and adnexa

1173

9515

1.33

14.26

3.1

3.0

1534.06

1404.46

ng/l

0.29

991

8141

Alzheimer’s disease (Early onset)

348

5040

0.62

14.17

3.0

3.3

2390.95

2377.32

ng/l

0.01

272

4354

Malnutrition

259

1652

1.90

14.14

5.2

3.5

2296.65

1564.50

ng/l

1.67

231

1407

Acute lymphocytic leukaemia

278

3.22

14.06

3.0

3.8

623.20

1011.07

ng/l

0.89

228

Other deformities of toe(s)

415

2901

1.62

14.04

2.8

3.0

1199.36

1305.01

ng/l

0.21

344

2500

Infarction of spleen

108

553

3.19

14.03

4.4

3.0

1511.16

1341.98

ng/l

0.29

100

458

Kela reimbursement Agammaglobulinemia (D80-84)

102

479

2.71

14.00

5.2

2.7

1066.74

657.23

ng/l

0.41

379

Scabies

420

2912

1.58

13.96

3.8

3.0

1465.85

1040.17

ng/l

1.35

333

2439

Drug-induced osteoporosis

174

1015

2.26

13.92

5.0

3.1

2028.29

1092.82

ng/l

1.21

158

858

Congenital malformations of the musculoskeletal system, not elsewhere classified

135

695

2.26

13.82

2.4

3.1

934.49

777.59

ng/l

0.16

108

564

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

290

1795

1.67

13.80

5.6

3.9

1316.76

696.82

ng/l

0.99

227

1399

Chromosomal abnormalities, not elsewhere classified

155

825

2.09

13.80

4.3

4.4

755.92

756.11

ng/l

0.00

133

673

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

4449

23983

1.16

13.77

3.0

3.2

1878.91

1688.81

ng/l

1.27

3840

20849

Benign lipomatous neoplasm of other sites/unspecified

1107

8973

1.34

13.74

3.2

3.1

1473.08

1513.83

ng/l

0.12

950

7683

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

372

2620

1.74

13.73

5.3

3.1

2299.74

1821.43

ng/l

1.22

342

2279

Multiple myeloma

372

2620

1.74

13.73

5.3

3.1

2299.74

1821.43

ng/l

1.22

342

2279

Melanocytic naevi

3074

26978

1.18

13.72

3.2

2.9

1427.46

1254.44

ng/l

0.92

2624

22919

Bullous disorders

729

5637

1.45

13.71

3.3

3.1

1828.12

1621.27

ng/l

0.54

636

4854

Postzoster neuralgia

231

1472

2.04

13.70

4.6

3.0

1847.35

1632.29

ng/l

0.30

208

1276

Blood alcohol or alcohol intoxication level

242

1494

1.83

13.70

3.0

2.9

1307.82

1013.34

ng/l

0.43

210

1237

Acquired absence of limb

135

726

2.47

13.68

4.7

2.8

6188.74

1414.86

ng/l

3.10

120

608

Complications following infusion, transfusion and therapeutic injection

202

1220

2.05

13.67

3.6

3.0

1786.32

1070.52

ng/l

1.05

179

1027

Postviral fatigue syndrome

266

3.08

13.65

2.3

3.3

883.27

383.04

ng/l

0.37

214

Mental retardation, wide definition

381

2598

1.61

13.63

3.2

3.7

1491.36

1179.21

ng/l

0.31

318

2185

Oral leukoplakia and related diseases, including avohilmo

1059

8551

1.35

13.61

2.8

3.0

1317.53

1340.81

ng/l

0.04

896

7321

Vitamin B12 deficiency anaemia

1456

12152

1.29

13.60

3.2

3.0

2199.28

1763.18

ng/l

2.59

1286

10489

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

2315

19718

1.22

13.57

2.9

1596.45

1322.15

ng/l

1.37

2020

16742

Maltreatment syndromes

361

2413

1.59

13.54

3.1

3.0

955.49

860.71

ng/l

0.15

291

1932

Vulvovaginal ulceration/inflammation in other diseases

425

2941

1.54

13.53

2.5

2.7

616.17

743.81

ng/l

0.51

332

2408

Benign neoplasm of mouth and pharynx

1297

10683

1.30

13.50

3.0

1494.49

1427.16

ng/l

0.21

1112

9155

L04AC Interleukin inhibitors

438

3078

1.55

13.45

2.7

2.9

831.94

927.75

ng/l

0.27

373

2549

Hyperfunction of pituitary gland

429

2996

1.55

13.44

3.2

2.9

815.95

989.47

ng/l

0.78

365

2484

Paralytic strabismus

863

6821

1.39

13.42

3.3

3.1

1496.98

1593.19

ng/l

0.25

739

5847

Adenocarcinoma of pancreas

172

2830

0.52

13.42

2.1

3.2

1600.87

1844.19

ng/l

0.27

155

2456

Single delivery by forceps and vacuum extractor

476

4108

0.69

13.40

1.9

2.4

213.57

512.69

ng/l

3.87

359

3247

Delivery

4030

23894

0.87

13.39

2.7

2.9

1062.61

1257.65

ng/l

2.81

3407

20202

Injury of eye and orbit

1378

11331

1.27

13.37

2.9

3.0

1016.29

1288.73

ng/l

2.21

1141

9510

Tumor necrosis factor alpha inhibitors

1178

9509

1.29

13.33

2.5

2.9

1026.69

900.92

ng/l

0.40

1008

7867

Other viral hepatitis

500

3588

1.49

13.24

2.9

3.0

1706.23

929.95

ng/l

0.91

416

2931

Polyarteritis nodosa and related conditions

184

1090

2.07

13.18

4.1

3.1

2197.38

1350.11

ng/l

0.50

170

928

Somnolence, stupor and coma

510

3731

1.52

13.17

3.4

3.1

2412.09

1670.89

ng/l

0.93

438

3191

Bacterial, viral and other infectious agents

807

6259

1.37

13.14

3.5

3.0

1302.37

1198.48

ng/l

0.28

688

5194

Pediculosis, acariasis and other infestations

567

4193

1.47

13.14

3.7

3.0

1366.52

1139.02

ng/l

0.78

460

3511

Benign neoplasm: Skin of ear and external auricular canal

517

3832

1.54

13.13

3.4

3.1

2231.57

1766.39

ng/l

1.09

432

3320

Single spontaneous delivery

4003

23861

0.87

13.12

2.7

2.9

1057.38

1256.98

ng/l

3.07

3381

20174

Other and unspecified psoriasis

749

5810

1.41

13.12

3.1

1571.81

1370.38

ng/l

0.39

646

4967

Atopic dermatitis

5280

40718

1.13

13.11

2.8

1038.33

1024.72

ng/l

0.07

4215

33967

Specific development disorders of scholastic skills

217

1268

1.78

13.11

4.9

3.6

1222.98

677.05

ng/l

0.61

178

959

Other bursitis of hip

256

1654

1.84

13.06

3.5

3.1

1022.91

1420.42

ng/l

1.42

206

1394

Inflammatory disease of cervix uteri

746

5791

1.41

13.03

2.9

2.8

1038.12

1184.89

ng/l

0.58

622

4939

Heterophoria

722

5519

1.39

13.03

3.2

3.0

682.23

1124.58

ng/l

3.42

592

4617

Biomechanical lesions, not elsewhere classified

572

4294

1.49

12.98

3.1

3.0

1573.13

1368.76

ng/l

0.43

485

3672

Disorders of optic nerve and visual pathways

929

7363

1.34

12.97

3.1

1569.14

1320.80

ng/l

0.83

775

6224

Filling of root of tooth

334

2269

1.67

12.96

3.5

2.9

1521.15

1027.20

ng/l

0.95

297

1903

Inflammatory diseases of the central nervous system

872

6875

1.36

12.96

3.0

1211.83

1338.16

ng/l

0.27

734

5822

TMD muscular pain linked with fibromyalgia

105

513

2.54

12.95

2.6

2.9

436.70

756.73

ng/l

0.91

431

Personal history of risk-factors, not elsewhere classified

127

657

2.26

12.93

3.9

2.6

1055.87

962.70

ng/l

0.14

111

523

Benign neoplasm: Rectosigmoid junction

552

4171

1.53

12.91

3.4

3.1

2130.02

1513.89

ng/l

1.14

484

3600

Other autoimmune haemolytic anaemias

183

1114

2.17

12.91

3.3

3.1

1885.86

1451.34

ng/l

0.64

160

959

Other obstructive and reflux uropathy

452

3231

1.53

12.90

3.1

2.8

2514.22

1176.81

ng/l

4.38

386

2709

Late syphilis

178

1060

2.11

12.82

4.3

3.1

4079.41

1249.62

ng/l

5.60

151

895

Mixed specific developmental disorders

108

474

2.28

12.82

7.2

6.0

838.77

1080.65

ng/l

0.25

373

Acne vulgaris

416

2871

1.50

12.80

3.2

2.9

1172.87

567.92

ng/l

1.36

317

2203

Other disorders of optic [2nd] nerve and visual pathways

674

5162

1.42

12.77

3.4

3.1

1767.94

1386.98

ng/l

1.09

568

4379

Burns and corrosions

1314

10816

1.27

12.73

2.9

3.1

1505.24

1325.39

ng/l

0.63

1096

9087

Other disorders of breast

1219

9973

1.29

12.73

2.6

2.8

980.85

1020.14

ng/l

0.10

1004

8404

Other localized connective tissue disorders

243

1560

1.85

12.72

3.4

2.8

2025.43

1052.52

ng/l

0.84

206

1299

Thyrotoxicosis with toxic multinodular goitre

766

6030

1.42

12.71

3.4

3.0

1524.88

1426.44

ng/l

0.29

677

5177

Mild mental retardation

236

1474

1.79

12.70

3.3

3.5

1421.01

1087.10

ng/l

0.35

196

1214

Alzheimer’s disease, wide definition

2979

28004

0.85

12.67

2.9

3.4

2446.98

2247.54

ng/l

1.12

2443

24470

Secondary thrombocytopenia

168

993

2.16

12.60

4.3

3.0

1578.71

966.84

ng/l

1.19

155

843

Injury of muscle and tendon at hip and thigh level

998

8026

1.33

12.60

3.1

3.0

1235.26

1220.83

ng/l

0.03

855

6811

Other and unspecified follicular disorders

402

2838

1.57

12.57

3.9

3.1

2325.49

1247.92

ng/l

1.58

347

2405

Polymyositis

129

709

2.45

12.53

4.9

3.1

1160.80

1192.59

ng/l

0.04

118

605

Pemphigoid

384

2762

1.67

12.52

3.5

3.2

2284.82

1848.81

ng/l

0.71

333

2404

Emotional disorders starting during childhood or adolescence

219

1301

1.74

12.50

2.9

4.0

554.22

648.76

ng/l

0.15

146

988

Other and specified injuries of hip and thigh

290

1953

1.76

12.50

3.6

3.2

2206.23

1654.73

ng/l

0.63

253

1661

Mitochondrial myopathy

251

3.60

12.41

2.8

3.3

2249.69

701.79

ng/l

0.60

207

Drug-induced hypoglycaemia without coma

214

1344

1.93

12.41

4.1

3.1

4269.45

1698.88

ng/l

2.51

185

1135

Malignant neoplasm of pancreas

503

6685

0.68

12.39

2.4

3.2

1279.25

1956.87

ng/l

3.84

443

5787

138

731

2.06

12.39

2.6

491.82

520.19

ng/l

0.09

123

580

Polycystic ovarian syndrome, broad definition

538

3908

1.42

12.37

2.3

310.88

398.40

ng/l

0.74

417

3046

Chronic tubulo-interstitial nephritis

476

3493

1.52

12.32

3.4

2.8

2843.35

1152.85

ng/l

6.90

410

2939

IBD patients in KELA-register

2176

18739

1.20

12.32

2.9

3.0

1314.92

1131.60

ng/l

0.96

1812

15694

Fracture of neck

710

5544

1.42

12.30

3.3

3.2

1673.60

1725.11

ng/l

0.12

617

4786

Nontoxic single thyroid nodule

800

6301

1.37

12.28

3.2

2.8

1029.24

1166.48

ng/l

0.59

675

5372

Causalgia

179

1057

1.97

12.27

2.3

2.9

680.26

784.50

ng/l

0.23

146

882

Chronic nephritic syndrome

468

3431

1.53

12.26

3.5

3.1

7337.01

1294.85

ng/l

11.02

425

2926

Viral haemorrhagic fevers, not elsewhere classified/unspecified

871

6937

1.35

12.22

3.1

3.0

965.35

1321.16

ng/l

2.41

774

5876

Intermittent heterotropia

451

3222

1.49

12.21

3.3

1074.27

1086.82

ng/l

0.02

373

2658

Chronic viral hepatitis

400

2798

1.53

12.18

2.9

3.0

1843.08

895.63

ng/l

0.87

327

2237

Other and unspecified types of non-Hodgkin lymphoma, hilmo

546

4140

1.50

12.16

4.1

3.2

2179.73

1666.99

ng/l

0.83

500

3559

Hypertrophic scar

472

3419

1.49

12.15

3.0

2.9

1393.82

970.81

ng/l

0.61

385

2818

Bitten or struck by other mammals

932

7417

1.32

12.14

3.1

2.9

1113.37

1010.01

ng/l

0.32

762

6177

Chronic lymphocytic leukaemia, helper endpoint

389

2812

1.64

12.11

3.0

1902.06

1668.35

ng/l

0.48

355

2422

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

389

2812

1.64

12.11

3.0

1902.06

1668.35

ng/l

0.48

355

2422

Erosion of teeth, including avohilmo

1906

15715

1.21

12.11

3.0

2.7

1048.71

986.04

ng/l

0.26

1557

13256

Contusion of other and unspecified parts of foot

400

2809

1.53

12.07

2.9

3.0

1004.84

971.83

ng/l

0.09

333

2315

Exposure to other and unspecified inanimate mechanical forces

654

5001

1.40

12.06

3.2

3.0

1155.55

1206.08

ng/l

0.14

541

4198

Respiratory conditions due to other external agents

287

1965

1.78

12.02

4.1

3.1

1337.07

1505.95

ng/l

0.43

263

1694

Hemiplegia

587

4450

1.44

11.99

3.4

3.0

1301.02

1725.78

ng/l

1.58

503

3784

Hypoplasia of dental enamel, prenatal

6.76

11.93

10.4

11.9

2990.84

1370.30

ng/l

0.75

Disturbances of smell and taste

475

3504

1.51

11.89

2.9

630.39

1046.55

ng/l

7.03

398

2964

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

300

2027

1.67

11.89

4.3

3.1

5001.89

1178.49

ng/l

6.89

266

1705

Other specified and unspecified retinal disorders

434

3179

1.56

11.86

3.1

1796.50

1452.04

ng/l

0.86

382

2712

Nonspecific lymphadenitis

567

4250

1.43

11.86

2.6

2.8

801.83

969.40

ng/l

0.78

480

3515

Intentional self-harm by unspecified means

478

2.37

11.86

2.3

3.0

473.03

721.42

ng/l

0.84

374

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1428

11988

1.26

11.85

3.0

1070.95

1266.53

ng/l

1.38

1226

10203

Nosocomial condition (hospital)

497

2.82

11.84

4.0

3.3

2739.71

1618.99

ng/l

0.56

416

Folate deficiency anaemia

133

757

2.39

11.84

4.2

3.2

2739.44

1438.80

ng/l

1.84

113

656

Problems related to social environment

318

2175

1.64

11.83

4.1

3.2

1903.65

1850.04

ng/l

0.06

275

1839

Malignant neoplasm of breast, HER2-negative

6109

41251

1.12

11.81

2.7

2.8

1138.78

1207.62

ng/l

0.67

5179

34899

Viral hepatitis

618

4682

1.40

11.80

2.9

1684.54

1047.28

ng/l

0.87

508

3855

Other and unspecified injuries of thorax

212

1334

1.86

11.80

2.9

3.0

1301.66

1204.34

ng/l

0.16

175

1125

Other benign neoplasms of connective and other soft tissue

1047

8530

1.31

11.75

3.0

1318.23

1320.95

ng/l

0.01

912

7230

Cushing syndrome

151

878

2.15

11.73

3.2

3.0

1712.27

1009.79

ng/l

0.98

132

745

Other disorders starting during childhood or adolescence

236

1456

1.68

11.69

6.1

4.4

1526.94

735.24

ng/l

1.03

182

1110

Bursitis of shoulder

281

1883

1.70

11.69

3.2

3.0

1115.52

1297.52

ng/l

0.41

247

1579

Collapsed vertebra, not elsewhere classified

134

776

2.44

11.67

3.8

3.2

2327.46

2008.14

ng/l

0.21

113

657

Other erythematous conditions

403

2908

1.56

11.65

3.4

3.0

1470.64

1238.85

ng/l

0.65

349

2463

Endometriosis ASRM stages 1,2

1447

12089

1.24

11.64

2.4

2.6

711.52

753.78

ng/l

0.14

1166

10006

Pneumococcal septicemia

382

2731

1.58

11.62

3.9

3.2

2645.11

1601.22

ng/l

2.64

321

2338

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

447

3293

1.54

11.61

3.8

3.0

1513.31

1401.42

ng/l

0.27

380

2778

Impotence

633

4901

1.43

11.59

3.6

3.2

1998.84

1641.59

ng/l

0.61

543

4301

Benign neoplasm of meninges

1196

9951

1.29

11.57

3.0

1491.63

1347.13

ng/l

0.54

1025

8494

Other secondary gonarthrosis

618

4770

1.43

11.56

3.0

3.1

1821.25

1394.20

ng/l

0.72

533

4088

Perforation of tympanic membrane

1078

8833

1.30

11.52

3.2

3.0

1458.15

1420.16

ng/l

0.10

924

7548

Carcinoma in situ of other and unspecified digestive organs

334

2372

1.68

11.51

3.7

3.0

1673.86

1537.74

ng/l

0.26

306

2023

Other and unspecified abdominal hernia

509

3838

1.49

11.50

2.9

3.0

1426.18

1547.99

ng/l

0.24

434

3300

D07AA Corticosteroids, weak (group I)

1341

11132

1.25

11.48

3.0

3.1

1190.45

1295.08

ng/l

0.44

1139

9283

L01XX Other antineoplastic agents

741

5908

1.41

11.46

3.5

3.1

2203.29

1612.87

ng/l

1.21

654

5112

Lichen sclerosus et atrophicus

1142

9455

1.29

11.41

2.8

2.9

1118.45

1170.97

ng/l

0.18

980

7994

Crohn's disease NAS

598

4547

1.41

11.36

3.1

1677.59

1130.63

ng/l

1.73

507

3799

Follicular lymphoma, hilmo

551

4231

1.48

11.35

3.1

3.0

1511.32

1413.54

ng/l

0.24

485

3633

Behavioural disorders, excluding more controls

123

642

2.06

11.34

3.3

3.6

797.05

754.76

ng/l

0.05

100

497

Femoral hernia

571

4383

1.45

11.34

3.3

3.0

1591.37

1571.46

ng/l

0.04

502

3779

Recurring oral aphthae

509

3820

1.47

11.31

3.5

3.1

1231.78

1335.83

ng/l

0.23

426

3250

Carcinoma in situ of skin, other sites/unspecified

197

1283

2.07

11.31

3.5

3.2

2500.75

1941.58

ng/l

0.79

180

1109

All dysplastic lesions of the vulva

420

3047

1.51

11.20

2.9

2.8

901.02

866.83

ng/l

0.09

357

2542

Iron deficiency

154

879

1.93

11.16

4.1

3.1

913.69

955.95

ng/l

0.07

125

728

Other and unspecified trigeminal disorders

190

1183

1.90

11.16

3.4

2.9

765.13

1067.81

ng/l

1.30

159

1000

Melanocytic naevi, other sites/unspecified

778

6165

1.35

11.10

3.7

3.0

1457.00

1237.45

ng/l

0.64

679

5214

Testicular hypofunction

317

2193

1.61

11.07

3.2

3.1

838.02

1162.75

ng/l

1.22

244

1822

Other diseases of spinal cord

345

2442

1.60

11.06

3.0

1130.85

1315.50

ng/l

0.53

291

2057

Atopic dermatitis, strict definition

2188

18559

1.18

11.05

2.9

1069.78

906.67

ng/l

0.61

1737

15201

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

574

4450

1.46

11.05

3.1

3.0

1914.57

1496.47

ng/l

1.06

515

3819

Mixed disorders of conduct and emotions, excluding more controls

446

2.22

11.01

3.9

3.3

1321.20

436.48

ng/l

0.75

316

Other and/or unspecified nontoxic goitre

950

7747

1.32

11.00

2.7

2.9

1099.19

1307.50

ng/l

0.93

832

6658

Testicular dysfunction

352

2485

1.57

11.00

3.2

3.1

861.49

1253.76

ng/l

1.59

275

2071

Lactose intolerance, other/unspecified

274

1839

1.66

10.95

3.0

2.9

1574.27

1066.46

ng/l

0.78

232

1519

Other predominantly sexually transmitted diseases, not elsewhere classified

1213

10001

1.25

10.91

2.7

928.77

805.27

ng/l

0.37

930

8102

Dementia, including avohilmo

6887

44188

1.11

10.89

3.1

3.3

2069.54

1879.10

ng/l

2.35

5811

38665

Carcinoma in situ of skin of scalp and neck

351

2578

1.69

10.89

3.6

3.4

2518.68

2080.53

ng/l

0.80

318

2270

Other and unspecified injuries of ankle and foot

356

2503

1.54

10.87

3.3

2.9

1604.87

971.87

ng/l

1.66

281

2057

Specific development disorders of speech and language

416

2874

1.47

10.83

4.6

3.7

1361.43

1286.34

ng/l

0.14

360

2342

Alzheimer’s disease (undefined)

1190

0.37

10.82

2.7

3.5

2999.32

3158.60

ng/l

0.06

1034

Primary biliary cholangitis (PBC)

258

1738

1.72

10.81

3.6

2.7

2024.32

1034.96

ng/l

1.93

234

1466

Urethritis and urethral syndrome

254

1696

1.70

10.78

3.1

3.0

1077.96

1188.68

ng/l

0.24

207

1403

Haemangioma and lymphangioma, any site

895

7234

1.32

10.78

2.9

3.0

1241.99

1253.20

ng/l

0.02

758

6115

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

860

6945

1.33

10.77

3.1

3.0

1158.45

1229.17

ng/l

0.20

720

5865

Disorders of sphingolipid metabolism and other lipid storage disorders

246

3.48

10.77

4.7

3.5

894.81

986.94

ng/l

0.11

209

Haemangioma, any site

842

6765

1.33

10.75

2.9

3.0

1155.70

1237.55

ng/l

0.23

710

5717

Motor disorders, excluding more controls

314

2.46

10.72

14.1

5.9

868.11

801.66

ng/l

0.11

254

Mental and behavioural disorders due to use of other stimulants, including caffeine

175

1041

1.80

10.71

2.4

3.1

1497.58

687.11

ng/l

1.04

134

792

Other inflammatory liver diseases

720

5702

1.37

10.69

3.5

2.9

1713.94

1327.05

ng/l

1.04

610

4829

Dependence on enabling machines and devices, not elsewhere classified

133

754

2.11

10.67

8.2

3.0

5793.00

1352.33

ng/l

3.75

127

638

Benign neoplasm of other and unspecified intrathoracic organs

155

942

2.09

10.67

3.7

3.1

885.28

1465.60

ng/l

2.64

140

776

Aneurysms, operations, SAH

2022

17651

1.20

10.66

2.8

3.0

1480.55

1481.40

ng/l

0.00

1770

15181

Sleep disorders, other/unspecified

269

1795

1.63

10.65

2.8

3.2

1003.34

969.81

ng/l

0.05

215

1459

Complications following abortion and ectopic and molar pregnancy

389

2829

1.54

10.63

3.0

2.8

928.44

927.72

ng/l

0.00

321

2391

Other specified disorders of kidney and ureter

393

2879

1.54

10.56

4.4

3.0

3870.03

1292.04

ng/l

4.39

351

2442

Postprocedural disorders of digestive system, not elsewhere classified

386

2823

1.55

10.52

3.0

3.1

2075.90

1500.17

ng/l

0.66

335

2417

Other and unspecified haemorrhagic conditions

198

1269

1.85

10.51

3.5

3.0

2328.83

1311.66

ng/l

1.35

169

1070

Oral lichen ruber planus wide, hypothyreosis or thyroxin

641

5053

1.41

10.51

2.8

3.0

917.13

1196.48

ng/l

1.71

533

4306

Benign neoplasm: Pituitary gland, craniopharyngeal duct

516

3909

1.43

10.51

2.6

2.9

1262.23

1251.73

ng/l

0.01

445

3277

Pedal cyclist injured in other and unspecified transport accidents

1099

9085

1.27

10.51

2.9

3.1

1262.95

1318.15

ng/l

0.16

917

7643

Inflammatory bowel disease, strict (require KELA)

2176

18974

1.18

10.49

2.9

3.0

1314.92

1147.91

ng/l

0.84

1812

15878

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

142

833

2.06

10.46

3.6

3.1

1745.74

971.97

ng/l

0.51

124

685

Symptoms and signs involving emotional state

270

1819

1.63

10.44

2.9

3.2

1375.02

1031.70

ng/l

0.79

226

1516

Melanocytic naevi of trunk

1173

9771

1.26

10.44

3.1

3.0

1458.37

1293.95

ng/l

0.56

1024

8307

Benign neoplasm of eye and adnexa

1173

9836

1.28

10.43

3.1

1534.06

1478.40

ng/l

0.11

991

8465

Myeloid leukaemia

324

2311

1.62

10.42

3.7

3.0

1490.74

1610.18

ng/l

0.16

301

1968

Spondylopathies in diseases classified elsewhere

174

1102

2.01

10.42

3.8

3.1

1273.29

1732.53

ng/l

1.29

151

956

Dental pulpitis 3

452

2338

1.42

10.38

2.8

3.4

1596.10

413.80

ng/l

0.96

321

1634

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

172

2672

0.56

10.36

2.1

3.1

1600.87

1704.65

ng/l

0.10

155

2296

Lesion of radial nerve

425

3151

1.50

10.33

3.3

2.9

1464.39

1338.33

ng/l

0.25

361

2675

Otitis media, unspecified

808

5901

1.31

10.32

4.1

3.0

957.73

1097.99

ng/l

0.65

664

4846

Alzheimer disease

3929

32448

0.88

10.32

3.0

3.4

2490.43

2175.99

ng/l

2.71

3216

28410

Other disorders of prostate

442

3315

1.50

10.30

3.3

3.2

2441.82

1928.28

ng/l

0.73

394

2927

Spermatocele

949

7809

1.31

10.28

3.6

3.2

1528.88

1754.74

ng/l

1.03

826

6878

Crohn's disease of small intestine

608

4698

1.37

10.27

2.9

3.0

1236.23

1030.04

ng/l

0.62

521

3917

Carcinoma in situ of skin of lower limb, including hip

289

2067

1.74

10.26

3.5

3.1

2273.13

1712.80

ng/l

0.97

246

1780

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

1252

10576

1.26

10.26

3.0

3.2

1645.38

1636.94

ng/l

0.02

1114

9087

Acute nasopharyngitis (common cold)

1061

8672

1.27

10.24

2.8

1010.03

949.26

ng/l

0.19

890

7146

Other/unspecified reactive arthropathies

661

5190

1.37

10.24

3.4

3.0

1577.37

1280.97

ng/l

0.61

578

4381

Disease of hard tissues of teeth, NOS

122

684

2.13

10.23

5.0

3.0

649.06

935.11

ng/l

1.24

111

568

Scleritis and episcleritis

575

4428

1.39

10.22

2.9

791.71

1053.77

ng/l

1.48

490

3695

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

233

1523

1.67

10.19

2.5

2.7

999.78

1087.86

ng/l

0.11

199

1255

Essential (haemorrhagic) thrombocythaemia

464

3522

1.49

10.17

3.2

2.9

2754.64

1354.25

ng/l

2.30

409

2986

Other noninflammatory disorders of cervix uteri

562

4347

1.41

10.17

2.8

937.46

1371.55

ng/l

3.53

461

3729

Adenocarcinoma and ductal carcinoma of pancreas

239

3452

0.61

10.16

2.1

3.2

1415.18

1753.96

ng/l

0.60

214

2990

Molar incisor enamel hypoplasia

139

766

1.88

10.13

10.6

4.8

1147.92

839.51

ng/l

0.43

125

601

Benign neoplasm of other and unspecified intrathoracic organs

155

956

2.05

10.13

3.7

3.3

885.28

1328.01

ng/l

1.85

140

797

6-mercaptopurine

228

1479

1.66

10.13

2.5

2.6

770.27

1065.96

ng/l

0.83

183

1191

Benign neoplasm: Cerebral meninges

1065

8883

1.29

10.10

2.9

3.0

1470.24

1314.80

ng/l

0.54

913

7570

Stenosis and insufficiency of lacrimal passages

1092

9114

1.28

10.08

3.0

1520.20

1538.55

ng/l

0.04

928

7780

Juvenile arthritis (FINNGEN)

305

2095

1.54

10.05

2.9

3.1

1547.34

928.08

ng/l

1.18

260

1666

Benign neoplasm: Parotid gland

895

7333

1.31

10.04

3.0

1613.52

1436.29

ng/l

0.38

786

6231

Other/unspecified soft tissue disorders related to use, overuse and pressure

284

1956

1.60

10.02

2.9

2.8

950.44

1088.27

ng/l

0.29

245

1625

Other and unspecified glaucoma

924

7648

1.32

10.02

3.1

3.2

2009.75

1861.81

ng/l

0.35

795

6625

Eustachian salpingitis and obstruction

559

4259

1.37

9.99

2.7

2.8

719.26

881.75

ng/l

0.65

439

3457

Manic episode

289

1995

1.59

9.99

2.5

3.0

1116.13

1065.02

ng/l

0.10

237

1673

Peritonsillar abscess

1832

15815

1.19

9.96

2.9

1162.75

1154.38

ng/l

0.02

1529

13242

Hypersomnia

162

995

1.91

9.95

3.7

3.1

852.34

931.97

ng/l

0.13

135

845

Conductive hearing loss, unspecified

871

7090

1.31

9.93

3.3

3.0

1527.09

1446.51

ng/l

0.15

727

6071

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

250

1658

1.61

9.91

4.2

3.5

861.24

941.58

ng/l

0.17

202

1337

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

556

4334

1.42

9.90

2.7

3.0

1325.24

1414.97

ng/l

0.19

506

3696

Malignant immunoproliferative diseases

151

946

2.13

9.90

3.8

3.4

1811.31

1554.30

ng/l

0.28

133

804

Alcohol-induced chronic pancreatitis

715

5720

1.35

9.90

2.9

3.0

1897.67

1368.64

ng/l

1.59

626

4888

Blindness, monocular

132

787

2.17

9.88

3.5

3.4

2403.88

1530.05

ng/l

1.12

115

676

Nontoxic diffuse goitre

379

2789

1.53

9.88

3.1

2.8

1120.02

1265.10

ng/l

0.36

331

2377

Cauda equina syndrome

159

982

1.95

9.87

3.1

3.0

1073.75

1153.16

ng/l

0.09

128

821

Injuries involving multiple body regions

371

2694

1.51

9.86

3.1

1296.25

1382.96

ng/l

0.21

305

2229

Lichen simplex chronicus

395

2922

1.51

9.86

3.2

2.9

1967.60

1263.78

ng/l

1.39

347

2471

Need for immunization against other single viral diseases

224

1493

1.73

9.82

4.1

3.1

7928.50

1197.97

ng/l

5.31

205

1243

Complications of labour and delivery

5367

32604

0.90

9.81

2.4

2.6

677.81

845.12

ng/l

3.34

4393

27209

Polycystic ovarian syndrome

263

1752

1.56

9.81

2.4

277.67

420.25

ng/l

1.28

203

1361

Drug-induced obesity

525

2.27

9.79

3.2

3.1

1208.50

862.25

ng/l

0.59

431

Hypersensitivity pneumonitis due to organic dust

218

1463

1.78

9.78

3.7

3.2

1195.27

1423.16

ng/l

0.39

198

1251

Osteonecrosis due to drugs

179

1166

1.96

9.78

4.3

3.2

2212.48

1283.52

ng/l

0.57

163

998

Burns and corrosions of external body surface, specified by site

1011

8340

1.27

9.77

3.1

1562.28

1334.63

ng/l

0.71

853

6989

Lesion of sciatic nerve

632

5034

1.40

9.76

3.3

3.1

1611.58

1906.07

ng/l

0.85

562

4375

Other abnormal immunological findings in serum

197

1268

1.76

9.75

3.4

3.0

680.59

1062.63

ng/l

2.21

165

1059

Tracheo-bronchomalasia

144

3.43

9.74

2.8

1.6

564.88

390.03

ng/l

0.38

120

Campylobacter enteritis

293

2058

1.60

9.73

3.3

3.1

1814.83

1312.78

ng/l

1.14

247

1734

Persistent delusional disorders

851

6946

1.31

9.70

3.0

1163.22

1492.00

ng/l

1.99

685

5899

Cysts of oral region, not elsewhere classified

463

3497

1.44

9.67

3.2

2.9

1416.96

1306.03

ng/l

0.21

391

2975

Carrier of infectious disease

241

1625

1.67

9.67

3.4

3.0

2792.58

1297.34

ng/l

1.63

200

1345

Hypertrichosis

146

855

1.86

9.66

2.1

2.7

406.83

530.31

ng/l

0.59

117

686

Brain glioblastoma and astrocytoma

1388

0.44

9.65

1.8

3.0

434.66

1256.02

ng/l

8.52

1187

Poisoning by narcotics and psychodysleptics [hallucinogens]

126

711

1.97

9.63

3.1

3.2

1163.68

1223.43

ng/l

0.06

563

Graves disease, strict definition

871

7083

1.29

9.61

2.9

2.8

945.35

982.12

ng/l

0.12

714

5915

Defects in the complement system

397

2.49

9.61

3.8

3.3

491.04

815.19

ng/l

1.22

327

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

3817

28149

1.13

9.57

2.6

2.7

1015.19

1105.58

ng/l

0.74

3247

23666

Diseases of middle ear and mastoid

5836

44097

1.10

9.57

3.1

2.9

1288.51

1277.06

ng/l

0.06

4799

36982

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

819

6702

1.33

9.57

3.2

3.1

1701.25

1547.26

ng/l

0.45

733

5737

Benign lipomatous neoplasm of other sites/unspecified

1107

9323

1.27

9.56

3.2

3.1

1473.08

1608.68

ng/l

0.52

950

8038

Other diseases of gallbladder

559

4380

1.41

9.55

3.3

3.0

1224.31

1587.66

ng/l

1.98

483

3747

Bullous pemphigoid

303

2202

1.65

9.52

3.4

3.3

2205.04

1968.48

ng/l

0.30

263

1927

Astigmatism

545

4196

1.38

9.50

3.8

3.3

1059.14

1228.51

ng/l

0.53

440

3516

Hordeolum and other deep inflammation of eyelid

526

4045

1.40

9.50

3.1

1255.14

1248.89

ng/l

0.01

449

3386

Anankastic personality disorder

304

2129

1.54

9.49

2.8

2.7

463.35

727.28

ng/l

2.35

256

1745

Evidence of alcohol involvement determined by blood alcohol level

159

979

1.87

9.48

2.9

1115.61

940.23

ng/l

0.29

140

821

Fall on and from ladder

916

7589

1.30

9.46

3.1

1369.44

1534.09

ng/l

0.51

787

6579

Dystonia

572

4468

1.38

9.46

2.8

2.9

1084.56

1217.24

ng/l

0.38

483

3749

Other misadventures during surgical and medical care

251

1736

1.68

9.45

3.8

3.0

2009.18

1273.68

ng/l

1.85

223

1487

Chalazion

1151

9664

1.25

9.42

2.9

3.0

982.72

1386.50

ng/l

3.98

972

8189

Other and unspecified erythematous conditions

354

2595

1.53

9.42

3.3

3.0

1516.02

1236.40

ng/l

0.72

306

2200

Laparoscopic right hemicolectomy

718

5850

1.37

9.41

2.8

3.1

1662.47

1542.15

ng/l

0.30

611

5075

Toxic effect of carbon monoxide

207

1374

1.76

9.40

2.8

3.1

1489.12

1279.72

ng/l

0.22

193

1167

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

888

7330

1.31

9.39

3.5

3.1

1975.58

1871.30

ng/l

0.23

782

6331

Small cell lung cancer

155

2425

0.57

9.38

2.5

3.3

1849.62

2359.93

ng/l

0.32

141

2104

Small cell lung cancer, helper endpoint

155

2425

0.57

9.38

2.5

3.3

1849.62

2359.93

ng/l

0.32

141

2104

Magnesium deficiency

237

3.69

9.37

3.7

3.0

2902.07

1164.64

ng/l

1.36

196

Erosion and ectropion of cervix uteri

328

2369

1.55

9.37

2.7

2.8

923.69

1359.35

ng/l

1.95

266

2016

Benign mammary dysplasia

1688

14697

1.21

9.34

2.7

2.9

1051.51

1235.62

ng/l

1.20

1455

12553

Other juvenile arthritis

249

1666

1.58

9.33

3.0

3.3

1592.04

939.98

ng/l

0.99

212

1339

Vascular syndromes of brain in cerebrovascular disorders

617

4940

1.40

9.31

3.8

3.2

1935.25

1830.64

ng/l

0.21

559

4321

Outcome of delivery

611

4883

0.76

9.28

2.1

2.2

234.67

448.70

ng/l

3.00

482

3857

Cholangitis (primary sclerosing, PSC), with reimbursement 202

180

1147

1.78

9.28

2.7

3.4

1215.75

957.44

ng/l

0.51

159

959

Polycythaemia vera

459

3541

1.47

9.28

3.7

3.0

2041.80

1613.33

ng/l

1.08

401

3030

Carcinoma in situ of other and unspecified genital organs

209

1400

1.75

9.25

3.1

2.8

1097.47

989.01

ng/l

0.16

182

1166

Other specified/unspecified deforming dorsopathies

192

1242

1.74

9.24

3.3

3.1

864.75

1246.82

ng/l

0.97

155

1043

Persons encountering health services in circumstances related to reproduction

4747

35127

0.90

9.24

2.8

648.49

904.50

ng/l

5.38

3904

29079

Amblyopia ex anopsia

367

2679

1.48

9.22

3.6

3.2

1833.21

1243.17

ng/l

1.03

305

2233

Lipomatosis, not elsewhere classified

203

3.67

9.21

3.6

3.0

946.74

967.16

ng/l

0.02

176

Biological medicines for asthma

135

802

1.95

9.20

3.4

2.8

424.14

687.43

ng/l

1.93

117

656

Other specified and unspecified disorders of lens

143

899

2.10

9.20

3.6

3.0

2328.82

1935.73

ng/l

0.29

106

780

Traumatic subarachnoid haemorrhage

406

3047

1.47

9.18

3.5

2.9

2670.73

1746.07

ng/l

1.27

349

2638

Follicular cysts of skin and subcutaneous tissue

1953

17137

1.18

9.18

3.0

1293.54

1374.84

ng/l

0.40

1685

14602

Benign neoplasm of urinary organs

548

4309

1.40

9.14

3.0

2381.72

1500.57

ng/l

1.38

466

3688

Abnormal findings on diagnostic imaging of central nervous system

429

3228

1.44

9.12

3.0

2.9

878.45

1095.66

ng/l

0.98

366

2711

Carcinoma in situ of other and unspecified digestive organs

334

2476

1.58

9.12

3.7

3.2

1673.86

1512.23

ng/l

0.32

306

2154

Habit and impulse disorders

136

801

1.89

9.09

2.3

2.9

1110.37

827.41

ng/l

0.17

107

650

Brain glioblastoma

1160

0.41

9.07

1.8

3.1

461.16

1242.68

ng/l

6.05

996

Metabolic disorder, other/unspecified

175

3.54

9.07

3.8

3.3

929.24

805.48

ng/l

0.15

140

Pilonidal cyst

655

5168

1.32

9.06

2.6

2.9

1386.15

974.24

ng/l

0.62

511

4198

Injury of muscle and tendon at wrist and hand level

1384

11849

1.22

9.04

2.9

3.0

1139.48

1272.11

ng/l

0.56

1173

10079

Carcinoma in situ of skin, other sites/unspecified

197

1354

1.91

9.03

3.5

3.4

2500.75

1915.14

ng/l

0.86

180

1177

Chronic hepatitis, not elsewhere classified

367

2719

1.49

8.99

2.8

2.9

1767.20

1049.36

ng/l

0.98

307

2265

Malignant immunoproliferative diseases

151

971

2.05

8.99

3.8

3.6

1811.31

1497.82

ng/l

0.36

133

840

Male infertility

330

2358

1.48

8.97

3.3

3.0

1482.61

1029.54

ng/l

0.42

279

1859

Dislocation, sprain and strain of joints and ligaments of head

344

2491

1.48

8.95

2.9

3.0

1126.50

1061.04

ng/l

0.08

290

2078

Other surgical follow-up care

322

2322

1.52

8.94

3.0

2.7

1983.55

1117.25

ng/l

1.55

289

1932

Other and unspecified acquired haemolytic anaemias

131

801

2.08

8.94

6.1

3.1

2218.52

1498.43

ng/l

1.21

119

682

Etanercept

533

4129

1.37

8.92

2.7

2.9

1214.31

915.40

ng/l

0.83

462

3410

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

274

1959

1.63

8.91

2.7

3.1

1113.93

1428.02

ng/l

0.96

248

1667

Paranoid personality disorder

198

1305

1.72

8.91

2.4

3.1

1187.17

1110.58

ng/l

0.08

161

1092

Other specified disorders of external ear

457

3534

1.45

8.90

2.9

3.2

1660.21

1572.25

ng/l

0.15

376

3075

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

202

1374

1.80

8.89

3.3

3.1

1558.41

1607.44

ng/l

0.07

188

1175

Chronic lymphocytic leukaemia

389

2967

1.52

8.84

3.0

3.1

1902.06

1766.93

ng/l

0.24

355

2595

Benign neoplasm of middle ear and respiratory system

903

7500

1.29

8.83

3.2

3.1

1233.04

1495.10

ng/l

1.57

788

6414

Medical abortion

7181

36378

1.09

8.81

2.7

1025.82

1098.00

ng/l

0.80

5964

30664

Disorders of adrenal gland, other and/or unspecified

372

2.66

8.79

3.6

3.3

838.76

1039.40

ng/l

0.30

315

Benign neoplasm of major salivary glands

1119

9486

1.25

8.77

3.2

3.0

1683.60

1433.23

ng/l

0.72

976

8110

Chronic Coagulation defects

220

1479

1.64

8.76

2.8

3.1

1273.97

1042.91

ng/l

0.38

176

1219

Prolapse and hernia of ovary and fallopian tube

584

4639

1.40

8.76

3.2

1657.28

2173.22

ng/l

2.40

509

3948

Anomalies of dental arch relationship, including avohilmo

1465

11264

1.20

8.74

3.5

2.9

748.79

945.40

ng/l

1.20

1187

9279

Benign neoplasm of bone and articular cartilage

760

6166

1.30

8.73

2.7

2.9

1011.01

1156.70

ng/l

0.51

634

5138

Uterine polyps

942

7819

1.27

8.72

2.7

902.90

1198.47

ng/l

2.68

786

6663

Hypoplasia of dental enamel , including avohilmo

125

705

1.85

8.72

10.4

4.7

1125.85

825.92

ng/l

0.37

112

556

Triptan medication for migraine, min. 3 purchases

4807

34823

1.11

8.69

2.4

2.6

531.13

831.37

ng/l

9.07

3833

28785

Infections of genitourinary tract in pregnancy

751

6061

1.29

8.69

2.6

795.90

746.14

ng/l

0.17

649

5003

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

270

1895

1.56

8.68

2.6

3.0

863.42

1168.20

ng/l

0.82

214

1582

Hypothyroidism due to medicaments and other exogenous substances

140

871

1.97

8.68

3.6

3.0

1948.18

1124.14

ng/l

1.59

128

734

Abrasion of teeth

3046

20191

1.14

8.67

2.8

827.43

1080.56

ng/l

6.11

2557

17208

Papilloedema, unspecified

223

1515

1.65

8.66

3.5

3.2

1561.64

1122.87

ng/l

0.86

188

1260

Other and unspecified mononeuropathies of lower limb

333

2457

1.52

8.65

3.6

2.8

1033.10

1150.15

ng/l

0.35

267

2067

Drug-induced systemic lupus erythematosus

492

2.33

8.65

3.5

3.2

1405.46

866.63

ng/l

0.74

413

Benign neoplasm of meninges

1196

10229

1.25

8.64

3.0

1491.63

1411.74

ng/l

0.25

1025

8778

Diabetic retinopathy, strict definition

2255

17719

1.18

8.63

4.1

3.5

4186.49

1668.34

ng/l

24.04

1957

15117

Carcinoma in situ of other and unspecified sites

451

3514

1.46

8.63

3.3

3.2

2431.56

1769.07

ng/l

0.97

400

3028

Preterm labour and delivery

2166

19130

1.16

8.63

2.4

2.5

593.37

736.19

ng/l

1.96

1774

15915

Amputation of ankle bones

288

2093

1.60

8.62

4.2

3.1

8701.71

1869.81

ng/l

7.90

262

1819

Clear cell adenocarcinoma of kidney

574

4606

1.39

8.55

3.1

1914.57

1454.97

ng/l

1.26

515

3976

Disorders of speech understanding and production

326

2312

1.48

8.53

4.7

3.9

1566.83

1428.71

ng/l

0.22

288

1919

Alzheimer’s disease (undefined), excluding more controls

1060

0.42

8.53

2.7

3.2

2999.32

2935.29

ng/l

0.02

909

Enteropathic arthropathies

209

1397

1.65

8.52

3.1

1187.74

992.59

ng/l

0.42

185

1164

Oesophageal obstruction

445

3445

1.44

8.51

2.9

3.1

1930.89

1715.98

ng/l

0.42

384

2979

Deep endometriosis

931

7745

1.26

8.50

2.7

2.9

806.27

1156.23

ng/l

3.32

767

6535

Acquired absence of organs, not elsewhere classified

145

909

1.90

8.49

2.9

2.8

2421.90

1409.69

ng/l

0.95

128

771

Alzheimer’s disease (Late onset)

2768

26151

0.87

8.49

3.0

3.4

2497.08

2297.87

ng/l

1.03

2269

22855

Carcinoma in situ of other and unspecified genital organs

209

1428

1.71

8.47

3.1

2.8

1097.47

1030.33

ng/l

0.09

182

1202

Impacted teeth

926

7069

1.24

8.45

2.9

2.8

887.28

710.45

ng/l

0.55

742

5450

Adalimumab

707

5693

1.30

8.44

2.4

2.9

851.28

875.08

ng/l

0.05

612

4681

Spinal osteochondrosis

121

715

1.96

8.44

3.1

3.3

2218.30

1366.64

ng/l

0.52

107

594

Autoimmune thyroiditis

175

1130

1.73

8.43

2.9

2.7

670.66

847.12

ng/l

0.69

145

931

Degenerative diseases of the nervous system

4443

36121

0.89

8.36

3.0

3.3

2415.57

2086.28

ng/l

3.16

3655

31590

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

1328

0.47

8.34

1.8

2.9

434.66

1312.94

ng/l

9.14

1118

Superficial injuries involving multiple body regions

258

1814

1.57

8.34

3.3

3.1

1429.67

1265.36

ng/l

0.37

212

1509

Other disorders of iris and ciliary body

311

2285

1.53

8.30

3.3

3.1

2843.68

1641.15

ng/l

1.61

270

1942

Episcleritis

476

3680

1.38

8.29

2.6

2.9

759.41

1002.13

ng/l

1.12

401

3061

Other and unspecified paralytic syndromes

167

1088

1.80

8.28

3.7

3.1

1005.54

1374.52

ng/l

1.12

146

910

Other disorders of cornea

1021

8617

1.25

8.28

3.1

1521.76

1396.17

ng/l

0.37

873

7347

Other factor of the environment

145

912

1.87

8.28

3.6

2.9

3750.44

1092.23

ng/l

1.63

131

771

Senility

137

845

1.90

8.27

3.3

3.2

3349.29

2834.09

ng/l

0.30

116

737

Gangrene, not elsewhere classified

108

640

2.16

8.26

3.8

2.6

6004.85

1473.57

ng/l

3.21

547

Alcohol withdrawal state with delirium

775

6388

1.30

8.25

2.9

3.1

1613.23

1530.02

ng/l

0.22

678

5475

Idiopathic thrombocytopenic purpura

336

2496

1.50

8.25

3.6

3.1

1361.58

1436.46

ng/l

0.14

298

2144

Other ulcerative colitis

522

4082

1.36

8.24

2.8

3.0

1545.96

1092.89

ng/l

0.95

438

3421

Deficiency of other B group vitamins

265

1903

1.59

8.23

3.2

3.1

1565.76

1680.72

ng/l

0.19

229

1647

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

1123

0.43

8.20

1.8

2.9

461.16

1331.44

ng/l

6.94

947

Viral meningitis

302

2175

1.49

8.19

3.3

2.9

732.96

956.22

ng/l

0.89

241

1777

Carcinoma in situ of skin of lower limb, including hip

289

2156

1.63

8.16

3.5

3.2

2273.13

1616.40

ng/l

1.31

246

1874

Oral leukoplakia and related diseases

679

5556

1.33

8.16

2.7

3.1

1537.24

1449.59

ng/l

0.12

581

4765

Endocrine disorders, other/unspecified

220

1517

1.64

8.15

3.2

2.9

1113.99

1070.06

ng/l

0.07

167

1271

Benign leiomyoma with endometriosis

1821

16083

1.18

8.15

2.7

2.9

1134.62

1190.86

ng/l

0.25

1498

13674

Gastrojejunal ulcer

167

1102

1.82

8.13

3.8

3.1

1307.26

1700.57

ng/l

0.93

150

949

Previous suicide attempt

473

2.13

8.13

2.8

2.9

1040.61

671.79

ng/l

0.50

375

Hirsutism in women

120

699

1.86

8.12

1.8

2.6

329.57

493.40

ng/l

0.86

555

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1428

12390

1.21

8.12

3.0

1070.95

1308.26

ng/l

1.86

1226

10581

Disorders of purine and pyrimidine metabolism

506

2.40

8.11

6.1

3.2

3262.17

1220.42

ng/l

1.84

433

Assault by unspecified means

158

997

1.73

8.10

2.7

3.1

1123.38

830.34

ng/l

0.43

114

802

Myeloid leukaemia

324

2419

1.52

8.09

3.7

3.2

1490.74

1681.44

ng/l

0.27

301

2084

Disorders of myoneural junction and muscle in diseases classified elsewhere

108

643

2.13

8.08

5.0

3.1

2743.38

1148.34

ng/l

1.23

535

Benign neoplasm: Pituitary gland, craniopharyngeal duct

516

4061

1.37

8.07

2.6

3.0

1262.23

1211.64

ng/l

0.07

445

3416

Dislocation, sprain and strain of joint and ligaments of hip

439

3417

1.43

8.07

3.4

3.2

1343.39

1619.90

ng/l

0.99

382

2935

Thyroiditis, unspecified

164

1062

1.76

8.06

3.4

2.7

2203.42

973.65

ng/l

1.62

136

897

Benign neoplasm of breast

1266

10888

1.22

8.05

2.6

2.8

1112.06

1108.45

ng/l

0.01

1054

9246

Vestibular neuronitis

998

8444

1.26

8.05

3.1

3.0

1303.26

1378.91

ng/l

0.16

862

7250

Herpesviral keratitis and keratoconjunctivitis

480

3761

1.39

8.04

3.1

3.0

1557.80

1374.28

ng/l

0.37

415

3199

Other and unspecified iridocyclitis

433

3334

1.41

8.04

2.9

3.0

1367.30

1140.49

ng/l

0.52

371

2800

Malignant neoplasm of brain

183

2702

0.62

8.04

2.2

3.1

752.02

1519.77

ng/l

3.72

162

2300

Acute epiglottitis

160

1030

1.77

8.03

2.6

3.0

1455.24

1199.96

ng/l

0.28

134

878

Foreign body in alimentary tract

573

4578

1.35

8.00

3.5

3.2

1865.77

1441.28

ng/l

0.86

491

3893

Toxic effect of other and unspecified substances

110

635

1.94

8.00

2.8

3.1

1448.74

845.50

ng/l

0.43

505

Viral encephalitis, not elsewhere classified/unspecified

236

1665

1.62

7.98

3.2

3.1

1416.73

1410.21

ng/l

0.01

195

1419

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

239

3310

0.65

7.96

2.1

3.1

1415.18

1662.40

ng/l

0.39

214

2847

Delivery, wide proxy

3500

20423

0.89

7.94

2.8

3.0

1196.41

1374.77

ng/l

2.02

2969

17308

Status epilepticus

380

2879

1.44

7.94

3.2

3.0

2379.29

1797.26

ng/l

0.66

326

2451

Other lesions of median nerve

370

2829

1.48

7.94

3.2

3.0

1687.57

1520.27

ng/l

0.30

314

2416

Shock, not elsewhere classified

123

757

1.97

7.89

8.7

3.0

4625.50

1494.18

ng/l

3.06

117

642

Unspecified chronic bronchitis

437

3387

1.41

7.87

4.5

3.0

1552.03

1939.30

ng/l

0.84

386

2907

Implicit parasitic Sepsis

368

2.58

7.86

4.4

3.1

1381.44

1462.65

ng/l

0.09

302

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

155

2336

0.60

7.86

2.5

3.2

1849.62

2022.14

ng/l

0.09

141

2017

Crohn's disease of large intestine

454

3507

1.38

7.84

2.8

3.0

1429.95

1020.99

ng/l

1.15

389

2912

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

117

733

2.15

7.84

3.6

3.3

1541.43

1516.61

ng/l

0.03

102

625

Overexertion and strenuous or repetitive movements

958

8051

1.25

7.84

2.8

3.0

1468.05

1183.11

ng/l

0.73

809

6751

Otorrhagia

553

2.25

7.83

5.0

3.0

2508.99

1578.72

ng/l

0.68

465

Carcinoma in situ, bladder

416

3254

1.46

7.83

3.4

3.2

2518.25

1744.95

ng/l

1.09

367

2819

Use of antiglaucoma preparations and miotics

1107

9526

1.25

7.78

3.2

2124.38

1970.15

ng/l

0.42

948

8262

Malignant neoplasm of kidney, except renal pelvis

1145

9869

1.24

7.78

3.2

3.1

2365.67

1707.18

ng/l

2.94

1025

8576

Oral lichen ruber planus, including avohilmo

630

5118

1.33

7.78

2.4

2.9

628.42

1091.84

ng/l

6.36

520

4347

Sequelae of injuries of upper limb

950

7989

1.25

7.76

2.7

3.0

888.66

1184.06

ng/l

2.60

787

6700

Embolic stroke

635

5188

1.34

7.76

3.9

3.3

2695.65

2017.09

ng/l

1.59

561

4517

Symptoms and signs involving appearance and behaviour

563

2.07

7.71

2.9

3.3

987.15

1134.69

ng/l

0.15

474

Dyshidrosis [pompholyx]

152

973

1.76

7.70

2.9

1432.44

882.38

ng/l

0.44

112

799

Multifocal fibrosclerosis

104

632

2.21

7.67

3.2

3.3

1614.99

1744.29

ng/l

0.12

537

Infection due to other mycobacteria

203

1413

1.68

7.67

4.3

2.9

1594.81

1377.73

ng/l

0.27

184

1201

Femoral hernia, unilateral

332

2505

1.49

7.66

3.1

3.0

1400.15

1449.81

ng/l

0.10

291

2163

Inguinal of femoral hernia, unilateral

332

2505

1.49

7.66

3.1

3.0

1400.15

1449.81

ng/l

0.10

291

2163

Inguinal hernia, unilateral

332

2505

1.49

7.66

3.1

3.0

1400.15

1449.81

ng/l

0.10

291

2163

Diastasis of muscle

453

2.19

7.64

3.1

3.6

725.52

1105.09

ng/l

0.92

383

Specific developmental disorder of motor function

373

2.11

7.63

14.1

6.8

868.11

1065.55

ng/l

0.18

301

Other benign neoplasms of connective and other soft tissue

1047

8915

1.23

7.59

3.0

1318.23

1316.40

ng/l

0.00

912

7578

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

549

4354

1.32

7.58

2.3

3.0

948.17

1026.27

ng/l

0.19

457

3621

Malignant melanoma

1825

16243

1.18

7.57

3.1

1661.36

1609.33

ng/l

0.13

1565

14102

Subacute thyroiditis

358

2706

1.44

7.56

2.6

2.7

688.57

1160.79

ng/l

2.05

304

2259

Localized scleroderma [morphea]

168

1120

1.74

7.55

3.0

2.8

678.45

1014.34

ng/l

1.44

141

938

Use of donepezil

2423

25661

0.87

7.54

2.8

3.4

1961.20

2217.40

ng/l

2.03

1974

22346

Prolonged pregnancy

480

5640

0.76

7.54

1.7

2.3

224.36

378.53

ng/l

2.09

378

4439

Unspecified protein-energy malnutrition

457

2.40

7.53

5.0

3.6

2908.67

1711.53

ng/l

1.05

378

Ankylosing hyperostosis [Forestier]

173

1172

1.75

7.50

3.1

952.36

1383.41

ng/l

1.44

154

1013

Intentional self-harm by sharp object

161

1034

1.66

7.48

2.7

3.0

551.47

872.96

ng/l

0.93

116

811

Androgenic alopecia

540

2.09

7.47

2.4

2.8

715.41

850.24

ng/l

0.19

453

Other acquired deformities of ankle and foot

100

588

2.05

7.44

2.9

3.1

736.62

1042.75

ng/l

1.18

502

Encephalitis

294

2168

1.49

7.39

3.1

1080.84

1297.21

ng/l

0.80

240

1830

Malignant neoplasm of urinary organs

1251

10900

1.22

7.36

3.2

2417.96

1731.88

ng/l

3.49

1124

9475

Other interventions on the root canals of the tooth

171

1137

1.68

7.35

3.5

2.9

1662.30

882.45

ng/l

1.14

151

947

Calculus of lower urinary tract

657

5423

1.32

7.32

3.1

3.2

1714.89

1974.71

ng/l

0.63

568

4742

Other Crohn's disease

569

4552

1.31

7.32

2.5

2.9

1149.11

982.89

ng/l

0.45

485

3775

Achalasia of cardia

221

1570

1.61

7.32

3.6

3.0

1276.69

1593.33

ng/l

0.81

195

1353

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

427

2.47

7.30

6.2

3.2

3320.30

1098.68

ng/l

1.73

361

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1579

13968

1.19

7.25

2.6

3.2

1399.52

1575.08

ng/l

1.14

1393

12059

Simple and mucopurulent chronic bronchitis

503

4013

1.35

7.25

4.1

3.1

2089.41

1983.69

ng/l

0.11

431

3454

Benign neoplasm: Cerebral meninges

1065

9162

1.23

7.23

2.9

3.0

1470.24

1416.78

ng/l

0.15

913

7865

Family history of other conditions

547

1.94

7.22

2.5

2.4

1167.87

729.02

ng/l

0.51

430

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

860

7249

1.26

7.22

3.1

3.0

1158.45

1237.05

ng/l

0.23

720

6167

Pulmonary oedema

239

1735

1.59

7.22

6.3

3.2

5925.30

2258.69

ng/l

5.74

216

1506

HSIL lesion of the vulva

187

1287

1.66

7.21

2.6

2.9

833.75

1064.44

ng/l

0.57

155

1082

Granulomatous disorders of skin and subcutaneous tissue

259

1877

1.52

7.19

3.2

2.8

1081.24

977.62

ng/l

0.28

226

1552

Syphilis

272

1995

1.51

7.18

3.7

3.0

3131.48

1301.15

ng/l

4.91

232

1686

Drug-induced polyneuropathy

119

755

1.98

7.18

4.0

3.3

863.22

1222.08

ng/l

1.01

108

646

Other renal tubulo-interstitial diseases

241

1725

1.54

7.17

3.0

2.8

2817.59

1007.10

ng/l

3.65

207

1435

Other and unspecified injuries of shoulder and upper arm

306

2282

1.47

7.17

3.5

3.0

1585.83

1198.51

ng/l

0.63

258

1912

Other superficial mycoses

194

1331

1.61

7.16

3.7

3.0

1359.22

1005.19

ng/l

0.68

172

1105

Crushed, pushed or stepped on by crowd or human stampede

518

4097

1.32

7.16

3.2

3.1

1174.37

1067.90

ng/l

0.28

418

3345

Other congenital malformations of the digestive system

382

2905

1.39

7.14

4.1

3.7

1308.47

1300.13

ng/l

0.01

337

2453

Conduct disorder

129

792

1.73

7.14

3.3

3.6

803.51

1010.95

ng/l

0.26

103

626

Open wound of abdomen, lower back and pelvis

270

1964

1.49

7.11

3.1

2206.44

1300.20

ng/l

1.33

229

1641

Endometriosis ASRM stages 3,4

2251

20221

1.14

7.10

2.6

2.7

878.68

1032.21

ng/l

1.58

1842

17072

Benign neoplasm: Other and unspecified parts of mouth

377

2916

1.42

7.10

3.1

3.0

1442.82

1312.30

ng/l

0.25

326

2467

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

1527

13516

1.19

7.10

3.0

3.2

1871.14

1751.34

ng/l

0.33

1319

11660

Panniculitis, unspecified

125

792

1.87

7.08

3.3

3.1

1468.23

1534.45

ng/l

0.06

113

663

Crohn disease (strict definition, require KELA)

508

4027

1.32

7.07

2.4

3.0

907.67

1024.07

ng/l

0.32

425

3345

Chronic myeloproliferative disease

192

1363

1.72

7.07

3.3

3.1

3097.05

1535.93

ng/l

2.55

172

1184

Other contact dermatitis

797

6651

1.26

7.05

3.2

3.0

1194.92

1352.24

ng/l

0.54

660

5599

Benign neoplasm: Parotid gland

895

7602

1.25

7.04

3.0

3.1

1613.52

1500.55

ng/l

0.22

786

6512

Dermatopolymyositis, unspecified

419

2.35

7.03

5.8

3.0

866.92

1051.98

ng/l

0.44

353

Malignant melanoma of skin

1373

12064

1.20

7.02

3.0

3.1

1387.25

1603.74

ng/l

1.31

1177

10456

Other prurigo

145

960

1.80

6.99

3.4

3.0

4347.35

1376.84

ng/l

1.17

130

817

Myasthenia gravis

207

1472

1.63

6.98

3.3

3.1

1409.59

1279.91

ng/l

0.19

176

1259

Necrotizing fasciitis

370

2.47

6.98

3.3

3747.81

1108.72

ng/l

1.34

311

Crohn disease (strict definition, require KELA, min 2 HDR)

498

3945

1.33

6.98

2.4

3.0

891.24

1031.74

ng/l

0.40

416

3280

Retained placenta and membranes, without haemorrhage

1017

8658

1.22

6.98

2.3

2.6

656.13

716.71

ng/l

0.32

820

7254

Disorder of external ear, unspecified

342

2616

1.44

6.95

3.3

3.0

1697.60

1267.75

ng/l

1.06

294

2236

Other specific arthropathies, wide

227

1621

1.55

6.94

3.2

2.8

1084.70

1185.10

ng/l

0.21

195

1358

Unspecified nephritic syndrome

259

1906

1.52

6.91

3.4

3.0

4126.89

1344.86

ng/l

3.38

236

1632

Abnormal serum enzyme levels

3960

36259

1.11

6.91

3.1

3.2

1746.90

1616.00

ng/l

0.80

3536

31538

469

2.02

6.91

2.5

3.1

815.63

974.24

ng/l

0.26

384

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

487

3912

1.36

6.91

3.2

3.1

1927.82

1469.45

ng/l

1.24

431

3342

Psoriasis (vulgaris), strict definition

305

2283

1.45

6.90

3.1

3.0

863.18

1083.65

ng/l

1.01

254

1917

Unspecified event, undetermined intent

232

1659

1.53

6.87

3.1

1864.34

1204.43

ng/l

0.98

185

1391

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2579

23511

1.14

6.87

2.8

3.2

1700.32

1731.38

ng/l

0.11

2245

20367

Contusion of ankle

321

2407

1.42

6.86

3.1

2.9

1408.40

1011.94

ng/l

0.98

265

1997

Haemangioma and lymphangioma, any site

895

7586

1.24

6.85

2.9

3.1

1241.99

1280.12

ng/l

0.09

758

6446

Monosomies and deletions from the autosomes, not elsewhere classified

3.99

6.83

4.3

7.5

443.11

883.14

ng/l

1.05

Benign neoplasm: salivary glands, exclude unknown (D119)

993

8527

1.23

6.83

3.1

1579.83

1503.92

ng/l

0.15

868

7317

Dislocation, sprain and strain of joints and ligaments of elbow

509

4055

1.32

6.82

2.9

868.10

1011.02

ng/l

0.53

430

3371

Localized skin eruption due to drugs and medicaments

131

847

1.81

6.80

2.9

3.0

1156.79

1097.57

ng/l

0.09

110

719

Calcaneal spur

145

959

1.75

6.79

2.8

3.0

714.82

1221.83

ng/l

2.79

129

811

Fistulae involving female genital tract

169

1147

1.66

6.79

2.8

2.9

912.54

1146.84

ng/l

0.67

143

968

Malignant neoplasm of corpus uteri

1057

9178

1.24

6.78

3.0

1753.85

1419.98

ng/l

0.96

921

7842

Allergic purpura

285

2115

1.46

6.74

3.5

3.2

1663.96

1233.20

ng/l

0.74

242

1773

Severe visual impairment, binocular

411

2.34

6.73

3.9

3.5

2384.10

1867.81

ng/l

0.25

350

Allergic contact dermatitis due to drugs in contact with skin

248

1818

1.53

6.73

3.2

3.0

1491.26

1186.77

ng/l

0.51

197

1542

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

1217

10662

1.21

6.72

2.9

3.0

1687.73

1390.87

ng/l

0.90

1053

9140

Sequelae of injuries of head

509

4089

1.33

6.71

3.0

1511.19

1316.19

ng/l

0.30

406

3474

Spirochaetal infections, other/unspecified

893

7609

1.24

6.69

2.8

3.0

881.36

1349.15

ng/l

4.02

702

6519

Pustulosis palmaris et plantaris

428

3379

1.37

6.69

2.8

1525.69

1040.77

ng/l

1.22

349

2859

Crossbite

422

3032

1.34

6.68

5.3

3.4

685.61

852.06

ng/l

0.56

338

2481

Other encephalitis

275

2042

1.48

6.68

3.1

3.2

1101.67

1323.56

ng/l

0.77

226

1721

Dental pulpitis 3, only avohilmo

392

2166

1.34

6.68

2.6

3.4

1731.02

419.33

ng/l

0.87

269

1510

Other and unspecified injuries of wrist and hand

328

2483

1.41

6.68

2.8

3.0

1556.05

981.77

ng/l

0.96

256

2080

Haemangioma, any site

842

7120

1.24

6.67

2.9

3.1

1155.70

1265.75

ng/l

0.34

710

6046

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2885

18708

0.90

6.67

2.3

2.4

449.00

629.09

ng/l

3.86

2320

15297

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1439

12615

1.17

6.67

3.1

3.0

1487.60

1207.60

ng/l

1.11

1194

10562

Retinal detachment with retinal break

1554

13798

1.18

6.66

3.3

3.1

1846.37

1511.09

ng/l

1.52

1350

11944

Failure of sterile precautions during surgical operation

238

3.03

6.65

5.0

2.9

1672.04

1363.13

ng/l

0.23

198

Unspecified contracted kidney

455

2.21

6.65

3.4

3.5

7131.30

1196.52

ng/l

2.09

377

Lifestyle-related condition

133

868

1.79

6.64

3.5

3.0

4111.22

1144.56

ng/l

1.67

119

731

Procreative management

2610

19919

1.12

6.63

3.2

2.8

700.58

954.71

ng/l

2.50

2162

16329

Benign neoplasm of middle ear and respiratory system

903

7710

1.24

6.63

3.2

3.1

1233.04

1594.64

ng/l

2.57

788

6614

Impetigo

327

2465

1.40

6.62

3.7

3.2

1455.92

1020.67

ng/l

0.74

278

2050

Primary ovarian failure

134

855

1.70

6.59

2.4

2.9

697.07

586.85

ng/l

0.18

117

703

Impaction of intestines

553

2.06

6.59

3.1

2002.60

1426.86

ng/l

0.56

474

Benign neoplasm: Kidney

394

3111

1.40

6.57

2.9

3.0

2484.16

1351.46

ng/l

1.31

335

2661

Other vitreous opacities

447

3578

1.37

6.57

3.2

3.0

1524.23

1346.07

ng/l

0.38

374

3061

Glaucoma, exfoliation

1578

14096

1.19

6.56

3.1

3.3

1947.90

2069.53

ng/l

0.41

1341

12243

Other congenital malformations, not elsewhere classified

383

2.11

6.54

5.0

3.8

848.10

773.20

ng/l

0.15

304

Other and unspecified nail disorders

219

1578

1.55

6.54

4.0

3.0

1380.06

1051.64

ng/l

0.75

193

1337

Hyperosmolality and hypernatraemia

173

1209

1.68

6.53

3.5

3.0

2628.78

1821.40

ng/l

0.54

154

1032

Disorders of synovium and tendon in diseases classified elsewhere

224

1619

1.54

6.52

2.6

3.0

2320.43

1340.05

ng/l

0.98

194

1383

Paraplegia, diplegia of upper limbs

250

1847

1.51

6.52

3.5

3.1

1047.99

1383.71

ng/l

1.10

223

1573

Parkinson's disease, including avohilmo

2109

19126

1.16

6.50

2.9

3.2

1362.14

1837.95

ng/l

7.15

1819

16674

Behavioural disorders

123

765

1.70

6.50

3.3

3.7

797.05

1031.33

ng/l

0.28

100

597

Chronic suppurative otitis media, including avohilmo

803

6773

1.25

6.49

3.5

3.2

1555.35

1544.18

ng/l

0.02

674

5764

Hyperprolactinaemia

249

1804

1.46

6.48

3.4

2.8

658.31

759.36

ng/l

0.39

206

1492

Congenital deformities of feet

192

1331

1.55

6.48

3.0

3.1

764.50

820.69

ng/l

0.12

159

1079

Adenocarcinoma and papillary adenocarcinoma of stomach

206

2830

0.66

6.47

2.8

3.2

2133.59

2059.45

ng/l

0.06

189

2454

Motor disorders

403

1.97

6.46

14.1

6.6

868.11

1362.42

ng/l

0.53

330

Other and unspecified acne

100

596

1.84

6.45

3.9

3.1

1555.60

664.35

ng/l

1.52

464

Diffuse brain injury

340

2599

1.39

6.43

2.8

1194.47

1505.95

ng/l

1.00

278

2221

Carcinoma in situ of other and unspecified sites

451

3654

1.38

6.42

3.3

3.2

2431.56

1888.44

ng/l

0.73

400

3222

Inflammatory disorders of male genital organs, not elsewhere classified

151

1018

1.69

6.41

3.3

3.1

1693.17

1618.09

ng/l

0.09

138

878

Total colectomy

405

3188

1.36

6.41

3.1

3.0

2108.69

1297.90

ng/l

0.94

349

2701

Total colectomy operation

405

3188

1.36

6.41

3.1

3.0

2108.69

1297.90

ng/l

0.94

349

2701

Macular hole

696

5880

1.29

6.40

3.3

3.1

1690.27

1427.16

ng/l

0.77

598

5105

Benign neoplasm: Conjunctiva

340

2629

1.41

6.39

2.8

2.9

1323.47

1308.26

ng/l

0.03

292

2221

Juvenile rheumatoid arthirtis

151

994

1.62

6.39

2.5

3.0

1201.15

927.07

ng/l

0.31

135

804

Female infertility, tubal origin

320

2409

1.39

6.36

2.4

703.83

641.35

ng/l

0.09

262

1999

Chronic iridocyclitis

503

4067

1.32

6.36

3.0

1369.10

1277.90

ng/l

0.14

427

3419

419

1.93

6.36

3.5

3.9

1326.23

385.30

ng/l

0.76

315

Donors of organs and tissues

114

712

1.78

6.33

3.5

2.3

442.26

520.21

ng/l

0.44

578

Transient global amnesia

1176

10333

1.21

6.33

2.9

3.1

996.65

1493.67

ng/l

7.98

1024

8978

Right hemicolectomy

746

6328

1.27

6.33

3.5

3.1

1902.72

1770.27

ng/l

0.23

661

5458

Other salmonella infections

398

3140

1.37

6.30

3.3

2.8

1701.83

1282.53

ng/l

0.46

321

2643

Benign neoplasm: Anus and anal canal

340

2652

1.43

6.29

2.8

3.0

1710.36

1535.27

ng/l

0.25

304

2263

Other and unspecified diseases of blood and blood-forming organs

287

2182

1.47

6.29

3.8

3.0

2311.05

1308.84

ng/l

1.85

235

1860

Toxic effect of ethanol

341

2614

1.38

6.29

3.2

3.0

1267.94

1263.87

ng/l

0.01

283

2181

Diabetes mellitus in pregnancy

1752

10034

1.15

6.28

2.1

2.3

522.58

403.88

ng/l

1.03

1335

7965

Atypical mycobacterium lung infection

159

1107

1.72

6.27

3.4

3.1

1362.12

1434.20

ng/l

0.11

142

937

Childhood allergy (age < 16)

504

3284

1.28

6.26

3.8

3.4

389.62

708.87

ng/l

1.42

345

2360

Other diseases of peritoneum

500

4064

1.33

6.26

3.1

2.9

1296.34

1315.77

ng/l

0.04

418

3433

Nonalcoholic steatohepatitis

542

2.00

6.25

3.0

2.9

988.41

719.28

ng/l

0.33

454

Schizotypal disorder

191

1334

1.54

6.25

2.3

2.9

998.78

729.23

ng/l

0.24

148

1083

Somnolence

132

865

1.73

6.24

3.4

3.1

1859.32

1256.94

ng/l

0.54

106

726

Mixed disorders of conduct and emotions

546

1.79

6.24

3.9

4.1

1321.20

747.10

ng/l

0.37

397

Unspecified threat to breathing

581

1.89

6.22

4.0

3.6

941.11

972.08

ng/l

0.04

486

Congenital malformation syndromes predominantly affecting facial appearance

3.36

6.21

3.1

5.0

1900.05

847.46

ng/l

0.30

Sequelae of injuries of lower limb

894

7632

1.22

6.19

2.9

3.0

1221.74

1196.19

ng/l

0.08

752

6397

Benign neoplasm of urinary organs

548

4523

1.31

6.14

3.0

2381.72

1493.02

ng/l

1.41

466

3890

Ulcerative rectosigmoiditis

747

6280

1.24

6.12

3.1

2.9

1118.85

1206.88

ng/l

0.29

634

5268

Pedal cyclist injured in transport accident

2126

19199

1.14

6.11

3.0

1132.67

1262.58

ng/l

0.89

1768

16198

Alzheimer’s disease, wide definition, excluding more controls

2221

13710

1.14

6.07

2.9

2243.72

1861.36

ng/l

2.62

1853

12010

Progressive vascular leukoencephalopathy

478

3943

1.37

6.07

3.1

3.3

2711.63

2074.75

ng/l

1.82

420

3434

Fourth [trochlear] nerve palsy

268

2035

1.48

6.06

3.3

3.0

1099.62

1397.04

ng/l

0.94

229

1764

Carcinoma in situ of rectum

115

761

1.91

6.04

4.2

3.1

1942.92

1414.73

ng/l

0.73

105

651

Pedestrian injured in transport accident

697

5851

1.25

6.03

2.7

3.0

1530.57

1459.12

ng/l

0.14

572

4949

Pneumoconiosis due to asbestos and other mineral fibres

299

2316

1.46

6.02

4.6

3.4

2317.01

2592.87

ng/l

0.47

270

2050

Other osteochondropathies

649

5400

1.26

6.00

2.9

1291.24

1228.60

ng/l

0.12

532

4508

Inflammatory disorders of breast

453

3612

1.31

6.00

2.7

1195.44

743.76

ng/l

1.23

372

2954

Torticollis

139

920

1.65

5.97

3.0

3.2

1329.81

1177.18

ng/l

0.12

112

764

Pustular psoriasis

469

3799

1.32

5.93

3.0

2.8

1608.44

1088.93

ng/l

1.39

382

3205

Lupus erythematosus

269

2040

1.46

5.93

3.0

2.9

1163.34

1085.22

ng/l

0.16

235

1714

Other and unspecified disorders of adult personality and behaviour

261

2.30

5.93

2.1

2.7

255.46

755.79

ng/l

2.75

210

Other congenital malformations of nervous system

408

1.98

5.92

3.2

3.5

475.31

671.67

ng/l

0.51

327

Benign leiomyoma with endometriosis

1821

16415

1.15

5.92

2.7

2.8

1134.62

1180.66

ng/l

0.20

1498

14054

Carcinoma in situ, bladder

416

3377

1.38

5.90

3.4

3.3

2518.25

1844.87

ng/l

0.89

367

2993

Traction detachment of retina

104

662

1.87

5.90

3.0

3.2

3343.95

1334.43

ng/l

1.80

547

Traumatic ischaemia of muscle

137

919

1.69

5.90

4.2

2.9

1866.31

961.85

ng/l

0.75

118

749

LSIL lesion of the vulva

256

1910

1.45

5.89

2.9

2.7

966.65

821.07

ng/l

0.32

220

1600

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

152

1062

1.70

5.88

3.9

3.2

3170.58

2101.93

ng/l

0.99

135

925

Ulcerative colitis (strict definition, require KELA)

1489

13198

1.16

5.88

3.1

3.0

1475.69

1201.33

ng/l

1.13

1233

11062

Hypermetropia

620

5144

1.26

5.88

3.1

3.2

1078.02

1249.72

ng/l

0.71

516

4311

Hyphaema and other vascular disorders of iris and ciliary body

227

1686

1.52

5.87

3.7

3.2

3193.76

1633.09

ng/l

1.70

201

1441

Anorexia (incl.atypical)

408

3212

1.32

5.86

3.0

2.9

2221.08

1107.54

ng/l

1.06

327

2619

Abnormal findings in secretions and smears from cervix uteri vagina vulva

3640

30910

0.91

5.85

2.5

870.18

806.16

ng/l

0.30

3022

25538

Other bursitis of knee

147

1004

1.65

5.84

3.8

3.4

1651.67

1392.00

ng/l

0.30

122

865

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

122

817

1.81

5.82

4.2

3.0

1852.50

1580.76

ng/l

0.34

112

684

Use of ropinirole

442

3609

1.35

5.80

2.9

3.0

978.65

1376.77

ng/l

2.13

370

3109

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

4.45

5.76

2.5

3.2

2216.49

1443.12

ng/l

0.60

Other or unspecified immunodeficiency

237

2.55

5.74

4.7

3.3

1882.29

896.32

ng/l

0.94

192

Benign neoplasm: Skin of trunk

419

3364

1.33

5.74

3.8

3.0

1793.85

1298.09

ng/l

0.57

345

2828

Effects of other external causes

218

1582

1.47

5.74

2.6

3.2

726.81

1044.74

ng/l

0.95

175

1307

IgA nephropathy (IgA glomerulonephritis)

233

1730

1.48

5.72

4.1

3.0

6148.15

1175.64

ng/l

7.17

206

1460

Benign neoplasm: Choroid

650

5484

1.27

5.72

3.2

3.1

1758.27

1401.69

ng/l

0.55

545

4679

Calcinosis cutis

144

3.67

5.71

5.4

3.3

11141.62

1314.21

ng/l

1.25

121

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

154

1067

1.62

5.71

3.5

3.0

1645.06

1210.19

ng/l

0.59

138

907

Alcoholic liver disease

1110

9743

1.20

5.71

3.1

1891.43

1522.84

ng/l

1.39

973

8369

Dissocial personality disorder

139

933

1.63

5.70

2.5

3.1

683.88

1041.03

ng/l

0.79

116

760

Haemophagocytic lymphohistiocytosis

106

4.34

5.70

5.7

3.3

1565.58

967.82

ng/l

0.77

Unspecified jaundice

569

4732

1.28

5.67

3.1

2093.67

1774.62

ng/l

0.51

484

4098

Sequelae of infectious and parasitic diseases

790

6739

1.23

5.66

3.3

3.0

1424.39

1574.57

ng/l

0.44

671

5686

Erectile dysfunction

1040

9142

1.21

5.64

9.4

3.3

1866.51

1873.31

ng/l

0.02

917

8060

Myopia

921

7905

1.20

5.63

3.0

2.9

949.27

973.40

ng/l

0.07

734

6521

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

134

926

1.75

5.62

2.9

3.0

1010.92

1592.87

ng/l

1.52

118

789

Other deformity of hallux (acquired)

103

664

1.85

5.62

2.7

3.3

881.61

1210.33

ng/l

1.07

561

Chronic conjunctivitis

303

2344

1.40

5.62

2.9

3.1

1080.42

1078.58

ng/l

0.00

256

1953

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1621

14486

1.15

5.61

3.1

3.0

1469.11

1201.29

ng/l

1.19

1347

12149

Atopic conjunctivitis

363

2853

1.34

5.59

2.6

2.9

1742.87

922.31

ng/l

0.81

293

2349

Benign neoplasm: Pancreas

317

2504

1.42

5.58

2.8

3.0

1323.93

1304.38

ng/l

0.03

290

2128

Malignant neoplasm of eye, brain and central nervous system

282

3647

0.73

5.58

2.6

3.1

831.44

1555.04

ng/l

5.23

245

3096

Other disorders of male genital organs

342

2678

1.36

5.57

3.5

3.3

2046.41

1512.82

ng/l

0.54

285

2278

Benign neoplasm of breast

1266

11200

1.18

5.57

2.6

2.8

1112.06

1167.90

ng/l

0.17

1054

9531

Listeriosis

401

2.24

5.56

4.3

3.1

5834.60

1290.18

ng/l

1.44

337

Carcinoma in situ of vulva

586

1.90

5.56

3.0

2.7

1037.70

920.61

ng/l

0.12

484

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

507

2.05

5.56

3.3

3.0

725.95

1072.70

ng/l

0.58

417

Other inflammation of vagina/vulva

239

1766

1.42

5.52

2.6

2.7

520.52

768.19

ng/l

1.55

198

1445

Parkinson's disease

2009

18334

1.14

5.51

2.9

3.2

1358.41

1841.40

ng/l

6.90

1729

15997

Suppurative otitis media, unspecified

239

1783

1.44

5.51

3.4

3.0

1723.67

1292.96

ng/l

0.71

203

1488

Type 1 diabetes, definitions combined

608

5015

1.24

5.49

2.9

2.8

2080.38

693.23

ng/l

4.98

521

4031

Assault by blunt object

118

770

1.68

5.49

3.2

2.9

1214.21

769.26

ng/l

0.38

621

Benign neoplasm of major salivary glands

1119

9857

1.19

5.49

3.2

3.1

1683.60

1526.52

ng/l

0.38

976

8465

Exposure to other and unspecified animate mechanical forces

217

1588

1.46

5.48

3.1

1292.03

1022.13

ng/l

0.46

168

1311

Disorders of porphyrin and bilirubin metabolism

120

796

1.71

5.48

2.5

3.2

2197.58

1034.10

ng/l

0.41

100

669

Carcinoma in situ of colon

181

1331

1.61

5.48

3.6

3.0

1466.17

1272.90

ng/l

0.28

165

1142

Other and unspecified aplastic anaemias

134

920

1.69

5.46

4.2

3.0

3104.77

1418.39

ng/l

2.07

119

775

Benign neoplasm: Tongue

306

2394

1.40

5.45

3.0

2.9

1257.91

1276.42

ng/l

0.03

266

2019

Erythema nodosum

304

2364

1.39

5.44

3.8

2.9

2057.07

1143.62

ng/l

0.62

257

1983

Oral lichen ruber planus, hypothyreosis or thyroxin

181

1316

1.57

5.43

2.4

2.8

690.92

929.18

ng/l

0.67

146

1112

Diabetes insipidus

103

666

1.80

5.41

3.5

3.1

976.47

971.44

ng/l

0.01

558

Pyoderma

207

1527

1.50

5.41

4.1

3.1

1557.50

1242.26

ng/l

0.62

171

1302

Isolated proteinuria with specified morphological lesion

137

948

1.68

5.41

4.3

3.1

4822.97

1134.94

ng/l

3.46

127

806

Psoas tendinitis

292

2.29

5.40

2.6

3.0

896.98

867.50

ng/l

0.03

251

Congenital malformations of eye, ear, face and neck

473

3838

1.28

5.39

3.6

3.3

1392.79

1097.27

ng/l

0.38

391

3175

Microscopic polyangiitis

514

2.05

5.39

3.8

3.3

2342.09

1111.85

ng/l

1.93

423

Autonomic disorders

241

1825

1.46

5.39

2.8

2.9

872.54

1279.37

ng/l

1.55

207

1546

Malignant neoplasm of colon

1928

17570

1.14

5.39

3.0

3.2

1770.02

1801.62

ng/l

0.09

1658

15259

Benign neoplasm: Other and unspecified parts of mouth

377

3028

1.35

5.39

3.1

3.0

1442.82

1221.26

ng/l

0.51

326

2578

Mucosal proctocolitis

1083

9460

1.18

5.39

2.9

3.0

1371.11

1142.50

ng/l

0.74

895

7871

Benign neoplasm: Liver

197

1435

1.50

5.38

2.8

1348.77

969.22

ng/l

0.49

167

1198

Disorders of eyelid in diseases classified elsewhere

335

2642

1.37

5.37

3.8

3.1

1717.32

1462.60

ng/l

0.56

292

2239

Unspecified visual impairment (binocular)

166

1186

1.58

5.37

3.2

3.3

1527.30

1290.07

ng/l

0.36

140

1011

Exposure to unspecified smoke, fire and flames

103

665

1.78

5.36

2.8

3.1

1509.47

1268.01

ng/l

0.21

551

Other disorders of electrolyte and fluid balance, not elsewhere classified

113

755

1.77

5.33

3.8

2.9

3485.32

1442.34

ng/l

1.30

104

631

Alzheimer’s disease (Late onset), excluding more controls

2118

12892

1.14

5.32

3.0

2332.75

1911.71

ng/l

2.85

1770

11303

Chronic suppurative otitis media

686

5815

1.24

5.32

3.6

3.2

1656.21

1545.21

ng/l

0.27

578

4963

Crohn disease (strict definition, all UC cases excluded)

409

3282

1.31

5.32

2.5

3.0

975.50

1039.27

ng/l

0.13

342

2741

Benign intracranial hypertension

340

2.00

5.31

4.2

3.1

1507.73

764.06

ng/l

0.39

256

Von Willebrand disease

113

738

1.69

5.30

2.5

2.9

1304.18

794.60

ng/l

0.61

619

Autism spe, excluding more controls

535

1.73

5.30

3.0

3.2

751.29

383.56

ng/l

0.34

410

Drug-induced headache, not elsewhere classified

343

2.13

5.30

2.4

2.9

863.95

733.22

ng/l

0.13

287

Pyoderma gangrenosum

505

1.93

5.28

3.0

3.4

1911.76

1356.74

ng/l

0.53

429

Poisoning by medicine, drug-induced

128

864

1.65

5.28

2.1

3.0

1137.61

784.16

ng/l

0.30

103

704

Lumbosacral root disorders, not elsewhere classified

151

1070

1.63

5.27

3.6

2.9

2186.91

1142.78

ng/l

0.49

133

925

Other disorders of pigmentation

470

3871

1.30

5.26

3.0

1554.91

1297.84

ng/l

0.23

395

3267

Pyogenic granuloma

174

1252

1.54

5.23

3.3

3.1

1997.06

1237.69

ng/l

1.02

143

1050

Other and unspecified mental retardation

116

760

1.65

5.23

3.3

4.8

1743.84

1171.40

ng/l

0.20

628

Benign neoplasm of bone and articular cartilage

760

6499

1.22

5.22

2.7

2.9

1011.01

1175.95

ng/l

0.63

634

5464

Toxic effect of corrosive substances

269

2.23

5.22

2.0

3.5

484.47

717.30

ng/l

0.82

226

Narcolepsy and cataplexy

377

2.00

5.22

3.6

2.8

1119.09

1131.78

ng/l

0.01

307

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

308

2434

1.40

5.20

2.6

3.1

1333.09

1449.75

ng/l

0.16

279

2061

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

300

2328

1.37

5.20

2.5

3.0

968.55

998.51

ng/l

0.06

253

1928

Other appendicitis

823

7091

1.21

5.19

2.9

1262.40

1185.59

ng/l

0.14

684

5989

Antenatal screening

1060

6878

0.86

5.18

2.1

2.3

305.12

511.30

ng/l

2.76

852

5503

Polyhydramnios

236

1751

1.40

5.17

2.2

2.5

1016.21

417.52

ng/l

0.66

197

1397

Other acute skin changes due to ultraviolet radiation

392

3177

1.33

5.15

3.2

3.0

1703.15

1532.98

ng/l

0.32

341

2707

Contact with nonpowered hand tool

418

3394

1.31

5.15

2.9

3.1

1029.83

1286.47

ng/l

1.00

339

2885

Hyperkinetic disorders (excl. ADHD)

514

1.75

5.14

3.1

4.2

744.43

754.33

ng/l

0.01

402

Benign neoplasm: Skin, unspecified

401

3249

1.32

5.14

3.2

2.9

1584.75

1319.77

ng/l

0.58

334

2735

Ankle and foot

610

1.81

5.14

3.4

3.3

911.99

999.19

ng/l

0.20

516

Torsion of ovary, ovarian pedicle and fallopian tube

157

1095

1.52

5.13

2.8

2.6

1145.97

819.01

ng/l

0.37

133

893

Other and unspecified hypertrophic disorders of skin

406

2.00

5.13

2.5

2.8

789.98

632.04

ng/l

0.33

340

Benign neoplasm of ovary

1914

17421

1.13

5.12

2.9

2.8

1095.61

1162.35

ng/l

0.31

1624

14718

Migraine with aura, drug-induced

111

735

1.70

5.10

2.4

3.0

819.48

778.49

ng/l

0.05

100

610

Other/unspecified crystal arthropathies

614

1.95

5.10

4.4

3.5

1662.37

1642.21

ng/l

0.02

531

Thyrotoxicosis factitia

253

2.51

5.09

3.6

3.1

821.21

932.19

ng/l

0.12

208

Malignant neoplasm of bone and articular cartilage

110

739

1.76

5.08

4.9

3.5

1232.41

1339.84

ng/l

0.11

102

629

Scar conditions and fibrosis of skin

353

2809

1.33

5.08

3.3

2.8

839.35

965.86

ng/l

0.57

301

2320

Benign neoplasm: Liver/bile ducts

221

1656

1.45

5.08

2.7

2.8

1438.34

992.96

ng/l

0.68

189

1386

Other intracranial haemorrhages

395

3231

1.34

5.08

3.8

3.2

1841.10

1859.45

ng/l

0.04

354

2811

Carcinoma in situ of rectum

115

794

1.80

5.05

4.2

3.4

1942.92

1343.13

ng/l

0.88

105

689

Routine general health check-up of defined subpopulation

128

856

1.58

5.05

2.4

1185.13

794.75

ng/l

0.34

115

702

Malignant neoplasm of other and unspecified parts of tongue

178

1315

1.56

5.04

2.6

3.1

935.04

1343.72

ng/l

1.77

162

1119

Disorder of the sleep-wake schedule

146

1016

1.56

5.04

3.5

3.4

1289.80

986.65

ng/l

0.18

111

834

Carcinoma in situ of vulva

602

1.84

5.03

3.0

2.9

1037.70

896.35

ng/l

0.16

512

L02BB Anti-androgens

1195

10680

1.18

5.02

3.3

3.4

2322.77

2169.93

ng/l

0.44

1084

9415

Flatulence and related conditions

114

766

1.69

5.00

4.1

2.9

1212.08

1275.83

ng/l

0.10

666

Iridocyclitis in diseases classified elsewhere

195

1447

1.49

4.99

3.3

3.2

1572.46

1224.15

ng/l

0.60

165

1215

Neuroendocrine tumor and carcinoma of pancreas

523

1.97

4.98

3.3

725.95

1105.49

ng/l

0.66

426

Cerebral palsy

114

751

1.63

4.95

3.1

3.5

1291.53

777.35

ng/l

0.30

616

Assault by hanging, strangulation and suffocation

3.26

4.94

1.5

2.8

279.41

697.53

ng/l

0.86

Localized adiposity

369

2.08

4.94

3.9

2.9

789.02

992.58

ng/l

0.35

312

Idiopathic urticaria

165

1178

1.51

4.94

2.7

2.9

1101.42

939.91

ng/l

0.25

142

970

Other bursal cyst

173

1264

1.53

4.93

2.7

3.1

1370.34

1329.10

ng/l

0.04

146

1073

Varicella [chickenpox]

358

2853

1.31

4.93

4.3

3.1

1093.56

1001.12

ng/l

0.18

289

2328

Type 1 diabetes, strict (exclude DM2)

597

4972

1.23

4.93

2.9

2102.45

707.62

ng/l

4.93

515

3996

Parkinson's disease, strict definition

1861

17027

1.14

4.92

2.9

3.2

1394.53

1849.59

ng/l

5.65

1601

14870

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

207

1558

1.48

4.91

3.8

3.1

1462.71

1521.77

ng/l

0.06

182

1320

Evidence of alcohol involvement determined by level of intoxication

559

1.75

4.90

3.1

3.0

1601.40

762.44

ng/l

0.57

446

Congenital malformations of the nervous system

152

1065

1.52

4.89

3.1

3.8

996.42

881.17

ng/l

0.21

125

871

Inguinal or femoral hernia, bilateral

1299

11646

1.17

4.89

3.1

3.2

1787.34

1704.78

ng/l

0.26

1127

10160

Chorioretinal inflammation

280

2187

1.38

4.89

3.4

3.0

1445.77

1140.32

ng/l

0.54

237

1841

Calcific tendinitis

107

715

1.72

4.89

3.1

3.3

865.62

1119.69

ng/l

0.43

611

Injury of cranial nerves

461

1.93

4.88

2.8

2.9

982.45

930.76

ng/l

0.05

392

Erythema multiforme

234

1786

1.43

4.88

3.4

3.0

1521.75

1260.13

ng/l

0.34

203

1496

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

709

6103

1.23

4.87

2.9

1255.21

1182.13

ng/l

0.11

628

5170

Haemorrhagic disorder due to circulating anticoagulants

168

1247

1.59

4.86

5.7

3.2

3003.45

2140.13

ng/l

1.58

140

1075

Other benign neoplasms of uterus

713

6186

1.24

4.86

3.1

1568.17

1489.47

ng/l

0.19

602

5282

Car occupant injured in noncollision transport accident

299

2340

1.35

4.86

2.8

3.1

1264.52

1169.49

ng/l

0.13

253

1949

Colorectal cancer

3105

28978

1.10

4.85

2.8

3.2

1642.63

1771.63

ng/l

0.75

2687

25141

Other facial nerve disorders

288

2261

1.37

4.85

2.8

2.9

840.61

1156.43

ng/l

1.67

240

1909

Injury of nerves at wrist and hand level

337

2685

1.33

4.84

3.1

1068.86

1145.52

ng/l

0.12

280

2261

Occupational exposure to risk-factors

346

2786

1.34

4.82

3.8

3.1

978.10

1412.14

ng/l

2.60

306

2428

Other conjunctival vascular disorders and cysts

261

2037

1.41

4.82

3.1

3.0

1694.23

1215.68

ng/l

0.81

226

1722

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

122

853

1.70

4.81

4.2

3.1

1852.50

1560.98

ng/l

0.38

112

719

Open wound of hip and thigh

280

2180

1.37

4.80

2.9

3.1

1236.44

1232.86

ng/l

0.00

239

1816

Other sideroblastic anaemias

349

2.21

4.80

6.9

3.0

2103.19

1443.82

ng/l

0.64

287

Contact with sharp object, undetermined intent

185

1357

1.47

4.80

2.9

3.1

1136.07

1083.05

ng/l

0.07

153

1125

Explicit fungal Sepsis

516

1.90

4.77

6.1

2.7

3166.20

1168.70

ng/l

1.47

438

Supervision of normal pregnancy

1008

6619

0.86

4.77

2.0

2.3

242.36

517.72

ng/l

5.85

762

5287

Acute drug-induced interstitial lung disorder

107

736

1.80

4.77

4.6

3.3

1499.94

1733.12

ng/l

0.35

635

Other congenital malformations of upper alimentary tract

605

1.83

4.77

4.7

3.4

993.47

1154.66

ng/l

0.25

512

Contact with machinery

1146

10193

1.17

4.75

3.0

3.1

1196.53

1483.78

ng/l

1.54

986

8765

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

760

6614

1.22

4.74

3.0

3.2

1432.42

1684.48

ng/l

1.08

684

5713

Unspecified lump in breast

1611

14584

1.14

4.74

2.6

2.8

1086.40

1078.72

ng/l

0.03

1416

12385

Ankylosing spondylitis, strict definition

342

2727

1.31

4.72

2.8

3.0

552.49

955.96

ng/l

2.31

274

2239

Burn and corrosion of trunk

287

2259

1.37

4.71

3.2

1130.59

1260.79

ng/l

0.31

247

1918

Monoplegia

172

1269

1.52

4.70

4.7

3.0

1221.20

1285.76

ng/l

0.10

160

1079

Other specified and unspecified disorders of conjunctiva

106

716

1.71

4.66

4.1

3.1

1622.74

1188.76

ng/l

0.41

609

Tetraplegia

590

1.81

4.66

3.0

3.7

1180.32

1264.25

ng/l

0.10

491

Complications peculiar to reattachment and amputation

602

1.83

4.65

3.8

3.0

3786.94

1542.04

ng/l

1.16

504

Benign neoplasm: Pancreas

317

2565

1.37

4.65

2.8

3.1

1323.93

1384.00

ng/l

0.11

290

2198

Endovascular or surgical operations to intracerebral aneurysms

692

5966

1.22

4.64

2.6

2.9

1349.63

1319.12

ng/l

0.07

616

5081

Chronic mastoiditis

321

2589

1.36

4.63

3.3

3.1

1927.33

1623.92

ng/l

0.60

277

2229

Foreign body in respiratory tract

481

4004

1.26

4.63

3.1

1177.05

1226.19

ng/l

0.11

402

3370

Chondromalacia

277

2175

1.37

4.63

2.5

2.9

827.07

965.47

ng/l

0.18

214

1835

Other or unspecified common variable immunodeficiency

191

2.45

4.62

3.6

2.3

852.17

798.79

ng/l

0.05

155

Wegener granulomatosis

177

1316

1.50

4.61

3.2

3.1

1528.32

1287.43

ng/l

0.31

164

1126

Other acute viral hepatitis

110

741

1.64

4.60

2.7

3.1

1111.22

839.51

ng/l

0.38

605

Behçet disease

208

2.46

4.58

2.7

3.1

533.17

973.82

ng/l

0.99

170

Alzheimer’s disease (Atypical or mixed)

1249

11231

1.17

4.58

3.3

3.5

2442.74

2534.17

ng/l

0.21

1020

9791

conjunctival degenerations and deposits

254

1994

1.41

4.57

2.8

3.0

956.04

1256.99

ng/l

0.93

225

1707

Injury of nerves at forearm level

127

886

1.59

4.55

3.6

3.1

1110.62

871.08

ng/l

0.22

100

744

Syndrome of inappropriate secretion of antidiuretic hormone

507

1.97

4.55

3.2

3.3

1331.36

1628.22

ng/l

0.25

429

malignant neoplasm of female genital organs

1813

16607

1.13

4.55

2.8

3.0

1667.95

1387.96

ng/l

1.15

1583

14251

Fibrosis of liver

548

1.86

4.55

3.8

2.9

1180.03

923.52

ng/l

0.41

464

Other nonthrombocytopenic purpura

110

759

1.70

4.54

4.6

3.3

1815.76

1259.10

ng/l

0.80

102

641

Granuloma annulare

150

1082

1.54

4.54

3.5

3.0

1087.64

944.94

ng/l

0.31

131

903

Open bite

270

2086

1.34

4.54

3.9

3.2

440.58

627.22

ng/l

1.68

217

1669

Open wound of shoulder and upper arm

183

1358

1.46

4.53

3.7

3.1

1562.58

1124.61

ng/l

1.05

149

1134

Lesion of femoral nerve

600

1.77

4.52

2.6

2.9

873.52

925.74

ng/l

0.08

512

Malignant neoplasm of oral cavity

397

3288

1.31

4.51

2.7

3.1

1378.72

1539.82

ng/l

0.30

360

2823

Other drug-induced secondary parkinsonism

120

848

1.68

4.51

3.5

3.2

1294.62

1128.53

ng/l

0.26

101

713

Distal bite

194

1421

1.41

4.49

4.6

3.7

773.48

651.86

ng/l

0.21

151

1154

Carcinoma in situ of colon

181

1378

1.53

4.48

3.6

3.1

1466.17

1367.29

ng/l

0.13

165

1202

Measles

563

1.71

4.48

2.5

2.9

778.16

687.45

ng/l

0.08

450

Wide developmental disorders, excluding more controls

114

751

1.55

4.47

3.3

3.8

650.88

540.70

ng/l

0.11

589

Benign neoplasm: Larynx

344

2795

1.33

4.47

3.3

3.0

1172.37

1524.36

ng/l

1.41

299

2358

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

327

2656

1.35

4.46

2.8

3.2

1261.38

1820.00

ng/l

1.15

284

2299

Atlantoaxial subluxation

574

1.81

4.44

3.0

3.2

1306.75

1153.23

ng/l

0.19

489

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

139

984

1.53

4.43

3.8

3.3

881.98

943.47

ng/l

0.09

120

824

Other nonscarring hair loss

538

1.75

4.43

4.2

3.0

1270.83

892.60

ng/l

0.42

444

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

193

1475

1.48

4.41

2.9

3.0

1652.39

1371.78

ng/l

0.42

169

1246

Use of rotigotine

141

1028

1.59

4.41

2.6

3.1

1179.40

1118.44

ng/l

0.08

116

873

Benign neoplasm: Liver

197

1486

1.43

4.40

2.8

3.0

1348.77

1054.89

ng/l

0.35

167

1239

Migraine, single triptan purchase ok & required. ICD-code if available is included

7965

51527

1.06

4.39

2.5

2.8

599.84

994.30

ng/l

23.09

6455

43014

Triptan medication for migraine, single purchase ok

7965

51527

1.06

4.39

2.5

2.8

599.84

994.30

ng/l

23.09

6455

43014

Corneal scars and opacities

287

2293

1.36

4.39

3.7

3.1

1598.34

1357.14

ng/l

0.50

251

1948

Use of rivastigmine

1674

18196

0.88

4.38

2.7

3.4

2018.02

2276.72

ng/l

1.19

1407

15762

Scleritis

124

869

1.59

4.38

3.3

3.0

834.10

1017.14

ng/l

0.40

112

724

Palindromic rheumatism

115

798

1.63

4.38

3.5

3.1

1182.93

1235.37

ng/l

0.06

101

674

Protein-energy malnutrition of moderate and mild degree

102

699

1.72

4.38

4.6

3.8

2321.18

1536.96

ng/l

0.99

588

Other rupture of muscle

443

1.88

4.38

3.1

3.4

1367.92

1372.20

ng/l

0.00

372

Cachexia

417

1.97

4.37

3.1

3.0

5634.53

1944.19

ng/l

1.30

352

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

297

2369

1.34

4.34

2.6

3.0

814.11

1085.38

ng/l

0.77

251

1994

Henoch-Schönlein purpura nephritis (HSPN)

217

2.30

4.34

3.4

3.2

1907.14

1197.31

ng/l

0.57

181

Sexual dysfunction

136

967

1.54

4.34

2.7

3.0

685.08

1038.37

ng/l

1.55

114

813

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

426

1.95

4.33

3.5

3.0

1361.67

1440.94

ng/l

0.07

349

Foreign body or object entering through skin

544

4601

1.23

4.33

2.9

3.0

1257.88

1201.63

ng/l

0.11

461

3864

Benign neoplasm: Kidney

394

3273

1.30

4.33

2.9

3.0

2484.16

1427.17

ng/l

1.18

335

2809

Horner syndrome

139

1005

1.56

4.32

2.7

3.0

1179.37

1217.32

ng/l

0.05

118

856

Embedded teeth, including avohilmo

503

4191

1.23

4.31

2.9

1317.40

828.92

ng/l

1.53

425

3329

Hereditary deficiency of other clotting factors

551

1.73

4.31

2.9

3.3

1431.22

1130.31

ng/l

0.33

462

Gilbert syndrome

473

1.81

4.31

2.4

3.0

685.46

885.33

ng/l

0.43

392

Oral lichen ruber planus

264

2099

1.38

4.30

2.5

2.9

702.87

1011.97

ng/l

1.47

220

1770

Tooth eruption problems

694

5879

1.19

4.28

3.3

3.1

1091.60

761.37

ng/l

1.28

571

4610

Other and unspecified nonscarring hair loss

395

1.88

4.26

2.8

1242.69

800.98

ng/l

0.39

320

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

2700

24157

1.10

4.26

2.8

1297.05

1227.64

ng/l

0.39

2286

20379

Family history of malignant neoplasm

789

6860

1.18

4.25

2.4

2.3

799.20

811.92

ng/l

0.02

670

5678

Assault by sharp object

128

898

1.53

4.23

2.7

3.0

1658.05

987.67

ng/l

0.58

102

736

Hypertrophy of tongue papillae

136

983

1.56

4.22

2.9

3.2

1217.84

1050.25

ng/l

0.27

108

842

Premenstrual syndrome

419

1.77

4.21

2.3

2.8

373.29

664.80

ng/l

0.58

342

Other bursitis, not elsewhere classified

111

772

1.63

4.20

2.8

3.2

934.34

1574.38

ng/l

2.01

662

Secondary parkinsonism

321

2621

1.34

4.19

3.2

3.1

1160.13

1813.31

ng/l

3.67

274

2257

Benign neoplasm: Anus and anal canal

340

2794

1.33

4.19

2.8

3.0

1710.36

1571.10

ng/l

0.20

304

2400

Congenital deformities of hip

119

821

1.54

4.18

3.8

4.0

833.81

956.56

ng/l

0.22

675

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

411

2.11

4.15

3.1

3.2

1043.97

1538.87

ng/l

1.04

346

Injury of nerves at lower leg level

105

723

1.64

4.15

2.2

3.1

1351.65

1194.24

ng/l

0.16

615

Amputation of thigh

365

3028

1.31

4.15

4.7

3.3

5000.67

2264.12

ng/l

6.98

324

2629

Anxious personality disorder

127

890

1.51

4.13

2.5

2.8

1895.18

838.10

ng/l

0.51

713

Secondary parkinsonism+Parkinsonism in other disease

330

2707

1.33

4.13

3.2

3.1

1141.94

1797.66

ng/l

3.91

283

2335

Poor fetal growth

560

4724

1.21

4.13

2.1

2.3

655.30

369.77

ng/l

0.59

442

3721

Common variable immunodeficiency

410

1.87

4.11

3.3

2.5

1390.19

1172.79

ng/l

0.11

340

Hereditary corneal dystrophies

370

3074

1.31

4.11

3.2

3.0

1731.79

1314.47

ng/l

0.67

304

2619

Benign neoplasm: Tongue

306

2486

1.33

4.10

3.0

1257.91

1217.64

ng/l

0.07

266

2110

Other benign neoplasm of uterus: Other parts/unspecified

591

5146

1.25

4.10

3.3

3.1

1714.19

1581.16

ng/l

0.30

507

4403

Benign neoplasm: Other and unspecified parts of small intestine

201

1563

1.45

4.09

3.1

2.9

1895.61

1337.54

ng/l

0.58

182

1317

Findings of drugs and other substances, not normally found in blood

371

2.01

4.09

3.5

3.1

1073.51

1252.97

ng/l

0.25

305

Dementia

6339

41884

1.07

4.08

3.1

3.2

2087.55

1889.57

ng/l

2.35

5346

36642

Colon adenocarcinoma

1527

13974

1.14

4.07

3.0

3.2

1871.14

1820.88

ng/l

0.12

1319

12129

Inguinal hernia, bilateral

1262

11422

1.15

4.06

3.1

3.2

1706.48

1702.29

ng/l

0.01

1096

9964

Other benign neoplasms of uterus

713

6274

1.22

4.06

3.1

1568.17

1556.81

ng/l

0.02

602

5386

Benign neoplasm: Conjunctiva

340

2791

1.31

4.06

2.8

3.0

1323.47

1335.67

ng/l

0.02

292

2383

Other and unspecified bullous disorders

113

799

1.62

4.05

3.9

3.2

1295.94

1330.42

ng/l

0.04

100

680

Other specified/unspecified disorders of bone/cartilage

286

2301

1.33

4.03

3.1

2.8

987.20

1135.71

ng/l

0.38

241

1939

Benign neoplasm of other and unspecified female genital organs

428

3587

1.26

4.03

2.6

2.9

926.88

1167.06

ng/l

0.74

352

3020

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

206

2638

0.73

4.02

2.8

3.2

2133.59

1855.13

ng/l

0.29

189

2260

Primary angle-closure glaucoma

558

4818

1.24

4.02

2.9

3.1

1517.63

1761.70

ng/l

0.94

480

4149

Undescended testicle

465

1.72

4.01

4.6

5.8

1457.57

1590.57

ng/l

0.08

380

Anomalies of pupillary function

179

1349

1.43

4.00

2.5

3.0

947.80

880.19

ng/l

0.11

140

1112

Contact with heat and hot substances

458

3846

1.24

4.00

3.0

3.2

1388.68

1327.36

ng/l

0.13

383

3253

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

418

1.75

3.99

1.9

2.5

605.17

483.43

ng/l

0.21

341

Benign neoplasm of male genital organs

229

1805

1.39

3.99

3.3

3.1

2101.67

1683.61

ng/l

0.51

190

1563

Other nonautoimmune haemolytic anaemias

179

3.00

3.99

8.2

3.5

3176.39

1234.21

ng/l

0.72

155

Migraine without aura, drug-induced

647

1.62

3.98

3.4

2.9

508.53

790.59

ng/l

0.93

527

Short stature, not elsewhere classified

518

1.61

3.98

5.3

7.4

614.07

1297.62

ng/l

1.21

421

Congenital malformations of genital organs

576

4873

1.20

3.98

3.1

3.0

721.96

817.88

ng/l

0.46

469

3952

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

416

3487

1.27

3.98

3.0

2.9

1199.68

1440.23

ng/l

0.78

366

2962

Benign neoplasm: Liver/bile ducts

221

1722

1.38

3.96

2.7

3.0

1438.34

1072.67

ng/l

0.52

189

1444

Perioral dermatitis

164

1217

1.44

3.96

2.7

2.8

902.31

850.99

ng/l

0.08

131

1005

Benign neoplasm: Spinal cord

149

1104

1.50

3.96

3.0

2.9

947.07

1044.61

ng/l

0.17

120

931

Adhesive middle ear disease

155

1147

1.47

3.96

3.3

3.0

1012.93

1151.44

ng/l

0.36

125

955

Organ-limited amyloidosis

362

2.05

3.96

6.6

3.2

4443.40

1664.22

ng/l

2.67

303

Other proliferative retinopathy

293

2.06

3.95

3.5

3.4

2695.27

1394.82

ng/l

1.31

249

Mantle cell lymphoma

123

903

1.63

3.95

3.0

3.4

1343.96

1926.24

ng/l

1.29

113

783

Pre-eclampsia superimposed on chronic hypertension

190

2.15

3.94

2.4

2.8

1753.03

366.89

ng/l

0.65

159

Sixth [abducent] nerve palsy

371

3090

1.29

3.94

3.3

3.2

1639.64

1561.56

ng/l

0.11

318

2662

Open wound of thorax

146

1072

1.48

3.93

3.0

3.1

1557.07

1183.40

ng/l

0.52

121

904

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

343

4163

0.79

3.93

2.8

3.1

788.58

1424.30

ng/l

5.63

306

3535

Generalized epilepsy

325

2635

1.29

3.93

2.8

3.1

744.33

1167.42

ng/l

2.33

261

2192

Diseases caused by chlamydiae

518

1.68

3.92

2.1

2.7

738.10

481.37

ng/l

0.31

428

Foreign body on external eye

1349

12212

1.13

3.92

2.9

3.1

1094.74

1216.77

ng/l

0.53

1119

10332

Other diseases caused by chlamydiae

624

1.62

3.91

2.3

2.8

747.87

670.34

ng/l

0.09

511

Histrionic personality disorder

388

1.91

3.91

3.3

2.9

570.87

1144.01

ng/l

1.76

328

Benign neoplasm: Skin of trunk

419

3515

1.26

3.91

3.8

3.0

1793.85

1264.29

ng/l

0.63

345

2978

Other and unspecified corneal deformities and disorders

309

2513

1.31

3.91

3.0

1226.10

1103.23

ng/l

0.24

281

2103

Sequelae of other and unspecified effects of external causes

371

1.92

3.91

3.7

3.5

939.41

1342.85

ng/l

0.63

303

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

118

858

1.63

3.90

3.3

3.1

1252.46

1541.73

ng/l

0.60

107

720

Certain conditions originating in the perinatal period

389

2822

1.24

3.90

4.7

3.8

1555.40

744.49

ng/l

1.14

316

2176

Long labour

1202

11710

0.88

3.89

2.2

2.4

415.05

520.33

ng/l

1.12

971

9488

Anogenital herpesviral [herpes simplex] infection

378

3105

1.25

3.88

2.6

2.8

603.53

760.26

ng/l

0.34

298

2522

Abnormality of red blood cells

406

1.89

3.87

3.0

3.1

1543.03

1266.35

ng/l

0.30

342

Acquired clawhand, clubhand, clawfoot and clubfoot

307

1.96

3.86

2.8

3.2

1454.84

1048.86

ng/l

0.29

263

Disorders of puberty, all

449

1.67

3.86

3.2

4.4

246.98

954.51

ng/l

1.27

346

Tibial collateral bursitis [Pellegrini-Stieda]

116

826

1.57

3.86

3.0

1160.33

1074.71

ng/l

0.13

100

708

Deformity of finger(s)

467

1.80

3.86

2.6

3.2

910.72

1064.78

ng/l

0.16

402

Use of rasagiline

312

2579

1.33

3.85

2.6

3.0

1042.71

1326.22

ng/l

1.32

269

2229

Shoulder region

149

1113

1.49

3.84

3.1

2476.84

1166.07

ng/l

2.10

129

939

Fasciculation

111

783

1.57

3.83

2.5

3.1

664.28

1048.59

ng/l

1.01

645

Left side

442

1.97

3.83

3.1

3.3

1541.10

1430.74

ng/l

0.07

368

Melanocytic naevi of lower limb, including hip

373

3091

1.27

3.82

3.1

2.9

1406.14

1154.96

ng/l

0.46

311

2584

Intercostal neuropathy

668

1.67

3.82

3.7

3.0

1317.77

1180.15

ng/l

0.15

559

Schizoid personality disorder

163

1223

1.44

3.81

2.9

3.0

1411.38

909.43

ng/l

0.27

136

1019

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

139

1031

1.52

3.81

3.8

3.2

1097.15

1550.76

ng/l

1.18

126

880

Other neurotic disorders

528

4531

1.23

3.79

2.9

1840.87

1401.83

ng/l

0.59

452

3856

Infectious mononucleosis

427

3548

1.23

3.79

3.2

2.8

853.99

664.07

ng/l

0.44

330

2758

Perichondritis of external ear

214

1692

1.40

3.79

3.6

3.0

1359.71

1626.56

ng/l

0.48

186

1443

Other and unspecified mononeuropathies of upper limb

287

2322

1.31

3.78

2.7

3.0

1091.30

1171.71

ng/l

0.16

249

1971

Endometriosis diagnosis and infertility diagnosis occurring together

652

5631

1.18

3.78

2.3

2.5

668.57

560.21

ng/l

0.23

524

4580

Malignant neoplasm of bladder

915

8186

1.17

3.78

3.1

3.3

2502.75

2164.50

ng/l

0.85

800

7180

Volvulus

291

2371

1.32

3.77

3.2

3.0

1660.76

1528.23

ng/l

0.24

250

2058

Disorder of thyroid, unspecified

140

1037

1.50

3.77

2.8

786.30

1096.42

ng/l

1.22

117

875

Benign neoplasm: Other and unspecified parts of small intestine

201

1582

1.42

3.77

3.1

1895.61

1295.89

ng/l

0.64

182

1357

Presbyopia

561

4828

1.21

3.75

2.6

2.8

567.27

973.06

ng/l

6.96

454

4051

Dental caries 1 and operation codes, only avohilmo

3448

16280

1.08

3.75

3.0

3.3

1203.07

1383.82

ng/l

1.20

2901

14006

Familial chondrocalcinosis

104

3.75

4.0

3.5

1892.59

1650.11

ng/l

0.10

Ulcerative enterocolitis

278

2238

1.31

3.74

3.3

3.0

1190.92

1146.57

ng/l

0.07

235

1859

Embedded and impacted teeth

1393

10693

1.12

3.73

2.9

2.8

1016.48

813.50

ng/l

0.93

1125

8389

Failed attempted abortion

354

1.76

3.73

2.5

2.3

301.95

545.40

ng/l

0.50

284

Injury of intra-abdominal organs

214

1671

1.36

3.71

3.2

3.1

1973.58

1200.77

ng/l

1.50

182

1388

Alzheimer’s disease (Early onset), excluding more controls

346

3930

0.79

3.71

2.9

3.0

2391.35

2282.78

ng/l

0.12

270

3397

Drug-induced myopathy

251

2.22

3.70

3.0

3.3

2154.58

1722.17

ng/l

0.34

212

Tuberculosis, IBD comorbidity

919

8225

1.17

3.68

3.8

3.2

2057.10

1926.80

ng/l

0.33

800

7102

Hydrocephalus

917

8215

1.17

3.67

2.6

3.2

1176.69

1783.76

ng/l

4.85

785

7104

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

419

3531

1.25

3.67

2.7

2.9

1149.68

1219.68

ng/l

0.14

370

2961

Benign neoplasm of ovary

1914

17712

1.11

3.66

2.9

2.8

1095.61

1182.37

ng/l

0.44

1624

15126

Severe visual impairment, monocular

108

776

1.61

3.66

3.7

3.3

2058.53

1555.50

ng/l

0.56

656

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

446

1.84

3.66

3.5

3.1

1361.67

1329.72

ng/l

0.03

376

Carcinoma in situ of oral cavity, oesophagus and stomach

524

1.80

3.64

4.1

3.2

1847.82

1901.06

ng/l

0.04

437

Disorders of optic nerve, not elsewhere classified

239

1923

1.37

3.64

3.4

3.1

2482.38

1475.64

ng/l

1.32

204

1652

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

739

6540

1.19

3.64

3.1

3.2

1395.01

1785.34

ng/l

1.38

648

5643

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

800

7078

1.17

3.64

3.0

1474.98

1215.15

ng/l

0.49

678

5975

Colitis due to radiation

137

1032

1.54

3.64

3.8

3.2

1857.35

1930.00

ng/l

0.06

122

898

Sequelae of tuberculosis

250

2021

1.35

3.64

3.9

3.3

2053.75

2397.98

ng/l

0.55

225

1738

Benign neoplasm: Pelvic bones, sacrum and coccyx

262

2.06

3.63

2.4

3.4

534.04

1302.12

ng/l

1.75

218

Drug-induced gout

489

1.88

3.61

6.6

3.4

3257.05

1897.23

ng/l

1.83

413

Acute appendicitis, with complications

2132

19800

1.10

3.59

3.1

3.0

1317.69

1413.37

ng/l

0.62

1830

16962

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

669

5871

1.19

3.58

2.9

3.0

1287.58

1329.61

ng/l

0.11

583

4976

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

162

1247

1.46

3.58

3.2

3.1

2686.95

1606.31

ng/l

0.57

146

1071

Other and unspecified acute skin changes due to ultraviolet radiation

309

2558

1.31

3.58

3.1

3.0

1914.46

1696.00

ng/l

0.34

271

2193

Alopecia areata

214

1678

1.35

3.57

2.9

1168.63

805.51

ng/l

0.55

181

1393

Portal vein thrombosis

166

1275

1.44

3.57

2.9

3.1

1832.63

1430.42

ng/l

0.40

132

1080

Contact with other sharp object(s)

466

3949

1.22

3.56

2.6

3.0

821.52

1000.55

ng/l

0.78

370

3270

Ovarian dysfunction, other/unspecified

289

1.91

3.56

2.0

2.7

566.40

669.48

ng/l

0.23

239

Disorders in reading

445

1.65

3.52

3.8

4.5

237.63

813.16

ng/l

0.96

339

Ectopic pregnancy

1399

12741

1.12

3.52

2.5

630.27

710.15

ng/l

0.51

1154

10696

Alcoholic gastritis

171

1321

1.43

3.52

3.9

3.1

1578.91

1325.59

ng/l

0.32

148

1142

Disorders of pituitary gland, other and/or unspecified

463

1.77

3.52

2.7

2.9

4957.43

1283.36

ng/l

0.64

387

Mononeuritis multiplex

256

2.18

3.50

2.1

3.1

1214.92

1294.42

ng/l

0.05

226

Carcinoma in situ of oral cavity, oesophagus and stomach

529

1.77

3.50

4.1

3.3

1847.82

1790.74

ng/l

0.05

440

Sequelae of other and unspecified infectious and parasitic diseases

459

3902

1.22

3.50

3.2

2.9

1072.13

1110.98

ng/l

0.07

380

3267

Disorders of orbit

414

3503

1.24

3.48

2.7

3.0

1116.69

1113.99

ng/l

0.01

348

2923

Anorexia

129

946

1.47

3.48

2.7

3.1

1998.30

1075.70

ng/l

1.37

109

774

Other bacterial agents as the cause of diseases classified to other chapters

117

858

1.54

3.47

4.9

3.4

2316.17

1354.94

ng/l

1.06

102

722

Burn and corrosion of ankle and foot

139

1040

1.47

3.46

3.1

2870.40

1101.85

ng/l

1.56

117

885

Disorders of puberty, other/unspecified

130

2.32

3.45

3.5

4.8

268.42

941.79

ng/l

1.28

105

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

141

1076

1.51

3.45

3.1

3.0

1471.15

1386.45

ng/l

0.10

122

910

Normotensive glaucoma

1073

9759

1.15

3.45

3.1

1645.85

1694.69

ng/l

0.11

929

8466

Malignant neoplasm of mesothelium and soft tissue

498

4310

1.23

3.45

3.2

1672.67

1684.16

ng/l

0.02

452

3729

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

130

979

1.53

3.43

2.9

2707.67

1399.83

ng/l

0.94

115

833

Benign neoplasm: Pelvic bones, sacrum and coccyx

267

2.01

3.43

2.4

2.9

534.04

1284.39

ng/l

1.68

223

Respiratory tuberculosis, bacteriologically and histologically confirmed

230

1850

1.35

3.43

4.1

3.1

2844.06

2075.06

ng/l

1.18

207

1581

Other benign neoplasm of uterus: Other parts/unspecified

591

5219

1.22

3.42

3.3

3.1

1714.19

1663.33

ng/l

0.10

507

4494

Mild or no visual impairment, binocular

296

1.92

3.42

3.1

3.5

1773.59

1362.27

ng/l

0.30

247

128

949

1.49

3.42

3.3

3.0

1909.63

1424.00

ng/l

0.70

104

798

Unequal limb length (acquired)

342

1.76

3.42

3.0

2.7

977.15

741.23

ng/l

0.19

270

Onychogryphosis

219

2.25

3.42

3.1

3.3

1815.19

1104.92

ng/l

0.55

183

Viral agents as the cause of diseases classified to other chapters

200

1573

1.36

3.41

3.5

3.1

1677.74

1056.64

ng/l

1.29

176

1329

Benign neoplasm: Skin, unspecified

401

3399

1.25

3.41

3.2

3.0

1584.75

1249.36

ng/l

0.87

334

2900

Trichomoniasis

103

746

1.60

3.40

3.1

2.7

2220.48

1027.39

ng/l

0.95

632

Other puerperal infections

349

2878

1.24

3.39

1.9

2.4

311.96

456.94

ng/l

1.38

278

2272

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

5390

46041

0.95

3.39

2.7

1240.91

1116.26

ng/l

0.76

4483

38821

Respiratory tuberculosis, confirmed

222

1782

1.35

3.38

4.1

3.1

2911.38

2054.85

ng/l

1.32

200

1520

Tuberculosis, wide

948

8546

1.16

3.38

3.7

3.2

2032.64

1981.65

ng/l

0.11

827

7381

Colorectal adenocarcinoma

2579

24256

1.09

3.37

2.8

3.2

1700.32

1765.04

ng/l

0.26

2245

21055

Leukaemia of unspecified cell type

700

1.59

3.37

3.5

3.2

1161.27

1394.05

ng/l

0.35

583

Divergent concomitant strabismus

663

5814

1.18

3.37

3.2

3.0

1042.90

1167.77

ng/l

0.47

558

4868

259

1.98

3.36

2.0

2.9

432.07

682.53

ng/l

0.81

218

Pulmonary eosinophilia, not elsewhere classified

147

1126

1.47

3.36

4.9

3.1

1668.98

1378.18

ng/l

0.42

136

960

Meningitis

454

3881

1.22

3.35

2.9

3.0

1254.31

1226.63

ng/l

0.03

385

3278

Other dermatomyositis

372

1.83

3.33

4.4

3.2

1025.16

1447.95

ng/l

0.66

319

Sequelae of hyperalimentation

118

2.74

3.33

2.6

3.4

1411.98

1697.48

ng/l

0.13

103

Defects in post-translational modification of lysosomal enzymes

5.81

3.33

2.5

2.1

598.91

337.99

ng/l

0.35

Contact with other hot fluids

241

1935

1.31

3.32

3.1

3.3

1285.02

1117.83

ng/l

0.35

195

1611

Abnormality of white blood cells, not elsewhere classified

643

1.61

3.32

4.6

3.0

1169.47

1074.91

ng/l

0.10

549

Ulcerative proctitis

498

4281

1.20

3.32

3.0

2.9

1695.35

1161.61

ng/l

1.03

421

3561

Other and unspecified myoneural disorders

296

1.97

3.30

3.5

2.9

1292.91

891.69

ng/l

0.48

243

Alzheimer disease, including avohilmo

4814

36305

0.94

3.29

3.0

3.3

2323.77

2090.17

ng/l

2.19

4027

31768

Disorders of puberty

389

1.66

3.29

3.4

4.6

282.27

1051.21

ng/l

1.17

301

Other meningitis

145

1096

1.43

3.29

3.0

3.1

848.07

1023.47

ng/l

0.51

118

913

All dysplastic lesions of the cervix uteri, vagina or vulva

1962

18046

1.09

3.29

2.5

2.4

678.11

700.08

ng/l

0.15

1613

14733

Benign neoplasm of brain and other parts of central nervous system

629

5527

1.18

3.28

2.9

3.0

1047.50

1354.37

ng/l

1.40

532

4677

Pedestrian injured in collision with pedal cycle

308

2555

1.28

3.28

2.8

3.1

1495.12

1309.53

ng/l

0.28

260

2173

Tuberculosis of other organs

274

2270

1.32

3.28

3.7

3.2

1849.41

1916.20

ng/l

0.08

235

1954

Benign neoplasm: Scapula and long bones of upper limb

654

1.56

3.27

3.1

2.9

827.55

794.95

ng/l

0.07

545

Ovarian dysfunction: estrogen excess

3.21

3.27

1.3

3.5

271.29

989.54

ng/l

—

Abnormal spermatozoa

1471

13592

1.12

3.27

3.2

3.3

1939.89

1722.74

ng/l

0.67

1213

11972

Maternal care for other known or suspected fetal problems

1140

6574

1.12

3.25

2.0

2.3

297.21

366.05

ng/l

0.77

829

5149

Use of entacapone

867

0.59

3.23

3.0

3.2

1676.92

2009.05

ng/l

0.22

735

Maxillary retrognathism

110

788

1.47

3.23

3.5

3.4

818.97

595.05

ng/l

0.40

644

Benign neoplasm: Spinal cord

149

1144

1.43

3.21

3.0

3.1

947.06

1049.06

ng/l

0.18

120

974

Dental caries 3 and operation codes, only avohilmo

3861

18370

1.07

3.21

3.0

3.3

1156.87

1325.66

ng/l

1.26

3240

15761

Intracranial and intraspinal abscess and granuloma

125

939

1.49

3.20

3.4

3.2

2518.03

1302.30

ng/l

0.50

111

803

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

100

703

1.48

3.19

2.1

2.6

398.33

389.32

ng/l

0.02

564

Peptic ulcer

116

861

1.51

3.19

3.3

3.1

1848.58

1608.80

ng/l

0.20

101

738

Benign neoplasm: Connective and other soft tissue, unspecified

125

936

1.48

3.19

2.9

1581.60

1197.84

ng/l

0.34

116

784

Other bursitis of elbow

667

1.59

3.18

4.5

3.3

1730.20

1561.28

ng/l

0.15

574

Superficial injury of neck

140

1051

1.41

3.17

2.8

3.1

1042.01

1005.42

ng/l

0.05

108

862

Benign neoplasm: Choroid

650

5764

1.19

3.16

3.2

3.1

1758.27

1375.78

ng/l

0.61

545

4955

Autism

635

1.50

3.16

3.1

3.4

737.98

746.01

ng/l

0.01

462

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

4.12

3.16

4.4

4.0

2094.28

769.59

ng/l

—

Contusion of toe(s) without damage to nail

173

1339

1.36

3.16

2.7

2.9

1490.14

837.72

ng/l

0.78

149

1109

Effects of heat and light

599

1.62

3.16

2.7

3.3

1612.30

1601.45

ng/l

0.01

505

Mental and behavioural disorders due to cannabinoids

136

1007

1.39

3.16

2.8

3.4

1176.96

690.83

ng/l

0.39

101

768

Other and unspecified pemphigoid

114

858

1.55

3.16

3.2

3.3

2372.35

1649.24

ng/l

0.60

104

739

Injury of muscle and tendon at forearm level

178

1395

1.37

3.15

2.7

3.1

1351.94

1000.81

ng/l

0.44

152

1181

0.00

3.14

0.0

10.5

—

1071.40

—

Other congenital malformations of skin

328

2738

1.25

3.14

2.9

3.0

1462.96

1110.08

ng/l

0.58

284

2286

Precocious central puberty

191

1.98

3.14

2.8

3.4

587.97

904.20

ng/l

0.51

150

Ulcerative colitis (strict definition, all Crohn cases excluded)

1232

11231

1.12

3.13

3.1

3.0

1334.76

1230.08

ng/l

0.30

1015

9390

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

110

817

1.53

3.12

2.9

3.0

2467.70

1385.24

ng/l

1.29

685

Benign neoplasm: Long bones of lower limb

260

2122

1.28

3.12

2.8

2.9

1126.04

1018.98

ng/l

0.14

214

1753

Tuberculosis of other organs, strict

311

2618

1.28

3.12

3.6

3.2

1779.90

2005.46

ng/l

0.39

269

2252

Factitial dermatitis

420

1.76

3.12

3.2

2.7

3145.88

1191.13

ng/l

0.43

352

Traumatic amputation of wrist and hand

446

3849

1.22

3.11

3.2

3.1

1126.59

1540.17

ng/l

1.43

394

3332

Other secondary coxarthrosis

353

2991

1.25

3.11

3.0

2.9

1413.11

1215.80

ng/l

0.55

310

2524

Peripheral retinal degeneration

319

2675

1.26

3.11

2.8

2.9

1125.38

1221.87

ng/l

0.16

281

2268

Disorders of other and unspecified cranial nerves

428

1.74

3.10

3.2

2.9

3525.18

1364.12

ng/l

0.89

368

Crystalline deposits in vitreous body

120

912

1.53

3.10

3.7

3.2

1089.37

1462.16

ng/l

0.96

103

793

Burns and corrosions confined to eye and internal organs

220

1765

1.31

3.09

2.4

3.0

1215.40

981.15

ng/l

0.30

171

1471

Osteomyelitis of vertebra

280

2.00

3.09

6.4

3.4

3248.22

1534.04

ng/l

0.71

238

Allergic colitis

102

722

1.46

3.09

5.1

5.2

2218.00

965.64

ng/l

0.41

572

Contact with sharp glass

265

2162

1.27

3.08

2.6

3.1

1191.58

971.32

ng/l

0.27

214

1764

Use of levodopa decarboxylase inhibitor

1729

16116

1.11

3.08

2.9

3.2

1587.19

1881.62

ng/l

1.23

1482

14070

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

200

1607

1.36

3.08

3.4

3.1

1275.79

1828.09

ng/l

1.63

187

1374

Congenital malformations of larynx

124

2.33

3.08

3.9

6.5

483.16

1068.33

ng/l

1.78

107

Ulcer of vagina/vulva

210

1681

1.32

3.08

3.0

2.9

913.20

1033.86

ng/l

0.30

174

1394

Convergent concomitant strabismus

408

3466

1.21

3.07

2.7

3.0

1447.15

981.20

ng/l

0.63

338

2862

Spinal enthesopathy

368

3116

1.24

3.07

3.7

3.1

1819.43

2674.77

ng/l

3.44

334

2656

Demyelinating diseases of the central nervous system

640

5628

1.17

3.07

2.5

2.8

738.87

919.22

ng/l

1.11

537

4653

Benign neoplasm: Oesophagus

137

1052

1.45

3.06

3.0

2.8

1477.09

1266.49

ng/l

0.34

110

877

Pathological resorption of teeth

260

2130

1.28

3.06

3.0

2.8

1396.64

1107.29

ng/l

0.40

227

1801

Benign neoplasm: Connective and other soft tissue of thorax

350

1.83

3.05

3.0

1747.10

1073.50

ng/l

0.44

293

Third [oculomotor] nerve palsy

210

1705

1.35

3.04

3.5

3.1

1695.51

1529.63

ng/l

0.18

178

1470

Urticaria due to cold and heat

454

1.64

3.04

2.9

2.8

503.00

628.18

ng/l

0.41

371

Dysplasia of cervi uteri

1783

12750

1.09

3.03

2.5

752.35

995.93

ng/l

3.38

1468

10585

Colitis, primary sclerosing

107

779

1.47

3.03

2.4

3.0

1179.33

801.44

ng/l

0.51

638

Other disorders of carbohydrate metabolism

315

1.83

3.03

2.9

3.2

6003.31

1200.99

ng/l

0.58

253

Retinal breaks without detachment

1732

16109

1.10

3.03

2.9

1111.36

1246.78

ng/l

0.91

1470

13910

Vascular dementia (subcortical)

388

3348

1.25

3.02

3.1

3.4

2417.54

2296.92

ng/l

0.18

330

2952

Separation of retinal layers (serosa)

393

3361

1.23

3.01

2.9

3.0

1098.96

1127.32

ng/l

0.07

335

2834

Pigmented purpuric dermatosis

113

847

1.50

3.01

3.5

3.0

2922.60

1078.31

ng/l

0.53

102

717

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1157

10605

1.13

3.01

2.6

3.2

1528.22

1611.83

ng/l

0.31

1021

9167

Other abnormal findings in urine

180

1437

1.38

3.01

3.8

3.2

2293.59

1723.18

ng/l

0.60

167

1240

Lichenoid drug reaction

297

2.07

3.00

3.8

3.5

1806.53

1293.94

ng/l

0.34

254

Other and unspecified localized connective tissue disorders

274

1.98

3.00

3.0

851.88

1098.12

ng/l

0.34

233

Nystagmus and other irregular eye movements

119

886

1.45

3.00

3.2

3.6

1278.39

1071.72

ng/l

0.27

103

739

Crowding of teeth, including avohilmo

388

2693

1.21

3.00

4.3

3.2

703.88

732.37

ng/l

0.06

301

2105

Pedestrian injured in other and unspecified transport accidents

122

918

1.46

2.99

2.6

3.3

1360.54

1193.60

ng/l

0.21

102

767

Abscess of Bartholin gland

183

1437

1.33

2.99

2.3

2.7

970.41

792.37

ng/l

0.18

137

1173

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1194

10964

1.13

2.98

2.6

3.2

1527.98

1601.83

ng/l

0.27

1054

9477

Optic neuritis

318

2657

1.24

2.98

2.5

2.9

978.27

960.65

ng/l

0.04

266

2206

Exposure to other specified electric current

567

1.54

2.98

3.3

3.2

421.03

701.62

ng/l

1.38

453

Epileptic seizures related to drugs

148

2.20

2.96

3.1

3.3

656.62

662.55

ng/l

0.01

119

LSIL lesion of the cervix uteri, vagina or vulva

908

8161

1.13

2.96

2.5

2.6

677.52

724.32

ng/l

0.23

754

6676

Polyglandular dysfunction

158

2.25

2.95

3.1

3.7

1275.79

850.93

ng/l

0.50

136

Drug-induced autoimmune haemolytic anaemia

104

2.81

2.94

2.6

2.5

2100.99

957.58

ng/l

0.68

Other and unspecified injuries of neck

466

1.61

2.93

3.0

565.30

967.29

ng/l

1.73

379

Other bullous disorders

276

2300

1.28

2.93

3.5

3.1

1245.53

1306.34

ng/l

0.14

246

1971

Other cranial nerve disorders in other disorders

213

2.10

2.93

4.1

2.9

787.73

1519.61

ng/l

0.98

182

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

112

845

1.51

2.92

3.4

3.2

2073.53

1590.54

ng/l

0.37

717

Mental and behavioural disorders associated with the puerperium

454

1.59

2.92

1.9

2.5

605.17

545.59

ng/l

0.09

366

Other and unspecified injuries of abdomen, lower back and pelvis

136

1040

1.41

2.91

4.4

3.2

1630.88

1246.96

ng/l

0.43

115

877

Benign neoplasm: Appendix

127

976

1.46

2.91

3.2

3.0

1141.19

1364.69

ng/l

0.39

113

820

Circumscribed brain atrophy

168

2093

0.74

2.91

2.7

3.2

784.58

1862.73

ng/l

11.53

140

1816

Other disorders of thyroid

144

1119

1.41

2.90

2.8

2.9

805.52

1020.93

ng/l

0.75

119

944

Leiomyosarcoma

641

1.59

2.90

2.9

3.2

2749.05

1409.17

ng/l

1.35

553

Benign neoplasm: Bronchus and lung

148

1157

1.41

2.89

3.1

3.0

1128.89

1538.41

ng/l

1.20

131

972

Encephalopathy

112

843

1.49

2.89

3.0

3.1

1727.61

1487.33

ng/l

0.27

714

Other specified and unspecified disorders of iris and ciliary body

281

1.88

2.89

2.4

3.3

2177.24

945.74

ng/l

0.47

240

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

167

1333

1.39

2.89

3.2

2.9

1506.50

1278.82

ng/l

0.38

136

1123

Endometriosis of intestine

526

1.53

2.88

2.2

2.8

166.01

653.65

ng/l

2.77

415

Combined immunodeficiencies

120

910

1.46

2.87

3.9

3.0

1853.19

1341.61

ng/l

0.65

108

773

Acquired pure red cell aplasia [erythroblastopenia]

381

1.78

2.87

4.6

3.2

2199.64

1304.81

ng/l

1.09

316

Cardiovascular devices associated with adverse incidents

3.93

2.87

10.4

4.1

1968.60

968.82

ng/l

0.40

Other maltreatment syndromes

212

1703

1.29

2.87

2.4

2.8

1057.89

873.41

ng/l

0.43

165

1380

Non-small cell lung cancer, squamous, helper endpoint

454

5199

0.83

2.86

3.0

3.3

1484.71

2294.60

ng/l

6.96

415

4502

Non-small cell lung cancer, squamous

454

5199

0.83

2.86

3.0

3.3

1484.71

2294.60

ng/l

6.96

415

4502

Aphakia

153

1190

1.37

2.86

3.3

3.1

1750.33

1621.59

ng/l

0.17

134

1024

Other disorders of optic disc

116

870

1.45

2.86

3.1

1693.48

1091.80

ng/l

0.48

728

Benign neoplasm: Connective and other soft tissue of thorax

356

1.79

2.86

3.0

3.3

1747.10

1085.62

ng/l

0.43

293

Exposure to smoke, fire and flames

225

1835

1.30

2.86

2.8

3.1

1490.29

1336.86

ng/l

0.21

198

1555

Iliotibial band syndrome

100

730

1.48

2.86

2.7

3.0

1051.78

940.61

ng/l

0.09

609

Benign neoplasm: Prostate

700

1.59

2.85

3.3

3.2

1746.95

1827.65

ng/l

0.09

609

Muscle wasting and atrophy, not elsewhere classified

504

1.65

2.85

3.9

3.3

1834.98

1464.13

ng/l

0.40

436

Other injuries of lower limb, level unspecified

628

1.56

2.84

3.4

3.2

1901.28

1254.88

ng/l

0.51

524

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

706

6307

1.16

2.84

3.0

2.9

1101.07

1171.02

ng/l

0.21

602

5323

Exposure to other and unspecified man-made environmental factors

139

1069

1.39

2.83

3.4

3.1

994.53

971.18

ng/l

0.04

124

889

Acute nephritic syndrome

221

1808

1.31

2.83

3.5

3.1

6203.36

1236.89

ng/l

3.04

198

1547

Other hereditary haemolytic anaemias

418

1.68

2.82

6.5

3.2

1505.29

938.63

ng/l

0.46

346

Malignant neoplasm of gum

432

1.80

2.82

2.8

3.1

1120.10

1497.87

ng/l

0.37

360

Loose body in joint

229

1874

1.29

2.82

2.8

3.1

1459.20

1461.42

ng/l

0.00

183

1586

Tuberculosis

794

7169

1.15

2.82

3.8

3.2

2211.42

2031.53

ng/l

0.44

703

6163

Benign neoplasm: Carotid body

183

2.11

2.82

2.9

3.0

1336.90

1096.75

ng/l

0.11

145

Intentional self-harm by hanging, strangulation and suffocation

429

0.49

2.81

2.9

3.0

998.24

1422.89

ng/l

0.36

345

Deep bite

766

5983

1.14

2.81

3.4

3.1

808.01

929.17

ng/l

0.34

630

4948

Disorders of phosphorus metabolism and phosphatases

314

1.80

2.80

3.8

2.7

1759.93

1080.51

ng/l

0.65

260

Benign neoplasm: Appendix

127

982

1.45

2.80

3.2

3.1

1141.19

1369.45

ng/l

0.41

113

835

Leukaemia of unspecified cell type

726

1.52

2.79

3.5

3.3

1161.27

1448.06

ng/l

0.45

610

Use of other anti-dementia drugs

3672

30551

1.07

2.79

3.0

3.4

2222.02

2276.83

ng/l

0.26

3057

26701

Use of memantine

3672

30551

1.07

2.79

3.0

3.4

2222.02

2276.83

ng/l

0.26

3057

26701

Non-small cell lung cancer, adenocarcinoma, helper endpoint

760

6868

1.16

2.78

3.0

3.1

1432.42

1803.93

ng/l

1.90

684

5964

Non-small cell lung cancer, adenocarcinoma

760

6868

1.16

2.78

3.0

3.1

1432.42

1803.93

ng/l

1.90

684

5964

Melanocytic naevi of lower limb, including hip

373

3195

1.22

2.76

3.1

2.9

1406.14

1142.95

ng/l

0.51

311

2671

Familial erythrocytosis

390

1.72

2.76

2.7

3.1

1816.24

1222.91

ng/l

0.41

333

Mature T/NK-cell lymphomas, hilmo

162

1296

1.39

2.76

3.2

2686.95

1531.64

ng/l

0.62

146

1115

Benign neoplasm: Connective and other soft tissue, unspecified

125

960

1.43

2.74

2.9

3.1

1581.60

1242.21

ng/l

0.29

116

813

Hypothermia

199

1622

1.33

2.73

3.4

3.2

2077.56

1664.31

ng/l

0.68

168

1400

Other and unspecified injuries of forearm

434

1.62

2.73

3.7

3.0

2396.34

1174.38

ng/l

0.59

357

Other disorders of Eustachian tube

271

2266

1.26

2.73

2.8

2.9

961.08

1103.40

ng/l

0.40

241

1914

Epiphora

234

1940

1.30

2.72

2.7

3.1

1165.41

1343.99

ng/l

0.35

204

1640

Burn and corrosion of other internal organs

207

1.99

2.72

2.3

3.3

344.11

716.42

ng/l

2.02

173

Malignant neoplasm of bone and articular cartilage of limbs

320

1.81

2.71

4.4

3.6

1404.80

1142.16

ng/l

0.14

268

Failed induction of labour

224

1811

1.26

2.70

1.8

2.6

335.84

342.15

ng/l

0.01

155

1417

Hypersensitivity angiitis

436

1.69

2.70

3.3

2.9

4799.19

1249.19

ng/l

0.78

364

Valgus deformity, not elsewhere classified

486

1.58

2.69

4.4

3.0

1010.64

1052.05

ng/l

0.05

413

Acquired keratosis [keratoderma] palmaris et plantaris

353

1.76

2.69

2.6

3.0

530.60

990.21

ng/l

2.52

300

Benign neoplasm: Pharynx, unspecified

583

1.55

2.69

3.1

2351.12

1285.25

ng/l

0.44

482

Injury of nerves and spinal cord at neck level

225

1857

1.30

2.68

3.7

3.1

1033.20

1273.77

ng/l

0.73

196

1591

Toxic liver disease

152

1200

1.37

2.68

2.8

3.1

1863.48

1068.54

ng/l

0.89

134

1009

Benign neoplasm: Scapula and long bones of upper limb

681

1.49

2.68

3.1

3.2

827.55

841.16

ng/l

0.03

570

Hypertrophy of (infrapatellar) fat pad

610

1.50

2.68

4.1

3.3

859.12

1147.88

ng/l

0.37

506

Chronic thyroiditis

321

1.80

2.67

3.4

2.9

1693.63

1207.24

ng/l

0.30

270

Fatigue fracture of vertebra

361

1.74

2.66

3.2

3.7

1202.62

1447.46

ng/l

0.40

313

Mental and behavioural disorders of puerperium, not classified elsewhere

464

1.55

2.66

1.9

2.5

605.17

552.99

ng/l

0.08

374

Abscess of lung

158

1257

1.37

2.66

4.2

3.2

1687.70

1569.18

ng/l

0.12

150

1079

Galactorrhea

474

1.56

2.66

2.7

2.8

661.39

601.28

ng/l

0.10

383

Unspecified renal colic

476

1.62

2.65

3.0

2.9

2366.59

1411.54

ng/l

0.53

403

Melanoma in situ

449

3948

1.21

2.64

3.0

2419.09

1600.27

ng/l

0.89

383

3394

Malignant neoplasm of tongue

216

1788

1.31

2.63

2.5

3.1

1243.44

1362.44

ng/l

0.13

194

1523

Disorders of glycoprotein metabolism

2.93

2.63

2.1

2.4

782.00

544.58

ng/l

0.26

Gastrointestinal stromal tumor and sarcoma

141

1122

1.42

2.63

3.1

1471.15

1397.01

ng/l

0.09

122

966

Abnormal findings on diagnostic imaging of breast

147

1164

1.38

2.62

3.2

2.7

764.47

995.69

ng/l

0.87

134

980

Other specified and unspecified disorders of eyelid

151

1201

1.38

2.61

2.7

3.2

762.00

1346.05

ng/l

4.21

128

1026

Complications associated with artificial fertilization

478

1.51

2.61

1.8

2.6

169.07

636.28

ng/l

1.86

384

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

156

1231

1.34

2.60

3.2

1317.05

1495.02

ng/l

0.25

134

1028

Benign neoplasm: Larynx

344

2960

1.23

2.60

3.3

3.1

1172.37

1712.37

ng/l

2.66

299

2537

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

104

776

1.43

2.59

3.2

2336.34

978.82

ng/l

0.92

634

Disorders of parathyroid gland, other and/or unspecified

682

1.54

2.59

3.5

3.0

1622.83

1476.82

ng/l

0.14

578

Motorcycle rider injured in other and unspecified transport accidents

389

3344

1.19

2.59

2.9

3.1

1402.59

1066.63

ng/l

0.55

302

2729

Other disorders of central nervous system

109

824

1.43

2.59

2.4

3.1

1201.11

1269.84

ng/l

0.05

695

Benign neoplasm: Skin of scalp and neck

238

1978

1.27

2.58

3.3

2.9

2068.57

1400.28

ng/l

0.36

211

1669

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

362

3134

1.22

2.57

2.9

742.81

1172.97

ng/l

3.06

328

2642

Other and unspecified vaccines and biological substances

358

1.66

2.57

3.3

2.8

433.26

740.19

ng/l

2.05

288

Pregnancy with abortive outcome

7300

36869

1.04

2.56

2.8

2.7

1043.92

1122.15

ng/l

0.94

6066

31061

Postpartum haemorrhage due to anatomy

405

3478

1.18

2.56

2.0

2.2

225.24

350.04

ng/l

2.07

300

2719

Malignant neoplasm of testis

136

1058

1.37

2.56

3.2

3.3

1116.71

1437.93

ng/l

0.62

115

876

All dysplastic lesions of the vagina

211

1729

1.28

2.56

3.0

2.8

630.93

878.45

ng/l

1.53

178

1441

Disorders of globe

279

2367

1.26

2.55

3.4

3.0

2205.67

1576.53

ng/l

1.03

254

2038

Contracture of joint

122

940

1.40

2.55

3.5

3.0

912.61

1281.49

ng/l

1.44

105

792

Osteopathy in diseases classified elsewhere

585

1.56

2.54

5.2

3.3

1348.11

901.49

ng/l

0.69

499

Cyst of Bartholin Gland

280

2352

1.23

2.54

2.3

2.8

585.71

741.08

ng/l

0.97

228

1958

Other disorders of amino-acid metabolism

348

1.72

2.53

3.7

3.1

4043.92

1567.48

ng/l

0.82

289

Delayed puberty

174

1.87

2.53

4.3

5.8

176.30

1399.69

ng/l

0.67

121

Peroneal tendinitis

124

953

1.38

2.52

2.6

3.0

508.53

894.74

ng/l

1.57

103

796

Deaf mutism, not elsewhere classified

415

1.65

2.52

2.9

3565.55

1241.09

ng/l

0.93

354

Disease of thymus, other/unspecified

132

2.35

2.52

3.0

3.6

1134.58

1083.11

ng/l

0.05

103

Other injuries of upper limb, level unspecified

102

769

1.45

2.50

3.4

3.1

1461.97

1073.88

ng/l

0.64

638

Chronic hepatitis NAS

134

1053

1.38

2.49

2.9

3.0

2874.15

1042.52

ng/l

1.15

125

886

Benign neoplasm: Skin of lip

152

1218

1.36

2.48

2.5

2.9

1348.37

1330.16

ng/l

0.02

133

1022

Toxic encephalopathy

196

2.13

2.47

3.9

3.5

1679.58

1317.87

ng/l

0.19

168

Congenital myopathies

109

2.37

2.47

2.8

3.4

884.24

941.26

ng/l

0.03

Alcohol-induced acute pancreatitis

345

2977

1.22

2.46

3.0

3.1

2084.49

1306.55

ng/l

1.48

293

2535

Labour and delivery complicated by umbilical cord complications

310

2628

1.21

2.46

2.3

2.6

416.86

577.64

ng/l

1.11

262

2176

Other and unspecified disorders of autonomic nervous system

261

1.81

2.46

3.7

3.1

626.45

1039.57

ng/l

1.21

214

Benign neoplasm: Oesophagus

137

1088

1.39

2.45

3.0

1477.09

1422.04

ng/l

0.07

110

922

IBD (strict) with PSC

509

1.52

2.45

2.2

3.2

828.85

586.86

ng/l

0.28

412

N06DA Anticholinesterases

4462

37505

0.95

2.45

2.8

3.3

1970.05

2113.64

ng/l

1.18

3718

32767

Use of anticholinesterases

4462

37505

0.95

2.45

2.8

3.3

1970.05

2113.64

ng/l

1.18

3718

32767

Autism spe

644

1.42

2.45

3.0

3.9

751.29

678.13

ng/l

0.05

474

Benign neoplasm: Retina

444

1.63

2.44

2.8

3.1

1172.49

1414.62

ng/l

0.17

367

Autoimmune hepatitis

532

1.53

2.44

3.2

2.6

781.25

854.92

ng/l

0.14

441

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

109

827

1.40

2.43

2.8

3.0

1441.40

1017.23

ng/l

0.41

673

Other acquired deformities of musculoskeletal system and connective tissue

454

3997

1.18

2.42

3.2

3.0

1189.76

1226.53

ng/l

0.08

396

3374

Benign neoplasm: Lip

228

1908

1.28

2.42

3.1

2.9

1420.20

1485.83

ng/l

0.11

189

1601

Major anomalies of jaw size

205

1681

1.27

2.42

3.0

527.35

755.46

ng/l

1.32

169

1387

Congenital malformations of posterior segment of eye

342

1.68

2.42

6.3

3.4

1612.75

1270.13

ng/l

0.21

287

Human immunodeficiency virus [HIV] disease resulting in other conditions

1091

0.70

2.41

2.5

3.1

949.30

948.88

ng/l

0.00

903

Recurrent and persistent haematuria

620

1.49

2.41

3.9

3.1

3270.06

1402.93

ng/l

0.93

523

Drug-induced tremor

541

1.57

2.40

3.2

3.4

2982.02

1288.18

ng/l

0.72

455

Malignant neoplasm of head and neck

929

8529

1.13

2.39

2.9

3.2

1717.90

1691.80

ng/l

0.05

822

7370

Myositis ossificans

225

1.90

2.39

2.6

3.1

1190.18

1421.33

ng/l

0.26

185

Disorders of male genital organs in diseases classified elsewhere

425

1.60

2.39

3.4

1451.74

1246.35

ng/l

0.12

358

Injury of urinary and pelvic organs

189

1548

1.29

2.38

3.5

3.2

2205.36

1523.02

ng/l

0.81

158

1310

Benign neoplasm: Long bones of lower limb

260

2188

1.24

2.38

2.8

3.0

1126.04

1006.06

ng/l

0.16

214

1821

Other disorders of amniotic fluid and membranes

642

5672

1.14

2.38

2.2

2.4

318.29

408.78

ng/l

0.71

493

4512

Varus deformity, not elsewhere classified

101

765

1.42

2.37

2.6

3.2

741.11

1043.07

ng/l

0.87

642

Benign neoplasm of other and unspecified female genital organs

428

3764

1.19

2.37

2.6

2.9

926.88

1135.93

ng/l

0.63

352

3163

Dental caries 2 and operation codes

7838

60340

1.04

2.36

3.0

2.8

876.59

1073.98

ng/l

4.82

6305

50763

Abscess of tendon sheath

427

1.60

2.36

3.5

3.3

2761.27

1094.47

ng/l

0.70

363

Other and unspecified parapsoriasis

462

1.64

2.35

3.1

3.2

1442.49

1228.76

ng/l

0.29

393

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

416

3658

1.19

2.35

3.0

1199.68

1394.78

ng/l

0.63

366

3129

Immunodeficiency associated with other major defects

195

1.97

2.34

2.7

4.0

1653.82

1012.17

ng/l

0.50

163

Gonococcal infection

271

2295

1.23

2.34

2.3

2.8

977.21

835.20

ng/l

0.33

223

1899

Benign neoplasm: Skin of lower limb, including hip

266

2259

1.24

2.34

3.3

2.9

1300.62

1208.42

ng/l

0.16

233

1902

Other hyperalimentation

251

1.85

2.33

2.7

3.1

1163.50

1444.25

ng/l

0.23

211

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

518

4578

1.15

2.33

2.5

669.35

566.53

ng/l

0.24

419

3745

Polyarteritis nodosa

593

1.51

2.33

4.0

3.1

3469.97

1498.10

ng/l

0.54

505

Chloasma

322

1.70

2.33

2.2

2.5

587.37

927.76

ng/l

1.29

268

HSIL lesion of the cervix uteri, vagina or vulva

1220

11262

1.10

2.32

2.6

2.5

701.11

681.11

ng/l

0.10

992

9164

Undefined dementia

1362

13413

0.91

2.32

3.2

3.4

2619.21

2552.24

ng/l

0.15

1116

11537

Parapsoriasis

177

1445

1.30

2.32

2.9

3.1

1326.14

1309.09

ng/l

0.02

150

1239

Lyme disease

2747

26145

1.07

2.32

2.7

2.9

796.11

1264.84

ng/l

17.76

2192

22502

Adenocarcinoma and Papillary adenocarcinoma of kidney

130

1041

1.40

2.31

2.9

3.2

2707.67

1474.48

ng/l

0.87

115

904

Other spirochaetal diseases

2778

26448

1.07

2.31

2.7

2.9

797.68

1263.26

ng/l

17.79

2222

22763

Benign neoplasm: Brain, supratentorial

141

1121

1.34

2.31

2.9

738.30

1113.34

ng/l

1.61

120

943

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

170

1403

1.34

2.29

3.7

3.1

2112.30

1833.45

ng/l

0.28

145

1221

Personal history of allergy to drugs, medicaments and biological substances

619

1.45

2.29

3.0

2.4

1680.40

853.56

ng/l

0.42

503

Impacted maxillary molar

208

1702

1.24

2.29

3.0

2.9

756.43

676.63

ng/l

0.12

162

1271

Congenital musculoskeletal deformities of head, face, spine and chest

591

1.45

2.29

3.1

3.4

670.33

1189.39

ng/l

1.02

476

Hydrocephalus in other diseases

442

1.60

2.28

3.1

3.3

632.61

1114.35

ng/l

1.94

368

Melanoma in situ of other and unspecified parts of face

146

1192

1.38

2.28

2.8

3.1

2818.16

1644.77

ng/l

0.53

124

1034

Unspecified transport accident

264

1.73

2.27

2.1

3.3

673.26

1137.60

ng/l

0.86

215

Thalassaemia

193

1.87

2.27

3.7

3.4

592.04

1193.70

ng/l

0.84

163

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

297

2566

1.23

2.27

2.6

2.9

1750.37

1200.33

ng/l

0.49

271

2165

Normal-pressure hydrocephalus

635

5773

1.16

2.26

2.6

3.3

1134.98

1890.16

ng/l

6.91

542

5040

Nonpyogenic thrombosis of intracranial venous system

607

1.47

2.26

2.4

3.1

1625.78

859.05

ng/l

0.72

504

Benign neoplasm: Nasopharynx

753

1.44

2.25

2.9

3.0

1230.50

1268.75

ng/l

0.04

640

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

581

5213

1.15

2.25

3.0

2.9

1128.78

1149.87

ng/l

0.05

492

4369

Foreign body entering into or through eye or natural orifice

708

6414

1.13

2.24

3.0

3.1

1609.33

1309.98

ng/l

0.84

586

5388

Benign neoplasm: Pharynx, unspecified

604

1.49

2.24

3.1

3.0

2351.12

1244.16

ng/l

0.46

506

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

419

3692

1.18

2.22

2.7

2.9

1149.68

1140.48

ng/l

0.02

370

3110

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

190

1584

1.30

2.22

3.0

1488.89

1337.11

ng/l

0.21

170

1329

Benign neoplasm of male genital organs

229

1940

1.26

2.20

3.3

3.2

2101.67

1928.70

ng/l

0.17

190

1686

Other disorders of bone density and structure

215

1795

1.25

2.20

3.6

2.8

1046.37

1004.48

ng/l

0.09

173

1495

Ankyloglossia

420

1.50

2.20

7.4

6.0

682.83

1445.04

ng/l

0.97

326

Benign neoplasm: Prostate

732

1.49

2.20

3.3

1746.95

1683.00

ng/l

0.07

643

Injury of nerves at shoulder and upper arm level

103

795

1.40

2.19

2.6

3.1

1117.59

1005.99

ng/l

0.13

657

Tic and related disorders

474

1.48

2.19

3.4

3.6

486.06

956.55

ng/l

2.31

382

Injury of nerves and spinal cord at thorax level

359

1.63

2.19

2.5

3.0

863.05

1024.26

ng/l

0.19

292

Cholesteatoma of middle ear

580

5233

1.15

2.18

3.3

3.1

1885.57

1629.18

ng/l

0.31

498

4507

HSIL lesion of the vagina

119

935

1.36

2.18

3.1

2.9

828.72

1029.84

ng/l

0.54

780

Actinomycosis

287

1.73

2.18

5.1

3.0

1081.19

1136.49

ng/l

0.07

232

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

332

2855

1.18

2.17

2.3

311.59

378.69

ng/l

0.42

262

2284

Acanthosis nigricans

221

1.81

2.17

3.1

3.2

1608.86

836.41

ng/l

0.75

190

Contact urticaria

189

1.87

2.17

3.1

3.0

2401.84

1166.34

ng/l

0.38

158

Optic atrophy

179

1479

1.29

2.16

3.5

3.2

1227.13

1354.15

ng/l

0.23

154

1251

Alcohol abuse counselling and surveillance

144

1158

1.32

2.15

2.2

2.9

1075.37

915.06

ng/l

0.31

115

955

Benign neoplasm: Other parts of oropharynx

703

1.43

2.15

3.4

2.9

1331.88

1165.79

ng/l

0.14

575

Benign neoplasm: Carotid body

200

1.89

2.14

2.9

3.1

1336.90

1153.44

ng/l

0.08

167

Femoral hernia, bilateral

292

1.77

2.14

3.3

4168.29

1779.51

ng/l

0.70

246

Lagophthalmos

142

1156

1.35

2.14

2.5

3.1

1886.49

1455.78

ng/l

0.47

122

997

Other specified and unspecified strabismus

100

769

1.39

2.13

2.7

3.4

1528.12

931.89

ng/l

0.35

648

Plasmodium falciparum malaria

183

0.38

2.13

2.0

2.9

752.76

1084.11

ng/l

—

149

Tic disorders

460

1.48

2.13

3.3

3.8

493.96

1340.83

ng/l

1.47

357

Overjet

114

876

1.34

2.13

3.2

4.3

704.79

635.84

ng/l

0.08

726

Acute myeloid leukaemia and myelodysplastic syndromes

207

1746

1.27

2.13

3.5

3.3

2188.53

2112.97

ng/l

0.08

193

1522

Benign neoplasm: Retina

457

1.56

2.13

2.8

3.3

1172.49

1410.36

ng/l

0.17

379

Arthropathy in Crohn disease

612

1.44

2.12

2.5

3.0

1083.82

758.32

ng/l

0.46

511

Foreign body in genitourinary tract

640

1.43

2.12

3.2

2.9

1215.01

1050.87

ng/l

0.29

537

Human immunodeficiency virus [HIV] disease

1236

0.73

2.12

2.7

3.1

943.53

1017.07

ng/l

0.13

1029

Benign neoplasm: Skin of lip

152

1244

1.32

2.11

2.5

3.0

1348.37

1315.74

ng/l

0.03

133

1058

Generalized epilepsy, mode (most common among epilepsy diagnosis)

231

1944

1.23

2.10

2.7

3.1

767.21

1078.76

ng/l

1.09

188

1614

Thyrotoxicosis with toxic single thyroid nodule

689

1.43

2.10

2.8

3.0

1222.72

1129.93

ng/l

0.11

588

Benign neoplasm: Bronchus and lung

148

1210

1.33

2.09

3.1

3.0

1128.89

1507.53

ng/l

1.11

131

1033

Burn and corrosion of hip and lower limb, except ankle and foot

196

1633

1.26

2.08

3.3

3.2

1266.93

1220.25

ng/l

0.07

161

1366

Other adrenocortical overactivity

243

1.68

2.08

3.8

4.2

885.60

765.16

ng/l

0.13

192

Benign neoplasm: Bladder

110

871

1.40

2.08

3.6

3.2

1858.56

1930.96

ng/l

0.07

747

Benign neoplasm: Lower jaw bone

272

1.70

2.08

3.1

2.9

1371.43

1148.30

ng/l

0.14

223

Other complications of labour and delivery, not elsewhere classified

311

3488

0.85

2.07

1.9

2.3

208.98

360.60

ng/l

1.75

230

2659

Traumatic amputation of ankle and foot

195

1.91

2.07

2.8

3.2

2595.00

1104.93

ng/l

0.39

169

Colour vision deficiencies

213

1.75

2.06

2.1

3.5

567.83

1197.61

ng/l

1.85

176

Melanoma in situ of other and unspecified parts of face

146

1207

1.35

2.06

2.8

3.1

2818.16

1584.71

ng/l

0.57

124

1043

Malignant neoplasm, without specification of site

277

3192

0.83

2.05

3.5

3.2

2469.03

2188.81

ng/l

0.38

238

2759

Inflammation of lacrimal passages (chronic)

185

1551

1.28

2.05

3.2

1477.53

1603.46

ng/l

0.17

168

1321

Benign neoplasm: Endocrine pancreas

559

1.51

2.04

3.0

3.1

1601.14

1126.86

ng/l

0.50

464

Benign neoplasm of other and unspecified sites

317

2764

1.20

2.04

3.1

3.0

891.83

1398.32

ng/l

2.40

263

2344

Moderate mental retardation

370

1.56

2.03

2.7

3.6

856.57

1068.47

ng/l

0.29

306

Other and unspecified neuropathies

369

1.62

2.02

3.2

802.49

1205.30

ng/l

0.72

306

Social disorders starting during childhood or adolecense, excluding more controls

172

1.76

2.01

3.2

2.7

1239.87

430.90

ng/l

0.38

133

Mandibular retrognathia

400

3506

1.16

2.01

2.6

3.0

445.61

715.23

ng/l

2.69

322

2858

Certolizumab pegol

105

814

1.35

2.01

1.8

2.8

623.92

608.73

ng/l

0.03

661

Arthropathy in ulcerative colitis

102

793

1.37

2.00

3.4

3.1

1190.06

711.88

ng/l

0.95

667

Abnormal findings in cerebrospinal fluid

203

1.83

2.00

2.4

2.7

886.74

680.58

ng/l

0.25

169

Superficial frostbite

449

1.51

1.99

3.2

1845.52

1177.20

ng/l

0.44

361

Vascular dementia (mixed)

191

1617

1.28

1.98

2.8

3.4

2197.26

2442.09

ng/l

0.37

160

1424

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

547

1.47

1.97

3.1

3.3

3115.79

1313.18

ng/l

0.80

455

612

5534

1.13

1.97

3.6

3.3

2163.17

2307.85

ng/l

0.26

541

4708

Injury of blood vessels of thorax

269

1.71

1.97

4.1

3.2

2723.47

1371.01

ng/l

0.78

225

Other protozoal intestinal diseases

120

956

1.33

1.97

2.7

3.0

748.42

1197.43

ng/l

1.76

813

Diseases of thymus

214

1.84

1.97

3.0

3.1

999.55

1193.00

ng/l

0.23

171

Abscess of external ear

119

947

1.33

1.96

3.7

3.2

1451.46

1049.28

ng/l

0.57

100

787

Other congenital malformations of posterior segment of eye (coloboma)

2.94

1.96

3.5

3.2

577.64

2317.73

ng/l

0.65

Malignant neoplasm of other and unspecified parts of mouth

575

1.51

1.95

3.1

3.3

1486.07

1431.12

ng/l

0.06

482

MS-disease / Multiple Sclerosis

510

4568

1.14

1.95

2.5

2.8

651.53

898.84

ng/l

2.23

426

3753

Myelodysplastic syndrome

111

893

1.39

1.95

3.4

3.3

2992.63

2237.04

ng/l

0.63

101

768

Type 1 diabetes, strict definition

363

3160

1.16

1.95

2.5

2.9

1672.55

446.40

ng/l

3.10

297

2450

Apocrine sweat disorders, other sweat gland disorders

355

1.62

1.94

4.7

3.2

1690.31

1170.83

ng/l

0.63

301

Secondary malignant neoplasm of other and unspecified sites

162

1356

1.31

1.94

2.5

3.2

1798.16

1568.79

ng/l

0.24

141

1179

Tarsal tunnel syndrome

108

858

1.37

1.94

2.6

2.9

1068.34

1094.99

ng/l

0.02

100

733

Other articular cartilage disorders

228

1944

1.23

1.94

2.9

3.0

1017.31

1255.46

ng/l

0.51

193

1651

Rhinophyma

611

1.48

1.92

3.4

1605.04

1726.24

ng/l

0.11

512

Universal erythroderma, KELA reimbursement

146

1199

1.30

1.92

3.7

3.1

2809.33

1260.98

ng/l

0.71

122

1014

Postpartum hemorraghe, all women as controls

1346

12511

1.08

1.92

2.0

2.3

430.20

484.15

ng/l

0.28

1050

10017

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

669

6118

1.13

1.92

2.9

3.0

1287.58

1323.29

ng/l

0.09

583

5220

Unspecified abortion

344

3012

1.17

1.91

2.1

2.6

696.26

646.54

ng/l

0.04

274

2538

Seminoma of testis, excluding all cancers (controls excluding all cancers)

624

1.41

1.91

2.9

3.1

991.48

1242.01

ng/l

0.41

509

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

221

1882

1.23

1.90

2.8

2754.09

1192.51

ng/l

1.29

194

1572

Acute inflammation of orbit

410

1.51

1.89

2.8

3.3

1219.82

1107.33

ng/l

0.06

345

Premature rupture of membranes

970

7731

0.91

1.89

2.2

2.4

349.21

464.11

ng/l

0.73

730

6157

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1959

17553

1.07

1.88

3.0

3.2

1298.11

1800.53

ng/l

10.03

1771

15170

Lipoprotein deficiency

169

1.95

1.88

3.4

3.1

905.00

1296.65

ng/l

0.42

144

Inhalation and ingestion of other objects causing obstruction of respiratory tract

429

1.51

1.88

3.1

3.2

1409.37

1340.75

ng/l

0.05

354

Female infertility

2235

13085

1.06

1.88

2.3

2.5

533.24

894.19

ng/l

8.27

1827

10825

Vascular dementia (multiple infarctions)

109

1359

0.76

1.87

2.8

3.5

1921.14

2867.64

ng/l

1.54

1200

Sequelae of malnutrition and other nutritional deficiencies

185

1.88

1.87

4.7

3.3

3653.92

1919.65

ng/l

0.45

160

Infections of breast associated with childbirth

183

1520

1.23

1.87

2.4

2.5

337.03

516.54

ng/l

1.03

150

1224

Retinoschisis and retinal cysts

265

2310

1.22

1.86

3.2

3.1

1395.75

1403.87

ng/l

0.01

224

1988

Enteritis due to Yersinia enterocolitica

328

1.58

1.86

3.8

3.4

641.33

1232.89

ng/l

1.29

274

Other injuries of spine and trunk, level unspecified

613

1.42

1.86

3.9

3.2

2317.77

1081.23

ng/l

0.63

522

Contact with lifting and transmission devices, not elsewhere classified

166

1383

1.27

1.85

2.5

3.1

801.55

1094.00

ng/l

0.96

132

1168

Malignant neoplasm of other connective and soft tissue

258

2244

1.22

1.85

3.4

3.2

2063.88

1539.62

ng/l

0.93

231

1954

Postpartum haemorrhage due to retained placenta

606

5481

1.12

1.85

2.0

2.2

313.66

379.72

ng/l

0.36

467

4395

Adult respiratory distress syndrome

139

1146

1.31

1.84

3.9

3.2

3070.76

1688.66

ng/l

1.04

124

985

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

777

1.38

1.83

2.8

3.3

1950.31

1414.41

ng/l

0.54

660

Defect, injury or illness of neck

329

1.57

1.83

2.3

2.9

799.32

1312.44

ng/l

0.59

269

Chronic inflammatory disorders of orbit

201

1.80

1.83

2.4

2.9

2105.19

971.13

ng/l

0.51

169

Dementia in Alzheimer disease

2498

20451

1.07

1.83

3.3

3.4

2219.46

2349.61

ng/l

0.60

1964

17890

Beningn neoplasm: Meninges, unspecified

177

1496

1.27

1.83

3.4

3.0

2026.01

1388.23

ng/l

0.67

152

1267

Benign neoplasm: Rectum/anal canal icd-9

117

949

1.34

1.82

3.4

3.1

2051.14

2077.02

ng/l

0.02

804

Benign neoplasm: Ciliary body

227

1.78

1.82

3.5

3.4

875.88

1095.93

ng/l

0.40

192

Xanthelasma of eyelid

778

1.38

1.82

2.6

3.1

1177.77

1363.69

ng/l

0.27

669

Wide developmental disorders

114

899

1.29

1.82

3.3

4.6

650.88

893.03

ng/l

0.24

689

Injury of blood vessels at lower leg level

367

1.57

1.82

3.3

3.0

2378.82

1249.60

ng/l

0.94

305

Sickle-cell disorders

185

1.83

1.82

3.6

3.3

485.76

1869.10

ng/l

2.38

153

Ankylosis of joint

452

1.50

1.81

3.0

1637.29

1446.56

ng/l

0.19

386

Guillain-Barre syndrome

157

1309

1.27

1.80

3.2

3.1

1719.73

1335.02

ng/l

0.33

136

1127

Disorder of pancreatic internal secretion, other and/or unspecified

566

1.43

1.78

3.0

3.2

1743.01

1036.14

ng/l

0.66

478

Glaucoma secondary to eye inflammation

707

1.38

1.78

3.4

3.2

2171.78

1451.12

ng/l

0.52

592

Golimumab

214

1819

1.21

1.78

2.1

2.8

866.45

790.34

ng/l

0.09

177

1487

Complications of the puerperium, not elsewhere classified

187

1564

1.22

1.77

2.9

2.5

701.94

474.65

ng/l

0.32

140

1261

Cutis laxa senilis

694

1.40

1.77

2.6

2.7

1030.67

1122.67

ng/l

0.11

587

Osteitis due to dental implant

582

1.45

1.76

3.5

3.1

2352.55

1084.07

ng/l

0.68

496

Burn and corrosion, body region unspecified

366

1.53

1.76

2.9

3.2

2035.53

1014.86

ng/l

1.20

311

Other and unspecified disease of Bartholin gland

278

2433

1.19

1.75

2.5

2.9

1099.36

1155.03

ng/l

0.09

240

2056

Congenital malformations of anterior segment of eye

574

1.41

1.74

2.7

3.6

624.73

1008.95

ng/l

1.61

488

Benign neoplasm: Other parts of oropharynx

727

1.37

1.74

3.4

3.0

1331.88

1144.27

ng/l

0.16

605

Anuria and oliguria

616

1.42

1.74

3.7

3.4

2896.12

1831.45

ng/l

0.75

528

Lower leg

411

1.50

1.73

3.1

3.0

998.71

1152.01

ng/l

0.21

343

Benign lipomatous neoplasm of of intra-abdominal organs

281

1.68

1.73

3.0

2.9

1716.94

1093.49

ng/l

0.43

229

Venous complications and haemorrhoids in the puerperium

705

1.36

1.73

2.4

2.9

465.70

740.22

ng/l

1.61

596

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

133

1101

1.30

1.73

2.6

3.0

1351.77

1516.86

ng/l

0.17

123

933

Beningn neoplasm: Meninges, unspecified

177

1505

1.26

1.73

3.4

2.9

2026.01

1454.58

ng/l

0.57

152

1268

Melanoma in situ, other sites/unspecified

291

1.68

1.72

2.7

3.0

2242.68

1241.93

ng/l

0.48

246

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

231

1998

1.21

1.72

3.5

2.9

1205.96

1308.89

ng/l

0.21

188

1681

Any dementia, excluding more controls

5125

34546

1.04

1.71

3.1

3.2

2345.52

1944.45

ng/l

5.51

4303

30296

Benign lipomatous neoplasm of of intra-abdominal organs

282

1.67

1.70

3.0

3.1

1716.94

1144.12

ng/l

0.39

227

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

101

819

1.37

1.70

2.6

3.2

3022.34

1855.65

ng/l

0.60

708

Postpartum care and examination

646

3743

1.11

1.70

2.0

2.2

375.97

371.84

ng/l

0.02

477

2902

Dietary zinc deficiency

4.39

1.70

2.5

2.0

878.67

892.29

ng/l

—

Other osteochondrodysplasias

486

1.42

1.70

2.9

3.4

2507.54

750.12

ng/l

1.17

403

Melanoma in situ, other sites/unspecified

292

1.68

1.70

2.7

3.1

2242.68

1173.90

ng/l

0.52

247

Vascular dementia

1105

10024

1.09

1.70

3.2

3.5

2555.71

2580.03

ng/l

0.05

918

8740

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

138

1152

1.30

1.70

3.2

3969.20

1865.68

ng/l

1.88

127

992

Benign neoplasm: Endocrine pancreas

577

1.45

1.70

3.0

3.3

1601.14

1347.69

ng/l

0.22

484

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

690

1.39

1.69

2.5

2.9

1172.73

1436.05

ng/l

0.36

583

Toxic effect of other gases, fumes and vapours

396

1.49

1.68

4.4

3.3

1966.90

1237.25

ng/l

0.64

328

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

775

1.35

1.68

4.9

3.1

1868.58

1272.07

ng/l

0.39

656

Assault by other specified means

442

1.43

1.67

3.3

2.7

1472.71

575.47

ng/l

1.26

347

Tic and related disorders

500

1.39

1.67

3.4

4.4

486.06

1349.89

ng/l

1.70

387

Ulcerative colitis (strict) with PSC

418

1.45

1.67

2.4

3.3

985.43

603.66

ng/l

0.36

339

Burns and corrosions of multiple and unspecified body regions

189

1608

1.23

1.67

2.9

3.2

1609.38

1294.38

ng/l

0.51

161

1354

Enduring personality changes

261

1.61

1.66

3.3

2.9

651.14

815.37

ng/l

0.34

219

Dental caries 2

7999

61294

1.03

1.66

3.0

2.8

894.34

1081.96

ng/l

4.27

6442

51586

Vitiligo

727

1.34

1.66

2.3

2.8

663.61

858.79

ng/l

0.61

600

Disorders of amino-acid transport

135

1.98

1.65

2.1

2.8

2417.43

1612.46

ng/l

0.29

107

Liposarcoma, excluding all cancers (controls excluding all cancers)

111

908

1.33

1.65

3.3

2.9

1843.33

1471.05

ng/l

0.42

774

Use of galantamine

909

8512

1.10

1.64

3.0

3.4

2046.11

2339.21

ng/l

1.09

767

7423

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

106

862

1.34

1.64

2.5

3.0

1102.81

1496.08

ng/l

0.95

724

Malignant neoplasm of oesophagus

214

2460

0.83

1.64

2.5

3.2

1396.14

1805.08

ng/l

1.45

189

2148

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

841

9023

0.91

1.64

2.8

3.2

1405.56

1739.76

ng/l

1.33

743

7773

Macular cyst

291

2584

1.19

1.64

3.0

3.1

1651.94

1389.24

ng/l

0.46

246

2217

Contact with other specified venomous animals

467

1.45

1.64

2.3

3.0

560.73

1092.89

ng/l

1.66

382

Use of tolcapone

0.00

1.64

0.0

3.4

—

1069.31

—

Other and unspecified papulosquamous disorders

487

1.45

1.64

3.5

3.0

829.96

1495.27

ng/l

1.76

409

Acute poliomyelitis

148

1245

1.27

1.63

3.6

3.0

1130.88

1240.47

ng/l

0.25

123

1047

Struck by thrown, projected or falling objec

377

3368

1.15

1.63

2.8

3.1

870.30

1174.20

ng/l

1.49

316

2821

Other nutritional anaemias

112

915

1.32

1.62

3.8

3.0

2473.20

1821.88

ng/l

0.78

104

779

Gestational diabetes (for exclusion)

1960

13162

1.06

1.62

2.0

2.3

471.01

418.94

ng/l

0.24

1462

10524

Acute mastoiditis

570

1.38

1.62

3.4

3.3

1207.54

937.18

ng/l

0.22

477

False labour

1622

9615

1.07

1.62

2.1

2.3

232.83

464.95

ng/l

6.92

1246

7667

Other effects of reduced temperature

159

1.85

1.62

4.2

3.2

1976.26

1570.62

ng/l

0.19

132

Shigellosis

197

1.70

1.61

3.2

3.0

1095.50

875.75

ng/l

0.25

170

Benign neoplasm: Bladder

110

902

1.33

1.61

3.6

3.2

1858.56

1708.73

ng/l

0.15

777

Intrahepatic Cholestasis of Pregnancy (ICP)

332

2929

1.15

1.61

2.3

2.4

311.59

431.03

ng/l

0.90

262

2354

Other congenital malformations of tongue, mouth and pharynx

474

1.39

1.61

7.8

5.5

887.50

1426.63

ng/l

0.64

373

Benign neoplasm: Nasopharynx

792

1.35

1.61

2.9

3.1

1230.50

1289.36

ng/l

0.07

668

Juvenile Open Angle Glaucoma

346

1.50

1.60

2.6

2.9

672.78

816.19

ng/l

0.26

284

Benign neoplasm of brain and other parts of central nervous system

629

5788

1.12

1.60

2.9

3.0

1047.50

1356.90

ng/l

1.43

532

4947

Methaemoglobinaemia

2.98

1.60

3.2

2.7

372.89

1127.80

ng/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

518

4698

1.12

1.60

2.5

2.6

669.35

602.40

ng/l

0.14

419

3834

Labyrinthine fistula

286

1.64

1.59

3.1

3.6

2403.00

1218.09

ng/l

0.57

250

Dacryoadenitis

621

1.38

1.59

3.0

3.2

1288.64

1608.46

ng/l

0.35

525

Ulcer of oesophagus, drug-induced

541

1.46

1.59

5.0

3.5

1672.19

1804.93

ng/l

0.16

458

Pneumoconiosis due to dust containing silica

356

1.57

1.58

3.9

3.5

1520.90

1848.26

ng/l

0.37

310

Other congenital malformations of circulatory system

221

1917

1.20

1.57

2.9

796.41

1084.96

ng/l

1.33

193

1617

Melanoma in situ

449

4091

1.15

1.57

3.0

3.2

2419.09

1589.06

ng/l

0.92

383

3540

Seminoma of testis

644

1.35

1.57

2.9

3.2

991.48

1171.31

ng/l

0.28

531

Juvenile osteochondrosis

213

1831

1.19

1.57

3.0

3.2

1205.71

992.92

ng/l

0.31

176

1483

Degeneration of nervous system due to alcohol

240

2106

1.20

1.57

3.2

3.1

2798.08

1497.61

ng/l

1.42

208

1832

Sequelae of intentional self-harm, assault and events of undetermined intent

329

1.49

1.57

4.4

2.7

373.99

760.94

ng/l

1.99

269

Contact with hot air and gases

471

1.43

1.56

2.5

3.3

1711.36

1356.61

ng/l

0.37

401

Degeneration of the brain due to alcohol

240

2107

1.20

1.56

3.2

3.1

2798.08

1521.10

ng/l

1.38

208

1840

Other, unspecified and serous retinal detachments

310

2762

1.17

1.56

3.9

3.1

2283.32

1469.24

ng/l

1.55

278

2357

Carcinoma in situ of vagina

274

1.58

1.56

3.5

2.9

1649.96

1020.40

ng/l

0.29

221

Other superficial injuries of ankle and foot

339

1.49

1.55

2.8

2.9

898.46

850.10

ng/l

0.07

274

Melanocytic naevi of upper limb, including shoulder

194

1667

1.21

1.55

3.3

3.0

1295.44

1243.09

ng/l

0.07

160

1391

Antepartum haemorrhage, not elsewhere classified

397

3550

1.13

1.55

2.3

2.4

320.36

418.07

ng/l

0.60

322

2848

Other congenital malformations of ear

385

1.42

1.55

3.9

3.2

511.30

531.52

ng/l

0.05

296

Benign neoplasm of thyroid gland

322

2873

1.16

1.55

2.8

947.41

1232.99

ng/l

0.77

273

2419

Necrobiosis lipoidica, not elsewhere classified

340

1.49

1.55

2.7

2.8

1011.67

786.13

ng/l

0.30

285

Benign neoplasm: Orbit, unspecified

510

1.42

1.54

3.4

3.1

1194.94

1422.68

ng/l

0.25

417

Benign neoplasm: Vulva

204

1767

1.21

1.54

2.4

2.8

1129.48

1085.21

ng/l

0.05

165

1480

Bullous keratopathy

104

856

1.34

1.54

3.1

3.3

2719.75

1428.77

ng/l

0.80

730

Pseudomembranous colitis

667

1.35

1.54

2.8

3.1

1595.24

1234.90

ng/l

0.22

564

Scissor bite

114

919

1.26

1.53

4.1

4.2

593.20

657.94

ng/l

0.11

740

Eccrine sweat disorders

194

1.73

1.53

2.3

3.3

1176.60

1233.84

ng/l

0.03

169

Malignant neoplasm of larynx

133

1579

0.79

1.53

2.3

3.2

2355.33

2019.55

ng/l

0.19

114

1382

Use of amantadine

162

1379

1.24

1.53

2.5

3.1

1128.29

1313.34

ng/l

0.35

141

1164

Other and unspecified disorders of orbit

388

1.49

1.53

3.1

3.2

1632.79

1170.11

ng/l

0.26

327

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

132

1092

1.25

1.53

3.6

3.5

2115.31

856.94

ng/l

1.36

122

898

Burn and corrosion of head and neck

168

1427

1.22

1.52

2.5

3.1

1386.42

1096.23

ng/l

0.38

141

1198

Benign neoplasm: Skin of lower limb, including hip

266

2349

1.18

1.51

3.3

3.0

1300.62

1249.32

ng/l

0.08

233

1998

Acute otitis externa, noninfective

156

1323

1.24

1.51

3.9

3.0

1200.52

1086.96

ng/l

0.19

139

1125

Use of selegiline

534

4910

1.13

1.51

3.0

3.2

1105.01

1780.45

ng/l

5.21

451

4226

Cervical root disorders

582

1.39

1.51

2.8

2.9

1198.58

883.66

ng/l

0.34

499

Exposure to excessive natural heat

188

1.77

1.51

2.9

3.4

2894.59

2001.37

ng/l

0.21

154

Need for immunization against combinations of infectious diseases

2.87

1.51

3.4

3.3

1703.29

528.80

ng/l

—

Neuroendocrine tumor and carcinoma of lung

702

1.36

1.50

2.5

3.2

1172.73

1241.18

ng/l

0.08

590

Impacted maxillary canine

356

1.44

1.49

3.6

4.4

984.71

914.34

ng/l

0.05

296

Abnormal reflex

380

1.48

1.49

2.8

3.1

1311.22

821.01

ng/l

0.36

303

Patellar tendinitis

107

867

1.28

1.49

2.6

3.3

242.22

1153.11

ng/l

8.87

698

Chlamydial lymphogranuloma (venereum)

0.00

1.49

0.0

4.6

—

706.30

—

Benign neoplasm: Skin of scalp and neck

238

2088

1.19

1.49

3.3

3.1

2068.57

1408.76

ng/l

0.35

211

1792

Chronic diseases of tonsils and adenoids

8779

54326

1.03

1.48

2.7

2.9

831.66

1146.96

ng/l

11.05

7202

45921

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

595

6453

0.90

1.48

3.1

951.94

1520.95

ng/l

7.06

530

5478

Other benign neoplasm of uterus: Corpus uteri

638

1.36

1.48

2.6

2.7

1010.68

1040.34

ng/l

0.03

530

Congenital malformations of ovaries, fallopian tubes and broad ligaments

323

2869

1.15

1.48

2.3

2.6

418.63

669.95

ng/l

2.84

256

2342

Benign neoplasm: Lip

228

2002

1.20

1.47

3.1

1420.20

1414.91

ng/l

0.01

189

1717

Benign neoplasm: Brain, supratentorial

141

1187

1.25

1.47

2.9

3.1

738.30

1140.87

ng/l

1.80

120

1014

Other and unspecified pemphigus

281

1.59

1.47

3.7

2965.62

1210.36

ng/l

1.16

240

Type 1 diabetes, strict definition, subgroup 1

327

2893

1.14

1.46

2.6

2.9

1714.06

418.78

ng/l

2.91

268

2229

Bus occupant injured in other and unspecified transport accidents

504

1.40

1.46

2.7

3.1

1532.49

1164.54

ng/l

0.26

413

Other specified/unspecified nutritional deficiencies

538

1.38

1.46

3.8

2.9

1393.53

1318.54

ng/l

0.10

447

Other lack of coordination

167

1433

1.23

1.45

3.2

3.3

932.80

1469.03

ng/l

1.84

145

1224

Granuloma faciale [eosinophilic granuloma of skin]

2.91

1.44

1.8

3.4

718.57

1509.22

ng/l

—

Q fever

3.30

1.44

3.3

2.7

871.00

981.03

ng/l

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

165

1.79

1.44

2.4

3.5

1221.68

2035.19

ng/l

0.69

137

Glaucoma secondary to drugs

256

1.60

1.44

3.6

2.9

991.78

988.04

ng/l

0.00

214

LeFortI or BSSRO operation

239

2088

1.17

1.43

1.9

2.7

455.45

671.61

ng/l

0.99

191

1691

Other and unspecified intracranial injuries

282

2508

1.16

1.42

3.2

3.1

2157.21

1812.82

ng/l

0.43

238

2136

Perineal laceration during delivery

606

5884

0.91

1.42

2.0

2.3

259.46

425.79

ng/l

2.14

476

4596

Other acantholytic disorders

261

1.66

1.42

2.6

3.4

801.91

1572.52

ng/l

1.57

220

Other benign neoplasm of uterus: Corpus uteri

642

1.35

1.42

2.6

2.9

1010.68

941.22

ng/l

0.06

544

Hereditary sideroblastic anaemia

343

1.51

1.42

3.9

3.1

1712.77

1618.15

ng/l

0.07

294

Inflammation of lacrimal passages (acute and unspecified)

161

1378

1.22

1.41

3.6

3.0

1504.47

1404.79

ng/l

0.12

144

1154

Lumbosacral plexus disorders

265

1.58

1.41

2.9

3.0

1283.66

1291.22

ng/l

0.01

213

Oral leukoplakia

194

1694

1.21

1.41

2.6

3.1

1245.44

1325.46

ng/l

0.15

166

1461

Other ill-defined and unspecified causes of mortality

713

6655

1.10

1.40

4.1

3.3

3315.25

2098.57

ng/l

5.67

631

5787

Benign neoplasm: Rectum/anal canal icd-9

117

981

1.29

1.40

3.4

3.3

2051.14

1988.42

ng/l

0.05

838

Other obstructed labour

510

4663

1.11

1.40

2.2

2.6

826.63

619.03

ng/l

0.80

411

3885

Benign neoplasm of other and unspecified sites

317

2846

1.16

1.40

3.1

3.0

891.83

1305.49

ng/l

2.03

263

2423

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

442

1.45

1.39

3.2

3.1

1583.69

1549.29

ng/l

0.03

373

Venous complications and haemorrhoids in pregnancy

630

1.30

1.39

1.7

2.7

385.10

431.92

ng/l

0.08

518

Guttate psoriasis

116

964

1.26

1.38

3.2

3.1

1826.09

1190.25

ng/l

0.32

100

818

Benign neoplasm: Lower jaw bone

299

1.51

1.38

3.1

1371.43

1125.75

ng/l

0.16

253

Bacterial meningitis

305

2730

1.15

1.38

2.9

3.1

1368.85

1178.55

ng/l

0.14

260

2310

Other disorders affecting eyelid function

743

0.73

1.37

3.1

1686.07

1299.00

ng/l

0.30

629

Right side

626

1.39

1.37

3.5

3.2

705.51

1386.18

ng/l

2.31

527

Melanocytic naevi of scalp and neck

189

1638

1.19

1.36

3.3

2.9

2674.67

1190.63

ng/l

1.07

169

1359

LSIL lesion of the vagina

107

883

1.27

1.35

2.7

2.9

518.16

918.14

ng/l

1.90

743

Sequelae of inflammatory diseases of the central nervous system

251

1.58

1.34

2.9

3.0

808.03

1045.55

ng/l

0.19

210

Brain meningioma, excluding all cancers (controls excluding all cancers)

515

4748

1.12

1.34

2.6

3.0

1274.52

1367.14

ng/l

0.20

443

4026

Paget disease

509

1.41

1.34

3.1

2.9

1620.93

1409.02

ng/l

0.21

432

Testicular dysfunction, other/unspecified

283

1.51

1.33

3.2

1138.45

783.53

ng/l

0.40

230

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

370

1.45

1.33

3.8

3.1

1135.52

919.80

ng/l

0.23

315

Epidural haemorrhage

623

1.32

1.33

3.3

2.8

2027.16

1321.54

ng/l

0.49

521

Benign neoplasm: Other/unspecified site

155

1334

1.22

1.32

3.2

2.9

1031.30

1309.06

ng/l

0.51

128

1120

Exfoliative dermatitis

115

967

1.27

1.32

3.3

3143.17

1639.78

ng/l

0.58

108

836

Villonodular synovitis (pigmented)

527

1.35

1.31

2.7

3.2

610.29

1080.32

ng/l

2.24

439

Toxic effect of organic solvents

241

1.54

1.30

3.3

3.6

1511.96

1062.87

ng/l

0.33

191

Multiple delivery

498

5422

0.90

1.30

2.3

2.6

738.08

721.47

ng/l

0.05

387

4539

Malignant neoplasm of heart, mediastinum and pleura

142

1222

1.24

1.30

3.1

3.3

1099.99

1929.29

ng/l

3.60

129

1068

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

231

2047

1.18

1.30

3.5

3.0

1205.96

1213.32

ng/l

0.01

188

1738

Ulcerative ileocolitis

307

2753

1.14

1.30

2.7

3.0

1192.35

1074.35

ng/l

0.22

254

2283

Pneumonia due to Haemophilus influenzae

252

1.55

1.30

4.7

2.7

1139.23

1044.26

ng/l

0.13

214

Benign neoplasm: Vulva

204

1794

1.19

1.29

2.4

2.8

1129.48

982.53

ng/l

0.19

165

1500

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

319

2890

1.15

1.28

2.6

3.0

1522.24

1685.92

ng/l

0.37

278

2467

Congenital malformations of uterus and cervix

800

1.26

1.28

4.0

2.7

723.84

786.01

ng/l

0.11

637

Noninfective disorders of pinna

152

1.72

1.28

1.7

3.7

633.86

966.56

ng/l

0.68

129

Other demyelinating diseases of the central nervous system

231

2037

1.16

1.26

2.3

3.0

627.97

806.43

ng/l

0.61

190

1677

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

130

1108

1.24

1.25

3.6

2.9

1145.57

1185.51

ng/l

0.04

104

923

L02BA Anti-estrogens

1522

15922

0.94

1.25

2.4

2.8

1123.08

1107.39

ng/l

0.04

1304

13534

Other congenital malformations of limb(s)

256

1.46

1.25

7.1

4.2

1544.94

697.01

ng/l

0.47

206

Burn and corrosion confined to eye and adnexa

172

1490

1.19

1.25

2.4

3.1

1269.00

914.65

ng/l

0.40

131

1236

Other and unspecified disorders of binocular movement

346

1.42

1.25

2.8

3.7

2710.21

1048.22

ng/l

0.73

284

Respiratory tuberculosis, confirmed and not-confirmed

644

6013

1.10

1.24

3.7

3.2

2179.61

1965.60

ng/l

0.48

567

5154

Respiratory tuberculosis

644

6013

1.10

1.24

3.7

3.2

2179.61

1956.13

ng/l

0.51

567

5154

Colitis, primary sclerosing, strict definition

583

1.31

1.24

2.3

3.2

1348.79

698.69

ng/l

0.70

474

Malignant neoplasm of lip

793

1.30

1.24

3.9

3.3

3224.48

2202.61

ng/l

0.61

687

Crushing injury of ankle and foot

316

1.48

1.24

3.1

2.7

2226.79

1491.20

ng/l

0.26

255

Cellulitis of external ear

803

1.27

1.23

3.2

853.78

1063.49

ng/l

0.36

692

Unattended death

794

0.75

1.23

4.3

3.3

2701.59

1816.63

ng/l

0.67

677

Melanocytic naevi of upper limb, including shoulder

194

1703

1.18

1.23

3.3

3.1

1295.44

1206.94

ng/l

0.12

160

1448

Mastocytosis

348

1.42

1.22

2.7

3.3

1260.14

943.24

ng/l

0.20

289

Melanocytic naevi of other and unspecified parts of face

482

4439

1.11

1.22

2.8

2.9

1117.27

1232.48

ng/l

0.26

388

3714

Toxic effect of contact with venomous animals

333

3018

1.13

1.22

2.8

3.0

867.60

1153.97

ng/l

0.75

277

2532

Respiratory and cardiovascular disorders specific to the perinatal period

563

1.28

1.21

7.8

7.4

1764.23

1102.86

ng/l

0.58

476

Melanocytic naevi of lip

597

1.31

1.21

2.6

2.9

2962.51

1224.54

ng/l

0.38

498

Transient acantholytic dermatosis [Grover]

194

1.74

1.21

2.1

3.6

795.88

1644.25

ng/l

1.45

163

Benign neoplasm: Orbit, unspecified

530

1.35

1.20

3.4

1194.94

1525.53

ng/l

0.40

444

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

251

1.47

1.20

2.3

2.8

609.16

1580.40

ng/l

0.79

189

Other abnormal auditory perceptions

742

1.28

1.20

3.1

577.54

856.49

ng/l

1.52

632

Dissection of cerebral arteries, nonruptured

545

1.33

1.20

3.4

3.1

1881.70

958.25

ng/l

0.75

453

Toxic effect of alcohol

186

1631

1.18

1.20

3.1

1254.40

1225.20

ng/l

0.04

154

1384

Postinfectious hypothyroidism

458

1.37

1.19

2.9

1971.78

1171.10

ng/l

0.43

390

Other and unspecified disorders of pigmentation

482

1.35

1.19

3.8

3.2

984.52

1048.29

ng/l

0.08

411

Maternal care for cervical incompetence

307

2773

1.14

1.19

3.0

2.8

702.76

818.71

ng/l

0.56

255

2300

Unspecified multiple injuries

204

1.56

1.18

2.9

2.7

810.47

1424.91

ng/l

0.72

165

Caught, crushed, jammed or pinched in or between objects

359

3266

1.12

1.18

2.8

3.1

976.06

1082.11

ng/l

0.30

288

2741

Injury of blood vessels at forearm level

240

1.53

1.18

3.0

3.1

3538.17

1084.91

ng/l

0.63

201

Serous carcinoma of ovary

362

3317

1.13

1.17

2.9

3.0

742.81

1189.42

ng/l

3.36

328

2795

Non-small cell lung cancer

1959

18878

1.05

1.17

3.0

3.2

1298.11

1968.09

ng/l

16.73

1771

16383

Labour and delivery complicated by fetal stress [distress]

934

6628

0.94

1.17

2.0

2.2

306.03

344.08

ng/l

0.31

715

5173

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

172

1512

1.20

1.17

3.5

3.2

1327.69

1632.15

ng/l

0.86

154

1279

Contusion of toe(s) with damage to nail

661

1.28

1.17

2.4

2.7

2011.69

1102.12

ng/l

0.60

535

Carcinoma in situ of vagina

291

1.46

1.17

3.5

2.9

1649.96

881.11

ng/l

0.38

241

Other and unspecified degenerative diseases of nervous system

215

2404

0.86

1.17

2.6

3.2

1247.23

2041.49

ng/l

4.34

181

2098

Other abortion

436

1.34

1.16

2.5

3.2

573.38

700.21

ng/l

0.22

361

Benign neoplasm: Ciliary body

252

1.54

1.15

3.5

3.4

875.88

1021.39

ng/l

0.25

214

Onycholysis

468

1.35

1.15

3.8

3.0

1665.75

970.25

ng/l

0.65

391

Chromophobe cell carcinoma of kidney

465

1.39

1.14

3.8

3.3

2104.35

1345.25

ng/l

0.48

391

Neuroendocrine tumor and carcinoma of stomach

456

1.39

1.14

3.2

3.4

1583.69

1415.76

ng/l

0.15

379

Hyperprolactinaemia, drug-induced

388

1.38

1.14

3.6

2.6

803.08

665.03

ng/l

0.17

319

Benign neoplasm: Bones of skull and face

684

1.28

1.14

2.8

905.11

1072.30

ng/l

0.27

567

Non-seminoma of testis

254

1.45

1.14

2.3

3.1

609.16

1458.46

ng/l

0.67

192

Staphylococcal scalded skin syndrome

2.23

1.13

2.2

6.9

869.78

775.22

ng/l

—

Unspecified dementia

1341

12637

0.94

1.13

3.2

3.5

2576.54

2527.08

ng/l

0.11

1101

11000

Frostbite

766

1.26

1.13

2.9

3.2

2050.07

1281.99

ng/l

0.62

637

Endometriosis of fallopian tube

412

1.35

1.13

2.4

2.9

3490.57

1088.71

ng/l

0.46

353

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

454

4903

0.90

1.13

3.0

3.3

1484.71

2173.66

ng/l

5.34

415

4243

Communicating hydrocephalus

177

2002

0.85

1.13

2.5

3.1

1440.37

1603.44

ng/l

0.15

157

1721

Open wounds involving multiple body regions

241

1.49

1.12

3.0

3.5

1394.11

1066.68

ng/l

0.23

198

Hyperfunction of pituitary gland, other and/or unspecified

134

1.75

1.12

3.9

3.0

954.84

1340.19

ng/l

0.37

112

Dementia due to Parkinson's disease

231

2558

0.86

1.11

3.3

3.4

1771.16

2144.60

ng/l

0.60

190

2234

Choroidal haemorrhage and rupture

306

1.47

1.11

3.5

2410.44

1739.43

ng/l

0.60

251

Cholesteatoma of external ear

693

1.30

1.11

3.1

3.3

1351.24

1577.26

ng/l

0.25

591

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

467

1.38

1.11

3.8

3.2

2104.35

1384.09

ng/l

0.45

399

Hereditary retinal dystrophy

125

1072

1.22

1.11

2.8

3.2

1731.03

1129.12

ng/l

0.59

103

901

Generalized epilepsy, strict definition

152

1317

1.18

1.11

2.7

3.3

791.32

985.76

ng/l

0.45

115

1100

Social disorders starting during childhood or adolescence

203

1.47

1.10

3.2

3.7

1239.87

420.41

ng/l

0.39

154

Left hemicolectomy

265

2404

1.15

1.10

3.4

3.1

1392.55

1631.84

ng/l

0.58

226

2072

Other fibroblastic disorders

277

1.46

1.10

2.0

3.3

3975.74

1283.55

ng/l

0.55

231

Benign neoplasm of thyroid gland

322

2940

1.13

1.09

2.8

2.9

947.41

1148.49

ng/l

0.52

273

2481

Other corneal oedema

722

1.29

1.09

3.6

3.2

3183.44

1414.34

ng/l

1.47

612

Corneal degeneration

148

1294

1.20

1.09

2.8

3.1

1261.10

1120.69

ng/l

0.20

126

1106

HSIL lesion of the cervix uteri

993

9395

1.06

1.09

2.5

2.4

658.58

577.72

ng/l

0.50

811

7570

Contracture of muscle

259

1.46

1.09

2.6

3.3

1111.65

1079.86

ng/l

0.02

217

Other haemoglobinopathies

151

1.68

1.09

11.0

3.0

1265.75

1192.24

ng/l

0.04

127

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

442

4762

0.90

1.09

3.2

3.3

1390.87

2013.68

ng/l

1.87

384

4116

Congenital malformations of ear causing impairment of hearing

190

1.53

1.08

2.8

3.9

3351.67

656.64

ng/l

0.50

157

Use of glatiramer acetate

718

1.25

1.08

2.2

2.8

572.39

550.00

ng/l

0.03

582

518

1.28

1.08

6.2

7.6

1813.73

1152.02

ng/l

0.55

430

Unspecified human immunodeficiency virus [HIV] disease

646

0.75

1.07

2.6

3.1

929.44

774.60

ng/l

0.23

521

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

307

1.45

1.07

4.1

2.7

839.54

1129.46

ng/l

0.42

257

Livedoid vasculitis

335

1.44

1.06

3.5

3.4

1368.83

1210.06

ng/l

0.19

287

Unspecified parasitic disease

693

1.28

1.06

3.3

3.1

1283.39

1223.28

ng/l

0.07

591

Other specified and unspecified disorders of eye and adnexa

357

3277

1.12

1.06

2.7

3.0

2226.04

1400.05

ng/l

0.86

302

2772

Habitual aborter

554

1.27

1.06

2.7

2.8

295.13

452.60

ng/l

0.43

430

Hereditary motor and sensory neuropathy

655

1.28

1.06

3.0

3.2

1295.48

1091.33

ng/l

0.16

547

Hirsutism, drug-induced

101

1.77

1.05

1.4

2.6

143.51

413.91

ng/l

1.21

Traumatic spondylopathy

203

1.56

1.05

3.5

3.2

1143.06

1670.81

ng/l

0.71

172

Anoxic brain damage

141

1233

1.20

1.05

4.6

3.2

2604.10

1914.65

ng/l

0.64

131

1064

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

380

3510

1.12

1.05

3.6

3.1

2868.64

1839.07

ng/l

2.18

343

3034

Other/unspecified mastoiditis and related conditions

414

1.37

1.05

3.9

3.2

1596.92

1288.31

ng/l

0.26

354

Other papulosquamous disorders

103

877

1.24

1.04

3.0

3.2

792.10

1369.23

ng/l

2.37

751

Disorders of endocrine glands in diseases classified elsewhere

110

1.74

1.04

8.4

3.0

1835.72

1734.03

ng/l

0.04

Meningococcal infection

454

1.32

1.04

3.7

3.3

1477.09

972.34

ng/l

0.40

381

Malignant neoplasm of stomach

494

5292

0.91

1.04

2.9

3.2

1925.85

1948.57

ng/l

0.04

446

4558

Polypectomy (DHB20)

668

6288

1.08

1.03

2.6

3.0

1176.41

1443.92

ng/l

1.06

594

5379

Internuclear ophthalmoplegia

263

1.45

1.03

3.4

2.6

1556.78

959.94

ng/l

0.43

224

Hypergammalglobulinemia, unspecified

1.99

1.03

1.7

3.2

1150.84

976.83

ng/l

0.09

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

589

1.31

1.02

3.4

3.2

5727.81

1718.97

ng/l

1.05

505

Malignant neoplasm of base of tongue

501

0.72

1.02

2.1

3.2

2722.80

1212.27

ng/l

0.35

422

Environmental-pollution-related condition

1.97

1.02

4.8

3.8

172.75

1018.51

ng/l

3.23

Viral infections of central nervous system, not elsewhere classified/unspecified

775

1.24

1.01

2.1

3.0

783.77

950.20

ng/l

0.25

648

Bilateral sagittal split ramus osteotomy operation

195

1730

1.15

1.01

2.0

2.7

431.13

651.00

ng/l

0.88

158

1399

Radiodermatitis

215

1.54

1.01

4.3

2.6

836.17

1024.49

ng/l

0.34

180

Benign neoplasm: Connective and other soft tissue of head, face and neck

146

1279

1.18

1.00

2.7

2.9

1504.07

1227.94

ng/l

0.36

127

1070

Maternal care for known or suspected fetal abnormality and damage

603

5742

0.93

1.00

2.1

2.3

429.54

382.80

ng/l

0.09

473

4561

Atypical virus infections of central nervous system

761

1.25

1.00

3.5

3.1

753.80

965.87

ng/l

0.53

638

Oral leukoplakia, including avohilmo

270

2461

1.14

1.00

2.5

3.0

1110.28

1215.85

ng/l

0.28

229

2094

Single delivery by caesarean section

894

5471

0.94

0.99

2.0

2.4

436.31

580.70

ng/l

0.70

696

4376

Benign neoplasm: Other/unspecified site

155

1370

1.18

0.98

3.2

3.0

1031.30

1188.42

ng/l

0.25

128

1159

Other and unspecified hydrocephalus

184

1644

1.16

0.98

2.9

3.2

978.48

1506.51

ng/l

1.89

156

1405

Obstructed labour due to malposition and malpresentation of fetus

1113

11009

0.95

0.98

2.1

2.3

411.69

469.82

ng/l

0.40

887

8868

Polyneuropathy due to other toxic agents

2.09

0.98

3.3

4.6

3293.83

1129.88

ng/l

0.39

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

692

1.27

0.98

2.7

3.1

1007.11

1262.23

ng/l

0.52

576

Marginal zone B-cell lymphoma

814

1.25

0.98

2.5

3.3

1685.14

1329.86

ng/l

0.30

697

Colorectal neuroendocrine tumor and carcinoma

130

1135

1.20

0.98

3.6

3.1

1145.57

1145.94

ng/l

0.00

104

965

Other zoonotic bacterial diseases, not elsewhere classified

106

1.82

0.98

2.5

3.7

1644.00

1630.64

ng/l

0.01

Short Achilles tendon (acquired)

207

1854

1.14

0.97

2.5

2.8

776.17

1060.16

ng/l

1.10

191

1523

Degenerative myopia

572

1.29

0.97

2.6

3.0

833.07

1105.43

ng/l

0.70

478

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

772

0.78

0.97

2.4

3.0

1924.35

1394.98

ng/l

0.19

646

Laparoscopic left hemicolectomy

181

1622

1.17

0.97

2.6

3.0

1069.98

1217.37

ng/l

0.40

160

1398

All dysplastic lesions of the cervix uteri

1512

14479

1.05

0.97

2.5

2.4

616.79

622.82

ng/l

0.03

1233

11725

Benign neoplasm: Bone and articular cartilage, unspecified

533

1.29

0.97

2.0

3.2

495.30

1155.39

ng/l

2.63

445

Disorders of glycine metabolism

2.19

0.97

3.0

3.5

1699.65

2105.30

ng/l

—

Blindness or visual impairment, binocular

373

1.36

0.97

3.6

3.3

2563.60

1331.83

ng/l

0.74

307

Other and unspecified medical devices associated with adverse incidents

485

1.33

0.97

3.4

3.2

1278.92

1174.91

ng/l

0.12

400

Malignant neoplasm of vulva

108

938

1.23

0.96

3.1

1809.54

1434.26

ng/l

0.45

799

Glaucoma secondary to eye trauma

602

1.29

0.96

3.1

3.4

1704.04

1832.22

ng/l

0.11

522

Migraine, unspecified, drug-induced

479

1.30

0.96

2.4

3.1

729.38

782.54

ng/l

0.10

397

Nail dystrophy

518

1.30

0.96

2.5

3.1

729.03

1178.48

ng/l

1.26

434

Benign neoplasm: Bone and articular cartilage, unspecified

534

1.28

0.96

2.0

2.8

495.30

1185.66

ng/l

2.73

435

Malignant neoplasm of retroperitoneum and peritoneum

668

1.27

0.95

2.7

3.4

1205.00

1330.21

ng/l

0.17

566

Carcinoma in situ of cervix uteri

470

4365

1.09

0.95

2.9

2.6

1035.92

802.83

ng/l

0.68

390

3505

Noise effects on inner ear

394

3656

1.10

0.95

3.0

3.1

1130.17

1557.19

ng/l

1.56

326

3163

Felty syndrome

521

1.31

0.95

3.9

3.4

2000.80

1395.51

ng/l

0.60

446

Pregnancy, childbirth and the puerperium

3394

18227

0.97

0.94

3.0

3.1

1386.55

1572.74

ng/l

2.02

2856

15487

Exophthalmic conditions

100

859

1.22

0.94

2.8

3.1

1105.36

1270.43

ng/l

0.22

725

Other congenital malformations of intestine

599

1.26

0.93

3.0

3.5

1996.26

993.75

ng/l

0.53

501

Pterygium

320

2956

1.12

0.92

3.3

3.1

1380.81

1694.41

ng/l

1.15

278

2575

Induced delusional disorder

2.00

0.92

3.0

3.3

460.75

605.42

ng/l

—

Other and unspecified disorders of refraction

1.99

0.91

3.6

3.9

293.16

862.69

ng/l

—

Polyglandular dysfunction, other/unspecified

2.01

0.91

1.5

5.0

159.00

906.84

ng/l

—

Abnormal findings on antenatal screening of mother

268

2430

1.11

0.91

2.0

2.4

395.50

317.27

ng/l

0.23

206

1888

Injury of nerves at ankle and foot level

464

1.29

0.91

3.1

2.9

969.40

1154.17

ng/l

0.26

385

Functional disorders of polymorphonuclear neutrophils

2.01

0.91

7.1

3.6

608.26

1153.56

ng/l

1.12

Intermittent hydrarthrosis

183

1.52

0.90

3.1

3.2

517.85

991.90

ng/l

1.38

163

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

205

1858

1.15

0.90

3.5

3.0

1569.18

1766.73

ng/l

0.20

178

1578

Other infective (teno)synovitis

296

1.38

0.90

3.9

3.2

2407.42

1043.69

ng/l

0.73

249

Disorder of mineral metabolism, other/unspecified

148

1.56

0.89

3.1

3.3

3933.88

1027.27

ng/l

0.57

123

Unspecified organic or symptomatic mental disorder

315

1.38

0.89

3.9

3.0

975.92

1787.03

ng/l

1.41

252

Immunodeficiency with increased immunoglobulin M [IgM]

2.98

0.89

5.6

2.8

624.20

1865.45

ng/l

—

Benign neoplasm: Skin of upper limb, including shoulder

178

1597

1.15

0.89

3.0

2.9

1684.14

1281.22

ng/l

0.43

153

1345

Drowning to ice

106

0.49

0.88

2.5

3.2

2656.18

868.18

ng/l

—

Degenerative macular diseases, drug-induced

336

1.38

0.87

3.0

3.4

1673.75

1804.93

ng/l

0.10

278

Alcohol induced polyneuropathy

106

925

1.21

0.87

2.7

3.1

2958.97

1229.28

ng/l

1.01

795

Beau lines

2.83

0.87

2.2

2.6

1230.84

700.99

ng/l

—

Other specified acquired deformities of limbs

296

1.36

0.87

2.3

3.6

1506.45

1105.50

ng/l

0.16

240

Nutritional marasmus

1.70

0.87

3.9

3.8

2691.47

1000.96

ng/l

0.48

Cytomegaloviral pneumonitis

170

1.58

0.86

4.0

2.8

2537.08

959.55

ng/l

1.13

135

Amoebiasis

396

1.31

0.86

3.3

3.2

1214.61

1059.28

ng/l

0.13

330

Pregnancy examination and test

748

4412

1.06

0.85

2.3

2.2

315.09

387.05

ng/l

0.39

583

3451

Malignant neoplasm of liver and intrahepatic bile ducts

303

3272

0.90

0.85

2.8

3.3

1417.27

2113.24

ng/l

1.42

263

2865

Vertical strabismus

287

2641

1.11

0.85

2.7

3.0

1359.77

1225.38

ng/l

0.19

241

2239

Benign neoplasm: Vagina

119

1046

1.19

0.84

3.0

2.7

546.38

1053.61

ng/l

3.20

103

868

Benign neoplasm: Hypopharynx

400

1.33

0.84

2.5

3.4

2261.17

1310.21

ng/l

0.52

332

Glaucoma-related operations

649

6169

1.08

0.84

3.0

3.2

1846.70

1729.64

ng/l

0.25

548

5358

Nontraumatic intracranial haemmorrhage

2481

24153

1.04

0.84

3.2

3.1

1858.69

1789.76

ng/l

0.29

2167

20845

Mandibular prognathia

806

1.20

0.84

3.9

3.4

990.40

767.46

ng/l

0.32

673

Other disorders originating in the perinatal period

303

1.32

0.84

3.9

8.8

1052.53

1171.41

ng/l

0.07

260

Benign neoplasm: Bones of skull and face

709

1.22

0.84

2.8

2.9

905.11

1073.67

ng/l

0.27

593

Other disorders of breast and lactation associated with childbirth

573

1.23

0.84

1.9

2.5

200.91

451.94

ng/l

3.80

447

Melanocytic naevi of lip

626

1.24

0.83

2.6

3.0

2962.51

1149.82

ng/l

0.40

530

Calcium deposit in bursa

160

1.53

0.83

3.1

2.5

3371.85

1074.73

ng/l

0.35

141

Adult-onset Still disease

263

1.38

0.83

5.9

2.7

579.38

792.17

ng/l

0.76

218

580

1.22

0.83

5.9

7.4

1468.85

1130.10

ng/l

0.28

476

Other specified/unspecified disorders of ear

212

1.44

0.82

2.5

3.1

851.31

1163.33

ng/l

0.43

181

Mesothelioma, excluding all cancers (controls excluding all cancers)

145

1299

1.17

0.82

3.2

3.1

1311.54

1831.11

ng/l

1.35

133

1121

Other menopausal disorders

2690

15086

1.03

0.82

2.2

2.7

549.00

1170.22

ng/l

33.93

2261

12845

Genetic anomalies of leukocytes

1.99

0.82

3.5

3.4

339.71

1397.60

ng/l

—

Pedestrian injured in collision with car, pick-up truck or van

218

1987

1.13

0.81

2.8

3.0

1895.07

1288.11

ng/l

0.75

171

1668

Subarachnoid haemorrhage

1151

11076

1.05

0.81

2.9

3.0

1744.91

1609.88

ng/l

0.44

1017

9499

Mental and behavioural disorders due to hallucinogens

183

1.42

0.81

2.0

2.6

409.59

492.94

ng/l

0.15

141

Postprocedural disorders of ear and mastoid process, not elsewhere classified

782

1.22

0.80

3.3

3.2

1533.26

1389.39

ng/l

0.12

668

Systemic atrophies primarily affecting the central nervous system

367

3927

0.91

0.80

2.7

3.1

1516.67

1625.82

ng/l

0.13

302

3358

Ovarian hyperstimulation (induction)

494

1.24

0.80

1.6

2.3

97.39

472.77

ng/l

1.65

375

Hypertensive encephalopathy

369

1.34

0.79

3.7

3.2

4216.29

1635.92

ng/l

1.02

312

Amyloidosis of skin

1.92

0.79

5.6

4.3

1153.44

1596.21

ng/l

0.42

Interstitial emphysema and related conditions originating in the perinatal period

1.78

0.79

12.1

8.7

1096.56

1240.60

ng/l

—

Traumatic subcutaneous emphysema

103

1.71

0.79

2.9

3.3

596.20

1067.27

ng/l

0.59

Other congenital malformations of skull and face bones

116

1.54

0.79

2.1

9.9

955.88

1035.83

ng/l

—

Other congenital malformations of face and neck

192

1736

1.13

0.79

3.1

1763.71

999.37

ng/l

0.48

157

1440

Melanocytic naevi of ear and external auricular canal

392

1.30

0.79

4.6

2.9

868.57

1082.64

ng/l

0.38

322

Erythema in diseases classified elsewhere

180

1.49

0.79

4.1

2.9

845.42

884.22

ng/l

0.04

154

Torsion of testis

809

1.18

0.79

3.9

4.0

1792.94

921.30

ng/l

0.46

631

Open wound of neck

518

1.25

0.79

3.6

3.1

1330.62

926.82

ng/l

0.44

432

Burn and corrosion of wrist and hand

259

2378

1.11

0.78

3.2

3.1

1253.21

1131.69

ng/l

0.20

214

1978

Unspecific neurodegenerative disorder

6006

40754

1.02

0.78

3.0

3.3

2149.81

1980.50

ng/l

1.72

5063

35692

Exposure to excessive heat of man-made origin

689

0.80

0.78

2.6

3.2

1935.43

1688.04

ng/l

0.14

581

Fractures involving multiple body regions

162

1.50

0.78

2.2

3.0

1416.59

1342.32

ng/l

0.05

134

Moderate visual impairment, monocular

331

1.33

0.78

3.5

3.2

786.77

1249.10

ng/l

0.90

287

Other and unspecified cicatricial alopecia

207

1.45

0.77

2.6

3.1

1889.57

1021.97

ng/l

0.28

170

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

2648

22618

0.97

0.77

3.1

3.2

1485.15

1747.83

ng/l

2.93

2402

19583

Benign neoplasm: Hypopharynx

405

1.30

0.77

2.5

3.1

2261.17

1079.19

ng/l

0.70

332

Other and unspecified disorders of psychological development

284

1.31

0.77

4.7

4.8

1105.07

1112.35

ng/l

0.00

215

Exposure to excessive natural cold

851

0.82

0.77

3.8

3.3

2349.44

1473.53

ng/l

0.66

714

Burns classified according to extent of body surface involved

678

1.21

0.77

2.7

3.2

1093.86

1199.81

ng/l

0.17

563

Fetus and newborn affected by other complications of labour and delivery

1.71

0.76

6.9

7.1

4937.89

1307.70

ng/l

—

Other transepidermal elimination disorders

2.33

0.76

5.6

1.9

3260.80

329.95

ng/l

—

Prophylactic surgery

373

1.28

0.76

2.1

2.3

493.75

587.96

ng/l

0.18

306

UC patients in KELA-register (code 208), prior to 1994

423

3976

1.09

0.76

3.0

2.9

1709.09

1239.85

ng/l

1.01

364

3373

Malignant neoplasm of parotid gland

721

1.22

0.75

2.6

3.1

1259.96

1488.78

ng/l

0.34

612

Physical medicine devices associated with adverse incidents

1.95

0.75

3.4

4.6

1037.60

799.32

ng/l

—

Edwards' syndrome and Patau's syndrome

1.86

0.75

3.4

3.1

3649.71

1076.98

ng/l

—

Neuroendocrine tumor and carcinoma of rectum

325

1.34

0.75

4.1

3.1

839.54

1152.52

ng/l

0.49

279

Pityriasis rosea

392

1.27

0.75

3.0

413.84

898.84

ng/l

2.07

321

Congenital malformations of gallbladder, bile ducts and liver

719

1.21

0.74

2.7

3.8

1835.11

1131.96

ng/l

0.59

615

Superficial injury of ankle and foot, unspecified

285

1.33

0.74

3.3

2.8

1004.46

1103.29

ng/l

0.11

223

Injury of muscle and tendon at ankle and foot level

188

1709

1.13

0.74

2.9

3.0

987.40

993.54

ng/l

0.01

151

1427

Whooping cough

248

1.34

0.74

3.1

3.0

2352.91

667.87

ng/l

0.67

191

Foreign body in ear

135

1205

1.15

0.73

3.1

3.2

1437.75

940.69

ng/l

0.78

115

1005

Melanocytic naevi of scalp and neck

189

1721

1.12

0.73

3.3

3.1

2674.67

1159.49

ng/l

1.10

169

1447

Benign neoplasm: Scrotum

334

1.32

0.73

3.0

3.2

3399.71

1055.46

ng/l

1.31

278

APECED

2.05

0.73

5.2

2.3

226.04

694.58

ng/l

—

Benign neoplasm: Vagina

119

1060

1.17

0.72

3.0

2.9

546.38

1061.69

ng/l

3.38

103

896

Female infertility, cervigal, vaginal, other or unspecified origin

1952

12680

1.03

0.72

2.3

2.5

519.55

885.06

ng/l

9.62

1595

10498

Complications following myocardial infarction

732

1.20

0.71

4.0

2.9

2106.87

1929.00

ng/l

0.16

612

Other acute disseminated demyelination

541

1.22

0.71

2.7

3.1

909.74

676.65

ng/l

0.18

444

Motor neuron disease (with DMD)

169

1535

1.13

0.71

2.9

1015.57

1566.22

ng/l

1.34

139

1319

Carcinoma in situ of breast, lobular

622

1.22

0.71

2.6

2.7

682.97

992.82

ng/l

0.79

510

Intussusception

183

1669

1.13

0.70

2.2

2.9

778.50

997.96

ng/l

0.86

158

1400

Disorders of tyrosine metabolism

1.66

0.70

3.9

3.3

4924.07

1795.41

ng/l

0.67

Non-Hodgkin lymphoma, all

438

4143

1.08

0.70

3.3

3.2

2914.39

2003.39

ng/l

1.22

386

3596

Malignant neoplasm of anus and anal canal

429

1.28

0.70

2.3

3.2

1502.48

1494.85

ng/l

0.00

363

Inhalation and ingestion of food causing obstruction of respiratory tract

821

0.83

0.70

3.9

3.3

980.28

1688.04

ng/l

2.17

693

Other disorders of binocular movement

147

1322

1.13

0.70

3.1

3.2

1492.62

1044.42

ng/l

0.50

119

1098

Carcinoma in situ of breast, lobular

623

1.22

0.69

2.6

2.9

682.97

954.89

ng/l

0.68

521

Type1 diabetes, definitions combined, early onset

259

2376

1.09

0.69

3.2

3.4

1926.56

542.52

ng/l

2.11

215

1810

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

802

1.19

0.69

2.9

3.1

1845.81

1505.56

ng/l

0.31

679

Tooth agenesis EXCLUDE clefts and syndromes

143

1280

1.13

0.68

3.7

3.4

893.30

717.89

ng/l

0.21

109

988

Use of cabergoline

866

0.84

0.68

3.1

920.65

1230.60

ng/l

0.62

722

Certain zoonotic bacterial diseases

167

1522

1.13

0.68

3.2

3.0

1560.66

1280.24

ng/l

0.32

146

1297

Postprocedural disorders of eye and adnexa, not elsewhere classified

286

1.36

0.67

2.5

3.4

1653.93

1803.71

ng/l

0.10

234

Spontaneous abortion

3869

26837

0.98

0.67

2.4

2.5

704.46

832.44

ng/l

1.55

3172

22399

Status post-ami

870

7421

0.95

0.67

4.6

2.8

3424.87

2020.46

ng/l

7.83

793

6340

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

859

1.18

0.67

2.8

3.1

998.29

1336.82

ng/l

0.81

723

Supervision of high-risk pregnancy

1125

6545

1.04

0.66

2.3

259.47

528.09

ng/l

5.45

892

5240

Melanoma in situ of trunk

138

1252

1.15

0.66

3.3

3.0

2172.51

1484.55

ng/l

0.63

117

1067

Other or unspecified paralytic strabismus

587

1.22

0.66

2.6

3.3

1171.19

1328.07

ng/l

0.16

513

Cholinergic urticaria

318

1.29

0.66

2.5

3.0

743.36

881.75

ng/l

0.22

263

Lymphocyte function antigen-1 [LFA-1] defect

100

1.68

0.66

4.1

3.5

3142.00

2572.91

ng/l

0.16

Striae atrophicae

621

1.19

0.66

3.2

3.1

906.44

950.77

ng/l

0.06

508

Injury of blood vessels at abdomen, lower back and pelvis level

339

1.30

0.65

3.7

3.5

826.71

1713.58

ng/l

2.14

286

Other combined immunodeficiencies

116

1.56

0.65

2.8

4.1

2602.55

1602.48

ng/l

0.18

100

Benign neoplasm: Spinal meninges

106

948

1.17

0.65

3.3

3.0

1597.17

1185.28

ng/l

0.46

808

Disorders of lacrimal system and orbit in diseases classified elsewhere

202

1859

1.11

0.65

2.5

2.9

1016.17

994.05

ng/l

0.03

170

1544

Carcinoma in situ of liver, gallbladder and bile ducts

1.78

0.65

1.7

3.1

1825.81

1837.17

ng/l

—

Immunodeficiency associated with other specified major defects, or unspecified

1.78

0.65

2.2

3.4

2528.78

965.26

ng/l

—

Maxillary hypoplasia

157

1.41

0.64

3.4

4.0

784.47

531.78

ng/l

0.23

132

Other disorders following mastoidectomy

378

1.28

0.64

3.0

3.3

2009.34

1638.84

ng/l

0.17

322

Other cestode infections

338

0.74

0.64

2.7

3.4

3251.96

1886.00

ng/l

0.44

283

Pedal cyclist injured in noncollision transport accidents

911

8766

1.05

0.64

3.3

3.0

985.02

1236.61

ng/l

1.90

767

7335

Dementia due to Parkinsons disease, excluding more controls

231

2147

1.11

0.64

3.3

2.9

1771.16

2056.86

ng/l

0.43

190

1868

Benign neoplasm: Mediastinum

295

1.32

0.64

3.7

3.1

923.36

1224.31

ng/l

0.47

243

Keratoconus

175

1600

1.12

0.63

2.7

3.1

1376.90

940.95

ng/l

0.75

146

1316

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

386

3639

1.08

0.63

2.5

2.6

672.94

751.20

ng/l

0.23

338

3058

Osteomalacia

616

1.20

0.63

3.2

3.1

994.78

971.93

ng/l

0.03

514

Acrodermatitis continua

142

1.46

0.63

2.0

3.0

2954.86

1079.13

ng/l

0.37

122

LSIL lesion of the cervix uteri

609

5804

1.06

0.62

2.5

2.6

570.92

622.13

ng/l

0.25

498

4720

Cerebral amyloid angiopathy

419

1.28

0.62

2.4

3.3

1970.53

1289.88

ng/l

0.45

360

Dermatitis herpetiformis

171

1569

1.12

0.62

3.3

3.1

1182.19

1184.39

ng/l

0.00

153

1343

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1127

10920

1.05

0.62

2.6

3.2

1490.56

1715.89

ng/l

1.19

992

9510

Haemophilus septicemia

161

1.44

0.62

3.6

3.1

2215.57

1184.08

ng/l

0.59

132

Exclusion endpoint for supernumerary teeth

539

1.19

0.62

4.9

3.8

1316.53

825.20

ng/l

0.41

427

Malignant neoplasm of rectum

1077

10430

1.05

0.61

2.6

3.2

1525.06

1714.07

ng/l

0.85

944

9063

Acute thyroiditis

304

1.29

0.61

3.3

3.0

674.11

1146.25

ng/l

0.81

254

Benign neoplasm: Brain, unspecified

489

1.22

0.61

2.6

3.0

1093.34

1436.62

ng/l

0.48

397

Carcinoma in situ of middle ear and respiratory system

464

1.24

0.61

3.5

3.1

743.28

1694.18

ng/l

2.32

389

Malignant neoplasm of endocrine gland

642

6149

1.06

0.61

3.0

1498.84

1220.32

ng/l

0.45

542

5191

Congenital malformations of breast

642

1.17

0.60

2.5

517.39

631.80

ng/l

0.22

514

Acquired stenosis of external ear canal

849

1.17

0.60

3.0

3.1

1407.96

1339.93

ng/l

0.06

728

Mesial bite

402

1.22

0.60

2.4

2.9

339.47

618.67

ng/l

1.16

332

Small plaque parapsoriasis

243

1.34

0.60

1.9

3.7

1555.42

1336.01

ng/l

0.15

200

Medical treatment for female infertility

903

9361

0.96

0.60

2.1

2.2

281.96

392.12

ng/l

1.61

727

7426

Anisometropia and aniseikonia

270

2526

1.09

0.59

3.4

3.1

1548.93

1300.59

ng/l

0.37

226

2149

Unspecified maternal hypertension

365

1.23

0.59

3.8

2.6

275.84

612.00

ng/l

0.84

296

Pedestrian injured in collision with heavy transport vehicle or bus

251

1.32

0.59

1.6

3.5

1520.68

1395.14

ng/l

0.06

205

Exposure to ignition of highly flammable material

296

1.28

0.59

2.4

2.9

472.58

769.99

ng/l

0.99

239

Other porphyria

136

1.46

0.58

2.7

2.9

1665.00

760.69

ng/l

0.32

110

Retained (old) intraocular foreign body

1.56

0.58

3.6

861.71

846.25

ng/l

—

Use of trihexyphenidyl

145

1.44

0.58

2.7

3.6

1762.29

1308.87

ng/l

0.32

124

Other diseases of appendix

111

1003

1.15

0.57

2.6

3.0

1208.57

1112.56

ng/l

0.09

839

Acute alcohol intoxication ICD-9

345

3262

1.08

0.57

3.6

3.1

1720.65

1694.27

ng/l

0.04

307

2782

Ill-defined and unknown causes of mortality

783

7557

1.05

0.57

4.1

3.3

3261.97

2098.92

ng/l

5.83

694

6564

Benign neoplasm: Brain, unspecified

493

1.21

0.56

2.6

3.5

1093.34

1393.92

ng/l

0.43

416

Mandibular hypoplasia

314

1.25

0.56

2.8

2.9

435.29

549.15

ng/l

0.26

259

Acne keloid

110

1.49

0.56

2.0

2.5

313.88

980.54

ng/l

—

Pneumoconiosis due to other inorganic dusts

356

1.26

0.56

3.2

3.6

2884.89

2064.96

ng/l

0.41

297

Postpartum hemorraghe, parous women as controls

1346

11437

1.03

0.55

2.0

2.3

430.20

464.35

ng/l

0.16

1050

9195

Adenocarcinoma and papilloma adenocarcinoma of rectum

1080

10486

1.04

0.55

2.6

3.2

1481.56

1733.20

ng/l

1.35

951

9127

Benign neoplasm: Uterine tubes and ligaments

590

1.19

0.55

2.9

2.8

989.12

1211.51

ng/l

0.29

489

Contact with other hot metals

125

1137

1.13

0.55

3.1

3.3

1692.78

1104.83

ng/l

0.70

107

954

Effects of air pressure and water pressure

289

1.26

0.54

1.6

2.5

263.26

646.80

ng/l

3.27

235

Toxic myoneural disorders

1.70

0.54

2.7

4.3

1940.71

939.23

ng/l

—

346

3260

1.07

0.54

1.9

2.3

399.97

328.56

ng/l

0.39

273

2547

Benign neoplasm: Spinal meninges

106

961

1.15

0.54

3.3

2.8

1597.17

1292.29

ng/l

0.31

815

Recurrent cholesteatoma of postmastoidectomy cavity

274

1.30

0.54

2.6

3.3

1083.03

1277.55

ng/l

0.23

225

Malignant neoplasm of breast, HER-negative

2340

22918

1.03

0.53

2.8

2.9

1346.00

1289.60

ng/l

0.28

1971

19576

Benign neoplasm: Connective and other soft tissue of head, face and neck

146

1341

1.12

0.53

2.7

3.1

1504.07

1232.47

ng/l

0.35

127

1140

Dysplastic lesion of the vagina of unknown severity

0.54

0.53

5.8

2.9

978.20

680.02

ng/l

—

Disorders of brain, other and unspecified

779

1.16

0.53

2.5

3.1

1409.54

1544.16

ng/l

0.12

669

Pedestrian injured in collision with two- or three-wheeled motor vehicle

264

1.28

0.52

2.2

3.4

799.85

1302.98

ng/l

0.57

221

Benign neoplasm: Skin of upper limb, including shoulder

178

1652

1.10

0.52

3.0

1684.14

1194.57

ng/l

0.56

153

1402

Renal cell carcinoma of kidney

380

3619

1.07

0.52

3.6

3.2

2868.64

1903.54

ng/l

1.97

343

3145

Malignant neoplasm of other and unspecified major salivary glands

294

1.28

0.52

2.8

3.1

1073.10

1206.07

ng/l

0.11

247

Disorders of other digestive organs in diseases classified elsewhere

1.61

0.52

1.9

3.7

389.84

890.19

ng/l

—

Other melanin hyperpigmentation

229

2150

1.09

0.52

2.9

3.0

1249.18

1462.30

ng/l

0.45

187

1846

Benign neoplasm: Uterine tubes and ligaments

593

1.19

0.52

2.9

3.1

989.12

1149.53

ng/l

0.20

511

Acne varioliformis

183

1.35

0.52

3.1

6700.89

1282.76

ng/l

0.87

152

Malaria

374

0.79

0.52

3.4

2.9

712.96

953.04

ng/l

0.50

304

Corneal pigmentations and deposits

359

1.24

0.51

3.9

3.2

1153.03

978.75

ng/l

0.22

296

Crushing injury of wrist and hand

136

1250

1.12

0.51

3.0

3.1

1750.06

1245.00

ng/l

0.46

119

1075

Malignant neoplasm of thyroid gland

598

5750

1.05

0.51

3.1

3.0

1203.88

1194.27

ng/l

0.02

507

4857

Helminthiases

149

1375

1.11

0.50

3.7

3.1

1461.73

1393.97

ng/l

0.07

128

1165

Vibratory urticaria

1.68

0.50

3.5

3.1

582.30

771.64

ng/l

—

Benign neoplasm: Mediastinum

305

1.26

0.49

3.7

3.2

923.36

1085.34

ng/l

0.23

247

Benign neoplasm: Scrotum

351

1.23

0.49

3.0

3.1

3399.71

1326.13

ng/l

1.10

293

Other obstetric trauma

218

2034

1.08

0.49

2.3

2.5

370.21

422.43

ng/l

0.15

174

1647

Mandibular retrognathia AND surgery (BSSRO)

143

1314

1.10

0.49

2.1

2.7

494.00

678.37

ng/l

0.47

116

1063

Other maternal disorders predominantly related to pregnancy

4818

29862

1.02

0.49

2.4

2.5

604.34

744.81

ng/l

2.36

3918

24688

Kela-code for behavioural disturbances in mental retardation

747

1.15

0.49

2.7

3.2

531.08

1294.47

ng/l

4.00

628

Vascular dementia (other)

656

1.18

0.48

3.7

3.4

2874.20

2405.42

ng/l

0.29

570

Injury of blood vessels at neck level

267

1.26

0.48

2.5

3.1

1624.26

946.26

ng/l

0.29

216

Premature separation of placenta [abruptio placentae]

108

979

1.12

0.48

2.3

2.8

223.26

480.50

ng/l

3.86

823

Melanocytic naevi of ear and external auricular canal

416

1.20

0.48

4.6

3.2

868.57

1278.32

ng/l

0.77

342

Melanocytic naevi of other and unspecified parts of face

482

4619

1.05

0.48

2.8

2.9

1117.27

1231.02

ng/l

0.27

388

3864

Burns and corrosions of multiple body regions

623

1.16

0.47

3.4

3.2

2146.83

1088.49

ng/l

1.01

516

Procedures for purposes other than remedying health state

191

1784

1.09

0.47

2.4

2.5

803.76

810.37

ng/l

0.01

162

1470

Injury of blood vessels at wrist and hand level

530

1.17

0.47

2.9

3.0

3014.53

1140.39

ng/l

0.72

440

Epiphyseal arrest

1.74

0.46

2.6

5.0

641.00

633.29

ng/l

—

Other disorders of choroid

136

1258

1.11

0.46

3.9

3.2

1984.52

1476.77

ng/l

1.02

122

1073

Victim of lightning

1.51

0.46

3.4

2.4

611.88

548.46

ng/l

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

400

1.21

0.46

2.6

3.2

502.34

1706.01

ng/l

6.10

342

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

140

1509

0.90

0.46

3.5

3.1

1632.17

1797.06

ng/l

0.16

130

1295

Iliac crest spur

1.51

0.45

3.2

3.6

644.22

2145.61

ng/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

158

1469

1.09

0.45

2.7

3.2

1686.10

1209.41

ng/l

0.46

139

1228

Carcinoma in situ of breast

325

1.22

0.45

2.1

2.8

303.74

1086.69

ng/l

3.35

261

Combined immunodeficiency, unspecified

1.50

0.43

3.9

3.1

4103.33

1034.78

ng/l

—

Benign neoplasm: Female genital organ, unspecified

244

1.26

0.42

2.1

2.4

1052.51

989.26

ng/l

0.04

209

Degenerative conditions of globe

469

1.18

0.42

3.5

3.3

2143.64

1830.71

ng/l

0.18

384

Convergence insufficiency and excess

697

0.87

0.42

3.1

2.8

565.70

726.50

ng/l

0.40

557

Benign neoplasm: Lacrimal gland and duct

1.46

0.42

2.5

3.3

689.86

1376.61

ng/l

—

Benign neoplasm: Endocrine gland, other/unspecified

301

1.23

0.42

2.6

3.4

1178.54

1109.81

ng/l

0.07

255

Cicatricial alopecia [scarring hair loss]

602

1.15

0.42

2.7

3.1

974.54

874.78

ng/l

0.07

503

Dental caries 2, only avohilmo

7684

60006

1.01

0.41

2.8

821.17

1074.96

ng/l

8.06

6147

50488

Vitreous prolapse

227

1.27

0.41

4.9

2.8

3010.73

1014.09

ng/l

0.67

196

Congenital malformations of eyelid, lacrimal apparatus and orbit

353

1.18

0.41

3.9

5.0

619.03

1020.71

ng/l

0.53

296

Other congenital malformations of integument

1.50

0.41

2.8

5.5

316.00

1084.53

ng/l

—

Exposure to uncontrolled fire in building or structure

545

1.16

0.41

2.8

3.3

1683.10

1280.70

ng/l

0.32

463

Compression of brain

1.38

0.41

5.4

3.5

1163.78

1648.92

ng/l

—

Pedal cyclist injured in collision with motor vehicle

234

2213

1.07

0.41

2.9

3.0

1208.52

1264.90

ng/l

0.07

179

1852

Carcinoma in situ of breast, intraductal

764

7422

1.04

0.40

2.6

2.7

829.75

1003.02

ng/l

1.06

635

6292

Melanocytic naevi of eyelid, including canthus

756

1.13

0.40

2.7

2.9

951.87

1228.32

ng/l

0.57

631

Benign neoplasm: Endocrine gland, other/unspecified

302

1.23

0.40

2.6

3.0

1178.54

990.85

ng/l

0.20

251

Disorders of acoustic nerve

0.64

0.40

1.7

3.1

1553.00

1083.73

ng/l

—

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

473

1.18

0.40

3.9

3.1

4820.18

1832.02

ng/l

0.43

404

Benign neoplasm: Cranial nerves

251

2637

0.94

0.39

2.7

3.0

1396.38

1284.89

ng/l

0.14

218

2254

Wilms' tumor, excluding all cancers (controls excluding all cancers)

549

1.15

0.39

3.7

3.4

3249.67

1876.20

ng/l

1.13

471

Malignant neoplasm of adrenal gland

293

1.21

0.39

2.7

3.5

1911.62

1257.39

ng/l

0.39

247

566

1.14

0.39

2.4

2.9

730.51

728.01

ng/l

0.00

471

Injury of blood vessels at hip and thigh level

295

1.23

0.39

3.5

3.1

917.66

1124.53

ng/l

0.29

248

Hepatocellular carcinoma

195

2058

0.93

0.38

2.9

3.2

1591.14

2114.70

ng/l

0.53

171

1816

Carcinoma in situ of prostate

590

1.15

0.38

2.5

3.2

1417.23

1441.40

ng/l

0.01

512

Neonatal jaundice from other and unspecified causes

384

0.85

0.38

10.5

9.2

1499.59

1394.23

ng/l

0.06

333

Placenta praevia

184

1728

1.07

0.38

1.8

2.5

327.46

430.94

ng/l

0.46

150

1388

Postdysenteric arthropathy

634

1.13

0.37

3.1

1784.88

998.60

ng/l

0.43

518

Maternal care for known or suspected abnormality of pelvic organs

1340

9453

0.98

0.37

2.2

2.4

441.01

510.31

ng/l

0.55

1060

7600

Crohn's disease (strict) with PSC

1.42

0.37

1.6

2.5

224.85

514.40

ng/l

1.23

Physiological and behavioural disorders associated with sexual development and orientation

1.40

0.37

2.8

3.1

533.83

768.85

ng/l

0.32

Increased muscle tone

483

1.15

0.36

3.1

3.5

1619.60

1054.20

ng/l

0.30

404

Maternal care for known or suspected disproportion

187

1761

1.07

0.36

1.9

2.5

622.99

385.06

ng/l

0.32

148

1427

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

653

1.12

0.36

2.9

3.0

468.34

708.17

ng/l

1.22

543

Carcinoma in situ of cervix uteri, exocervix

321

1.18

0.36

2.2

2.7

1240.08

450.49

ng/l

0.58

262

Traumatic amputation of forearm

1.51

0.36

2.9

1429.14

1513.45

ng/l

—

Abscess of spleen

1.54

0.35

2.9

3.5

7095.22

2024.06

ng/l

—

Other congenital malformations of female genitalia

302

1.18

0.35

3.5

2.7

1049.92

813.90

ng/l

0.27

235

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

106

982

1.10

0.35

3.4

3.0

1557.20

954.44

ng/l

0.49

799

Cleft lip, lip and palate or palate

729

0.89

0.35

5.0

3.3

1229.87

722.85

ng/l

0.45

587

Carcinoma in situ, other and unspecified urinary organs

1.50

0.35

1.6

2.9

829.68

792.75

ng/l

—

Intentional self-harm by crashing of motor vehicle

1.36

0.35

22.7

4.2

763.17

1115.22

ng/l

—

Other perinatal haematological disorders

1.37

0.35

4.7

9.0

1239.00

1571.11

ng/l

—

Frostbite involving multiple body regions and unspecified frostbite

147

1.29

0.35

3.3

3.1

2232.08

1208.53

ng/l

0.27

124

Cleft lip and cleft lip and palate

391

0.85

0.35

5.5

3.2

1493.90

725.33

ng/l

0.37

314

Malignant neoplasm of breast, HER-positive

3769

37579

0.99

0.35

2.6

2.8

1011.47

1163.45

ng/l

1.62

3208

31964

Other specified transport accidents

276

1.19

0.34

2.0

3.5

5320.78

846.06

ng/l

0.46

221

Other/unspecified postprocedural disorders of ear and mastoid process

291

0.81

0.34

4.4

3.1

2392.84

1255.65

ng/l

0.42

250

Mucinous and mucinous cystic tumor

346

0.83

0.34

3.1

3.2

434.98

1205.01

ng/l

2.70

294

Iodine-deficiency-related thyroid disorders and allied conditions

103

1.41

0.34

1.6

2.8

227.53

1490.00

ng/l

2.10

Carcinoma in situ, other and unspecified urinary organs

1.43

0.34

1.6

2.9

829.67

977.19

ng/l

—

Intracerebral haemorrhage

1493

14669

1.02

0.34

3.4

3.2

1885.26

1963.09

ng/l

0.25

1299

12669

Secondary sideroblastic anaemia due to drugs and toxins

1.46

0.33

2.8

3.6

3333.38

2752.03

ng/l

—

Cholera

412

3983

1.05

0.33

2.3

2.9

1276.94

1219.98

ng/l

0.11

311

3393

Graves ophthalmopathy

198

1882

1.07

0.33

2.5

2.8

1031.18

878.06

ng/l

0.24

167

1566

Benign neoplasm: Short bones of upper limb

114

1064

1.09

0.33

2.1

2.8

944.33

951.15

ng/l

0.01

890

Benign neoplasm: Brain, infratentorial

392

1.16

0.32

2.1

3.1

436.74

1133.90

ng/l

1.97

320

Brain meningioma

499

4843

1.04

0.32

2.6

3.0

1289.86

1300.29

ng/l

0.02

429

4130

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

117

0.71

0.32

3.8

334.78

1905.71

ng/l

—

Melanocytic naevi of eyelid, including canthus

767

1.11

0.32

2.7

3.1

951.87

1110.39

ng/l

0.30

647

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

614

1.12

0.32

2.6

2.8

1408.35

1124.17

ng/l

0.20

512

Pedal cyclist injured in collision with pedestrian or animal

533

0.88

0.32

3.1

3.2

629.03

899.97

ng/l

0.96

446

Carcinoma in situ of liver, gallbladder and bile ducts

1.44

0.31

1.7

3.4

1825.81

1482.13

ng/l

—

Deep bite that required surgery

592

1.11

0.31

1.8

2.8

683.21

592.18

ng/l

0.10

488

Carcinoma in situ of middle ear and respiratory system

492

1.15

0.31

3.5

3.3

743.28

1535.33

ng/l

1.89

415

Multiple gestation

434

4195

1.04

0.31

2.3

2.4

428.38

414.08

ng/l

0.05

339

3380

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

848

1.10

0.31

3.3

2.7

1843.43

1180.42

ng/l

0.41

702

Other congenital malformations of peripheral vascular system

728

1.10

0.31

4.1

3.3

1395.97

917.12

ng/l

0.73

602

Other specified/unspecified disorders of tympanic membrane

262

1.19

0.30

2.5

3.6

297.43

981.94

ng/l

6.92

223

Cleft hard palate NOS

176

1.22

0.30

3.5

1080.53

664.71

ng/l

0.46

142

Graves ophthalmopathy, strict

176

1673

1.07

0.30

2.4

2.8

1110.70

865.74

ng/l

0.37

147

1392

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

637

1.12

0.30

2.2

2.8

840.21

1634.30

ng/l

2.44

531

Papillary adenocarcinoma of thyroid gland

441

4277

1.04

0.30

3.2

2.9

1262.55

1089.71

ng/l

0.41

373

3604

Synovial hypertrophy, not elsewhere classified

538

1.11

0.29

2.4

3.2

896.25

884.69

ng/l

0.02

432

Twin gestation

418

4045

1.04

0.29

2.3

2.4

429.14

403.50

ng/l

0.09

327

3252

Qualitative platelet defects

292

1.17

0.29

3.3

1084.38

1090.66

ng/l

0.01

243

Malignant neoplasm of oropharynx

135

1424

0.93

0.28

3.5

3.1

1641.80

1255.62

ng/l

0.49

118

1222

Carcinoma in situ of cervix uteri, endocervix

490

1.12

0.28

2.2

2.6

638.97

695.84

ng/l

0.06

399

Melanoma of uvea

101

949

1.09

0.28

3.4

3.1

1088.46

1558.05

ng/l

1.31

808

Frontotemporal dementia, wide, incl. Pick's disease

681

0.89

0.28

2.7

3.1

796.32

1574.82

ng/l

2.40

583

Congenital lens malformations

292

1.16

0.27

4.1

3.5

922.80

1110.77

ng/l

0.20

242

Memory loss

1077

10587

1.03

0.27

2.7

3.2

1748.84

1740.88

ng/l

0.02

909

9254

Polymorphous light eruption

464

1.12

0.27

2.1

2.9

607.18

843.44

ng/l

0.59

393

Other abnormal products of conception

1827

11990

1.02

0.27

2.1

2.3

385.66

480.36

ng/l

0.67

1425

9695

Malignant neoplasm of tonsil

123

1298

0.93

0.27

3.5

3.1

1185.96

1233.18

ng/l

0.08

107

1110

Human immunodeficiency virus [HIV] disease resulting in other specified diseases

1.52

0.27

2.2

3.9

1696.20

2323.28

ng/l

—

Other specified and unspecified disorders of choroid

306

0.85

0.26

4.1

3.2

1633.38

1035.36

ng/l

0.56

247

Family history of other specific disorders

647

1.10

0.26

2.6

767.88

807.44

ng/l

0.05

517

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

367

3563

1.04

0.26

2.6

3.1

1482.81

1657.58

ng/l

0.36

327

3050

Other and unspecified postprocedural disorders of eye and adnexa

201

1.22

0.26

2.6

3.2

1541.61

1781.10

ng/l

0.13

166

Benign neoplasm: Peripheral nerves and autonomic nervous system

137

1302

1.07

0.26

2.9

3.0

750.78

1217.52

ng/l

2.05

112

1089

Benign neoplasm: other/unspecified salivary gland

268

2588

1.05

0.26

3.9

3.0

1816.38

1512.76

ng/l

0.44

225

2198

Relapsing fevers

115

1.27

0.26

1.6

3.3

343.56

771.59

ng/l

1.52

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

368

0.87

0.25

3.2

2.8

5895.64

1258.52

ng/l

0.44

307

Cyst of spleen

125

1.26

0.25

5.5

2.8

775.53

1046.34

ng/l

0.31

102

Mumps

207

1988

1.05

0.25

2.5

2.9

809.22

1054.62

ng/l

0.70

176

1647

Carcinoma in situ of prostate

606

1.11

0.25

2.5

3.2

1417.23

1298.93

ng/l

0.07

523

Malignant neoplasm of other and unspecified parts of biliary tract

120

1262

0.93

0.24

4.3

3.2

1297.39

1746.15

ng/l

0.65

105

1091

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

191

1.19

0.24

3.0

2.9

964.82

1006.11

ng/l

0.04

155

Contact with other and unspecified heat and hot substances

449

1.12

0.24

2.7

3.2

1416.39

1327.96

ng/l

0.06

373

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

624

1.10

0.24

2.6

3.1

1408.35

1202.64

ng/l

0.14

530

Obstructed labour due to maternal pelvic abnormality

1232

12510

0.98

0.24

2.5

2.6

903.23

789.84

ng/l

0.36

997

10557

Postpartum haemorrhage

1346

11535

1.02

0.24

2.0

2.3

430.20

519.00

ng/l

0.51

1050

9293

Use of levodopa decarbox-comt-inhibitor

351

3416

1.04

0.24

2.7

3.1

1100.91

1760.46

ng/l

4.85

297

2965

Disorders of urea cycle metabolism

1.28

0.24

6.2

2.6

5699.52

1281.09

ng/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

137

1307

1.06

0.23

2.9

3.1

750.78

1174.23

ng/l

1.82

112

1105

Gastric ulcer - Acute with haemorrhage, drug-induced

176

0.81

0.23

4.1

3.2

3055.61

1800.03

ng/l

0.35

139

Other disorders of kidney and ureter in diseases classified elsewhere

1.36

0.23

3.2

3.6

4207.50

1086.10

ng/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

138

1316

1.06

0.23

3.6

3.3

1835.15

1364.72

ng/l

0.34

111

1122

Open bite that required surgery (Lefort1 or BSSRO)

357

0.89

0.23

1.8

2.4

230.24

464.15

ng/l

1.70

278

L02BG Aromatase inhibitors

3262

32344

1.01

0.22

2.6

2.8

1041.57

1164.51

ng/l

0.99

2783

27585

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

440

0.90

0.22

2.1

3.5

416.79

646.18

ng/l

0.67

366

Haemorrhagic and haematological disorders of fetus and newborn

465

1.09

0.22

8.6

1173.43

1242.80

ng/l

0.05

399

Degenerative and vascular disorders of ear

137

1.24

0.22

2.7

883.45

1180.03

ng/l

0.34

122

Carcinoma in situ of cervix uteri

470

4585

1.03

0.22

2.9

2.6

1035.92

768.67

ng/l

0.86

390

3699

Respiratory tuberculosis, clinically confirmed

122

1278

0.94

0.22

3.4

3.3

1345.09

2239.68

ng/l

2.07

105

1093

Melanoma in situ of trunk

138

1323

1.06

0.22

3.3

3.2

2172.51

1528.22

ng/l

0.58

117

1155

Mesothelioma

145

1392

1.06

0.21

3.2

1311.54

1825.30

ng/l

1.39

133

1218

Wilms' tumor

570

1.10

0.21

3.7

3.6

3249.67

1748.98

ng/l

1.30

485

Mucinous and mucinous cystic tumor of rectum

435

1.12

0.21

2.7

3.3

1699.26

1314.39

ng/l

0.38

362

Discontinuity and dislocation of ear ossicles

385

1.12

0.21

2.2

3.0

630.42

1008.13

ng/l

1.16

323

Exposure to uncontrolled fire, not in building or structure

154

0.81

0.21

4.3

3.4

2440.15

1101.94

ng/l

0.36

129

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

465

4750

0.97

0.21

3.3

3.1

2221.60

1902.60

ng/l

0.65

404

4095

Carcinoma in situ of breast

347

1.12

0.21

2.1

2.7

303.74

1015.02

ng/l

3.55

288

Melanoma of uvea

101

961

1.07

0.21

3.4

3.3

1088.46

1467.48

ng/l

1.00

826

Niacin deficiency [pellagra]

1.35

0.21

3.9

2.5

342.38

1934.32

ng/l

—

Solar urticaria

1.30

0.21

3.3

3.5

734.10

1107.63

ng/l

—

Desensitization to allergens

222

2300

0.96

0.21

2.5

3.1

1131.69

612.29

ng/l

0.33

168

1840

Lichen ruber moniliformis

0.67

0.21

2.2

3.7

635.80

1433.88

ng/l

—

Endometroid carcinoma of ovary

864

1.07

0.20

3.3

2.8

1843.43

1219.15

ng/l

0.38

725

Benign neoplasm: Lacrimal gland and duct

110

1.27

0.20

2.5

3.9

689.86

1245.53

ng/l

—

Hereditary erythropoietic porphyria

1.27

0.20

3.1

2.8

717.86

1963.21

ng/l

—

Dermatitis due to ingested food

111

1016

1.06

0.20

3.7

5.1

1572.97

933.47

ng/l

0.31

805

Thiamine deficiency

465

1.10

0.20

2.5

3.0

1180.54

1208.95

ng/l

0.04

394

Moyamoya

1.22

0.19

1.0

1.7

301.29

450.74

ng/l

—

Tularaemia

110

1051

1.06

0.19

3.2

3.0

1636.64

1278.19

ng/l

0.28

893

Frostbite with tissue necrosis

236

0.86

0.19

1.9

3.0

1796.25

1308.75

ng/l

0.15

189

Obstructive hydrocephalus

127

1218

1.06

0.19

2.8

3.3

1070.94

1478.08

ng/l

1.07

108

1043

Sequelae of other accidents

125

1303

0.95

0.19

2.6

3.1

1575.64

1508.10

ng/l

0.07

106

1099

Malignant neoplasm of uterus, part unspecified

0.71

0.19

1.7

4.1

622.83

2201.95

ng/l

—

Biliary cirrhosis, secondary

1.28

0.19

3.2

2.6

4042.89

1501.67

ng/l

—

Acute myringitis

446

1.09

0.18

4.8

3.0

520.71

1182.87

ng/l

2.82

381

Granulosa cell carcinoma of ovary

196

1.16

0.18

3.0

2.9

964.82

732.00

ng/l

0.32

162

Other specified/unspecified diseases of inner ear

448

1.10

0.18

3.3

3.0

1471.82

1527.48

ng/l

0.04

377

Lichen planopilaris

235

1.14

0.18

1.8

3.0

271.63

903.45

ng/l

4.06

196

Pediculosis and phthiriasis

196

1.15

0.18

2.3

2.9

951.24

703.85

ng/l

0.37

166

Cerebral atherosclerosis

128

1227

1.06

0.18

3.5

3.2

2673.24

2257.60

ng/l

0.30

112

1058

Medullary carcinoma of thyroid gland

1.22

0.18

4.1

2.8

735.11

738.55

ng/l

—

Malignant neoplasm of other and ill-defined digestive organs

717

0.93

0.17

2.9

3.4

1773.58

1863.04

ng/l

0.07

601

Epileptic seizures related to alcohol

513

0.92

0.17

2.5

3.0

2073.05

998.01

ng/l

0.97

430

Asymmetry of jaw

720

1.06

0.17

3.1

2.9

460.98

698.39

ng/l

0.62

579

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

488

1.09

0.17

3.2

2.8

1131.26

1149.50

ng/l

0.02

398

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

870

1.06

0.16

2.8

3.1

1354.51

1839.64

ng/l

0.36

743

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

1.14

0.16

2.6

3.2

1054.22

1001.18

ng/l

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

208

2138

0.96

0.16

3.1

1379.52

1393.70

ng/l

0.01

183

1812

Caries in Clefts patients

390

1.09

0.16

6.3

2.9

1424.55

582.51

ng/l

0.50

305

Perioral dermatitis, drug-induced

0.81

0.16

6.4

3.1

799.70

1955.56

ng/l

—

Transient synovitis

381

1.09

0.15

4.6

3.3

1975.50

890.97

ng/l

0.45

304

Any dementia

5460

38645

0.99

0.15

3.1

3.3

2390.42

1984.47

ng/l

5.93

4578

33844

Tonsillectomy and adenotomy

4264

29869

0.99

0.15

2.7

2.8

677.74

887.88

ng/l

2.53

3347

24486

Use of interferon beta-1a

110

1057

1.05

0.15

2.1

2.8

599.61

632.61

ng/l

0.06

859

Other congenital malformations of male genital organs

276

1.10

0.14

4.8

6.4

1879.04

1088.25

ng/l

0.54

224

Benign neoplasm: Male genital organ, other/unspecified

1.24

0.14

2.8

3.1

1227.70

835.31

ng/l

—

Viral conjunctivitis

134

1296

1.04

0.14

2.6

2.9

1614.42

985.87

ng/l

0.63

118

1076

Other benign neoplasm of uterus: Cervix uteri

433

1.08

0.14

2.3

2.7

620.43

890.58

ng/l

0.84

360

Malignant neoplasm of rectosigmoid junction

163

1586

1.04

0.14

2.5

3.1

1255.07

1611.41

ng/l

0.99

142

1380

Benign neoplasm: Short bones of upper limb

114

1102

1.04

0.13

2.1

2.9

944.33

832.46

ng/l

0.14

929

Benign neoplasm: Female genital organ, unspecified

269

1.11

0.13

2.1

2.7

1052.51

1178.98

ng/l

0.08

229

Contraceptive management

3344

23380

1.01

0.12

2.5

2.6

465.24

744.52

ng/l

9.22

2690

19181

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

435

1.06

0.12

1.7

2.6

397.20

510.41

ng/l

0.26

345

Maternal care for known or suspected malpresentation of fetus

750

5655

0.99

0.11

2.0

2.3

422.99

367.31

ng/l

0.13

570

4420

Benign neoplasm: Parathyroid gland

102

989

1.04

0.11

3.5

2.9

4881.00

1251.85

ng/l

1.24

831

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

448

1.07

0.11

2.7

2.9

1699.26

1402.51

ng/l

0.27

374

Malignant neoplasm of ovary

434

4283

1.02

0.11

2.9

3.0

1101.15

1281.41

ng/l

0.46

383

3643

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

526

1.06

0.11

3.3

2.8

1239.19

1072.66

ng/l

0.13

428

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

757

0.96

0.10

2.4

3.0

909.77

941.59

ng/l

0.04

638

Malignant neoplasm of meninges

1.13

0.10

2.0

2.4

105.08

773.55

ng/l

—

Other drug-induced osteomalacia in adults

1.08

0.10

2.2

2.3

421.00

370.09

ng/l

—

Toxoplasmosis

431

0.94

0.10

3.3

3.0

1426.51

1018.39

ng/l

0.56

355

Scarlet fever

291

1.07

0.10

3.5

2.8

1437.54

558.52

ng/l

0.58

231

Benign neoplasm: Tonsil

102

992

1.04

0.09

2.7

2.9

1877.25

1116.02

ng/l

0.79

836

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

639

6327

1.01

0.09

3.0

3.2

1883.02

1858.82

ng/l

0.04

579

5450

Occlusion and stenosis of arteries, not leading to stroke

146

1428

1.03

0.09

4.3

3.3

2663.35

2244.25

ng/l

0.31

132

1241

Leprosy [Hansen's disease]

1.09

0.09

6.0

3.4

1358.50

1583.45

ng/l

—

Carcinoma in situ of anus and anal canal

1.20

0.09

4.6

3.0

2557.60

2218.67

ng/l

—

Drug-induced tics and other tics of organic origin

0.76

0.09

2.4

3.1

923.40

771.80

ng/l

—

Other degenerative diseases of the basal ganglia

165

1618

1.03

0.09

2.7

3.1

936.17

1673.42

ng/l

3.44

149

1413

Melanoma in situ of eyelid, including canthus

0.82

0.09

3.5

3.2

657.33

985.09

ng/l

—

Benign neoplasm: Brain, infratentorial

420

1.06

0.09

2.1

3.6

436.74

1239.32

ng/l

2.62

354

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.81

0.09

4.7

3.6

2172.33

1161.81

ng/l

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

187

1836

1.03

0.09

3.3

3.0

1969.58

1373.45

ng/l

0.63

167

1553

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

162

1588

1.03

0.09

3.0

3.1

1579.91

1723.47

ng/l

0.15

142

1364

Infections specific to the perinatal period

292

1.07

0.09

8.5

6.8

2277.09

703.74

ng/l

0.73

245

Cleft palate

409

0.95

0.08

4.1

3.5

762.77

714.97

ng/l

0.07

319

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

660

1.04

0.08

2.2

3.2

915.15

1232.98

ng/l

0.54

567

Mandibular prognathia AND surgery (LeFortI or BSSRO)

225

1.08

0.08

1.9

2.8

502.51

489.48

ng/l

0.02

190

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

620

1.04

0.08

2.9

3.1

1728.42

1610.73

ng/l

0.05

521

Abnormalities of forces of labour

552

5468

1.01

0.08

2.0

2.4

546.72

454.49

ng/l

0.23

444

4509

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

3102

25919

1.00

0.07

3.1

3.2

1499.88

1701.24

ng/l

1.94

2809

22439

Vaginal lichen planus

346

0.94

0.07

1.9

2.8

671.52

913.76

ng/l

0.42

303

Foreign object accidentally left in body during surgical and medical care

234

0.93

0.07

4.0

3.2

2142.63

886.74

ng/l

0.60

193

Injury of muscle and tendon at neck level

0.84

0.07

3.8

3.6

669.00

780.80

ng/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

639

0.96

0.07

4.1

3.0

945.33

1380.29

ng/l

1.02

540

Pervasive developmental disorders excl. Autism + Asperger

352

1.05

0.07

3.3

5.4

228.91

705.56

ng/l

2.87

265

Carcinoma in situ of cervix uteri, exocervix

354

1.05

0.07

2.2

2.8

1240.08

542.99

ng/l

0.49

295

Malignant neoplasm of palate

217

1.08

0.07

2.8

3.4

1232.13

1203.09

ng/l

0.03

183

Melanoma in situ of upper limb, including shoulder

622

1.04

0.07

2.4

3.1

2108.72

1441.92

ng/l

0.42

524

Other sexually transmitted chlamydial diseases

226

2228

1.02

0.07

2.1

2.8

370.63

528.80

ng/l

0.73

146

1675

Benign neoplasm: other/unspecified salivary gland

268

2649

1.02

0.06

3.9

3.0

1816.38

1569.14

ng/l

0.34

225

2282

Liposarcoma

712

1.04

0.06

3.3

3.1

2008.16

1265.06

ng/l

0.78

611

Occupant of pick-up truck or van injured in other and unspecified transport accidents

365

1.05

0.06

3.4

3.0

989.79

854.07

ng/l

0.19

301

Pityriasis lichenoides chronica

326

1.06

0.06

2.1

3.4

1941.08

1730.13

ng/l

0.09

279

Hydatidiform mole

739

0.97

0.06

2.4

2.7

910.04

693.12

ng/l

0.16

616

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

782

1.03

0.06

2.4

3.0

1437.97

1406.21

ng/l

0.02

664

Follicular adenocarcinoma of thyroid gland

564

1.04

0.06

3.2

3.3

758.73

1391.98

ng/l

2.60

485

Placental disorders

314

0.95

0.06

1.4

2.9

130.93

443.33

ng/l

3.37

257

Vascular dementia (undefined)

426

4186

1.01

0.06

3.4

3.5

3060.70

2800.93

ng/l

0.43

347

3676

Infliximab

336

1.05

0.05

2.4

2.7

276.46

564.93

ng/l

0.80

270

Medicines for HER+ breast cancer

3999

38868

1.00

0.05

2.6

2.8

1023.46

1166.22

ng/l

1.51

3401

33026

Febrile neutrophilic dermatosis [Sweet]

120

1.12

0.05

4.0

3.5

1827.94

1191.07

ng/l

0.33

104

Dysplastic lesion of unknown severity of the cervix uteri

475

1.04

0.05

1.7

2.8

313.58

652.98

ng/l

2.14

390

Chondrosarcoma

272

0.94

0.05

2.2

3.4

1955.21

1387.83

ng/l

0.15

227

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

278

1.06

0.05

2.4

2.9

1565.83

1554.32

ng/l

0.00

235

Motor neuron disease

148

1500

0.98

0.05

2.7

2.8

1093.15

1573.32

ng/l

0.92

121

1290

Benign neoplasm: Tonsil

102

1003

1.02

0.05

2.7

3.1

1877.25

1035.31

ng/l

0.92

852

Dementia in other diseases classified elsewhere

470

4729

0.99

0.04

3.1

3.2

1438.07

1858.36

ng/l

1.47

377

4120

Benign neoplasm: Short bones of lower limb

715

1.03

0.04

2.8

3.0

1451.39

1002.32

ng/l

0.40

588

Carcinoma in situ of cervix uteri, endocervix

527

1.03

0.04

2.2

2.7

638.97

783.80

ng/l

0.15

432

Respiratory tuberculosis, not confirmed

451

4485

1.01

0.04

3.5

3.2

1733.24

2006.58

ng/l

0.61

395

3863

Early syphilis

814

0.98

0.04

2.7

3.1

1068.75

976.35

ng/l

0.14

683

ILD medications: acetylcysteine

777

1.02

0.03

3.5

2.9

1595.89

2364.43

ng/l

1.16

651

Malignant neoplasm of digestive organs

5083

49967

1.00

0.03

2.9

3.2

1618.07

1813.61

ng/l

2.14

4435

43289

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

340

1.04

0.03

2.8

3.1

675.55

1545.20

ng/l

1.95

282

Malignant neoplasm of other and unspecified female genital organs

131

1296

1.02

0.03

2.3

2.9

1229.73

1090.56

ng/l

0.24

120

1090

Frontotemporal dementia

561

0.97

0.03

2.7

3.2

708.49

1574.35

ng/l

2.93

483

Accidental poisoning by and exposure to alcohol

108

1094

0.98

0.03

3.0

1621.57

1338.04

ng/l

0.18

894

Acute hepatitis A

350

0.96

0.03

2.3

3.0

1619.34

867.97

ng/l

0.46

286

Sweet's syndrome

122

1.09

0.03

4.0

3.6

1827.94

1774.76

ng/l

0.02

104

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

410

1.03

0.03

3.0

3.1

1427.51

1351.41

ng/l

0.03

349

Rubella [German measles]

250

2517

0.99

0.03

2.9

2.8

565.76

776.47

ng/l

1.27

218

2105

Carcinoma in situ of breast, other/unspecified

127

1283

0.99

0.03

2.5

2.8

1015.76

1110.43

ng/l

0.18

104

1084

Diving or jumping into water causing injury other than drowning or submersion

281

1.04

0.02

2.1

3.2

513.30

835.45

ng/l

0.84

233

Benign neoplasm: Ill-defined sites within the digestive system

560

0.98

0.02

2.8

3.2

1674.77

1172.49

ng/l

0.28

476

Benign neoplasm: Cranial nerves

251

2525

0.99

0.02

2.7

2.9

1396.38

1275.28

ng/l

0.15

218

2144

Malignant neoplasm of eye and adnexa

770

1.02

0.02

3.4

1118.20

1454.17

ng/l

0.64

654

Carcinoma in situ of anus and anal canal

1.11

0.02

4.6

3.3

2557.60

2003.32

ng/l

—

Precocious puberty

107

0.93

0.02

1.4

4.1

653.20

604.00

ng/l

—

Acute disseminated encephalitis/encephalomyelitis

133

1.07

0.02

2.4

2.9

845.32

895.41

ng/l

—

109

Other disorders of binocular vision

701

1.01

0.02

2.3

3.0

346.87

923.04

ng/l

4.99

567

Contact with venomous snakes and lizards

779

0.99

0.02

2.5

3.2

540.59

1137.05

ng/l

3.71

655

Post-traumatic hydrocephalus, unspecified

234

1.03

0.00

2.5

3.2

2130.84

1799.37

ng/l

0.15

191

Other benign neoplasm of uterus: Cervix uteri

466

0.98

0.00

2.3

3.0

620.43

811.72

ng/l

0.59

394

Melanoma in situ of lower limb, including hip

514

1.02

0.00

4.2

2.9

1119.44

1141.98

ng/l

0.03

432

Benign neoplasm: Short bones of lower limb

736

0.99

0.00

2.8

3.1

1451.39

962.51

ng/l

0.45

607

Carcinoma in situ of breast, other/unspecified

127

1276

0.99

0.00

2.5

2.7

1015.76

1123.97

ng/l

0.21

104

1061

Carcinoma in situ of breast, intraductal

764

7639

1.00

0.00

2.6

2.8

829.75

1033.93

ng/l

1.36

635

6510

Other assisted single delivery

642

1.00

0.00

1.5

2.8

240.63

414.35

ng/l

0.62

528

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

195

1953

1.00

0.00

2.7

3.1

2036.16

1826.45

ng/l

0.16

169

1679

Secondary malignant neoplasm of respiratory and digestive organs

132

1322

1.00

0.00

2.4

3.2

1222.17

1764.80

ng/l

1.66

118

1148

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

516

1.01

0.00

3.2

1131.26

1010.04

ng/l

0.17

430

Otosclerosis

748

7484

1.00

0.00

2.9

3.0

1487.11

1405.63

ng/l

0.11

619

6438

Melanoma in situ of lower limb, including hip

519

1.00

0.00

4.2

3.0

1119.44

1184.55

ng/l

0.08

438

Use of teriflunomide

411

1.00

0.00

2.0

3.0

483.82

636.45

ng/l

0.23

339

Benign neoplasm: Male genital organ, other/unspecified

101

0.99

0.00

2.8

3.0

1227.70

1506.98

ng/l

—

Ductal carcinoma of pancreas

678

1.00

0.00

2.2

3.1

915.15

1156.67

ng/l

0.38

573

Malignant neoplasm of cervix uteri

106

1061

1.00

0.00

2.3

2.9

3450.07

1176.48

ng/l

1.05

885

Melanoma in situ of upper limb, including shoulder

638

1.00

0.00

2.4

3.3

2108.72

1413.79

ng/l

0.45

533

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

151

1511

1.00

0.00

3.3

3.0

1565.37

1379.32

ng/l

0.15

134

1284

Hypotony of eye

127

1.03

0.00

4.2

2.8

2271.35

1062.39

ng/l

0.36

103

Motorcycle rider injured in noncollision transport accidents

172

1725

1.00

0.00

2.6

3.1

653.10

993.87

ng/l

1.38

135

1408

Hereditary ataxia

112

1117

1.00

0.00

2.8

3.3

1708.39

1427.33

ng/l

0.13

952

Benign neoplasm: Ill-defined sites within the digestive system

553

0.99

0.00

2.8

2.9

1674.77

1081.92

ng/l

0.34

457

Other and unspecified spinal muscular atrophies

744

0.99

0.00

3.0

3.2

1841.47

1498.99

ng/l

0.23

634

Sequelae of poliomyelitis

835

0.99

0.00

2.3

3.1

1270.62

1635.27

ng/l

0.36

723

Other infiltrative disorders of skin and subcutaneous tissue

412

0.99

0.00

3.8

3.2

2291.46

1107.96

ng/l

0.73

359

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

0.86

0.00

4.8

2.7

1731.20

1092.62

ng/l

—

Irritant contact dermatitis due to drugs in contact with skin

0.93

0.00

1.2

3.9

159.04

1004.44

ng/l

—

Other degenerative disorders of globe

1.00

0.00

3.8

3.5

1939.80

1549.19

ng/l

—

Keratosis punctata

1.06

0.00

3.9

3.3

727.57

721.79

ng/l

—

Congenital absence, atresia and stenosis of small intestine

1.02

0.00

4.0

4.8

862.00

932.99

ng/l

—

Von Hippel-Lindau syndrome

1.05

0.00

5.6

2.8

7590.40

685.86

ng/l

—

Hookworm diseases

0.95

0.00

2.2

3.2

369.00

1183.20

ng/l

—

Benign neoplasm: Parathyroid gland

102

1020

1.00

0.00

3.5

3.1

4881.00

1279.58

ng/l

1.23

866

Other hypertrophic osteoarthropathy

1.00

0.00

1.0

4.3

565.67

2799.62

ng/l

—

Melanoma in situ of eyelid, including canthus

0.85

0.00

3.5

3.7

657.33

1265.91

ng/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

325

3250

1.00

0.00

3.6

3.1

1882.05

1989.53

ng/l

0.14

287

2812

Contact with other specified venomous plants

1.04

0.00

2.0

2.5

343.33

1340.40

ng/l

—

Lichen striatus

0.94

0.00

1.3

3.3

240.93

1993.39

ng/l

—

Macular pucker, drug-induced

1.05

-0.00

2.7

3.0

1492.00

881.32

ng/l

—